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Abstract 
Methyl branched trisubstituted (Z)-double bonds are a common motif in many polyketides 
with interesting biological activity such as epothilone B, discodermolide and peloruside A. 
These natural products are potent antitumor agents which, like paxlitaxel have a stabilizing 
effect on microtubules and thus interrupt the mitotic cycle and lead to apoptosis. Due to their 
pharmacological importance their synthesis has been investigated intensively. Regardless 
the numerous different strategies which have been employed, like carbonyl olefination, olefin 
metathesis, alkyne functionalization, allylic rearrangements and cross coupling chemistry, the 
stereoselective construction of the trisubstituted double bond has been the weak point in 
these efforts concerning yields and selectivity. As many of these protocols employ toxic 
and/or expensive reagents, the question arises why simple E2 elimination and in particular 
the well-known Grob fragmentation has not been used before. We envisaged a new 
hydroxide induced decarboxylative Grob-type fragmentation as olefination reaction to solve 
this problem. The strategy was centered on β-mesyloxy-δ-lactones. Axial addition of the 
hydroxide leads to a tetrahedral intermediate, which undergoes fragmentation via a chair 
transition state to form the olefin stereounambiguously. On preparing the fragmentation 
precursor, three stereogenic centers, one of which is quaternary, have to be generated. In 
analogy to the Grob fragmentation the stereochemical requirements are the antiperiplanar 
arrangement of the bonds to be broken during the course of the reaction. The synthesis of 
the fragmentation precursors started from aldehydes featuring quaternary α-centers, which 
were prepared in enantioselective way by enzymatic desymmetrization of meso malonates in 
case of epothilone B and peloruside A or by organoaluminium-promoted epoxide 
rearrangement in case of discodermolide. This stereoinformation was used to prepare the 
missing stereocenters on the chain by aldol strategy. All δ-lactones fragmented to the 
desired olefins in excellent selectivity and yield and the formal synthesis goals were reached 
easily. The scope of the fragmentation reaction was probed by employing different 
diastereomeric cyclic and acyclic precursors. Diastereoisomers which fulfill all 
stereochemical requirements to react via the chair transition state gave smoothly the olefins. 
On the other hand, diastereoisomers with the leaving group in axial position, thus making the 
fragmentation via the chair transition state impossible, gave, presumably via the open chain 
carboxylate, both the olefin and the β-lactone. En route to the fragmentation precursors 
unexpected behavior of the aldehydes with the quaternary centers was observed. This 
induced further investigations of nucleophile additions to this kind of aldehydes which turned 
out to give preferentially the product by substrate control of the electrophile.  
 V
Zusammenfassung 
Methylverzweigte, trisubstituierte (Z)-Doppelbindungen sind ein häufig vorkommendes 
Strukturmotiv in vielen Polyketiden, wie Epothilon B, Discodermolid und Pelorusid A, die sich 
durch ihre interessanten biologischen Eigenschaften auszeichnen. Diese Naturstoffe sind 
hochaktive Antitumorwirkstoffe und ähnlich wie Paxlitaxel stabilisieren sie Mikrotubuli, 
wodurch der Mitosezyklus gestört wird und die Apoptose eintritt. Auf Grund dieser wichtigen 
pharmakologischen Eigenschaften wurde ihre Synthese gründlich untersucht. Obwohl die 
verschiedensten olefinbildenden Strategien wie Carbonylolefinierungen, Olefinmetathese, 
Funktionalisierung von Alkinen, Allylumlagerungen und Kreuzkupplungen angewandt 
wurden, war dieser Schritt oft der Schwachpunkt bezüglich Selektivität und Ausbeute. 
Außerdem wurden häufig toxische und/oder teure Reagenzien verwendet, sodass sich die 
Frage stellte, warum simple E2 Eliminierungen und im speziellen die bekannte Grob-
Fragmentierung bislang nicht angewandt wurden. Diese Arbeit beschreibt eine neue, durch 
Hydroxidionen induzierte, Grob-Fragmentierung als Olefinierungsreaktion. Unsere Strategie 
konzentrierte sich auf β-Mesyloxy-δ-lactone. Der axiale Angriff eines Hydroxidions führt zu 
einer tetraedrischen Zwischenstufe, die über eine Sesselkonformation fragmentiert und so 
stereochemisch eindeutig Olefine bildet. Bei der Herstellung der Fragmentierungsvorstufen 
müssen drei Stereozentren, von denen eines quarternär ist, aufgebaut werden. 
Stereochemische Voraussetzungen sind in Analogie zur Grob-Fragmentierung eine 
antiperiplanare Anordung der zu brechenden Bindungen. Die Synthese der 
Fragmentierungsvorstufen begann ausgehend von Aldehyden mit quaternären α-Zentren, die 
einerseits bei Epothilon B und Pelorusid A durch enzymatische Hydrolyse von meso 
Malonaten und andererseits bei Discodermolid durch Epoxidumlagerung enantioselektiv 
hergestellt wurden. Ihre Stereoinformation wurde genutzt, um mittels Aldolstrategie die 
verbleibenden Stereozentren der Kette aufzubauen. Alle δ-Lactone konnten in 
hervorragender Selektivität und Ausbeute in die gewünschten Olefine fragmentiert werden, 
um die Formalsyntheseziele zu erreichen. Um die Bandbreite der Reaktion zu testen, wurden 
verschiedene diastereomere zyklische und azyklische Fragmentierungsvorstufen untersucht. 
Diastereomere, die alle stereochemischen Vorraussetzungen erfüllten, um über einen 
Sessel-Übergangszustand zu fragmentieren, ergaben die gewünschten Olefine. 
Diastereomere mit der Abgangsgruppe in axialer Anordnung, die nicht über einen Sessel-
Übergangszustand fragmentieren können, lieferten vermutlich über das offene Carboxylat 
Olefin and β-Lacton. Die unerwartete Stereokontrolle der Aldoladdition in der 
Epothilonsynthese des Aldehydes mit quaternärem α-Zentrum führte zur weiteren 
Untersuchung von Nucleophiladditionen an ähnliche Verbindungen. Die Stereochemie der 
Produkte wurde vorrangig durch Substratkontrolle des Elektrophils induziert. 
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1. Introduction 
1.1. Background  
One of the major challenges for a synthetic organic chemist is the stereoselective formation 
of both single and double carbon-carbon bonds. While there are numerous olefination 
methods known, to date a variety of natural occurring structures remain which lack a 
successful synthesis concerning selectivity and/or yield; methyl branched (Z)-olefins 
especially have proven to be a major challenge. 
There are a huge number of natural products from different sources with interesting 
biological activities which feature a trisubstituted (Z)-double bond; three highly active 
compounds with moderate complexity are shown below, which are all microtubule stabilizing 
anticancer agents (MSAA). 
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Figure 1: The MSAA epothilone B (1), discodermolide (3) and peloruside A (2). 
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1.2. Antitumor Agents  
1.2.1. Introduction  
Cancer is a group of diseases characterized by anormal and uncontrolled cell division, 
unfortunately in most cases neither its cause nor its mode of action to cause death is known. 
There are four major forms of treatment: surgery (wide surgical excision of the tumor and the 
surrounding tissue), radiotherapy (some tumors are radiosensitive; often used to reduce the 
size of a tumor before surgery or to destroy remaining cancer cells after surgery), hormones 
(some tumors require hormones for their growth and therefore regress when deprived of 
these) and anticancer drugs (chemotherapy); which method is applied depends on the nature 
of the individual tumor and often combinations are used.[1]  
 
1.2.2. Chemotherapy 
The main difference between cancer cells and normal cells is the rapid and uncontrolled cell 
division in these anormal cells, like normal cells they synthesize deoxyribonucleic acid 
(DNA). The difference is therefore a quantitative, meaning that agents which react with 
anormal cells will very likely also react with the normal ones. Thus, chemotherapy relies on 
the rapid cell division as distinguishing feature and the fact that cancer cell mitoses can be 
halted fast enough to leave the normal cells sufficient time for self repair mechanisms to 
work. Anticancer drugs arrest the growth and division of cells by inhibiting the synthesis of 
DNA or RNA, altering the structure of DNA, inhibiting protein synthesis or disrupting the 
mitotic spindle. So there are two major modes of action of cytotoxic drugs: damaging the 
DNA by intercalation, alkylation, oxidation, double strand cross linking, rupture, 
antimetabolites and related, and by interrupting the mitotic cycle by stabilization or 
destabilization of microtubules.[2, 3] 
 
1.2.3. Microtubule Stabilizing Anticancer Agents[4]  
The so-called microtubules are a fundamental part of the cytoskeleton and are vital for 
mitosis, motility, secretion and proliferation.[5] One of their most important functions is building 
the mitotic spindle, which controls the movement of the daughter chromosomes throughout 
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the cell division. Microtubules are dynamic structures made of many individual protein 
subunits (Figure 2). First the α- and ß-tubule dimerize to form α/ß-heterodimers which 
polymerize further to protofilaments. Subsequent aggregation of this protofilaments leads to 
microtubules which are in a mobile equilibrium with the smaller fragments. De- and 
polymerization of microtubules is crucial for the correct segregation of the chromatides. Any 
disruption of the equilibrium interrupts the mitotic cycle and leads to apoptosis, the 
“programmed” cell death. Microtubule binding agents act in the metaphase of mitosis, when 
the mitotic spindle is fully developed.[6]  
 
Figure 2: Formation of the microtubules in the cell. 
This mode of action was first found in paclitaxel (4), a diterpene, isolated in 1971 from the 
pacific yew tree taxus brevifolia, by Wall and Wani who named it taxol®  (4) (Scheme 1).[7] To 
today, it is one of the most widely used anticancer drugs with annual sales of about 1 billion 
USD. Even though it is far from being an ideal drug for several reasons – poor bioavailability, 
solubility problems, several serious side effects and multi drug resistance (MDR). Lately it 
was found that paclitaxel (4) induced the over expression of P-glycoprotein PgP, an energy-
dependent drug transport protein, which generally results in broad-spectrum resistance to 
many anticancer agents. The supply problem, due to the poor yielding isolation from the tree, 
was circumvent by the development of a semisynthetic route from 10-deacetylbaccatin III (5), 
isolated from the European yew taxus baccata, which also serves to provide the more potent 
synthetic congener taxotere (6).  
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Scheme 1: Taxenes. 
Other natural products like laulimalide (7), sarcodyctin (8), eleutherobin (9) and dictyostatin 
(10) (Scheme 2), have been found, similar to epothilone and taxol, to have stabilizing 
capability.[5] Ojima has proposed a common pharmacophore uniting these structure diverse 
molecules.[8] 
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Scheme 2: Microtubule stabilizing natural products. 
On the other hand, vinblastine (11), colchicine (12) and combretastatin A-7 (13) (Scheme 3) 
cause apoptosis by depolymerization of microtubules.[5] 
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Scheme 3: Inhibitors of microtubule polymerization. 
 
1.3. Isolation, Structural Elucidation and Biological Activity  
1.3.1. Epothilones[9, 10] 
In 1987 two metabolites, later named epothilone A (14) and B (1), were isolated by Höfle and 
Reichenbach at GFB (Gesellschaft für Biologisch-chemische Forschung) in Braunschweig 
from the mycobacterium sorangium cellulosum strain Soce90, which was harvested off the 
shores of the Zambesi River in the Republic of South Africa. The family of epothilones 
meanwhile comprises many members from which epothilone A to F (1, 14-18) are the most 
common (Scheme 4).  
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Scheme 4: Family of epothilones. 
The epothilones are 16-membered macrolides, named after their fundamental structural 
features (epoxide, thiazole and ketone). The absolute configuration of epothilone B (1) is 
known from spectroscopic and crystal data (Figure 3). Its structural features are the  
16-membered macrolactone, seven stereogenic centres and a thiazolalkylidene moiety. 
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Figure 3: (a) X-ray crystal structures of epothilone B (1) from dichloromethane/petroleum ether and 
(b) methanol/water (modelling by W.-D. Schubert).[11] 
In early tests, epothilone A (14) and B (1) both exhibited antifungal activity but also significant 
toxicity in cell culture assays thus interest in this family of natural products ceased. Until 
1993, when they scored a hit in parallel tests by Merck, Sharp and Dohme, which were 
screening for natural products with taxane-like antitumor activity. In the tubulin polymerization 
assay, epothilone A (14) turned out to be as active as paclitaxel (4) and epothilone B (1) 
even fifty times more active. Epothilone B (1) showed further advantages over paclitaxel (4): 
it is more soluble in water, acts more rapidly, is also available in kg quantities by fermentation 
and is still active against cell lines showing multi-drug-resistance (MDR). Apparently 
epothilone B (1) and paclitaxel (4) either bind to the same or to a similar allosteric site as 
they show a classical competitive inhibitor pattern.  
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1.3.2. Discodermolide[12] 
Discodermolide (3) was isolated in 1990 by Gunasekera and co-workers at the Harbor 
Branch Oceanographic Institute from the Caribbean deep-sea sponge Discodermia dissolute, 
which was initially collected off the Bahamas at a depth over 33 m.[13, 14] After exhaustive 
extractions and purification crystalline discodermolide (3) was isolated in 0.002% wet weight 
from the frozen sponge. Structure determination by extensive NMR studies revealed a linear 
C24 backbone featuring 13 stereogenic centers, a tetrasubstituted δ-lactone, one di- and one 
trisubstituted (Z)-alkene, a carbamate moiety and a terminal (Z)-diene (Scheme 5). The 
relative configuration was determined by single-crystal X-ray diffraction, whereas the 
absolute configuration was only proven by the first total synthesis of the unnatural antipode 
by Schreiber and co-workers in 1993.[15] Discodermolide (3) reveals in solution as well as in 
crystalline form a U-shaped conformation due to the two internal (Z)-alkenes to minimize the 
allylic strain, thus it shares a close stereochemical homology with dictyostatin (10).[16]  
 
Scheme 5: Discodermolide (3). 
Initially, discodermolide (3) was found to be a potent immunosuppressive agent and to 
exhibit antifungal activity.[17, 18] Further biological screening revealed striking cytotoxicity 
through a similar mechanism like paclitaxel (4) by stabilizing microtubule, but far more potent 
then taxol® (4). Additionally the anti-proliferation activity remains in cell lines already resistant 
to taxol® (4). Competition studies to probe the binding site showed the ability of 
discodermolide (3) to replace taxol® (4) which indicates the same or overlapping binding sites 
on β-tubule. However, the presence of taxol® (4) increased the cytotoxicity of discodermolide 
(3) significantly, which suggests overlapping binding sites and demonstrates a useful 
synergetic potential, when used in a combination therapy. This remarkable bioprofile 
attracted the attention of Novartis Pharma AG, but unfortunately, after an enormous synthetic 
effort, trials had to be halted in clinical Phase I due to severe toxicity.  
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1.3.3. Peloruside A[19] 
Peloruside A (2) was isolated in 2000 from the marine sponge Mycale hentscheli by 
Northcote an co-workers collected from the Pelorus Sound on the north coast of the South 
Island of New Zealand.[20] 170 g wet weight sponge yielded 3 mg of peloruside A (2). It is a 
highly oxygenated, stereochemically rich polyketide featuring a 16-membered macrolide 
containing a pyranose ring, ten stereogenic centers and a branched unsaturated side chain 
(Scheme 6). The relative configuration was determined by extensive NMR studies, but only 
the total synthesis of ent-peloruside A (ent-2) by De Brabander in 2003 established the 
absolute configuration.[21]  
 
Scheme 6: Peloruside A (2). 
Soon after the isolation its paclitaxel-like microtubule stabilizing activity was reported.[22, 23] 
Peloruside A (2) exhibits cytotoxicity against a range of cancer cells and retains potency 
against MDR cells. Laulimalide (7) was able to displace peloruside A (2), which suggests that 
these compounds have related binding sites different from the taxol® binding site on the  
β-tubule. Synergistic effects have been observed with taxoid site drugs like taxol® (4), 
epothilone B (1), discodermolide (3) and others. 
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2. Literature Syntheses 
This chapter will provide an overview of the literature syntheses regarding the introduction of 
the trisubstituted (Z)-double bond and thus is divided in different olefination strategies.  
 
2.1. Carbonyl Olefination Reactions 
2.1.1. Wittig Reaction 
Nicolaou used a classic Wittig reaction in his epothilone B (1) synthesis, employing 
phosphonium iodide 20 and methyl ketone 21 to generate the trisubstituted double bond in 
73% yield as 1:1 mixture of E:Z diastereoisomers (Scheme 7).[24] 
OTBS
S
N
OTBS
S
N
PPh3I
20
22
OTBS
NaHMDS, 20
21
O
OTBS
(73 %) E:Z = 1:1
OTBS
S
N
19
1.NaBH4
2.I2, PPh3, Im
3.PPh3
(84%)
 
Scheme 7: Nicolaou’s Wittig reaction. 
Nicolaou was able to improve the selectivity by employing stabilized Wittig ylide 24 with 
aldehyde 23, to get to (E)-olefin 25 as single diastereoisomer in excellent yield (Scheme 8). 
A drawback was the ester functionality, which had to be reduced to the methyl group of the 
desired trisubstituted (Z)-olefin 26 in three additional steps by reduction to the allylic alcohol 
and deoxygenation by reduction of the corresponding chloride formed under Apple 
conditions. Five additional steps led to northern fragment 28. 
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Scheme 8: Nicolaou’s Wittig reaction using a stabilized ylide. 
 
2.1.2. Still-Gennari Reaction 
Mulzer employed a Still-Gennari reaction in his epothilone B (1) synthesis, which provided in 
89% yield (Z)-olefin 30 in an excellent E:Z ratio (Scheme 9). The ester moiety of 30 was 
reduced to the allylic alcohol, converted into unstable iodide 31, and immediately coupled 
with monodeprotonated sulfone 32. Reductive removal of the sulfone group with sodium 
amalgam led to northern fragment 33.[25] 
 
Scheme 9: Mulzer’s Still-Gennari olefination. 
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Schreiber and co-workers achieved the first total synthesis of the unnatural antipode of 
discodermolide (2) in 1993,[15] followed by a fully detailed report of the natural enantiomer in 
1996,[26] always relying on the Still-Gennari olefination to install the desired (Z)-olefin. For the 
synthesis of stereo-triad 34 the Roush crotylation was used. Protection of the homoallylic 
alcohol as its silyl ether was followed by oxidative cleavage to provide the required aldehyde 
for the olefination (Scheme 10). The trisubstituted (Z)-olefin in 36 was installed in excellent 
yield and selectivity and the allylic alcohol could be further converted, via the mesylate, into 
the corresponding bromide for coupling with a C16-C24 ketone. 
OH
TBSO
1.TBSOTf
2.O3, Me2S; KHMDS,
18-crown-6
3.LiAlH4
OTBS
TBSO OH
(79%)
34 36
(CF3CH2O)2P OMe
OO
35
 
Scheme 10: Schreiber’s Still-Gennari olefination for discodermolide (F). 
Taylor used a Still-Gennari olefination to stereoselectively generate the trisubstituted  
(Z)-alkene in the peloruside A side chain 39.[27] The stereogenic center came from a 
stereoselective Evans alkylation. After change of protecting groups, the auxiliary was 
reductively removed and the newly generated free primary alcohol 38 was oxidized to the 
corresponding aldehyde (Scheme 11). Olefination gave exclusively desired (Z)-olefin 39 and 
for this molecule the substitution pattern is appropriate as peloruside A (2) contains a 
hydroxyl group at C15, so no redundant functionality had to be removed like in the epothilone 
B (1) synthesis.  
 
Scheme 11: Taylor’s synthesis of the branched side chain of peloruside A (2). 
There is of course a number of olefination methods left like Peterson, Julia or Corey-Winter 
olefination, which have not been investigated in any of the syntheses for one of these three 
natural products. 
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2.2. Cross Coupling reactions 
2.2.1. Suzuki Coupling 
State of the art for the synthesis of the epothilone B (1) double bond, remains Danishefsky’s 
Suzuki coupling which he employed in the first total synthesis in 1997 (Scheme 12). Starting 
from homoallylic alcohol 40, which was cleaved by ozonolysis to the corresponding aldehyde 
and condensed with the appropriate Wittig reagent, (Z)-vinyl iodide 41 was reached as only 
product, albeit in only 43% yield.[28] Now the key Suzuki coupling could be probed, therefore 
olefin 42 underwent hydroboration with 9-BBN and the resulting borane was directly coupled 
with (Z)-vinyl iodide 41 under palladium mediation, which resulted in 77% yield of highly 
advanced intermediate 43 featuring the trisubstituted (Z)-double bond. 
 
Scheme 12: Danishefsky’s Suzuki coupling. 
Later Danishefsky developed alternative ways to synthesize the crucial (Z)-vinyl iodide on big 
scale via a Horner-like condensation between ketone 45 and phosphonate 44 (Scheme 
13).[29] Thus, a simple, straightforward synthesis of ketone 45 featuring the (Z)-vinyl iodide 
had to be developed. The first approach depended on a highly diastereoselective Evans 
alkylation of 49 with diiodide 48, generated from 2-butynol (47) in two steps. Three more 
steps afforded ketone 45 via the Weinreb amide. The second, faster but less selective route 
starts with the known reaction of propyne (51) with B-iodo-9-BBN and methyl vinyl ketone to 
produce 52. The hydroxyl group was introduced in 87% ee by Sharpless asymmetric 
dihydroxylation of the silyl enol ether of 52. Silyl ether formation gave ketone 45. 
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Scheme 13: Danishefsky’s alterative way for the (Z)-vinyl iodide. 
Marshall employed a Suzuki coupling to build up the whole carbon skeleton of 
discodermolide (3) at a late stage. The most challenging reaction of the entire sequence was 
the conversion of the aldehyde, derived from alcohol 54 by Dess-Martin oxidation, into  
(Z)-vinyl iodide 55 (Scheme 14). Yields for the olefination were in the range of 40% of an 
85:15 inseparable mixture of (Z)- to (E)-isomers; and an unsaturated aldehyde as main  
by-product through elimination of the β-OMOM group. The following Suzuki coupling 
proceeded in good yield and selectivity to generate the desired trisubstituted (Z)-olefin in 57.  
 
Scheme 14: Marshall’s discodermolide (3) synthesis. 
Panek’s strategy relied on a hydrozirkonation-cross-coupling approach to allow a convergent 
assembling of the trisubstituted (Z)-olefin by installation of the crucial vinyl iodide early but 
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keeping it masked as vinyl silane throughout the synthesis (Scheme 15).[30] Thus, aldehyde 
58 was prepared by double stereodifferentiating crotylation reactions using chiral 
crotylsilanes and was homologated by Corey-Fuchs olefination. The generated vinyl 
dibromide was treated with base and the resulting lithium acetylene was trapped to yield 
alkine 59. Hydrozirconation with Schwartz’s reagent and quenching with iodine was carried 
out and provided in 92% yield and excellent selectivity the geminal iodovinylsilane 60. 
Negishi coupling of 60 with methylzinc chloride catalyzed with palladium gave methyl 
branched vinyl silane 61. The masked vinyl iodide was carried through a number of 
transformations to 62 and Kishi’s iododesilylation conditions were used to generate 63. Now 
Suzuki coupling with trialkyl boronate generated from alkyl iodide 56 gave in good yields and 
selectivity the desired trisubstituted (Z)-double bond in 64. 
 
Scheme 15: Panek’s discodermolide (3) synthesis.  
Another example to circumvent the installation of the (Z)-vinyl iodide for the Suzuki coupling 
by Zhao-Wittig reaction was the synthesis by Betzer, Ardisson and co-workers who 
employed a dyotropic rearrangement of a lithiodihydrofuran to generate a vinyl stannane 
(Scheme 16).[31] Thus, starting from dihydrofurane 65 deprotonation to the corresponding 
lithio derivative was followed by a 1,2-cuprate transfer with a cyano-Gilman dimethyl cuprate 
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to accomplish the installation of the methyl branched olefin which was trapped as  
(Z)-vinyltin derivative 67. After oxidation to the aldehyde, diastereoselective allylation with 
(R)-crotyltitanium 68 generated an O-enecarbamate which was converted to terminal alkyne 
69 by Fritsch-Buttenberg-Wiechell rearrangement. Further conversions featured 70 which 
was iododestannated with iodine to generate (Z)-vinyl iodide 63 and coupling with the trialkyl 
boronate generated from alkyl iodide 71 assembled the whole carbon skeleton of 
discodermolide (3) in acceptable yield and excellent selectivity.  
 
Scheme 16: Discodermolide (3) synthesis by Betzer and Ardisson. 
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2.2.2. Negishi Coupling 
Schinzer used in his approach to epothilone B (1) a Negishi coupling, therefore a (Z)-vinyl 
iodide was also needed, which was generated by Zhao-Wittig reaction from aldehyde 23 
(Scheme 17).[32, 33] Thus, (Z)-vinyl iodide 73 was obtained in very good selectivity but in only 
very moderate yield, palladium catalyzed coupling with 74 yielded in stereochemically 
homogenous form the northern fragment 33 of epothilone B containing the desired 
trisubstituted (Z)-double bond. 
 
Scheme 17: Schinzer’s Negishi coupling. 
Smith III and co-workers were the second to finish a total synthesis of the unnatural 
discodermolide enantiomer in 1995, followed by a synthesis on gram scale of the natural 
compound.[34, 35] A Negishi coupling was employed to install the crucial trisubstituted double 
bond in 79, which worked in acceptable yield and good selectivity (Scheme 18). 
Unfortunately the generation of the (Z)-vinyl iodide again proved troublesome apparent in 
both the low yield and moderate selectivity to synthesis 77.  
 
Scheme 18: Smith’s first generation approach to discodermolide (3). 
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In an additional study, Smith III investigated the mechanism of the Zhao-Wittig reaction and 
found, apart from desired (Z)-vinyl iodide 77, three different by-products: methyl ketone 81 
and two diastereomeric cis epoxides 82 and 83.[36] Variation of the reaction temperature 
hardly had any effect on the yield of the iodoalkene but changed markedly the contribution of 
the by-products, i.e.: at lower temperatures no ketone formation was observed whereas at 
higher temperatures it was the only by-product observed. 
 
Scheme 19: Unexpected by-products in the Zhao-Wittig reaction. 
The formation of the epoxides can be rationalized via the betaine intermediate 85 (Scheme 
20), which is formed in the presence of lithium salts, and can then be transformed to the 
epoxy phosphonium salt 86 by a Darzen-like addition-cyclization pathway competitive to the 
expected formation of vinyl iodide 77. Methanolysis converts the epoxy phosphonium salt 86 
into epoxide 82 and 83 presumably via oxiranyl anion 88. The conversion of epoxy 
phosphonium salt 86 into the methyl ketone is not well understood but might be due to the 
instability of oxiranyl anion 88 at elevated temperatures.  
 
Scheme 20: Rationalization for by-product formation in the Zhao-Wittig reaction. 
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2.3. Ring Closing Metathesis (RCM) 
2.3.1. RCM as Macrocyclization 
RCM as a strategy for the macrocyclization was also investigated by Danishefsky (Scheme 
21).[28] Alas, despite variation of the catalyst and the substrate, the best conditions resulted in 
a 1:1 E:Z mixture of diastereoisomers in quite good yield. 
  
Scheme 21: Danishefsky’s RCM approach. 
 
2.3.2. RCM of Medium-Sized Rings 
In the first total synthesis of ent-peloruside A (ent-2) by De Brabander in 2003 the 
trisubstituted (Z)-olefin was generated by RCM of a six-membered ring (Scheme 22).[21] The 
RCM precursor was generated by acylation of homoallylic alcohol 91 with methacryloyl 
chloride (92). Treatment with Grubbs’ second generation catalyst provided lactone 94 in 50% 
to 70% yield with 20% of the dimer. The required trisubstituted enone 95 was then generated 
by the addition of methyl lithium and silyl protection of the primary alcohol.  
 
Scheme 22: De Brabander’s RCM for the peloruside A side chain 95. 
A very interesting observation was made by Ermolenko, who also used a RCM to generate 
the trisubstituted (Z)-olefin of peloruside A (2) (Scheme 23).[37] Upon preparation of the RCM 
precursor esterification under standard Steglich conditions with DCC and DMAP led to 
Literature Syntheses 
 19
severe racemization of the acid, thus giving an inseparable mixture of esters 98 and 99. 
When this mixture was subjected to the RCM reaction employing Grubbs’ second generation 
catalyst, after three days, a resolution of the diastereoisomers had taken place. Unreacted 
ester 98 was recovered almost completely, while the desired lactone 101 was formed out of 
the correct ester 99, additionally yields based on 99 were very good. 
 
Scheme 23: Highly diastereomer-discriminating RCM. 
Kalesse describe a successful RCM strategy to close a ten-membered lactone for the 
disubstituted (Z)-double bond of epothilone A (14).[38]  
Mulzer later employed a RCM to form a nine-membered silicon-tethered ring containing the 
crucial trisubstituted double bond of epothilone B (1) (Scheme 24).[39] Compound 102 was 
used as substrate and thus delivered the nine-membered ring in a diastereomeric ratio of 5:1 
in favor of (Z)-olefin 103. After opening of the nine-membered ring the diastereoisomers were 
separated. The quite simple triol had to be converted into northern fragment 28 by step wise 
elongation via introduction of one carbon by a Mitsunobu reaction and two more by a Horner-
Wadsworth-Emmons reaction with Oppolzer’s sultam 106, which also enabled the generation 
of the chiral methyl group at C8. The thiazolalkylidene moiety was installed by Wittig 
reaction. 
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Scheme 24: Mulzer’s RCM approach to a medium sized ring. 
 
2.4. Cupration 
The epothilone B (1) synthesis of White took advantage of the clean regio- and 
stereoselectivity of carbocupration of propargylic alcohol (106) to establish the (Z)-double 
bond in low yields in iodo alcohol 107 at the very beginning (Scheme 25).[40] Halogen-metal 
exchange was followed by transmetallation with copper cyanide for conjugated addition to 
oxazolidinone 108. Then the C15 hydroxyl group was introduced using Davis’ oxaziridine 
110. After protection and removal of the chiral auxiliary, the thiazolalkylidene moiety was 
introduced by Horner reaction of the corresponding methyl ketone to generate 112. 
 
Scheme 25: White’s carbocupration. 
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Avery established the desired (Z)-configuration of the epothilone B northern fragment 28 by 
classic Normant alkyne cupration and electrophilie trapping, which additionally also set the 
stereochemistry at C15 (Scheme 26).[41, 42] Therefore, the Grignard reagent prepared from 
bromide 113 was transmetallated to provide the cuprate and step wise elongated by the 
addition of propyne and lithiohexyne. Intermediate 114 was used to open epoxide 115 which 
provided desired (Z)-olefin 116 in good yield. Protecting group manipulations and oxidation 
generated methyl ketone 117, which after HWE reaction, was regio- and stereoselectively 
hydroborated, followed by oxidation to give 28. 
 
Scheme 26: Avery’s Normant alkyne cupration and electrophile trapping. 
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2.5. Pericyclic Reactions 
2.5.1. Cycloadditions: Hetero-Diels-Alder Reaction 
Cycloadditions have also been used to generate trisubstituted (Z)-double bonds incorporated 
in a ring system, as was shown by Myles in his synthesis of discodermolide (3) (Scheme 
27).[43, 44] He took advantage of a titanium promoted hetero-Diels-Alder reaction between 
aldehyde 118 and Danishefsky diene 119 to generate pyrone 120 in a 7:1 diastereomeric 
ratio, whose cyclic framework enforced complete control of the alkene geometry. After Luche 
reduction, acid mediated Ferrier rearrangement led to lactol 121. Reductive opening gave 
primary alcohol 122. The corresponding allyl iodide 123 was accessible by protecting group 
manipulations and conversion into the iodide, which could be used in an alkylation reaction 
with the C16-C21 ketone.  
 
Scheme 27: Myles’ hetero-Diels-Alder for the discodermolide (3) synthesis. 
 
2.5.2. Claisen-type [3,3]-Rearrangement 
In his first generation synthesis of discodermolide (3) Paterson generated the trisubstituted 
double bond by a Claisen-type [3,3]-rearrangement (Scheme 28).[45, 46] As precursor a 2:1 
diastereomeric mixture of acetal 124 was used, whose stereocenters were generated by his 
well established boron mediated anti-aldol addition. After oxidation of the selenide to the 
selenoxide, ketene acetal 125 formed, which rearranged via the preferred bicyclic-chair 
conformation to give eight-membered lactone 128 with complete stereocontrol. Ring opening 
Literature Syntheses 
 23
of the lactone to the hydroxy acid was followed by esterification under Steglich conditions 
and silyl protection of the secondary alcohol to generate aryl ester 127. 
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Scheme 28: Paterson’s discodermolide (3) synthesis. 
 
2.5.3. Allylic Rearrangement 
Taylor used a different synthetic strategy in his epothilone B (1) synthesis in form of a 
tandem sequence (Scheme 29). A Nozaki-Hiyama-Kishi coupling to form the C12-C13 bond 
in 129 was followed by a stereoselective thionyl chloride induced allylic rearrangement to 
generate the trisubstituted double bond in 130.[47] Super hydride very efficiently removed both 
the auxiliary and the allylic chloride to generate 131. 
 
Scheme 29: Taylor’s approach to the epothilone B trisubstituted double bond. 
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2.6. Miscellaneous 
Thomas applied his tin(IV) bromide promoted reaction between allylstannane 132 and 
aldehyde 134 to introduce the trisubstituted double bond of the epothilone B northern 
fragment 238 (Scheme 30).[48, 49] Bis-protected dihydroxyalkenylstannane 132 was 
transmetallated to allytin tribromide which reacted in a stereoselective manner with aldehyde 
134 to give alcohol 136 in 62% yield as a 1:1 epimeric mixture, containing less than 2% of 
the (E)-isomer. The (Z)-stereogeometry of the double bond was fixed due to the axial 
position of the α-substituent situated next to tin in the six membered transition state 135. The 
hydroxyl group was removed by Barton-McCombie deoxygenation. After further protecting 
group manipulations and introduction of the methyl ketone via Grignard addition and 
oxidation, the thiazole ring was attached by HWE olefination to give northern fragment 138.  
 
Scheme 30: Thomas’ synthesis of epothilone B (1). 
Evans relied on his established aldol methodology to build up the required stereogenic 
centers in the advanced fragments 139 and 140 of his discodermolide synthesis (Scheme 
31).[12] The trisubstituted (Z)-olefin came from a two-step formal aldol condensation between 
aldehyde 140 and lactone 139. A three step sequence of reductive lactone opening followed 
by deoxygenation established the desired trisubstituted (Z)-olefin moiety in 142. 
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Scheme 31: Evans’ synthesis of discodermolide (3). 
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3. Grob Fragmentation 
3.1. Introduction 
Fragmentation reactions have been known for quite a long time as powerful tools to build up 
double or even triple bonds.[50] According to the definition by Grob, these are processes 
where the reacting molecule breaks in three fragments (Figure 4). The electrofugal group 
a=b forms stable cations or neutral molecules, the middle group c=d gives an unsaturated 
fragment and the nucleofugal group X⎯ leaves with the binding electron pair.[51, 52] Substrates 
contain a certain carbon and heteroatom combination and are typically 1,3-dihetero-
functionalized compounds featuring a nucelophilic atom with a negative charge or lone 
electron pair and a leaving group in a 1,3 relationship.  
 
Figure 4: Schematic Grob Fragmentation.  
Fragmentation substrates can also react via different pathways like substitution of the leaving 
group, elimination or ring-closing reaction (Figure 5), but in general careful selection of the 
conditions minimizes these intermolecular processes.  
X Y
X Y
X OR
X
X
FragmentationElimination
Ring-closure
Subsitution
 
Figure 5: Possible reaction pathways of 1,3-diheterosubstituted compounds. 
Stereoelectronic and stereochemical factors influence the outcome of the reaction, which can 
proceed via a concerted or a stepwise mechanism (Figure 6).[53] In the two step process, 
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either similar to an E1 or SN1 reaction, the leaving group is first cleaved to form a 
carbocation, which can then further react via fragmentation, elimination, substitution or ring-
closure or the elecrofugal group leaves first to form a carbanion, which can eliminate the 
leaving group Y- in the second step. In the concerted process each of the five centers 
contributes to the transition state which results in strict structural and stereoelectronic 
requirements.  
X YX Y
X
Fragmentation
Elimination
Substitution
Ring-closure
-X
Y Y
-Y
stepwise
concerted 3 2 1
 
Figure 6: Concerted vs. stepwise mechanism. 
For a typical fragmentation reaction, stereoelectronically two polarized bonds are needed, 
which will be broken during the course of the reaction, a substituent with an electron donating 
lone pair and an electron withdrawing leaving group. Stereochemical requirements of the 
Grob fragmentation are the antiperiplanar arrangement of the leaving group and the electron 
pair of the electrofugal group to the C2-C3 bond or with other words: that the two breaking 
bonds are antiperiplanar to each other (Scheme 32). This can be illustrated impressively by 
the base induced fragmentation of cyclic 1,3-diol monosulfonates 143, 145, 146 and 148.[54] 
The fragmentation of 1,3-diols is also known as Wharton fragmentation.  
 
Scheme 32: Wharton fragmentation for medium-sized rings. 
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3.2. Some Examples in Literature 
The first fragmentation was published by Eschenmoser in 1952 (Scheme 33), who used  
β-mesyloxy ketone 150 which was treated with potassium hydroxide or methyl magnesium 
iodide to generate fragmentation product 149 and 152, respectively.[55] 
  
Scheme 33: First fragmentation described by Eschenmoser. 
Corey used a fragmentation reaction in his synthesis of β-caryophyllene (157) where he very 
efficiently elaborated a fused bicyclic ring system to a nine-membered ring (Scheme 34).[56] 
Bicycle 153 was thus generated by the Hajos-Parrish procedure and elaborated into 
fragmentation precursor 154, which upon treatment with sodium hydride underwent 
fragmentation in excellent yield and selectivity. Further elaboration led to β-caryophyllene 
(157). 
 
Scheme 34: Corey’s β-caryophyllene synthesis. 
Open chain olefins have also been synthesised like the (Z)-olefin of juvenile insect hormones 
by Edwards.[57] Robinson annulation of simple starting material generated bicycle 158, which 
was converted to fragmentation precursor 159 by a series of reduction, selective alkylation 
and finally installation of the leaving group. Fragmentation worked smoothly in the presence 
of sodium hydride to generate desired trisubstituted (Z)-olefin 161.  
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Scheme 35: Fragmentation to build a linear trisubstituted olefin.  
Eschenmoser described a decarboxylative double fragmentation as macrolide synthesis, 
generating two double bonds in one step (Scheme 36).[58] As elaborated fragmentation 
precursor crystalline amidinium salt 163 was used which upon heating was converted to 165, 
presumably by a two step mechanism via the dioxoniumion to give two double bonds - a 
disubstituted (Z)- and a trisubstituted (E)-olefin (Scheme 37).  
 
Scheme 36: Schematic decarboxylative double fragmentation.  
 
Scheme 37: Eschenmoser’s decarboxylative double fragmentation.  
In his synthesis of vinigrol Baran accessed the tricyclic carbon skeleton by Grob 
fragmentation of a tetracyclic ring system at a late stage of the synthesis (Scheme 38).[59] 
The complex tetracyclic precursor 170 was constructed very elegantly and efficiently by two 
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Diels-Alder reactions and upon treatment with KHMDS the core structure of vinigrol 172 was 
reached in very good yield. 
 
Scheme 38: Baran’s vinigrol synthesis.  
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4. Results and Discussion – The Concept  
4.1. The Hydroxide Induced Decarboxylative Grob-type 
Fragmentation 
Our attention was first caught by the challenge to develop a new route for the stereoselective 
introduction of the trisubstituted C12,13-(Z)-double bond of epothilone D (16). The northern 
fragment of epothilone D (16) seemed to be an ideal example due to the huge number of 
different olefination strategies already applied in many total and formal syntheses as 
mentioned above, which still have not provided completely convincing results.  
For this purpose a new hydroxide induced decarboxylative Grob-type fragmentation should 
be used (Figure 7), whose applicability was already proven by model studies and a short 
racemic synthesis.[60] 
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Figure 7: Hydroxide induced decarboxylative Grob-type fragmentation. 
As fragmentation precursor ß-mesyloxy-δ-lactone 173 was chosen. Upon addition of 
hydroxide the tetrahedral intermediate 174 will be formed, which undergoes fragmentation to 
form olefin 175 stereounambiguously by elimination of carbon dioxide and the leaving group. 
On preparing lactone 173, three stereogenic centers, one of them quaternary,[61-63] have to 
be generated with the relative configuration indicated. For stereoelectronic reasons, clean 
fragmentation can be expected if the lactone adopts a chair conformation with the  
OMs-substituent in an equatorial position. This may be facilitated by introducing a bulky 
residue R2 cis to the OMs which anchors the desired conformer. The fragmentation 
generates a homoallylic carbinol center, which is stereogenic in both epothilone B (1) (C15) 
and discodermolide (3) (C11). Thus, these centers have to be homochiral requiring the 
fragmentation precursor 173 to be prepared in a diastereo- and enantioselective manner. 
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5. Results and Discussion - Epothilone B 
5.1. General Retrosynthesis 
 
Scheme 39: General retrosynthesis of epothilone B (1). 
In most syntheses the C12,13-epoxide is introduced in the last step through stereoselective 
epoxidation of the C12,13-olefin in epothilone D (16). Further disconnection by opening the 
macrolactone to the seco-acid and dissection between C6 and C7 leads to the northern 
fragment (176) containing the trisubstituted (Z)-double bond and the smaller southern 
fragment (177) (Scheme 39).  
For the synthesis of the northern fragment 176 of epothilone B two independent strategies 
were pursued: on the one hand, preparation of the whole carbon skeleton and lactonization 
of a highly advanced ß,δ-dihydroxy ester with the fragmentation reaction in the last step, the 
PLE route; and on the other hand, an early lactone formation and introduction of the 
quaternary center on a ß-keto lactone with the fragmentation reaction halfway thru the 
synthesis, the lactate route. 
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5.2. First Approach: Pig Liver Esterase (PLE) Route 
This approach starts with the enantioselective generation of the quaternary center, which 
should then serve to control the formation of the remaining centers by means of a 
stereochemical relay (Scheme 40). The key steps are the enantioselectively generation of 
the quaternary center of 179 by enzymatic desymmetrization of a meso compound and the 
substrate controlled aldol addition with methyl ketone 178 to assemble the whole carbon 
skeleton. Reduction followed by cyclization gives fragmentation precursor 181. 
 
Scheme 40: Synthetic strategy for the PLE route. 
 
5.2.1. Quaternary Center by Desymmetrization 
Synthesis of the meso substrate 
The synthesis of side chain 185 was accomplished in a straight forward manner starting from 
(R)-Roche ester (182). Protection as its silyl ether under standard conditions and reduction to 
alcohol 183 was followed by Swern oxidation (Scheme 41). The resulting α-chiral aldehyde 
was C2 elongated by means of a Horner-Wadsworth-Emmons reaction using Masamune-
Roush conditions, giving exclusively α,ß-unsaturated (E)-ester 184.[64] DIBALH reduction to 
the corresponding allylic alcohol was followed by protection, to give elongated allylic 
carbonate 185. 
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Scheme 41: Synthesis of allylic carbonate 185. 
The allylic side chain 185 was attached to dimethyl malonate (186) in a Tsuji-Trost reaction. 
Subsequent methylation created the quaternary center (Scheme 42).[65, 66] For the 
hydrogenation various standard methods such as palladium on charcoal or Pd(OH)2 were 
tested and led either to decomposition or TBS cleavage. Finally, using Adam’s catalyst 
turned out to be the method of choice.[67] 
 
Scheme 42: Preparation of meso malonate 188. 
 
Enzymatic Hydrolysis of 188 
With meso malonate 188 in hand, enzymatic desymmetrization was attempted testing 
different enzymes for example pig liver esterase (PLE), porcupine pancreas lipase (PPL) and 
α-chymotrypsine in biphasic or aqueous buffer systems using a pH-stat-controlled burette 
(Scheme 43). Even though these enzymes are reported to have a broad substrate scope, 
none of the mentioned resulted in any conversion.[68, 69]  
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Scheme 43: Enzymatic desymmetrisation by hydrolysis. 
Beside the enzymatic hydrolysis it was tested whether enantioselective esterification of meso 
diol 190 might prove more successful (Scheme 44). Therefore, malonate 188 was reduced to 
diol 190 and subjected to desymmetrization investigating different lipases like PPL, 
Pseudomonas sp. lipase (PSL), lipase AK and chirazyme with vinyl acetate as acetate donor. 
Only with chirazyme traces of product could be observed, however the best result after 
intensive optimization was 15% conversion after one week reaction time at 40 °C in pure 
vinyl acetate, making this not a practicable strategy. 
MeO
O O
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HO OH
TBSO
LiAlH4
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OAc AcO OH
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188 190 191
 
Scheme 44: Enzymatic desymmetrization by esterification. 
 
Simpler substrate for the enzymatic hydrolysis 
Extensive literature search suggested that the long apolar side chain with the polar end 
seemed to be the problem, as most of the tested enzymes are reported to either tolerate 
small to very bulky apolar groups or short polar groups. Thus, a simplified substrate 193 was 
prepared starting again from dimethyl malonate (186) by allylation with allyl bromide and 
subsequent methylation to install the quaternary center of meso malonate 193 (Scheme 45). 
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Scheme 45: Preparation of simplified meso malonate 193. 
This time treatment with PLE smoothly provided mono acid 194 in good yield and high 
enantioselectivity (Scheme 46). Conversion worked quickest in an aqueous buffer at ambient 
temperature. The reaction can also be carried out in biphasic mixtures; however such 
conditions result in prolonged reaction times. 
 
Scheme 46: Enzymatic desymmetrization by hydrolysis of 193. 
 
Determination of the absolute configuration and enantiomeric ratio 
The absolute configuration was assigned by comparison with literature data of the 
hydrogenated mono acid 195 (Scheme 47).[70, 71]  
 
Scheme 47: Conversion of 194 into known mono acid 195. 
For the determination of the enantiomeric excess the carboxylic group of mono acid 194 was 
first selectively reduced to alcohol 197 via the mixed anhydride and then further converted 
with Mosher’s chloride into the corresponding ester 198 and 199 (Scheme 48).[72] 1H-NMR, 
19F-NMR and HPLC analysis of Mosher’s ester 198 and 199 confirmed a 95:5 ratio of major 
to minor MTPA diastereoisomer which equates to 90% ee.  
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Scheme 48: Determination of the diasteromeric ratio of Mosher’s ester 198 and 199. 
 
Selective manipulation of the methyl ester group 
The greate advantage of mono acid 194 is the possibility to versatilely and independently 
manipulate three of the substituents of the quaternary center. On one hand, the allylic moiety 
can be elaborated in many ways; and on the other hand, both carbonyl groups can be further 
transformed selectively and independently. Thus, conversion into the tert-butyl ester by 
treatment with isobutene (200) under acidic conditions worked excellent and now the less 
sterically hindered ester was reduced to the corresponding alcohol in 74% yield and further 
oxidized to aldehyde 202 (Scheme 49).  
 
Scheme 49: Selective conversion of the methyl ester of malonate 201. 
 
5.2.2. Chain Elongation 
The first idea was to directly elongate the allylic moiety of 197 by cross metathesis (CM) with 
olefin 203 derived from alcohol 183 (Scheme 50).[73, 74] Swern oxidation of alcohol 183 was 
followed by Wittig reaction to generate the rather volatile terminal olefin 203.  
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Scheme 50: Chain elongation of 197 by cross metathesis.  
Despite extensive optimization, a selection is shown below (Table 1), yields unfortunately 
never exceeded 38%, which might be due to deactivation of the catalyst by the 
bishomoallylic alcohol of mono ester 197. An intramolecular stabilization between the 
hydroxyl group of 197 and the metal of the ruthenium carbenoid, in the reaction of olefin 197 
with the catalyst via the metalacyclobutane, to form a five membered cyclic intermediate is 
possible.  
 
catalyst solvent rxn time 197 (eq.) 203 (eq.) yield 
Grubbs II (5 mol%) DCM 24 h 1 1 24% 
Grubbs II (5 mol%) DCM 24 h 1 2 26% 
Grubbs-Hoveyda II (5 mol%) DCM 48 h 1 2 28% 
Grubbs-Hoveyda II (10 mol%) DCM 48 h 1 2 38% 
Grubbs-Hoveyda II (10 mol%) toluene 1 h 1 2 15% 
Table 1: Cross metathesis conditions. 
At the same time, classical olefination methods such as Wittig reaction and Julia-Lythgoe-
Kocienski reaction were also probed.[75] The allylic moiety of 197 was therefore cleaved by 
ozonolysis to the aldehyde functionality which was immediately attacked by the 
bishomoallylic hydroxyl group to give five-membered lactol 205 (Scheme 51).  
Results and Discussion 
 39
 
Scheme 51: Ozonolysis of the allylic moiety. 
Sulfone 206 was derived from alcohol 183 by conversion to the sulfide under Mitsunobu 
conditions and subsequent oxidation. To be able to use higher temperatures and longer 
reaction times also the corresponding Wittig salt 207 was prepared (Scheme 52).[76] Thus, 
alcohol 183 was transformed by Appel reaction into the corresponding iodide. Treatment with 
PPh3 generated upon heating the desired Wittig salt 207.  
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Scheme 52: Preparation of Julia sulfone 206 and Wittig salt 207. 
However, lactol 205 proved to be nonreactive in the attempted carbonyl olefination reactions 
(Scheme 53), possibly due to the steric hindrance exhibited by the quaternary center and the 
high stability of the five-membered ring the amount of the aldehyde in the equilibrium was too 
small to enable the olefination reaction. 
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Scheme 53: Chain elongation by carbonyl olefination. 
As the free alcohol functionality seemed to be responsible for the difficulties by deactivation 
of the catalyst in case of the cross metathesis and by lactol formation to inhibit carbonyl 
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olefination, it was transformed into its triethyl silyl ether (Scheme 54). CM, with the Grubbs-
Hoveyda catalyst in DCM, proceeded smoothly to give almost quantitatively the desired 
elongated olefin 209 in an inconsequential E:Z mixture. Oxidative cleavage of 208 gave 
aldehyde 210 along with varying amounts of lactol 205, whose formation could fortunately be 
suppressed by the addition of 10 mol% of PPTS. With aldehyde 210 in hand, Julia-Lythgoe-
Kocienski olefination reaction gave in nearly quantitative yield desired elongated olefin 209 in 
an inconsequential 1:1 E:Z mixture. 
 
Scheme 54: Successful chain elongation of silyl ether 208. 
The TES group was easily cleaved with substoichiometric amounts of PPTS and the double 
bond was hydrogenated using Adam’s catalyst. Subsequent oxidation with Dess-Martin 
periodinane (DMP) yielded aldehyde 212 for the following aldol addition (Scheme 55). 
 
Scheme 55: Synthesis of aldehyde 212. 
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5.2.3. Fragmentation Precursor 
Aldol addition with the lithium enolate of ketone 216 
With aldehyde 212 in hand, an aldol addition to build up the complete carbon skeleton of the 
fragmentation precursor was possible. As enolizable partner for aldehyde 212 thiazole 
methyl ketone 216 was prepared in two steps (Scheme 56). Thus, known ester 213 was 
generated by condensation of thioacetamide and ethyl bromopyruvate,[77] and reduced to 
aldehyde 214, which was used in a Horner-Wadsworth-Emmons reaction with phosphonate 
215, prepared by α-methylation of the product from an Arbuzov reaction between 
chloroacetone and trimethyl phosphate,[78] to gain enone 216.  
 
Scheme 56: Synthesis of methyl ketone 216. 
Aldehyde 212 was then incubated with magnesium bromide etherate and added to the 
lithium enolate of methyl ketone 216 and the aldol product was formed as a single 
diastereoisomer in excellent yield (Scheme 57).  
 
Scheme 57: Aldol addition. 
Evans-Carreira anti-reduction with triacetoxy boronhydride to generate anti diol 217 was 
followed by hydrolysis of the methyl ester to the acid and the δ-lactone ring was closed to 
generate fragmentation precursor 181 (Scheme 58).[79]  
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Scheme 58: Conversion to the δ-lactone. 
Now, structural determination by correlation NMR experiments was possible (Scheme 59). 
Surprisingly, careful interpretation of the NOESY spectra revealed the structure of the  
δ-lactone to be 218 and not 181 as assumed. 
OO
OH
S
N
TBSO
218
O
H3C
H
O
H
HO
TBSO
HH
NOE
S
N
218
 
Scheme 59: Structural determination of the δ-lactone. 
Thus, aldol addition did not proceed under Cram chelate control as assumed but the Felkin-
Anh product was formed (Scheme 61). MgBr2·Et2O was obviously only activating aldehyde 
212 without forming a chelate complex, as longer reaction times were observed without its 
addition. Therefore different Lewis acids were tested: Et2AlCl, SnCl4, ZnCl2, TiCl4, Ti(OiPr)4 
with the lithium enolate of methyl ketone 216; but the aldol addition always resulted in the 
Felkin-Anh product 220 in varying yields.  
 
Mukaiyama aldol addition  
Finally, when a Mukaiyama aldol addition was used the Cram chelate product 180 was 
isolated. However the best results never exceeded 23% yield, which were obtained with TiCl4 
and trimethyl silyl enol ether 219. 
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Scheme 60: Silyl enol ether 219 of methyl ketone 216.  
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Scheme 61: Cram chelate vs. Felkin-Anh transition state. 
Even though initial efforts were targeted on the Cram chelate aldol product, as it features the 
correct relative stereochemical arrangement between α- and β-center to form the 
fragmentation precursor for the (Z)-olefin. Felkin-Anh product 220 was used in the following 
synthesis, due to the better accessibility. Hence, the stereochemistry had to be corrected at a 
later stage.  
 
Reformatsky reaction 
As an alternative C-C bond formation strategy, a Reformatsky reaction was investigated. 
Thus, α-bromo ketone 221 was prepared first,[80] and reacted with aldehyde 212; 
unfortunately just the use of SmI2 featured the Cram chelate product alas as the minor 
diastereoisomer in a 1:4 diastereomeric ratio (Scheme 62). 
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Scheme 62: Reformatsky reaction. 
 
Alternative acetate aldol addition 
The unfavorable stereochemical outcome of the aldol addition between thiazole methyl 
ketone 216 and aldehyde 212 is only explicable by the strong influence of the quaternary 
center, which hinders the desired connection in the neopentyl position. Hence, the center of 
reaction was moved one carbon further away to an aldol addition between methyl ketone 222 
with aldehyde 223, derived from (S)-ethyl lactate and featuring a stereocenter in α-position to 
direct the stereochemical outcome by substrate control. Methyl ketone 222 was generated in 
two steps from aldehyde 212 by addition of methyl magnesium bromide and subsequent 
oxidation of the secondary alcohol. Aldehyde 223 was incubated with magnesium bromide 
etherate in advance and added to the enolate (Scheme 63). Here, several methods of 
enolization were investigated. The use of the lithium enolate mainly led to self-condensation 
of methyl ketone 222 and product mixtures in up to 50% yield; when the boron enolate was 
used, the reaction worked better concerning yields although the diastereomeric ratio was 
never higher than 3:2.  
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Scheme 63: Acetate aldol. 
 
Building the quaternary center by double Frater-Seebach alkylation 
To further investigate the above mentioned acetate aldol reaction on a maybe more 
favorable simpler substrate aceto acetate 227 was prepared, whose quaternary center 
originated from a double Frater-Seebach alkylation (Scheme 64).[81] The allyl moiety was 
introduced first by double deprotonation of methyl-3-hydroxybutanoate (225) with LDA and 
reaction with allyl bromide, in the second step methyl iodide was used as electrophile. NMR 
analyses showed only a single diastereoisomer. Dess-Martin oxidation gave aceto acetate 
227 for additional investigations of the behavior in the acetate aldol addition.  
 
Scheme 64: Synthesis of aceto acetate 227. 
The stereochemical outcome should be controlled by the chiral α-center of aldehyde 223 or 
229 either under Cram chelate or Felkin-Anh control. Unfortunately the best results were a 
4:1 diastereomeric ratio in modest yield under Cram chelate conditions. When the Felkin-Anh 
product was aimed for, yields were better but the selectivity dropped (Scheme 65).  
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Scheme 65: Investigation of Cram chelate vs. Felkin-Anh control in acetate aldol addition. 
In literature, high stereocontrol in acetate aldol additions is only observed when the acetated 
Crimmins’ auxiliary is employed.[82] As other methyl ketones lead to moderate to bad 
selectivity our results were in accordance and therefore, not completely unexpected.  
 
Correcting the stereochemistry of the fragmentation precursor 
As alternative way to introduce the right relative stereochemistry inversion of the β-position 
by an oxidation-reduction sequence of the six-membered lactone was envisaged. With the 
use of a small hydride donor, attack on the carbonyl should be axial, leading to the equatorial 
hydroxyl group. Also the δ-position, the later C15, had to be inverted which is possible by 
simple generating syn diol 232 instead of anti diol 231 (Scheme 66). Syn reduction did work 
very well after some affords (Table 2), when catecholborane was found to convert hydroxy 
ketone 220 in good yields and high selectivity to syn diol 231.[83] 
 
Scheme 66: Syn reduction of hydroxy ketone 220. 
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reagent product syn:anti (231:232) 
BEt3, MeOH, NaBH4 (-30 °C) 3:1 
BEt3, MeOH, NaBH4 (-78 °C) 4:1 
BBu3, MeOH, NaBH4 (0 °C) borane ester very stable 
DIBALH ester reduced, TBS deprotected 
Zn(BH4)2 1:1, ester reduced 
LiBH4 1:1, ester reduced 
SmI2, NEt3, H2O no reaction 
catecholborane 86% only syn (231) 
Table 2: Conditions for syn reduction of hyxdoxy ketone 220. 
With syn diol 231 in hand, saponification with lithium hydroxide in THF worked smoothly and 
was followed by lactonization under Steglich conditions to yield δ-lactone 233 with the 
desired absolute configuration at the later C15 (Scheme 67). Now the β-position had to be 
inverted. Therefore, the β-hydroxyl group was oxidized under neutral conditions using 
buffered Dess-Martin periodinane and subsequent reduction with NaBH4 at low temperatures 
led exclusively to desired δ-lactone 181.  
 
Scheme 67: Fragmentation precursor 181. 
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This time NOESY spectra verified the structure of δ-lactone 181, showing clear NOE cross 
peaks (Scheme 68). 
 
Scheme 68: NOE signals of fragmentation precursor 181. 
 
5.2.4. Fragmentation 
Fragmentation precursor 234 was prepared by conversion of the hydroxyl group of 181 into 
the corresponding mesylate. First the well established conditions from the test system,[60] 
namely potassium hydroxide in methanol, were used, which gave apart from desired olefin 
235, methyl ester 236 as side product by lactone opening with methoxide (Scheme 69). 
Thus, when fragmentation conditions were switched to lithium hydroxide in THF the desired 
northern fragment 235 was formed smoothly as the only product in excellent yield and 
selectivity.  
 
Scheme 69: Fragmentation of 181. 
To finish the formal synthesis, the free secondary alcohol was protected as silyl ether 33.[25, 
33, 84] 
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Scheme 70: Formal synthesis of the epothilone B northern fragment 33. 
 
5.2.5. Testing the Fragmentation Reaction of Different Diastereomeric 
Precursors 
Fragmentation precursors 
Starting from easily accessible anti and syn dihydroxy esters 231 and 232 all four 
diastereomeric δ-lactones 181, 218, 233 and 237 are available (Scheme 71).  
 
Scheme 71: Four diastereomeric precursors. 
 
Fragmentations 
With all four diastereoisomers in hand, the leaving group in form of a mesylate was 
introduced under standard conditions, methansulfonyl chloride in Et2O and triethylamine, and 
used directly in the following fragmentation reaction. Lactones 181 and 218 with a syn 
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arrangement of the β- and δ-hydroxyl group are able to react directly via the chair transition 
states and smoothly gave, depending on the relative configuration between α- and β-centers, 
(E)- or (Z)-olefins in good to excellent yields (Scheme 72). Also, the use of different 
hydroxides (LiOH, KOH, NaOH) in THF at 0 °C for the fragmentation of 181, showed similar 
results and always gave olefin 235 as single product in about 80% yield. 
 
Scheme 72: Fragmentation reaction via the chair transition state. 
Whereas, with the other two diastereoisomers featuring an anti arrangement of the β- and  
δ-hydroxyl group the mesylate adopts an axial configuration and a Grob-type fragmentation 
in a chair conformation should be impossible. On the other hand, a flip to the boat 
conformation 241b and 245b respectively might stereoelectronically be suitable to undergo 
fragmentation, however, the species itself is energetically unfavorable. Nevertheless, in both 
cases the olefin was obtained under the usual conditions, alongside the β-lactone. This result 
may be rationalized in terms of a ring opening to form carboxylate 242 and 246 respectively, 
which undergoes both fragmentation to the olefin and SN2 cyclization to the β-lactone 
(Scheme 73). For the decarboxylation of β-lactone 244 and 248 to yield additional amounts 
of the corresponding olefin, various conditions were tested and thermal or microwave 
assisted decarboxylation in DMF or NMP worked best. 
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Scheme 73: Fragmentation reaction via an open or boat transition state. 
Variation of the temperature in the fragmentation via the open chain or boat transition state 
led to slightly different amounts of olefin and β-lactone, with rising temperature the amount of 
the olefin increased (Scheme 74). Varying the leaving group showed similar product 
distribution with slightly lower yields in case of the instable triflate (Table 3).  
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Scheme 74: Fragmentation reaction of 233. 
LG T 243 244 
OMs 0 °C 34% 36% 
OMs r.t. 24% 46% 
OTf 0 °C 23% 21% 
OTs r.t. 35% 36% 
Table 3: Varying temperature and LG in the Fragmentation of 233. 
The other diastereoisomer 237 which reacted via the open chain or boat transition state 
showed corresponding results giving (Z)-olefin 247 and β-lactone 248 (Scheme 75, Table 4). 
  
Scheme 75: Fragmentation reaction of 237. 
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base T 247 248 
LiOH r.t. 52% 36% 
LiOH 0 °C 43% 34% 
Table 4: Variation of the temperature in the fragmentation of 237. 
 
Fragmentation induced with carbon nucleophiles 
Different carbon nucleophiles were also tested for the fragmentation of 234 and they turned 
out to induce the fragmentation reaction as well, always giving the (Z)-olefin either in form of 
carbonate 249 and 250 respectively or unprotected alcohol 235 (Scheme 76). Here, 
temperature control is very crucial, as yields dropped significantly at higher temperature. 
When fragmentation of 233 via the boat transition state was attempted with organo lithium 
species, only decomposition was observed. 
 
Scheme 76: Fragmentation using carbon nucleophiles. 
 
5.2.6. Fragmentation of the Open Chain 
As we were able to show that fragmentation could be carried out successfully on the cyclic 
fragmentation precursors, the next step for a more general method was to move to a linear 
fragmentation precursor. Starting from dihydroxy ester 231 the δ-position had to be protected 
regioselectively as the corresponding silyl ether. First attempts were with a  
tert-butyldimethylsily ether, here the allylic alcohol in δ-position can be selectively protected 
with TBSCl but conversion is very slowly and the use of the more reactive TBSOTf only 
addresses the β-position, due to the different nucleophilicity of the two positions. Finally, the 
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bulky TIPS group was employed and the mesylate was introduced in β-position under 
standard conditions. All attempts to convert ester 251 into the carboxylate either by using 
various hydroxides, KOTMS or the Krapcho protocol failed (Scheme 77).[85, 86] The only base 
strong enough to bring forth a reaction was KOTMS in refluxing toluene. Unfortunately 
detailed NMR analyses revealed the major product to be the cyclic sulfite 252, from 
deprotonation of the mesylate and attack on the ester to form the six-membered ring. To 
avoid this, a different leaving group should be installed, but the TIPS group proved to be 
sterically too demanding for any of the other groups (Tf, Ns, Ts) tested. 
 
Scheme 77: Fragmentation of the open chain precursor 251. 
However, the ester could be reduced to the alcohol and was then reoxidized to aldehyde 
254, which upon treatment with hydroxide gave olefin 253 in excellent yield and selectivity 
(Scheme 79).  
OMs O
OTBS
TIPSO
S
N
TIPSO
S
N
OTBS251
254 253
1.DIBALH
2.DMP
(82%)
LiOH
(82%)
 
Scheme 78: Fragmentation of open chain aldehyde 254. 
 
Results and Discussion 
 55
Cyclic protecting and also leaving group 
The protecting group in the δ-position seemed to present a problem, either through 
regioselectivity problems in the introduction or by presenting steric bulk, which prevented the 
hydroxide addition to the ester group. Thus, a cyclic protecting group between β- and  
δ-position, which should additionally serve as leaving group, was envisaged (Scheme 79). A 
cyclic carbonate could be introduced by standard methods with phosgene, triphosgene or 
carbonyldiimidazole. Alas, fragmentation did not give the expected product due to 
regioselectivity problems of the hydroxide attack. As alternative a cyclic sulfate should be 
generated by standard two step procedure. The cyclic sulfite was easily available but the 
oxidation step led either to decomposition with sodium periodate as oxidants or with NMO to 
no conversion. Also the direct use of sulfuryl chloride led only to decomposition, presumably 
through uncontrolled chlorination of the thiazole, and therefore proved unsuccessful.  
 
Scheme 79: Cyclic leaving group. 
 
Decarboxylation of β-lactone 259 
Another obvious route to the trisubstituted (Z)-olefin with 257 in hand was to form β-lactone 
259 and afterwards decarboxylate (Scheme 80). Hence, saponification of 257 was attempted 
but unfortunately confirmed the disappointing results already observed in the above 
described fragmentation. No acid was isolated, presumably due to the steric bulk from the 
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TIPS group. Thus, transesterification with Othera’s catalyst 258 was investigated under 
numerous conditions by variation of the solvent (toluene, xylene, chlorobenzene, etc.), 
temperature and also using microwave irradiation but yields never exceeded 45%.[87, 88] 
However, thermal decarboxylation in DMF proceeded smoothly to the desired trisubstituted 
(Z)-olefin in the northern fragment 260 of epothilone B. 
 
Scheme 80: (Z)-olefin 260 by decarboxylation of β-lactone 259. 
 
5.3. Second Approach: Lactate Route 
In this approach β-keto lactone 262 is synthesized enantioselectively by Mukaiyama aldol 
reaction between silyl enol ether 261 and aldehyde 223, derived from (S)-ethyl lactate (265). 
The quaternary center is introduced by Tsuji-Trost allylation and the fragmentation takes 
place at an earlier stage in the synthesis (Scheme 81). 
 
Scheme 81: Synthetic outline for the second approach to epothilone B (1). 
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5.3.1. Building Lactone 262 
To build up β-keto lactone 262 enantioselectively a Cram chelate controlled Mukaiyama aldol 
reaction was used with stereocontrol by 1,2 induction of chiral aldehyde 223.[89] Thus, known 
aldehyde 223 was prepared by conversion of (S)-ethyl lactate (265) with Bundle’s reagent 
into the corresponding PMB ether and reduction to alcohol 266; subsequent Swern oxidation 
gave α-chiral aldehyde 223 (Scheme 82).[38] Dioxenone 268 was generated either from  
tert-butyl acetoacetate (267), after methylation, by treatment with sulfuric acid in acetone or 
from methyl acetoacetate (269) via conversion into the PMB ester and treatment with TFA in 
acetone.[90, 91] After deprotonation with freshly prepared LDA, the enolate was trapped as 
trimethylsilyl enol ether, which could be stored for some weeks in the fridge when purified by 
bulp-to-bulp distillation.  
 
Scheme 82: Synthesis of aldehyde 223 and silyl enol ether 261. 
After some optimization the best results for the aldol addition proved to be two equivalent of 
the silyl enol ether and two equivalents of freshly prepared magnesium bromide etherate to 
give in almost quantitative yield 270 as single aldol adduct (Scheme 83).[92] Additional 
induction by a chiral Lewis acid was not necessary and stronger Lewis acids generally 
resulted in lower yields by attacking the dioxenone or cleaving the PMB ether. Subsequent 
treatment with potassium carbonate in methanol gave β-keto lactone 262 in quantitative yield 
as white crystals.  
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Scheme 83: Mukaiyama aldol addition. 
The syn configuration between the two hydroxyl groups was confirmed by conversion into the 
corresponding PMP-acetal through an oxidative shift of the PMB group (Scheme 84). 
Unfortunately, both acetals 271a and 271b were formed as is often observed in  
five-membered rings but interpretation of the NOESY spectra showed unambiguously the 
expected syn configuration. 
 
Scheme 84: PMP acetals of Cram chelate product 270. 
 
5.3.2. Quaternary Center by Tsuji-Trost Allylation 
The next obstacle was the introduction of the quaternary center by an asymmetric allylic 
alkylation, which was first tested with allyl acetate. Biphasic Tsuji-Trost allylation, developed 
for the test system,[60] without chiral induction using palladium-tetrakis(triphenylphosphine) 
gave in excellent yields a 3:1 ratio of diastereoisomers (Scheme 85); for structural 
determination these two diastereoisomers were separated by HPLC and NOE cross peaks 
confirmed the configuration of the two compounds.  
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Scheme 85: Tsuji-Trost allylation with allyl acetate. 
Alas, extensive optimization, concerning the choice of ligand, solvent, base and source of 
palladium proved not very successful. A small selection is shown in table 5. 
Pd/Ln* base solvent yield 
ax:eq 
273a:273b 
Pd(PPh3)4 K2CO3 H2O/EtOAc 98% 3:1 
Pd2(dba)3·CHCl3 
(R,R)-Trost DACH 
LDA THF lactone opening - 
Pd2(dba)3·CHCl3 
(R,R)-Trost DACH 
LiHMDS THF 82% 1:2 
Pd2(dba)3·CHCl3 
(R,R)-Trost DACH 
DBU toluene 60% 2:3 
Pd2(dba)3·CHCl3 
(S,S)-Trost DACH 
LiHMDS THF 75% 3:1 
Pd2(dba)3·CHCl3 
(S,S)-Trost DACH 
DBU toluene 92% 7:2 
Table 5: Conditions and results for Tsuji-Trost allylation with allyl acetate. 
Intramolecular allylation, as described by Trost and Stoltz, was tested as well (Scheme 
86).[93, 94] Therefore, the potassium enolate of 262 was trapped as allyl carbonate 275, which 
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could be used in the allylation without any additional base or other additives, but no 
significant increase in diastereoselectivity was observed.  
 
Scheme 86: Intramolecular Tsuji-Trost allylation. 
Nevertheless, allylation with elaborated allylic carbonate 274 was tested; here additional 
different carbonates and acetates as leaving groups could be varied (Scheme 87, Table 6).  
 
Scheme 87: Tsuji-Trost allylation with the elongated allylic carbonate 276. 
Surprisingly, the Trost ligands seemed to hinder smooth reaction, presumably through their 
additional steric bulk. Thus, best conditions were ethyl carbonate as leaving group in a 
biphasic system with palladium-tetrakis(triphenylphosphine) as catalyst and potassium 
carbonate as base, which yielded almost quantitatively allylation product 277 in a 4:1 
diastereomeric ratio.  
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Pd/Ln* OLG base solvent yield 
ax:eq 
377a:377b 
Pd(PPh3)4 OTroc K2CO3 H2O/EtOAc 97% 3:1 
Pd2(dba)3·CHCl3 
(R,R)-Trost DACH 
OTroc DBU toluene 60% 2:3 
Pd2(dba)3·CHCl3 
(S,S)-Trost DACH 
OTroc DBU toluene 54% 3:2 
Pd(PPh3)4 OTroc DBU toluene 41% 3:1 
Pd(PPh3)4 OC(O)CH2Cl DBU toluene 17% 4:1 
Pd(PPh3)4 OC(O)OEt DBU toluene 34% 4:1 
Pd(PPh3)4 OC(O)OEt - H2O/EtOAc 85% 4:1 
Pd(PPh3)4 OC(O)OEt K2CO3 H2O/EtOAc 97% 4:1 
Table 6: Conditions and results for Tsuji-Trost allylation with elongated allyl carbonate. 
Comparison with literature revealed the nucelophiles most common to be rather simple and 
achiral, like malonates or simple β-keto esters. This suggests that the use of more complex 
chiral nucleophiles has been neglected so fare as it presents a nontrivial problem in 
stereoselective Tsuji-Trost allylation. In literature examples chirality is always induced solely 
be the chiral ligands.[65, 66]  
 
5.3.3. Fragmentation Precursor 
Only reduction of the β-position and hydrogenation of the double bond was left to generate 
the fragmentation precursor. The seemingly trivial task of selectively reducing the β-position 
of 277 turned out to be more trouble than expected and always gave 1:1 mixtures. It was 
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perceivable that the PMB protected moiety of the former lactates was too flexible and thus 
not adapt as conformative anchor (Scheme 88). 
 
Scheme 88: Reduction of the β-position. 
 
Alternative lactone for Tsuji-Trost reaction 
To install a better conformative lock, efforts were made to introduce the thiazolalkylidene 
moiety earlier. Therefore, the free hydroxyl group was protected as acetate, based on the 
idea to cleave the acetate and the acetonide together with K2CO3 in one-pot, when the 
lactone is generated. The PMB ether was cleaved oxidatively with DDQ and the free alcohol 
was converted into methyl ketone 280 with buffered DMP (Scheme 89). 
 
Scheme 89: Transformation of dioxenone 270. 
The next step was the Wittig reaction with thiazole salt 105. Despite extensive optimization 
the only product ever isolated was 283 coming from acetate elimination to the conjugated 
aromatic system, before or after the Wittig reaction took place (Scheme 90). Problems were 
the good potential of acetate to act as leaving group and the high temperatures which were 
needed in the Wittig reaction to generate the double bond, due to the good stabilization of 
the betaine intermediate formed. 
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Scheme 90: Thiazole Wittig reaction. 
To generate fragmentation precursor 284 the double bond in 278 had to be hydrated. This 
could be achieved quantitatively under mild conditions by using Adam’s catalyst (Scheme 
92). 
 
Scheme 91: Generation of fragmentation precursor 284. 
 
5.3.4. Fragmentation 
Going on with the epimeric mixture of lactone 284, mesylation installed the required leaving 
group in β-position and treatment with potassium hydroxide in methanol at 0 °C gave desired  
(Z)-olefin 264 as only fragmentation product in 58% yield (Scheme 92). Obviously only the 
diastereoisomers with the correct relative configuration between α- and β-position, therefore 
fulfilling the stereochemical requirements for the fragmentation reaction take part in the 
reaction. This was proven by HPLC separation of the mixture and using only the 
diastereoisomer with the equatorial β-hydroxyl group and axial side chain in the 
fragmentation reaction, which produced 264 in 91% yield. 
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Scheme 92: Fragmentation of 284. 
 
5.3.5. Endgame 
To complete the synthesis, the secondary alcohol group of 264 was protected with TBSOTf 
(Scheme 93). Then the PMB group was oxidatively removed using DDQ and the resulting 
free hydroxyl function of 285 was oxidized with DMP to give methyl ketone 286, as precursor 
for attaching the thiazole ring via Wittig reaction. The Wittig salt 105 was deprotonated at  
0 °C, using nBuLi and the resulting mixture was cooled to -78 °C, before adding ketone 286. 
The reaction mixture was first warmed to room temperature, then slowly to 50 °C for 1 h. 
Thus, giving in nearly quantitative yield only the (E,Z)-isomer 33, the northern fragment. The 
reaction temperature of the ketone addition was crucial, as at higher temperatures formation 
of a side product, the (Z,Z)-isomer was observed. 
 
Scheme 93: Endgame. 
With (E,Z)-diene 33 the same formal synthesis goal as from the PLE route was achieved, 
thus providing a second route for the a formal synthesis of epothilone B (1). 
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5.4. Summary – Epothilone B 
Two independent approaches to finish the formal synthesis of epothilone B were developed, 
using a new decarboxylative Grob-type fragmentation reaction to build up the trisubstituted 
C12,13-(Z)-double bond. The key to a successful synthesis lies in the stereoselective 
generation of the quaternary α-center of the fragmentation precursor.  
In the PLE route this crucial step was performed at the beginning by enzymatic 
desymmetrization of meso malonate 193. Thereby obtained stereoinformation was used as 
relay to generate the missing stereocenters along the chain by substrate control. An 
unexpected behavior of aldehyde 212 was observed, namely the strong hindrance of the 
quaternary α-center to induce Cram chelate controlled aldol addition, which on the other 
hand led to excellent stereocontrol for the Felkin-Anh adduct. The δ-lactone was closed at a 
late stage and fragmentation led to the desire (Z)-olefin as single product. Thus, the first 
formal synthesis was accomplished in 18 steps over the longest linear sequence and 24% 
yield. Additionally, aldol adduct 220 was transformed into four diastereomeric fragmentation 
precursors, whose behavior under fragmentation conditions was investigated and thus gave 
four diastereoisomers 235, 240, 243 and 247 of the epothilone B northern fragment. 
Fragmentation of the δ-lactones derived from anti dihydroxy esters proceeded via the chair 
transition state to the desired olefins. Whereas fragmentation of the δ-lactones derived from 
syn dihydroxy esters which bear the leaving group in axial position and thus make 
fragmentation via the chair transition state impossible, react presumably via the carboxylate 
to both olefin and β-lactone. The olefin geometry is determined by the relative configuration 
between α- and β-center and thus selectable during the synthesis of the fragmentation 
precursor. On thermolysis the β-lactones gave additional amounts of the olefin, so that 
overall fragmentation of the syn diols also gave the olefin in pure form and acceptable yield.  
In the second approach, the lactate route, the quaternary center was installed by asymmetric 
allylic alkylation of enantiomerically pure β-keto lactone 262. Despite intensive optimization 
best results were a 4:1 ratio in favor of the desired axial compound. Additionally, the 
selective reduction of the β-position provided always disappointing 1:1 mixtures as most 
probably the side chain, derived from the former lactate is not an efficient conformational 
anchor for the δ-lactone. However, after separation of the desired diastereoisomer 
fragmentation worked smoothly to provide desire (Z)-olefin 264. Also the diastereomeric 
mixture could be employed to give only the desired olefinic product after fragmentation in 
correspondingly lower yield. A high yielding efficient endgame furnished the northern 
fragment 33 in 33% yield and 14 steps over the longest linear sequence.  
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6. Results and Discussion - Discodermolide 
6.1. General Retrosynthesis 
 
Scheme 94: General retrosynthesis for discodermolide (3). 
Discodermolide (3) is generally dissected in three rather equally complex building blocks 
(Scheme 95); one obvious disconnection is the Wittig reaction between C8 and C9 to 
generate the disubstituted C8,9-(Z)-olefin and the other cut is, depending on the strategy for 
the generation of the trisubstituted double bond, in the area between C14 and C18. The 
middle part contains the trisubstituted (Z)-double bond and thus should be prepared by the 
decarboxylative Grob-typ fragmentation. Fragmentation precursor 291 is led back to 
diprotected tetraol 290 with five successive stereocenters, which come from a Paterson aldol 
addition between chiral ethyl ketone 288 and aldehyde 289 containing the quaternary center 
(Scheme 96). 
 
Scheme 95: Synthetic strategy for discodermolide (3). 
In following the synthetic approaches to discodermolide (3) are described depending on the 
strategy to generate the quaternary center in aldehyde compound 289.  
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6.2. Enzymatic Hydrolysis  
In analogy to the epothilone B PLE route (chapter 5.2.), aldehyde 292 should be gained from 
the mono acid derived from the corresponding meso malonate by enzymatic hydrolysis. A 
methallyl moiety was chosen as means to install the C16 center by enantioselective 
hydroboration after the fragmentation (Scheme 96). The δ-lactone as fragmentation 
precursor would be derived from dihydroxy ester 293 with all stereocenters already set 
correctly.  
 
Scheme 96: Synthetic strategy for the PLE route. 
 
6.2.1. Quaternary Center by Desymmetrization 
In the established fashion meso malonate 296 with a methallyl moiety was prepared by 
double alkylation of dimethyl malonate 186, through deprotonation with sodium hydride and 
reaction with methallyl bromide followed by methylation to introduce the quaternary center 
(Scheme 97). 
 
Scheme 97: Preparation of meso malonate 296. 
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Meso malonate 296 was used in an enzymatic desymmetrization by hydrolysis with PLE, 
which worked now noticeably faster than for 193 and gave mono acid 297 in excellent yield 
(Scheme 98). Then the carboxylate was selectively reduced to the alcohol by a two step 
procedure via the mixed anhydride and alcohol 298 was used for the determination of the 
enantiomeric excess.  
 
Scheme 98: Enzymatic desymmetrization and reduction to alcohol 298. 
 
Determination of the enantiomeric ratio of 298 
Alcohol 298 was converted into Mosher’s ester 299 and 300 and HPLC analyses, 1H-NMR 
and 19F-NMR proved a 7:2 diastereomeric ratio (Scheme 99), due to poor selectivity in the 
enzymatic hydrolysis. The absolute configuration was assumed in analogy to the earlier 
gained mono acid 194 from the epothilone synthesis, as no literature known compounds 
were within easy reach.  
 
Scheme 99: Determination of the enantiomeric ratio of 298. 
To obtain better selectivity in the enzymatic hydrolysis different enzymes were tested but no 
improvement was achieved (Scheme 100). 
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Scheme 100: Testing different enzymes for the hydrolysis of 296. 
 
6.2.2. Fragmentation Precursor 
First chiral ethyl ketone 288 was prepared starting from mono protected diol 301 (Scheme 
101), derived from (S)-Roche ester (ent-182) by protection with PMB Bundle’s reagent 
followed by reduction. Swern oxidation led to the α-chiral aldehyde which was used in a 
Grignard addition with ethyl magnesium bromide to generate diol 302. Subsequent Swern 
oxidation yielded ethyl ketone 288, thus easily accessible from 301 on multi-gram scale in a 
three step procedure and 85% overall yield.[95] 
 
Scheme 101: Synthesis of chiral ethyl ketone 288. 
To obtain aldehyde ent-292, alcohol 298 was oxidized with Dess-Martin periodinane, which 
was then used in an anti-anti-selective Paterson aldol addition with dicyclohexylboron 
chloride (Scheme 102).[45, 96] Thus, ethyl ketone 288 was enolized with the Lewis acid and 
triethylamine at 0 °C and treated at -78 °C with the aldehyde. The desired aldol adduct was 
isolated in nearly quantitative yield and good selectivity.  
 
Scheme 102: Paterson aldol addition. 
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Evans-Carreira reduction to anti diol 304 was accomplished with the sodium salt of triacetoxy 
boronhydride in good yield (Scheme 103). At this stage the excellent selectivity of the aldol 
reaction and subsequent reduction step was confirmed by HPLC analysis, which still showed 
a 7:2 diastereomeric ratio, derived from the quaternary center. 
 
Scheme 103: Reduction to anti diol 304. 
Saponification with lithium hydroxide was followed by cyclization under Steglich conditions to 
δ-lactone 305 (Scheme 104). At this stage the diastereoisomers were easily separable by 
column chromatography and the NOESY experiments of the major compound confirmed the 
relative stereochemical arrangement of the fragmentation precursor, thereby supporting the 
assumption for the absolute configuration of the mono acid to be (S)-configuration, in 
accordance with the results observed earlier. 
 
Scheme 104: Generation of δ-lactone 305. 
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6.2.3. Fragmentation  
The mesylate was installed under standard conditions and was directly treated with lithium 
hydroxide to give expected (E)-olefin 307 as only fragmentation product in moderate yield 
(Scheme 105). The low yield of the fragmentation reaction might result from an imperfect 
installation of the leaving group due to steric hindrance. Supported by the fact that lactone 
305 was also isolated after the fragmentation. Thus, triflate was tested as leaving group but 
maximum yields never exceeded 45%. With the far more reactive triflate side reactions are 
also more likely.  
 
Scheme 105: Fragmentation of 305 to (E)-olefin 307. 
Due to the disappointing selectivity of the enzymatic desymmetrization no further attempts of 
correcting the relative stereochemical arrangement between α- and β-center to obtain the 
(Z)-olefin or optimization of the fragmentation reaction were made and this approach was 
abandoned.  
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6.3. Introduction of the Quaternary Center by Regioselective 
Epoxide Opening  
In a second approach Tanaka’s titanium mediated ring opening of epoxides was tested.[97, 98] 
He reported the formation of chiral quaternary centers by opening of chiral epoxides on the 
more substituted carbon C2, which is achieved via a SN2 anti attack of a nucleophile on a 
relatively stable intermediate 309 (Scheme 106). This was only observed when the C3 
position had only one substituent R1; with R1= H attack was preferably on the C3 position due 
to the higher reactivity and with two substituents at C3 the tertiary carbocation was formed 
and a SN1 like ring-opening gave in both cases a 1,2 diol. Yields for this epoxide opening 
were in general moderate. 
 
Scheme 106: Tanaka’s titanium mediated ring opening of epoxides.  
Thus, monoprotected diol 311 should be prepared and after oxidation used in a Paterson 
aldol addition which can easily be converted to fragmentation precursor 314 (Scheme 107). 
The terminal double bond of fragmentation product 315 can either be regioselectively and 
oxidatively cleaved or used in a hydroboration for further transformations.  
 
Scheme 107: Synthetic strategy for the regioselective epoxide opening. 
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6.3.1. Epoxide Opening 
Methallyl alcohol (316) was converted into epoxide 317 by a Sharpless epoxidation in good 
yield and high enantiomeric excess,[99] which was then further protected as MOM or benzyl 
ether both reported substrates for the epoxide opening (Scheme 108).  
 
Scheme 108: Preparation of epoxide 318 and 319. 
First obstacle of this reaction was the generation of the titanium species which can be 
achieved by conversion of the commercially available chlorotitanium triisopropoxide with 
phenol into the chlorotitanium triphenoxide, a dark red amorphous solid, which can be 
purified by bulp-to-bulp distillation at 250 °C.[100] As this distillation is not a trivial task, 
especially transferring the purified glass-like solid which is additionally very susceptible to 
oxidation, the purification protocol was changed to a repeated aceotropic distillation with 
toluene. Now the epoxide opening was attempted, here also the use of allyl magnesium 
chloride is of utmost importance as the bromide does not work. Depending on the substrate 
epoxide opening was achieved in 29% to 37% in contrast to 41% to 46% reported (Scheme 
109). However, over 1.5 mmol reaction size the yields dropped significantly, thus the reaction 
was not upscale-able and therefore useless at the beginning of a synthetic route and 
hereupon abandoned. 
 
Scheme 109: Investigation of the epoxide ring opening reaction. 
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6.4. Diastereoselective Carboxalkylation of Enolates 
Braun and co-workers reported the diastereoselective formation of quaternary carbon 
centers by a simple diastereoselective carboxalkylation of lithium enolates with (-)-menthyl 
chloroformate (322) (Scheme 110).[101, 102] They employed this strategy on cyclic and acyclic 
enolates generated from esters or acids and reached selectivity better than 9:1 very much 
depending on the solvent system. In acyclic systems esters were observed to give better 
results. 
 
Scheme 110: Carboxalkylation of enolates with (-)-menthyl chloroformate (322). 
Methyl ester 326 featuring a methyl group and an alkyl chain in α-position should be 
subjected to the diastereoselective carboxalkylation to give diester 327, which can be 
regioselectively converted to aldehyde 329 (Scheme 111). The protecting group PG has to 
be selectively modifiable in the fragmentation product 331. 
 
Scheme 111: Synthetic strategy for the asymmetric acylation. 
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6.4.1. Quaternary Center by Acylation 
Starting from δ-valerolactone (332) the methyl ester is easily accessible by acidic opening 
with methanol followed by α-methylation of the lithium enolate with methyliodide to give ester 
334 as substrate for the acylation.  
 
Scheme 112: Preparation of substrate 334. 
When ester 334 was subjected to carboxalkylation with (-)-menthyl chloroformate (322) the 
resulting diastereomeric ratio in the product mixture was disappointingly low (Scheme 113). 
Also the use of 8-phenylmenthol, which is generally known to improve selectivity, when 
employed instead of the simple menthol moiety, could not increase the diastereomeric ratio. 
Thus, direct carboxalkylation of δ-valerolactone (332) was attempted, assuming that the 
cyclic template might improve selectivity, unfortunately δ-valerolactone (332) polymerizes 
very easily under basic conditions.  
 
Scheme 113: Carboxalkylation of methyl ester 334 and δ-valerolactone (332). 
These unfavorable results might be due to the similarity of the α-substituents of the 
substrate, two alkyl substituents were used in this case whereas the substrates described in 
literature always feature an alkyl and an aryl substituent. 
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6.5. Wagner-Meerwein Rearrangement of Epoxide for the 
Generation of the Quaternary Center 
Yamamoto described the stereocontrolled rearrangement of epoxy silyl ethers to β-siloxy 
aldehydes by Lewis acid catalyzes under mild conditions (Scheme 114).[103] His choice of 
catalyst fell on a sterically hindered, oxygenophilic organoaluminium reagent, as this 
compound will not react as base or nucelophile and its steric repulsion will promote the 
transfer of the siloxy methyl moiety. 
 
Scheme 114: Organoaluminium-catalyzed rearrangement of epoxides. 
Aldehyde 339 bearing the quaternary center is a known compound and will give the carbon 
skeleton for fragmentation precursor 340 upon aldolization with ethyl ketone 288 (Scheme 
115). The terminal olefin can be further transformed regioselectively to intercept a formal 
synthesis intermediate. 
 
Scheme 115: Synthetic strategy to discodermolide (3). 
 
6.5.1. Quaternary Center by Rearrangement 
Yamamoto’s organoaluminium-promoted rearrangement was first studied with  
tert-butyldimethylsilyl ether of epoxy geraniol (342) to construct a quaternary center. Here 
especial focus was on the stereochemical outcome of the reaction and it was found that the 
optical purity of the product matches the optical purity of the starting material; this chirality 
transfer comes from an anti migration of the siloxy methyl group (Scheme 116). Thus, 
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optically active epoxy silyl ether 342, which was derived from Sharpless asymmetric 
epoxidation of geraniol using L-(+)-diethyl tartrate and subsequent conversion into its silyl 
ether, was treated with methylaluminium bis(4-bromo-2,6-di-tert-butylphenoxide) (MABR) 
(343) to provide aldehyde 339 in 97% yield and 95% ee.[99] This reaction can be performed 
with catalytic amounts of MABR on multi-gram scale. 
 
Scheme 116: Yamamoto’s organoaluminium-promoted rearrangement. 
 
6.5.2. Fragmentation Precursor 
The complete carbon skeleton of the fragmentation precursor was constructed in excellent 
yield and selectivity, also on big scale, using an anti-anti-selective Paterson boron aldol 
reaction between chiral ethyl ketone 288 and aldehyde 339.[45] Thus, ethyl ketone 288 was 
enolized with dicyclohexylboron chloride and triethylamine at 0 °C and treated at -78 °C with 
aldehyde 339 (Scheme 117). The desired aldol adduct was isolated on small scale in nearly 
quantitative yield and good selectivity; when the reaction was preformed on 50 mmol scale 
the yields were still very good, around 75% to 80%. Then hydroxy ketone 345 was converted 
to diprotected tetraol 346 in an Evans-Carreira anti-reduction,[79] which proceeded very slowly 
and therefore was stopped after three days and 50% conversion.  
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Scheme 117:Paterson’s anti-anti-selective boron aldol addition. 
To confirm the stereochemical outcome of these two reactions and thus prove the 
configuration of the generated stereopentade the following three PMP acetals 347 to 349 
were made and subjected to extensive NOE experiments (Scheme 118). 
 
Scheme 118: PMP acetals of tetraol 346. 
 
6.5.3. Fragmentation of the Open Chain Precursor 
The cyclic carbonate could be introduced under standard conditions with phosgene. Then the 
silyl ether was cleaved with TBAF and oxidized to the corresponding aldehyde 351 in 
moderate 70% yield for each of the two steps. Next the fragmentation of aldehyde 351 was 
attempted in analogy to the fragmentation of aldehyde 254 from the epothilone route, but 
only decomposition was observed (Scheme 119). This might be due to several reasons: 
there is the regioselectivity problem of hydroxide attack, which might occure on the aldehyde 
or the carbonate. Additionally in aldehyde 254 the bulky TIPS group might have hampered 
the free rotation of the carbon chain and thus favored a conformation which fulfilled the 
stereochemical requirements for the fragmentation reaction to generate olefin 253. 
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Scheme 119: Cyclic carbonate as leaving group. 
Despite the negative results with the former cyclic sulfate, its introduction was attempted in a 
two step procedure. Again, the cyclic sulfite was easily available but the oxidation step led to 
decomposition (Scheme 120). 
 
Scheme 120: Introduction of a cyclic sulfate as leaving group.  
 
6.5.4. Conversion into δ-Lactone 340 
For the preparation of the δ-lactone the primary neopentyl position had to be oxidized to the 
acid and cyclized to the lactone. So the first attempt was to cleave the TBS ether with 
HF·pyridine and selectively oxidize the primary position of triol 353 with one equivalent of 
DMP (Scheme 121). As triol 353 is rather water soluble, the work-up of this reaction was a 
major issue and best results were achieved with HF·pyridine due to the ability of TBAF to act 
as phase transfer catalyst. The oxidation product was found to be ketone 354, 
unambiguously determined by the 13C-NMR, by selective oxidation of the sterically less 
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hindered secondary alcohol, which demonstrated very impressively the unpredictability of the 
reactivity of neopentyl positions.  
PMBO
OH OH
OH
HF.py DMP
346
353 354
(92%) (65%)
PMBO
O OH
OH
 
Scheme 121: Selective oxidation of triol 353. 
As the primary position was not regioselectively oxidizable, the two secondary alcohols had 
to be protected first, which was accomplished with an acetonide. This seemingly trivial 
reaction required optimization efforts as the TBS group was very easily cleaved under acidic 
conditions (Scheme 122, Table 7). Thus, the first reaction provided as only products 
acetonide 356 and 357 with the free primary alcohol, which was very promising. Extensive 
optimization showed that the nature of the acid, the amount and the reaction time had to be 
adjusted very precisely to get useful products. In harsh conditions acetonide cleavage to the 
starting material 346 or free triol 353 was observed which led to a four component mixture, 
two of them inseparable, as the mixture of staring material 346 and acetonide 357 with the 
free hydroxyl group is not separable by column chromatography. In the end the reaction was 
carried out with only 10 mol% of CSA and stopped after 60% to 70% conversion. The 
recovered starting material could be easily recycled. 
PMBO
O O
OTBS
MeO OMe
PMBO
O O
OH
356 357
acid346
355
 
Scheme 122: Acetonide protection of diprotected tetraol 346. 
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acid eq. rxn time products 
CSA 0.2 4 h 36% 356 and 38% 357 
CSA 0.1 2 h 68% 356 and 31% 346 
pTsOH 0.2 2 h 26% 356 and mixture of 346 and 357 
PPTS 0.5 8 h 58% 356 and mixture of 346 and 357 
Table 7: Conditions for acetonide protection of diprotected tetraol 346. 
The silyl ether of 356 was cleaved in the next step with HF·pyridine to generate known 
acetonide 357 (Scheme 123). From experience with the oxidation of free triol 353, the 
secondary alcohol was known to be the most reactive side. Thus, a second route to 357 was 
tested by directly installing the acetonide on the free triol 353, which was accomplished 
regioselectively in good yields. Here also the reaction time is crucial as migration of the 
acetonide is observed at longer duration. 
 
Scheme 123: Two ways to generate acetonide 357. 
Now the primary alcohol was oxidized in two steps to acid 358; IBX oxidation led to the 
aldehyde and further treatment under Pinnick conditions gave acid 358. In acidic conditions 
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the acetonide was opened and the free dihydroxy acid cyclized spontaneously to δ-lactone 
340 (Scheme 124). 
 
Scheme 124: Building the fragmentation precursor.  
 
6.5.5. Fragmentation 
With δ-lactone 340 in hand the leaving group was installed in β-position, due to steric 
hindrance harsher conditions were needed than for the previous entries, namely 
stoichiometric amounts of DMAP in a 1:1 CH2Cl2:pyridine mixture with three to five 
equivalents of mesyl chloride. The generated mesylate was directly used in the following 
fragmentation reaction yielding desired (Z)-olefin 341 as single product via the chair 
transition state (Scheme 125). 
 
Scheme 125: Fragmentation reaction. 
The somewhat lower yield in comparison to other examples can most likely be traced back to 
the problem of installing the leaving group. Different alternative leaving groups were 
investigated such as tosylate, nosylate and triflate; however, without success due to their 
even bigger sterical extension. 
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6.5.6. First Formal Synthesis Goal 
To finish the formal synthesis and intersect one of Paterson’s intermediates, the terminal 
olefin had to be converted into an ester. Thus, the homoallylic alcohol was protected as silyl 
ether and the terminal double bond was selectively epoxidized with mCPBA. In order to avoid 
epoxidation of the second double bond, adjustment of reaction times and temperature is 
crucial. Then the epoxide was cleaved to the aldehyde, which was oxidized to acid 361 
(Scheme 126).  
 
Scheme 126: Conversion of the terminal olefin into acid 361. 
Now two formal synthesis goals were within reach, either conversion into methyl ester 362 by 
treatment with diazomethane or esterification under Steglich conditions with 2,6-dimethyl 
phenol to aromatic ester 363 (Scheme 127). Both esterifications worked very well and the 
analytical data matched perfectly with the reported ones.[45] 
 
Scheme 127: Synthesis of Paterson’s esters 362 and 363. 
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6.5.7. Second Formal Synthesis Goal 
The second formal synthesis goal was an intermediate from Smith’s synthesis with the 
eastern part of the molecule already attached. The C16 to C20 fragment contains five 
contiguous stereogenic centers from which four are syn and the last one anti to each other - 
an unusual configuration in polyketides (Scheme 128). The C16 methyl group should be 
installed by asymmetric methylation of a chiral auxiliary. Further dissection is between C17 
and C18 which will be closed in a syn selective aldol addition. The ketone fragment 366 
already contains the C20 stereocenter. 
 
Scheme 128: Retrosynthetic analysis for the introduction of the eastern part. 
 
6.5.8. Stereoselective Methylation at C16 
Thus, the first task was to install Oppolzer’s sultam as chiral auxiliary for the methylation of 
C16, which was easily possible using Steglich’s reagent, acid 361 and sultam 367.[104] The 
conversion via the acid chloride of 361 is also possible but yields are lower in the acylation 
reaction. Next the sodium enolate of 368 was formed and methyliodide introduced the 
desired C16 center in good yields and selectivity (Scheme 129). The auxiliary was 
reductively removed in the next step to provide α-chiral aldehyde 370 for the following aldol 
addition. 
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Scheme 129: Introduction of the C16 methyl group. 
 
6.5.9. Attaching the C18 to C21 Fragment 
Extended Evans’ auxiliary 
The most obvious building block for the C18-C21 fragment is β-ketoimide 374, which already 
contains the C20 stereocenter. A syn selective aldolization should generate the required C17 
and C18 stereocenters.[105, 106] Thus, β-ketoimide 374 was prepared according to the known 
literature procedure (Scheme 130).[107, 108] Starting from D-phenylalanin (371), reduction led to 
the amino alcohol which was carbonylated with diethylcarbonate to generate  
(4R)-benzyloxazolidinone (372), the Evans’ auxiliary. Acylation with propionyl chloride gave 
373 which was treated with dibutylboron triflate to form the syn aldol adduct with propanal. 
Subsequent Parikh-Doering oxidation to avoid epimerization of the α-methyl group, gave 
extended Evans’ auxiliary 374.  
 
Scheme 130: Preparation of extended Evans’ auxiliary 374. 
Hence, β-ketoimide 374 was subjected to the following aldolization reaction conditions using 
either tin(II) triflate or freshly prepared dibutylborontriflate to generate the (Z)-boron enolate 
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but no reaction with aldehyde 370 was observed (Scheme 131). A closer look at transition 
state 376 revealed it to be the stereochemically mismatched case due to syn-pentane 
interaction.  
 
Scheme 131: Extended Evans aldol addition. 
 
Paterson aldol addition 
The next idea was to test Paterson aldol addition (Scheme 132). The ethyl ketones 377 
employed are sterically less demanding than the extended Evans’ auxiliary and might still be 
able to give aldol adducts despite the disfavored interaction between the two methyl groups. 
An additional advantage was the possibility of using ethyl ketone 388 with the terminal  
(Z)-diene already in place which would provide a very convergent approach and shorten the 
synthesis drastically.  
 
Scheme 132: Paterson aldol addition. 
First the simple ethyl ketones 380 and 382 were prepared, starting from (S)-Roche ester 
(ent-182) by protection either with benzyl Bundle’s reagent or TBSCl and further conversion 
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into the corresponding Weinreb amide 379 and 381. Addition of ethylmagnesium bromide 
gave ethyl ketones 380 and 382 (Scheme 133). 
 
Scheme 133: Preparation of ethyl ketones 380 and 382. 
For the generation of ethyl ketone 388 featuring the (Z)-diene, the initial strategy was based 
on a (Z)-selective allyl Wittig reaction (Scheme 134). Thus, monoprotected diol 383, derived 
from (R)-Roche ester (182) by protection and reduction, was oxidized to the corresponding 
aldehyde with IBX in DMSO at ambient temperature, which was directly employed in the 
following olefination reaction. Different bases for example NaHMDS, tBuOK or LDA were 
used and temperature was varied from low to ambient temperature, but no reaction was 
observed only deprotection and decomposition of the starting material. 
PGO OH PGO
PG = TES, THP, TIPS, TBDPS
1.IBX
2.base,
PPh3Br
384383
 
Scheme 134: Preparation of the terminal (Z)-diene via Wittig reaction. 
Then the strategy was changed to the Nozaki-Hiyama/Peterson protocol, first developed in 
the Paterson group and modified by Novartis to a one pot procedure (Scheme 135).[109] Thus, 
bromoallylsilane 385 was prepared and used in a chromium(II) mediated Nozaki-Hiyama 
coupling with the aldehyde derived from ent-301, basic workup with potassium hydroxide 
gave desired (Z)-diene 386 by a Peterson-type syn elimination. Now the PMB group was 
cleaved and the resulting alcohol was oxidized to aldehyde 387. Grignard addition with 
ethylmagnesium bromide gave the corresponding secondary alcohol and Dess-Martin 
oxidation yielded ethyl ketone 388. 
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Scheme 135: Ethyl ketone 388 featuring the (Z)-diene via Nozaki-Hiyama/Peterson protocol. 
Now the aldol addition could be tested and the initial idea was to use  
(-)-diisopinocampheylboron triflate to generate the chiral (Z)-boron enolate which determines 
the stereochemical outcome of the reaction.[110] Alas, the isopinocampheyl moieties seemed 
to be too sterically demanding to lead to any reaction as the mismatched transition state had 
to be overcome. Also the use of lithium enolates only gave mixtures of diastereoisomers. So 
in the end simply employing freshly prepared dibutylboron triflate gave the aldol adduct as 
single diastereoisomer (Table 8).  
ketone LA, base product 
382 (-)-Ipc2BOTf, DIPEA no reaction 
380 (-)-Ipc2BOTf, DIPEA no reaction 
388 (-)-Ipc2BOTf, DIPEA no reaction 
382 LiHMDS 1:1 
388 LiHMDS 3:2 
388 Bu2BOTf, TEA 1 diast. 
382 Bu2BOTf, TEA 1 diast. 
Table 8: Conditions for Paterson aldol addition. 
Without chiral induction from the isopinocampheyl moieties two possible syn aldol adducts 
can be generated via the (Z)-boron enolate.[111] With α-chiral aldehydes, (Z)-boron enolates 
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normally lead to anti-Felkin products through transition state 392 to avoid the destabilizing 
syn-pentane steric interaction in the cyclic chair transition state 391.[96] Thus, aldolization to 
the undesired syn aldol adduct 390 is more likely (Scheme 136).  
 
Scheme 136: Aldolization with dibutylboron triflate. 
 
Determination of the configuration at C17 and C18  
For the determination of the absolute configuration at C17 both (R)- and (S)-Mosher esters 
393 and 394 were synthesized (Scheme 137) and the difference of the chemical shifts of both 
compounds provided evidence for the stereochemistry of the C17 center and the desired  
(R)-configuration could be deduced.[112, 113] 
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Scheme 137: Determination of the absolute configuration at C17. 
To prove the syn selectivity of the aldol addition cyclic acetale 396 was prepared (Scheme 
138) by substrate controlled syn reduction with catecholborane to diol 395 and subsequent 
acid mediated acetalization with anisaldehyde dimethyl acetal.  
 
Scheme 138: Determination of the relative configuration between C17-C19 of 389. 
NMR correlation spectroscopy showed clearly NOE cross peaks between the methyl group 
at C18 and the acetal proton and thus revealed the configuration between C17 and C18 to 
be anti and not syn as assumed (Scheme 139).  
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Scheme 139: Determination of the relative configuration between C17-C19 of 397. 
To validate this unexpected result, namely the aldol reaction via the (E)-enolate bespite using 
dibutylboron triflate, the relative configuration between C18-C20 in 398 was also 
investigated. Thus, after syn reduction to diol 399 treatment with anisaldehyde dimethyl 
acetal led to acetal 400 (Scheme 140).  
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Scheme 140: Determination of the relative configuration between C17-C19 of 398. 
NOESY experiments confirmed the product of the aldol addition to feature the undesired anti 
arrangement between C17 and C18 (Scheme 141). 
 
Scheme 141: Determination of the relative configuration between C17-C19 of 401. 
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Stepwise elongation 
Thus, the synthetic strategy was changed to a step wise installation of the C17-C20 
stereocenters by reliable auxiliary chemistry. The first step was a classic syn selective Evans 
aldolization with oxazolidinone ent-373,[114] followed by protection of the generated alcohol as 
silyl ether and reductive removal of the auxiliary to generate alcohol 403 (Scheme 142).  
 
Scheme 142: Syn selective Evans aldolization. 
Then a second aldol addition should be perform, this time anti selective to install the missing 
C20 and C21 stereocenters in non-Evans anti product 404 (Scheme 143).[115] When the first 
few attempts appeared not to be successful, a simplified model substrate was prepared for 
further optimization.  
 
Scheme 143: Non-Evans anti aldol reaction. 
 
Model substrate 
As model substrate stereotriade 76 was chosen, a common building block in many 
discodermolide syntheses, featuring a primary PMB ether, a secondary TBS group and the 
same relative configuration in α- and β-position of aldehyde 76 and 412 and thus able to 
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mimic the real substrate sufficiently well (Scheme 144). After oxidation of alcohol 301 to the 
corresponding aldehyde, syn selective aldolization with acylated Evans’ auxiliary 373 gave 
aldol adduct 405, which was converted into the Weinreb amide and the free hydroxyl group 
was protected as silyl ether 406.[35] Aldehyde 76 can be easily gained by reduction with 
DIBALH. 
 
Scheme 144: Synthesis of aldehyde 76 as model substrate. 
Aldehyde 76 was now subjected to the non-Evans anti aldol reaction (Scheme 145) but 
despite many efforts an aldol adduct was observed only once alas with low yield and hardly 
any selectivity (Table 9).  
 
Scheme 145: Model substrate for non-Evans anti aldol reaction. 
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LA eq. additives yield 
MgCl2 0.1 (in EtOAc) TMSCl, NaSbF6 63% sm 
MgCl2 0.1 (in THF) TMSCl, NaSbF6 50% sm 
MgCl2 0.2 TMSCl 52% sm 
MgCl2 2 + 20 eq. NEt3 TMSCl 
60% TMS enol 
ether of sm 
MgCl2 2 + 3 eq. NEt3 TMSCl 35% 1:2 mix 
Cy2BCl 1.2 - 59% sm 
Table 9: Conditions for non-Evans anti aldol reaction. 
Thus, a new strategy for the missing two stereocenters at C19 and C20 was developed in 
form of a Roush crotylation which was first tested on model aldehyde 76 (Scheme 146).[116] A 
stock solution of (S,S)-diisopropyl tartrate (E)-crotylboronate (408) was prepared by 
deprotonation of trans-2-butene with Schlosser’s base, formation of the boronate with 
triisopropylborate and followed by transesterification with (S,S)-diisopropyl tartrate. 
Treatment of aldehyde 76 with (E)-crotylboronate reagent 408 gave desired homoallylic 
alcohol 409 in excellent yield and selectivity over night. The terminal double bond was 
epoxidized under vanadium-catalysis. Here control of the reaction temperature is crucial to 
avoid oxidative cleavage of the PMB ether.[117] Now periodate cleavage of the epoxide moiety 
was directly followed by reduction of the generated aldehyde to the corresponding diol, which 
was easily converted into PMP acetal 411. 
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Scheme 146: Roush crotylation of model aldehyde 76 and conversion into acetal 411. 
 
Smith’s intermediate 415 
Encouraged by this promising results the Roush crotylation was employed for the real 
system (Scheme 147). Thus, a stock solution of (R,R)-diisopropyl tartrate (E)-crotylboronate 
(ent-408) was prepared for the treatment of aldehyde 412 to generate desired allylic alcohol 
413 in good yield and as a single diastereoisomer.  
 
Scheme 147: Roush crotylation of the real system. 
Regioselective epoxidation of the terminal homoallylic double bond was possible by 
vanadium-catalysis which yielded epoxide 414 in good yields without affecting the 
trisubstituted double bond. The following periodate cleavage of the epoxide moiety generated 
the corresponding aldehyde and was directly reduced to the diol. Its mediocre yields are not 
optimized. The diol was easily converted into PMP acetal 415 identical in every aspect with 
Smith’s intermediate, thus finishing a second formal synthesis (Scheme 148).[35] 
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Scheme 148: Conversion of 413 into Smith’s intermediate 415. 
 
6.6. Summary – Discodermolide 
The synthetic strategy to the discodermolide fragmentation precursor relied on an early 
introduction of the quaternary center. After investigation of several strategies, such as 
enzymatic desymmetrization, Tanaka’s titanium mediated ring opening of epoxides or 
Braun’s diastereoselective carboxalkylation of enolates with (-)-menthyl chloroformate (322), 
Yamamoto’s organoaluminum-promoted rearrangement of TBS protected epoxy geraniol to 
aldehyde 339 proved to be the method of choice. A Paterson aldol addition generated the 
whole carbon skeleton of the fragmentation precursor and protecting group manipulations 
and oxidations led to δ-lacton 340. The fragmentation reaction via the chair transition state 
furnished desired (Z)-olefin 341 in good yield and excellent selectivity. Esters 362 and 363, 
both intermediates from Paterson’s synthesis, were easily gained by oxidative cleavage of 
the terminal double bond, followed by esterification. Thus providing the first formal synthesis 
goal in 17 steps and 27% yield. Additionally, more highly advanced intermediate 415 from 
Smith’s synthesis was generated by stepwise introduction of the five contiguous C16-C21 
stereogenic centers when a more convergent approach failed due to a mismatched transition 
state in the aldol connection. Thus, the second formal synthesis goal was reached in 27 
steps and 7.2% yield.  
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7. Results and Discussion - Peloruside A 
7.1. Retrosynthetic Analysis 
Peloruside A contains the trisubstituted (Z)-double bond between C16 and C17 in form of a 
methyl branched side chain. Thus, simple diol 416 featuring one stereogenic center and the 
trisubstituted (Z)-double bond was aimed for as formal synthesis goal (Scheme 149), which 
can be led back to δ-lactone 417 as fragmentation precursor. 
 
Scheme 149: Retrosynthethic analysis of peloruside A (2). 
To synthesize δ-lactone 417 an aldehyde equivalent 418 and a 1,3-dicarbonyl compound 
419 containing the quaternary stereocenter is required (Scheme 150). As fragmentation 
precursor the indicated configuration of δ-lactone 417 was chosen as the ethyl group in  
γ-position will be in equatorial position and thus make introduction of the mesyl group easier 
compared to the discodermolide precursor 340 with the axial γ-subsitutent. 
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Scheme 150: Synthetic strategy for peloruside A fragment 420. 
In following the synthetic approaches are mentioned depending on their strategy to introduce 
the stereogenic quaternary center. 
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7.2. α-Alkylation of Menthyl Tiglate 
A quaternary center containing a vinyl moiety can be gained by reaction of the lithium enolate 
of menthyl tiglate (423) with formaldehyde (Scheme 151).[118] In this case the menthyl group 
does not act as chiral auxiliary by inducing stereoselectivity as in Braun’s generation of 
quaternary center (chapter 6.4.) but, as the authors claim, as an auxiliary to enable 
separation of the diastereomeric product mixture by chromatography. Thus, menthyl ester 
423 was prepared under Steglich conditions in good yield and used in the following aldol 
addition. To accomplish acceptable yields paraformaldehyde had to be cracked thermally 
and introduced as gas into the reaction mixture containing the enolate at low temperatures. 
Unfortunately, separation of the diastereomeric product mixture is only possible by HPLC 
using chiral columns, which makes this strategy not viable due to the early stage where 
separation is necessary.  
 
Scheme 151: Generation of the quaternary center. 
Additionally, aldol addition with aldehyde 425 derived from (S)-Roche ester (ent-182) was 
tested to gain aldol adduct 426 via a Felkin-Anh transition state in a hopefully double 
stereodifferentiating way. Regrettably, this reaction did not proceed at all presumably due to 
too much steric hindrance. When simple formylation with methyl formate was tested also no 
formylation product was observed.  
 
Scheme 152: Aldol addition of aldehyde 425 with menthyl ester 423.  
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7.3. Enzymatic Desymmetrization with PLE 
7.3.1. Quaternary Center by Desymmetrization 
Mono acid 428 was known to be derived in excellent enantiomeric excess from incubation of 
meso malonate 427 with PLE (Scheme 153), which can be easily transformed into the 
corresponding aldehyde and used to build up the carbon skeleton of the fragmentation 
precursor in an aldol addition.[119] 
 
Scheme 153: Known mono acid 428. 
Thus, meso malonate 427 had to be prepared first and therefore tert-butyl chloromethyl ether 
was needed, which can be generated via free radical chlorination by irradiation of tert-butyl 
methyl ether with N-chlorosuccinimide or in a two step procedure via the tert-butyl 
methoxymethyl ether by cleavage with boron trichloride (Scheme 154).[120] Alkylation of 
dimethyl malonate 186 with tert-butyl chloromethyl ether gave malonate 429 in moderate 
yields and was followed by methylation to build up the quaternary center in malonate 427. 
Enzymatic hydrolysis with PLE in aqueous buffer system to mono acid 428 worked smoothly 
and in excellent yield. Again it was observed that biphasic systems elongated the reaction 
times.  
 
Scheme 154: Preparation of meso malonate 427. 
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7.3.2. Fragmentation Precursor 
The carboxylate was regioselectively reduced to the alcohol in the already known two step 
sequence via the mixed anhydride and oxidized to aldehyde 430 with IBX. To build up the 
complete carbon skeleton of the fragmentation precursor a syn selective Evans aldol reaction 
was designated (Scheme 155). Thus, Evans’ auxiliary 372 was acylated with butyryl chloride 
to provide 37, which was treated with freshly prepared dibutylboron triflate to generate the 
(Z)-enolate for the aldol addition with aldehyde 430. Aldol adduct 431 could be gained in 
good yield as a single diastereoisomer despite a possible sterical clash between the alkyl 
group of the enolate and the bulky α-substituents of the aldehyde.[121, 122] The most crucial 
parameter was the concentration, as conversion stopped early in diluted reaction mixtures. 
Furthermore, freshly prepared dibutylboron triflate was essential as with aged stock solutions 
product mixtures were observed. 
 
Scheme 155: Syn selective Evans aldol addition. 
The reductive removal of the auxiliary turned out to be tricky as free diol 432 was prone to 
cyclize to lactone 433 which is then reduced by excess lithium boronhydride to lactol 434 
(Scheme 156, Table 10). Lactone 433 and lactol 434 are inseparable by column 
chromatography. Lactol 434 can be reoxidized with manganese oxide in DCM in a very mild 
and selective way to lactone 433 without affecting the β-hydroxyl group, a huge excess of 
activated oxidants and long reaction times in the range of days are needed. 
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Scheme 156: Reductive removal of the auxiliary. 
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eq. (LiBH4) T rxn time solvent products 
2 -20 °C 3 h Et2O, 0.25% MeOH 21% 432 
1.5 -20 °C 4 h Et2O, 0.5% MeOH 28% 432; 29% 434 
1.5 -20 °C 3 h Et2O, 0.5% H2O decomposition 
1.5 -20 °C 3 h THF no rxn 
1.3 -10 °C 0.5 h Et2O, 2% MeOH 66% 432 
1 0 °C 0.5 h Et2O, 2% MeOH 25% 432, 27% 434 
1 0 °C 0.5 h Et2O, 1% MeOH 56% 432, 12% 434 
1 0 °C 0.5 h Et2O, 0.5% MeOH 80% 432 
0.75 0 °C 0.5 h Et2O, 2% MeOH 26% 432, 27% 434, 25% 431 
Table 10: Conditions for reductive removal of the auxiliary. 
Treatment of dihydroxy ester 432 with potassium carbonate in methanol gave desired  
δ-lactone 433 in quantitative yield, other bases such as lithium hydroxide in THF worked as 
well but in significantly lower yield. Introduction of the mesylate as leaving group was 
accomplished in almost quantitative yield with DMAP as additive (Scheme 157).  
 
Scheme 157: Synthesis of the fragmentation precursor 435. 
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7.3.3. Fragmentation 
The fragmentation reaction worked smoothly via the chair transition state to give desired  
(Z)-olefin 437 in high yields and as a single diastereoisomer (Scheme 158). Special attention 
had to be paid to the work up as homoallylic alcohol 437 is volatile. 
O O
OtBu
OMs OH
OtBu
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OH
OtBu
(83%)
LiOH
435 437436  
Scheme 158: Fragmentation reaction. 
To intercept a formal synthesis intermediate a protecting group change was necessary. 
Thus, the free alcohol was protected as TIPS ether and then the tert-butyl ether had to be 
cleaved selectively. Unfortunately, all attempts regenerated 437 or cleaved both ethers. 
Therefore benzyl was used as protecting group which could be installed by silver mediation 
in benzyl bromide as solvent.[123] Catalytic amounts of TFA yielded monoprotected diol 438 
an intermediate form Gosh’s synthesis (Scheme 159).[124] 
 
Scheme 159: Protecting group manipulations. 
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7.4. Summary – Peloruside A 
For the generation of the simple peloruside A intermediate 438 from Ghosh’s synthesis 
enzymatic desymmetrization was used again to install the quaternary center. Evans 
aldolization set the remaining stereocenters and built up the fragmentation precursor. 
Hydroxide induced fragmentation via the chair transition state provided desired (Z)-olefin 
437. Now only a change of protecting groups was necessary to finish the formal synthesis in 
10 steps and 34% yield.  
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8. Results and Discussion - Nucleophile Additions to an 
Aldehyde with Quaternary α-Center 
Due to the unanticipated behavior of aldehyde 212 in the aldol addition to generate the 
fragmentation precursor for epothilone B, the nucleophile addition to this kind of aldehydes 
with quaternary α-centers, where one of the substituents is an ester functionality, was 
investigated.  
Thus, aldehyde 439 was generated as substrate from alcohol 197 by oxidation with IBX 
(Scheme 160). 
 
Scheme 160: Aldehyde 439 with quaternary α-center. 
 
8.1. Allylation 
8.1.1. Allylation with Chiral Allyl Reagents  
The allylation methods developed by Roush and Brown use modified allyboronates featuring 
either enantiomerically pure tartrate or isopinocampheyl esters which are broadly used for 
the diastereo- and enantioselective addition to aldehydes.[125-127] Thus, the chiral 
allylboronates were prepared and used for the allyl addition to aldehyde 439 (Scheme 161). 
In general generation of the (R)-configured newly formed stereocenter was expected to be 
favored from experience with the aldol addition in the fragmentation precursor synthesis.  
 
Scheme 161: Roush and Brown allylation of aldehyde 439. 
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All allylation reactions were found to give as major diastereoisomer 440 in (R)-configuration 
(Table 11). This means that with aldehyde 439 substrate control completely overruled the 
reagent control of the reaction. When both, the substrate and reagent control, induced  
(R)-configuration yields and diastereomeric ratios were excellent. Only in the mismatched 
cases the diastereomeric ratio dropped still favoring product 440 as major diastereoisomer, 
despite reagent control for 441 and hence the (S)-configuration.  
reagent (ligand) yield 440:441 
(-)-iPc 51% 3:1 
(+)-iPc quant. 20:1 
L-(+)-DIPT 69% 8:1 
D-(-)-DIPT 60% 20:1 
Table 11: Roush and Brown allylation of aldehyde 439. 
 
8.1.2. Allylation with Achiral Allyl Reagents  
The results of investigating the Sakurai reaction were exactly as described in all textbooks: 
the boron Lewis acid reacted via the open transition state to generate exclusively Felkin-Anh 
product 440, whereas titanium tetrachloride induced the chelated transition state which led to 
(S)-product 441.[128, 129] With allystannane and chelating Lewis acids (S)-product 441 was 
found again as the major product however in a lower diastereomeric ratio (Scheme 162, 
Table 12). 
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Scheme 162: Allyl addition to aldehyde 439. 
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LA T X yield 440:441 
BF3·Et2O -78 °C TMS 84% 440 
TiCl4 -78 °C TMS 85% 441 
TiCl4 -78 °C SnBu3 quant. 1:2 
MgBr2·Et2O r.t. SnBu3 87% 1:7 
Table 12: Allyl addition to aldehyde 439. 
To prove the configuration of the newly formed stereogenic homoallyl centers, the hydroxy 
esters 440 and 441 were converted into the corresponding β-lactones 442 and 443 (Scheme 
163) by saponification and esterification under carboxylate activation to retain the 
configuration of the β-position. NOE experiments confirmed the relative configuration 
between α- and β-position. 
 
Scheme 163: Transformation into the β-lactones.  
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8.2. Aldol Additions 
Next aldol additions were tested; here different ways of controlling the stereochemical 
outcome on the one hand from the aldehyde and on the other hand from the enol compound 
were investigated. 
 
8.2.1. Boron Enolates[96] 
In the Paterson aldol addition the stereocontrol comes from the methyl center of the ethyl 
ketone and the enolate geometry. Thus with ethyl ketone 380 in the anti-anti-selective as well 
as in the syn-syn-selective reaction the newly formed hydroxyl center has (R)-configuration, 
which is the matched double-stereodifferentiating case in accordance with substrate control 
from aldehyde 439 (Scheme 164). This was also found in the products, as there was in 
general a good diastereomeric ratio. 
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Scheme 164: Matched boron mediated aldol additions. 
When ethyl ketone ent-380 was used, the stereocontrol from the borone enolate induces the 
(S)-configuration, which is the unfavored outcome concerning the aldehyde. This 
mismatched constellation was clearly represented in the 1:1 diastereoisomeric mixture of the 
products (Scheme 165).  
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Scheme 165: Mismatched boron mediated aldol additions. 
The aldol additions with acylated Evans’ auxiliary 37 as enol compound further confirmed the 
above mentioned results. In the syn-selective aldol reaction, the matched case, product 449 
with (R)-configuration of the newly formed hydroxyl group was obtained in a good 
diastereomeric ratio. Whereas the anti-selective Evans aldolization would lead to the  
(S)-configuration in product 448, which is the mismatched configuration concerning the 
aldehyde compound, represented by a low diastereomeric ratio (Scheme 166).  
 
Scheme 166: Evans aldol additions. 
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8.2.2. Lithium Enolates 
Aldol addition between aldehyde 439 and the lithium enolates of methyl ketone 450 and 452, 
very similar to the one already described in the epothilone precursor synthesis, was 
investigated (Scheme 167, Table 13). Here the (R)-configured product was the only product 
found. Despite the use of chelating Lewis acids only reactions via a Felkin-Anh transition 
state were observed.  
 
Scheme 167: Aldol addition with lithium enolates.  
R LA yield 
H MgBr2·Et2O 91% 
H TiCl4 no rxn 
H - 97% 
OMe MgBr2·Et2O 71% 
OMe TiCl4 no rxn 
OMe - 72% 
Table 13: Aldol addition with lithium enolates.  
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8.2.3. Mukaiyama Aldol reaction 
Mukaiyama aldol reactions between various silyl enol ethers of methyl ketones 450 and 452 
with aldehyde 439 were investigated (Scheme 168, Table 14). The tert-butyldimethyl silyl 
enol ethers proved to be very stable and induction of the reaction was only possible with the 
very strong Lewis acid titanium tetrachloride. The same was observed for the trimethyl silyl 
enol ethers. Selectivity of the reactions was excellent, as only a single product, the  
(S)-configured Cram chelate product was observed. However yields were low to moderate 
and dropped with longer reaction times.  
 
Scheme 168: Mukaiyama aldol addition. 
R LA SiR’3 yield 
H MgBr2·Et2O TBS no rxn 
H TiCl4 TBS 35% 
H SnCl4 TBS no rxn 
H MgBr2·Et2O TMS no rxn 
H SnCl4 TMS no rxn 
H TiCl4 TMS 42% (1 h), 34% (2.5 h) 
OMe TiCl4 TMS 59% 
Table 14: Mukaiyama aldol addition. 
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8.3. Fragmentations 
8.3.1. Fragmentation Precursors 
To prove the relative configuration between α- and β-center of the adducts gained in the aldol 
additions, the corresponding δ-lactones were prepared and NOE experiments verified the 
before assumed stereochemical arrangement.  
Thus, all four diastereoisomers were reduced to the syn diols with catecholborane and 
saponification with lithium hydroxide in THF was followed by EDC mediated cyclization to the 
δ-lactones (Scheme 169). 
 
Scheme 169: Fragmentation precursors from syn dihydroxy esters. 
Evans-Carreira anti-reduction of the four diastereoisomers led to the anti diols and was 
followed by saponification with lithium hydroxide and cyclization to the δ-lactones (Scheme 
170). 
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Scheme 170: Fragmentation precursors from anti dihydroxy esters. 
 
8.3.2. Fragmentations 
With the δ-lactones in hand installation of a mesylate as leaving group gave the 
fragmentation precursors, which were tested under fragmentation conditions. 
The fragmentation precursors derived from the anti diols fulfill all stereochemical 
requirements for the fragmentation via the chair transition state and thus gave smoothly only 
the olefins (Scheme 171). 
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Scheme 171: Fragmentation via the chair transition state. 
On the other hand, the fragmentation precursors derived from the syn diols have the leaving 
group in the axial position and thus make fragmentation via the chair transition state 
stereochemically impossible. However, fragmentation occurred again, presumably via the 
open carboxylate to form the olefin and β-lactone from SN2 attack of the carboxylate on the 
leaving group, respectively (Scheme 172).  
 
Scheme 172: Fragmentation via an open transition state. 
It was observed that fragmentation precursors with all large substituents in equatorial 
position gave lower yields in the fragmentation reaction whereas when the allyl moiety was 
axial better yields were obtained. This might be due to saponification as side reaction 
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notwithstanding a dihydroxy acid was never isolated. As this is a very hydrophilic compound, 
this is not further surprising. With the allyl moiety in axial position the strain might be bigger 
and thus fragmentation might occur faster, suppressing side reactions.  
 
8.4. Aldol Addition of an Ethyl Ketone featuring a Quaternary 
α-Center 
To further probe the influence of a quaternary α-center in aldol reaction, the connectivity was 
reversed. Thus, ethyl ketone 487 was prepared starting from known aldehyde 439 to give 
after Gringard addition secondary alcohol 486 in a 4:1 diastereomeric ratio, which was further 
oxidized to ethyl ketone 487 with IBX (Scheme 173). 
 
Scheme 173: Preparation of ethyl ketone 487. 
When ethyl ketone 487 was converted into the (Z)-enolate and treated with aromatic 
aldehyde 488 and 490 a 1:1 diastereomeric mixture of syn-aldol adducts was generated 
(Scheme 174). This implies that a quaternary α-center is not able to induce stereoselectivity 
in contrast to tertiary centers like the often used chiral α-methyl groups for the Paterson aldol 
addition demonstrates.  
 
Scheme 174: Aldol addition of (Z)-boron enolates.  
The aldol addition via the (E)-boron enolate was also attempted but did not give any results 
(Scheme 175).  
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Scheme 175: Aldol addition of (E)-boron enolates.  
 
8.5. Summary - Nucleophile Additions 
In the allylation of aldehyde 439 the stereochemical outcome correlated with the nature of the 
Lewis acid, giving the Cram chelate product with TiCl4, SnCl4 and MgBr2·Et2O and the  
Felkin-Anh product with BF3·Et2O. When Brown or Roush allylation protocols were tested, 
substrate control overruled the reagent control and the chiral ligands were only able to 
modify this basic trend. This behavior was also observed in the Paterson aldol additions 
giving in the matched cases good to acceptable selectivity and in the mismatched cases 1:1 
mixtures. The aldol additions of aldehyde 439 and the lithium enolates of methyl ketone gave 
in excellent selectivity always the Felkin-Anh adduct through substrate control. Whereas in 
Mukaiyama aldol reaction with chelating Lewis acids the Cram chelate products were 
isolated, although in moderate to low yields but in excellent selectivity. Conversion of the 
aldol adducts into the δ-lactones provided new fragmentation precursors which were tested 
under fragmentation conditions. The δ-lactones derived from the anti dihydroxy esters fulfill 
all stereochemical requirements for the fragmentation via the chair transition state and gave 
smoothly only the olefins. Whereas the δ-lactones derived from the syn dihydroxy esters 
reacted presumably via the open carboxylate and both olefin and β-lactone were obtained. 
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9. Conclusion and Outlook 
The aim of this Ph.D. research was to establish a new hydroxide induced Grob-type 
fragmentation as methodology for the generation of methyl branched trisubstituted  
(Z)-olefins. Therefore, three formal syntheses with the fragmentation as olefination step were 
developed. Thus, β-mesyloxy lactones with three stereogenic centers, one of them 
quaternary, had to be prepared.  
In the epothilone B synthesis two different strategies where developed one relying on the 
introduction of the quaternary center at an early stage and using this as relay to establish the 
remaining stereocenters and the other generated the quaternary center by α-allylation of  
β-keto lactone 262 (chapter 5). As the introduction of the quaternary center at the beginning 
of the synthesis proved more reliable, the formal synthesis of discodermolide (chapter 6) and 
peloruside A (chapter 7) employed this strategy. As means of enantioselective generation of 
the quaternary centers on the one hand enzymatic desymmetrization of meso malonates 193 
and 427 was used and on the other hand organoaluminum-promoted rearrangement of chiral 
epoxide 342. All fragmentation precursors were built up by aldol strategy. Fragmentation 
worked in all cases smoothly giving the desired (Z)-olefins in high yield and excellent 
selectivity. The olefin geometry was determined by the relative configuration between α- and 
β-center.  
The scope of the fragmentation was tested by using different diastereomeric δ-lactones and 
acyclic fragmentation precursors (chapter 5 and 8). As general trend δ-lactones derived from 
the anti dihydroxy esters fulfill all stereochemical requirements for the fragmentation via the 
chair transition state and gave smoothly only the olefins. Whereas the δ-lactones derived 
from the syn dihydroxy esters reacted presumably via the open carboxylate to give the olefin 
and β-lactones from SN2 attack of the carboxylate on the β-position. As thermolysis of the  
β-lactones generated additional amounts of the olefin a uniform product was obtained in both 
cases in excellent selectivity and good yields. For open chain fragmentation precursor 251 
steric hindrance by the quaternary center was observed which had to be evaded by 
fragmentation of corresponding aldehyde 254.  
Based on the unusual behavior of aldehyde 212 nucleophilic additions to aldehyde 439 with 
quaternary α-center were briefly investigated. The results led to the conclusion that with this 
kind of 1,3-dicarbonyl compounds substrate control overrules reagent control in case of 
Brown or Roush allylation; whereas allylation with achiral reagents is predictable according to 
the nature of the Lewis acid. In boron aldol additions the induction from the enol compound is 
not sufficient. Chelation in aldol additions is only possible with very strong Lewis acids. 
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The hydroxide induced Grob-type fragmentation presents a versatile tool for the 
stereoselective synthesis of trisubstituted double bonds. The fragmentation is easy to 
perform, works very fast and the conditions are compatible with nearly all functional groups. 
The different substituents on the fragmentation precursors can be freely selected to give a 
broad range of olefins which can be transformed further into interesting synthetic 
intermediates.  
To extend the scope of this method even further, it would be interesting to investigate 
fragmentation precursors with two elaborated α-substituents, to generate more complex 
trisubstituted olefins. The introduction of a second β-substituent, thereby generating two 
vicinal quaternary centers, to gain tetrasubstituted olefins would be a great challenge. 
Additionally more nucleophiles, different from hydroxide or carbon nucleophiles, to induce the 
fragmentation could be tested. 
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10. Experimental Section 
10.1. General Experimental 
Synthetic Methods  
The following general procedures were used in all reactions unless otherwise noted. 
Reaction vessels were dried by repeated heating under vacuum (heat gun) followed by 
purging with dry argon. Oxygen- and moisture sensitive reactions were carried out under a 
slight argon overpressure (balloon) and in dry solvents. Sensitive liquids and solutions were 
transferred by double tipped needle or syringe through rubber septa. All reactions were 
stirred magnetically. Solvents for palladium catalysed coupling reactions, cross metathesis 
and aluminium promoted rearrangement were degassed by “pump-freeze-thaw” method.  
 
Solvents 
All solvents (hexane, ethyl acetate, dichloromethane, diethyl ether) were distilled prior to use. 
Anhydrous solvents were stored under argon over molecular sieve (4 Å). Diethyl ether and 
tetrahydrofuran was distilled from sodium/benzophenone, toluene from sodium. 
Dichloromethane and acetone were dried over phosphorpentoxide. Acetonitrile, 
diisopropylamine, dimethylformamide, 2,6-lutidine and triethylamine were distilled from 
calcium hydride. Methanol was refluxed over magnesium filings for several hours and then 
distilled. Pyridine was distilled from potassium hydroxide. All other solvents were HPLC 
grade. 
 
Chemicals 
All commercially available reagents were used without further purification unless stated 
otherwise. 
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Chromatography 
Thin-layer chromatography (TLC) 
All reactions were monitored using Merck silica gel 60 F254 plates. UV active spots were 
detected at longwave UV (254 nm) and shortwave UV (180 nm). For visualizing the following 
reagents were use: Anisaldehyde [anisaldehyde (6 g) in ethanol (250 mL) and conc. H2SO4 
(25 mL)], Ceric(IV) sulfate [Ce(SO4)2 (0.1 g), phosphormolybdic acid (20 g) in H2SO4 (10%, 
400 mL)], Vanilline [vanilline (0.5 g) in ethanol (20 mL) and H2SO4 (15%, 80 mL)]. 
Column Chromatography 
Preparative column chromatography was performed with silica gel 60 from Merck (0.040 - 
0.063 µm, 240 - 400 mesh). 
Analytic and preparative HPLC 
For the determination of diastereomeric ratios in analytic scale a Jasco System (PU-980 
pump, UV-975 UV detector, RI-930 RI detector) with a Nucleosil 50 column (5 μm, 4 mm x 
241 mm) at ambient temperature was used. Preparative HPLC was preformed on a Dynamix 
System (SD-1 pump, UV-1 UV-detector (λ = 254 nm)) using a Supersphere 60 Si column  
(4 µm, 25 mm x 250 mm, Merck) at ambient temperature. 
 
Spectroscopy 
NMR Spectroscopy 
NMR spectra were recorded on either a Bruker Avance DPX 250 MHz, a Bruker Avance 
DPX 400 MHz or a Bruker Avance DPX 600 MHz spectrometer, measured unless otherwise 
stated in CDCl3 solutions and referenced to the residual CHCl3 signal (δH = 7.26, δC = 77.00). 
All chemical shifts are given in ppm (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, b = broad) and all coupling constants J are given in Hz. Assignment of proton 
resonances were confirmed, when possible, by correlation spectroscopy.  
Mass Spectroscopy  
Mass spectra were measured on a Micro Mass, Trio200 Fisions Instrument. High resolution 
mass spectra (HRMS) were preformed with a Finnigan Mat 8230, with a resolution of 10000. 
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Infrared Spectroscopy 
IR spectra were recorded as thin film on a silicon plate with a Perkin-Elmer 1600 FT-IR 
spectrometer. 
 
Polarimetry 
Optical rotations were measured on a P 341 Perkin-Elmer polarimeter in a 10 cm cell at  
20 °C with 589 nm wavelength. The concentration c is given in g/100 mL. 
[ ]
c
100  
d
α α measured20D ⋅=  
 
Melting points 
Melting points (mp) were determined on a Leica Galen III apparatus and are uncorrected.  
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10.2. Experimental Procedures  
10.2.1. Epothilone B: Pig Liver Esterase Route 
2-Allyl-2-methyl-malonic acid dimethyl ester (193) 
MeO
O
OMe
O
 
Malonate 192 (1.20 g, 69.60 mmol) in THF (50 mL) was added to a stirred suspension of 
NaH (3.05 g, 60% dispersion in mineral oil, 76.56 mmol) in THF (150 mL) at 0 °C and stirring 
was continued for 1 h. MeI (8.3 mL, 139.20 mmol) was added and the mixture warmed to r.t. 
over night. The reaction was quenched with saturated NH4Cl solution, layers were separated 
and the aqueous solution was extracted with Et2O. The combined organic layers were dried 
over MgSO4 and the solvent was evaporated. The crude product was purified by column 
chromatography (hexane:EtOAc = 5:1) to yield 1.20 g (93%) of 193 as pale yellow oil.  
Rf = 0.64 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.74-5.63 (m, 1H), 5.12-5.08 (m, 2H), 3.72 (s, 6H), 2.61 (d,  
J = 7.36 Hz, 2H), 1.40 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 172.3, 132.5, 119.1, 53.6, 52.4, 40.2, 19.8.  
HRMS (ESI) (m/z): [M]+ calcd for C9H14O4: 186.0892, found: 186.0888. 
 
(S)-2-Allyl-2-methyl-malonic acid monomethyl ester (194) 
HO
O
OMe
O
 
To malonate 193 (3.00 g, 16 mmol) suspended in 0.05M KH2PO4 buffer (50 mL) at pH 7 was 
added PLE and via a pH-stat-controlled burette 0.5M NaOH (32 mL) was added over 48 h. 
After addition was completed, 1N NaOH was added to the mixture to reach pH 10 and by-
products were removed with Et2O. Upon acidification with 3N HCl to pH 1 mono acid 194 
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was extracted with DCM, the organic layers were dried over MgSO4 and the solvent was 
evaporated. For analytical purposes a sample was purified by column chromatography 
(hexane:EtOAc = 3:1 to 1:1) giving 2.48 g (90%) of mono acid 194. 
Rf = 0.08 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.76-5.66 (m, 1H), 5.15-5.11 (m, 2H), 3.75 (s, 3H), 2.66 (dd,  
J = 14.12, 7.40 Hz, 1H), 2.60 (dd, J = 14.10, 7.40 Hz, 1H), 1.44 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 177.0, 172.3, 132.2, 119.5, 53.5, 52.7, 40.2, 19.9.  
IR (film): 2076, 1716, 1642, 1231, 1068 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C8H12O4: 172.0736, found: 172.0734.  
[α]D20 1.32 (c = 2.8, CHCl3) 
 
(S)-2-Methyl-2-propyl-malonic acid monomethyl ester (195) 
 
Mono acid 194 (50 mg, 0.29 mmol) and Pd/C (10 mg, 5%) in ethyl acetate (2 mL) were 
stirred for 2 h under hydrogen atmosphere. The catalyst was filtered off over celite and the 
solvent was removed to yield 49 mg (98%) of hydrogenation product 195 as colorless oil. 
Rf = 0.09 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.76 (s, 3H), 1.93-1.80 (m, 2H), 1.46 (s, 3H), 1.33-1.23 (m, 
2H), 0.93 (t, J = 7.20 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.9, 172.2, 53.6, 52.7, 38.2, 20.3, 17.9, 14.2.  
HRMS (ESI) (m/z): [M-OCH3]+ calcd for C7H11O3 : 143.0708, found: 143.0706.  
[α]D20 -1.92 (c = 2.45, CHCl3) 
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(S)-2-Hydroxymethyl-2-methyl-pent-4-enoic acid methyl ester (197) 
 
To a solution of mono acid 194 (4.20 g, 25.00 mmol) in THF (30 mL) at 0 °C, was added 
triethylamine (3.9 mL, 27.50 mmol) followed by methyl chloroformate (2.1 mL, 27.50 mmol). 
After 10 min at 0 °C, the reaction mixture was warmed to r.t. and stirred for 45 min. The white 
precipitate was filtered off, washed with Et2O and the combined organic phase was 
concentrated. The residue was dissolved in methanol (25 mL) and cooled to 0 °C where 
NaBH4 (1.88 g, 50.00 mmol) was added portion wise. After 1 h the reaction was carefully 
quenched with a saturated solution of NH4Cl and extracted with DCM. The combined organic 
layer was dried over MgSO4 and the solvent was removed under reduced pressure. Column 
chromatography (hexane:EtOAc = 3:1) gave 2.95 g (75%) of alcohol 197. 
Rf = 0.34 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.80-5.69 (m, 1H), 5.11-5.07 (m, 2H), 3.71 (s, 3H), 3.68 (dd,  
J = 11.35, 6.85 Hz, 1H), 3.53 (dd, J = 11.36, 6.56 Hz, 1H), 2.34 (d, J = 7.56 Hz, 1H), 2.29 (t, 
J = 6.82 Hz, 1H), 1.17 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 177.1, 133.2, 118.5, 67.8, 51.9, 47.8, 39.9, 19.5.  
IR (film): 3435, 2979, 1725, 1641, 1437, 1045 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C8H14O3: 158.0943, found: 158.0933. 
[α]D20 -4.40 (c = 1.5, CH2Cl2) 
 
MTPA esters of 197: 
General Procedure:  
To a solution of alcohol 197 (10 mg, 0.063 mmol) in DCM (1 mL) at r.t. was added 
triethylamine (0.1 mL) and a catalytic amount of DMAP. MTPACl (24 μL, 0.128 mmol) was 
added and the mixture was stirred for 1.5 h. A saturated NH4Cl solution was added and the 
layers were separated. The aqueous layer was extracted with DCM, the combined organic 
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layer was dried over MgSO4 and the solvent was evaporated. Purification by column 
chromatography (hexane:EtOAc = 10:1) yielded 20 mg (90%) of the MTPA esters. 
1H-NMR, 19F-NMR and HPLC analysis confirmed a 95:5 ratio of major to minor MTPA 
diastereoisomer.  
 
(R)-MTPA ester (198) 
 
Major: 
1H-NMR (400 MHz, CDCl3): δ = 7.49 (m, 2H), 7.39 (m, 3H), 5.71-5.60 (m, 1H), 5.10-5.00 (m, 
2H), 4.42 (d, J = 10.84 Hz, 1H), 4.28 (d, J = 10.88 Hz, 1H), 3.62 (s, 3H), 3.52 (s, 3H), 2.36 
(dd, J = 14.04, 7.44 Hz, 1H), 2.31 (dd, J = 13.9, 7.58 Hz, 1H), 1.20 (s, 3H). 
Minor: 
1H-NMR (400 MHz, CDCl3): δ = 7.49 (m, 2H), 7.39 (m, 3H), 5.71-5.60 (m, 1H), 5.10-5.00 (m, 
2H), 4.39 (d, J = 10.88 Hz, 1H), 4.31 (d, J = 10.88 Hz, 1H), 3.63 (s, 3H), 3.52 (s, 3H), 2.36 
(dd, J = 14.04, 7.44 Hz, 1H), 2.31 (dd, J = 13.9, 7.58 Hz, 1H), 1.20 (s, 3H). 
 
(S)-MTPA ester (199) 
 
Major: 
1H-NMR (600 MHz, CDCl3): δ = 7.49 (m, 2H), 7.40 (m, 3H), 5.70-5.62 (m, 1H), 5.10-5.02 (m, 
2H), 4,39 (d, J = 10.85 Hz, 1H), 4.31 (d, J = 10.85 Hz, 1H), 3.63 (s, 3H), 3.52 (s, 3H), 2.35 
(dd, J = 13.91, 7.55 Hz, 1H), 2.31 (dd, J = 14.03, 7.67 Hz, 1H), 1.20 (s, 3H). 
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Minor: 
1H-NMR (600 MHz, CDCl3): δ = 7.49 (m, 2H), 7.40 (m, 3H), 5.70-5.62 (m, 1H), 5.10-5.02 (m, 
2H), 4.42 (d, J = 10.85 Hz, 1H), 4.27 (d, J = 10.85 Hz, 1H), 3.62 (s, 3H), 3.52 (s, 3H), 2.35 
(dd, J = 13.91, 7.55 Hz, 1H), 2.31 (dd, J = 14.03, 7.67 Hz, 1H), 1.20 (s, 3H). 
 
(R)-2-Allyl-2-methyl-malonic acid tert-butyl ester methyl ester (201) 
 
To acid 194 (100 mg, 0.58 mmol) in DCM (2 mL) was added a catalytic amount of H2SO4conc. 
and isobutene (1 mL) at -78 °C. The mixture was stirred in a sealed tube for 48 h at r.t.. The 
organic phase was washed with brine, saturated NaHCO3 solution and brine and was dried 
over MgSO4 and the solvent was removed under reduced pressure. Purification by column 
chromatography (hexane:EtOAc = 10:1) yielded 100 mg (75%) of diester 201 and 25 mg 
(25%) of acid 194. 
Rf = 0.64 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.75-5.65 (m, 1H), 5.13-5.08 (m, 2H), 3.71 (s, 3H), 2.57 (d,  
J = 7.32 Hz, 2H), 1.43 (s, 9H), 1.35 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 172.8, 170.8, 132.8, 118.9, 81.5, 54.1, 52.2, 40.1, 27.8, 
19.7.  
IR (film): 1732, 1369, 1296, 1253, 1146, 1114 cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C11H17O4: 213.1127, found: 213.1131.  
[α]D20 8.42 (c = 1.2, CH2Cl2) 
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(R)-2-Hydroxymethyl-2-methyl-pent-4-enoic acid tert-butyl ester (492) 
 
To diester 201 (100 mg, 0.44 mmol) in THF (3 mL) at -78 °C was added DIBALH (0.67 mL, 
1.5M in toluene, 1.01 mmol) and the mixture was allowed to reach -20 °C over 7 h. The 
reaction was quenched with methanol, a saturated sodium potassium tartrate solution was 
added and the mixture was stirred for 2 h. Layers were separated and the aqueous layer was 
extracted with hexane:Et2O (1:1). The combined organic layers were dried over MgSO4 and 
the solvent was removed under reduced pressure. Purification by column chromatography 
(hexane:EtOAc = 5:1) yielded 43 mg (49%) of alcohol 492 and 25 mg (25%) of diester 201. 
Rf = 0.27 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.82-5.71 (m, 1H), 5.12-5.06 (m, 2H), 3.64 (dd, J = 11.24, 
6.92 Hz, 1H), 3.48 (dd, J = 11.36, 6.56 Hz, 1H), 2.41 (t, J = 6.82 Hz, 1H (OH)), 2.30 (dd, J = 
7.46, 3.42 Hz, 2H), 1.46 (s, 9H), 1.13 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.1, 133.5, 118.2, 81.1, 67.9, 47.7, 40.2, 28.1, 19.7.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C10H17O3: 185.1178, found: 185.1175.  
 
(R)-2-Formyl-2-methyl-pent-4-enoic acid tert-butyl ester (202) 
tBuO
O O
 
Dess-Martin periodinane (824 mg, 2.16 mmol) was added portion wise to a solution of 
alcohol 492 (100 mg, 0.54 mmol) in DCM (2 mL) at 0 °C. After 4 h at r.t. a saturated solution 
of NaHCO3 was added, the layers were separated and the aqueous layer was extracted with 
DCM. The combined organic phase was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 10:1) yielded 75 mg (75%) of aldehyde 202 as 
colorless oil. 
Experimental Section 
 127
Rf = 0.74 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.66 (s, 1H), 5.75-5.64 (m, 1H), 5.15-5.10 (m, 2H), 2.58 (dd,  
J = 14.02, 7.20 Hz, 1H), 2.46 (dd, J = 14.02, 7.45 Hz, 1H), 1.46 (s, 9H), 1.25 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 199.6, 170.8, 132.0, 119.2, 82.3, 57.8, 38.6, 28.0, 16.8.  
IR (film): 1721, 1369, 1252, 1148 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C11H18O3: 198.1256, found: 198.1261.  
[α]D20 7.11 (c = 0.45, CH2Cl2) 
 
(-)-(2R)-3-(tert-Butyl-dimethyl-silyloxy)-2-methyl-propionic acid methyl ester (493) 
 
To a stirred solution of (R)-methyl-2-hydroxy-2-methylpropionate (182) (2.0 g, 17.0 mmol) 
and imidazole (2.3 g, 34.0 mmol) in DMF (20 mL) was added TBSCl (2.9 g, 22.1 mmol) at 0 
°C and stirring was continued at r.t. for 5 h. The reaction mixture was quenched with water 
and extracted with Et2O. The combined organic solution was dried over MgSO4 and the 
solvent was evaporated. Column chromatography (hexane:EtOAc = 10:1) furnished 3.9 g 
(quant.) of the TBS ether 493 as colorless oil.  
Rf = 0.70 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.76 (dd, J = 9.5, 7.0 Hz, 1H), 3.66 (s, 3H), 3.63 (dd, J = 9.5, 
6.0 Hz, 1H), 2.63 (m, 1H), 1.12 (d, J = 7.0 Hz, 3H), 0.86 (s, 9H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 175.4, 65.2, 51.5, 42.5, 25.6, 18.2, 13.4, -5.5.  
[α]D20 -18.10 (c = 3.03, CHCl3)  
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(-)-(2S)-3-(tert-Butyl-dimethyl-silyloxy)-2-methyl-propan-1-ol (183) 
 
To a stirred solution of DIBALH (11.3 mL, 1.5 M in toluene, 17.0 mmol) in THF (20 mL) at  
-78 °C was added dropwise TBS protected ester 493 (1.9 g, 8.5 mmol). After 6 h the reaction 
mixture was quenched with saturated sodium potassium tartrate solution and the mixture 
was stirred over night. The layers were separated, the aqueous phase extracted with 
hexane:Et2O (1:1) and the combined organic solution was dried over MgSO4. After 
evaporation of the solvent, the crude product was purified by column chromatography 
(hexane:EtOAc = 9:1) to yield 1.47 g (85%) of alcohol 183 as colorless oil. 
Rf = 0.23 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.72 (dd, J = 10.0, 4.0 Hz, 1H), 3.61 (m, 2H), 3.53 (dd, J = 
10.0, 8.0 Hz, 1H), 2.78 (dd, Hz, J = 6.0, 4.5 Hz, 1H), 1.93 (m, 1H), 0.89 (s, 9H), 0.83 (d, J = 
6.5 Hz, 3H), 0.06 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 68.8, 68.3, 37.0, 25.9, 18.2, 13.1, -5.6.  
[α]D20 -20.60 (c = 0.8, CHCl3)  
 
(-)-(2R)-3-(tert-Butyl-dimethyl-silyloxy)-2-methyl-propionaldehyde (494) 
 
To a solution of oxalylchloride (1.26 mL, 14.7 mmol) in DCM (100 mL) at -78 °C was added 
DMSO (2.1 mL, 29.4 mmol) dropwise and the mixture was stirred for 30 min. Alcohol 183 
(1.5 g, 7.35 mmol) in DCM (10 mL) was added and stirring was continued for 1 h before 
triethylamine (6.3 mL, 44.1 mmol) was added. The reaction mixture was shifted to an ice 
bath. After 45 min the reaction mixture was quenched with saturated NH4Cl solution, the 
organic layer separated and the aqueous solution was extracted with DCM. The combined 
organic solution was dried over MgSO4 and the solvent was evaporated. The residue was 
dissolved in hexane:EtOAc (5:1) and filtered over a short plug of silica gel to yield 1.5 g 
(quant.) of aldehyde 494 which was used without further purification.  
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1H-NMR (250 MHz, CDCl3): δ = 9.73 (d, J = 1.6 Hz, 1H), 3.86 (dd, J = 10.2, 5.3 Hz, 1H), 3.80 
(dd, J = 9.5, 5.6 Hz, 1H), 2.60-2.46 (m, 1H), 1.09 (d, J = 7.1 Hz, 3H), 0.88 (s, 9H), 0.06 (s, 
6H). 
 
tert-Butyl-dimethyl-((S)-2-methyl-but-3-enyloxy)-silane (203) 
 
To a stirred suspension of methyltriphenylphosphoniumbromide (5.40 g, 14.8 mmol) in THF 
(30 mL) at 0 °C was added potassium tert-butoxide (1.70 g, 14.8 mmol) and stirring was 
continued for 1 h. Aldehyde 494 (1.4 g, 6.9 mmol) in THF (7 mL) was added and the reaction 
mixture was warmed to r.t.. After 2 h water was added the aqueous layer was extracted with 
DCM. After removal of the solvent olefin 203 (volatile!) was purified by column 
chromatography (pentane) to yield 1.20 g (87%). 
Rf = 0.82 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.81-5.73 (m, 1H), 5.05-4.97 (m, 2H), 3.51 (dd, J = 9.72, 
6.19 Hz, 1H), 3.41 (dd, J = 9.85, 7.07 Hz, 1H), 2.36-2.29 (m, 1H), 0.99 (d, J = 6.82 Hz, 3H), 
0.89 (s, 9H), 0.04 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 141.4, 113.9, 67.9, 40.4, 25.9, 14.1, 3.8, -5.3, -5.4. 
IR (film): 2955, 2929, 1256, 1089 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C11H24OSi: 200.1596, found: 200.1589.  
[α]D20 -6.00 (c = 1.15, CH2Cl2) 
 
2-[(R)-3-(tert-Butyl-dimethyl-silanyloxy)-2-methyl-propylsulfanyl]-benzothiazole (495) 
 
To a solution of DIAD (1 mL, 5.3 mmol) in THF (30 mL) at 0 °C, was added a solution of 
alcohol (494) (1.00 g, 4.9 mmol), 2-mercaptobenzothiazole (870 mg, 5.2 mmol) and triphenyl 
phosphine (1.41 g, 5.4 mmol) in THF (20 mL). After 4.5 h a saturated solution of NaHCO3 
Experimental Section  
 130 
was added and the mixture was filtered over celite. The phases were separated and the 
aqueous phase was extracted with Et2O. The combined organic layer was dried over MgSO4, 
filtered and the solvents were removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 15:1) gave 1.58 g (91%) of product 495 as yellow oil. 
Rf = 0.79 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.85 (d, J = 8.08 Hz, 1H), 7.74 (d, J = 8.08 Hz, 1H), 7.40 (t,  
J = 7.18 Hz, 1H), 7.29 (d, J = 7.32 Hz, 1H), 3.65 (dd, J = 9.98, 5.18 Hz, 1H), 3.56 (dd, J = 
10.08, 5.81 Hz, 1H), 3.51 (dd, J = 13.02, 6.18 Hz, 1H), 3.23 (dd, J = 13.00, 6.96 Hz, 1H), 
2.17-2.09 (m, 1H), 1.07 (d, J = 6.80 Hz, 3H), 0.91 (s, 9H), 0.06 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 162.4, 153.4, 135.2, 125.9, 124.1, 121.5, 120.8, 74.3, 66.4, 
37.0, 36.0, 25.9, 21.6, 16.2, -5.3 -5.4.  
IR (film): 2955, 1461, 1428, 1250, 1095 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C17H27ONSiS2: 353.1303, found: 353.1314.  
[α]D20 -6.41 (c = 1.45, CH2Cl2) 
 
2-[(R)-3-(tert-Butyl-dimethyl-silanyloxy)-2-methyl-propane-1-sulfonyl]-benzothiazole 
(206) 
 
A solution of sulfide 495 (800 mg, 2.24 mmol) in ethanol (8 mL) was added to ammonium 
heptamolybdate tetrahydrate (560 mg, 0.44 mmol) in a 30% hydrogen peroxide solution (2 
mL, 18.25 mmol) at 0 °C. After stirring for 4 h another portion of hydrogen peroxide (0.75 mL, 
6.70 mmol) was added and stirring was continued for 3 h. Brine was added and the aqueous 
layer was extracted with Et2O. The combined organic layer was dried over MgSO4 and 
concentrated under reduced pressure. Column chromatography (hexane:EtOAc = 5:1) gave 
780 mg (90%) of sulfone 206 as pale yellow oil.  
Rf = 0.39 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 8.21 (d, J = 7.08 Hz, 1H), 8.01 (d, J = 8.08 Hz, 1H), 7.66-
7.57 (m, 2H), 3.83 (dd, J = 14.38, 4.54 Hz, 1H), 3.64 (dd, J = 9.84, 4.80 Hz, 1H), 3.44 (dd, J 
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= 9.82, 6.14 Hz, 1H), 3.29 (dd, J = 14.44, 7.88 Hz, 1H), 2.45-2.37 (m, 1H), 1.13 (d, J = 6.68 
Hz, 3H), 0.83 (s, 9H), 0.00 (s, 3H), -0.02 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 166.5, 152.8, 139.2, 136.8, 127.9, 127.6, 125.5, 122.3, 66.3, 
57.6, 34.7, 31.6, 25.8, 16.7, 14.1, -5.5, -5.6.  
IR (film): 3446, 1675, 1471, 1318, 1147 cm-1  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C16H22O3NSiS2: 370.0967, found: 370.0969.  
[α]D20 0.56 (c = 1.25, CH2Cl2) 
 
tert-Butyl-(3-iodo-2-methyl-propoxy)-dimethyl-silane (496) 
 
To a solution of alcohol 183 (200 mg, 0.98 mmol) in acetonitrile (6 mL) and Et2O (5 mL) at 0 
°C was added imidazole (125 mg, 1.93 mmol) followed by triphenyl phosphine (460 mg, 1.75 
mmol) and iodide (465 mg, 1.83 mmol). After 10 min the cooling bath was removed and the 
mixture was stirred at r.t. for 2 h. The reaction was quenched by the addition of a saturated 
Na2S2O3 solution and the layers were separated. The aqueous layer was extracted with Et2O 
and the combined organic phases were washed with a saturated Na2S2O3 solution and dried 
over MgSO4. After removal of the solvent, column chromatography (hexane:EtOAc = 40:1) 
yielded 306 mg (quant.) of iodide 496.  
Rf = 0.90 (hexane:EtOAc = 20:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.52 (dd, J = 9.96, 9.92 Hz, 1H), 3.39 (dd, J = 9.96, 6.96 Hz, 
1H), 3.31 (dd, J = 9.46, 5.18 Hz, 1H), 3.24 (dd, J = 9.60, 5.56 Hz, 1H), 1.64 (m, 1H), 0.95 (d, 
J = 6.82 Hz, 3H), 0.89 (s, 9H), 0.06 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 66.7, 37.4, 25.9, 17.2, 13.8, -5.4.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C9H20OISi: 299.0328, found: 299.0325.  
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(S)-2-Methyl-2-triethylsilanyloxymethyl-pent-4-enoic acid methyl ester (208) 
TESO OMe
O
 
Triethylchlorosilane (2.4 mL, 12.54 mmol) was added to alcohol 197 (1.80 g, 11.4 mmol) in 
pyridine (20 mL) at r.t.. After 2 h water was added and the mixture was extracted with Et2O. 
The combined ethereal phase was washed with water, dried over MgSO4 and the solvent 
was evaporated. Column chromatography (hexane:EtOAc = 10:1) gave 3.10 g of silyl ether 
208 as colorless oil. 
Rf = 0.76 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.77-5.66 (m, 1H), 5.07-5.02 (m, 2H), 3.66 (s, 3H), 3.65 (d,  
J = 9.25 Hz, 1H), 3.58 (d, J = 9.40 Hz, 1H), 2.39 (dd, J = 13.52, 7.00 Hz, 1H), 2.22 (dd, J = 
13.52, 7.72 Hz, 1H), 1.14 (s, 3H), 0.93 (t, J = 7.96 Hz, 9H), 0.57 (q, J = 8.00 Hz, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.2, 133.9, 117.9, 67.9, 51.5, 48.5, 39.4, 19.1, 6.7, 4.3.  
IR (film): 2954, 2877, 1736, 1458, 1149, 1101 cm-1. 
HRMS (ESI) (m/z): [M-CH3]+ calcd for C13H25O3Si: 257.1573, found: 257.1571.  
[α]D20 -3.00 (c = 1.2, CH2Cl2) 
 
(S)-2-Methyl-4-oxo-2-triethylsilanyloxymethyl-butyric acid methyl ester (210) 
TESO OMe
O
O  
A steam of ozone was bubbled through a solution of 208 (1.50 g, 5.37 mmol) in DCM (100 
mL) for 5 min at -78 °C. Triphenyl phospine (2.12 g, 8.06 mmol) and PPTS (129 mg, 0.54 
mmol) were added to the solution and it was aged in the fridge over night. After removal of 
the solvent, the crude product was purified by quick column chromatography (hexane:EtOAc 
= 3:1) to yield 1.47 g of aldehyde 210 as colorless oil. 
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Rf = 0.50 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.77 (dd, J = 2.28, 1.76 Hz, 1H), 3.87 (d, J = 9.36 Hz, 1H), 
3.71 (s, 3H), 3.55 (d, J = 9.60 Hz, 1H), 2.75 (dd, J = 16.68, 2.28 Hz, 1H), 2,60 (dd, J = 16.64, 
1.76 Hz, 1H), 1.24 (s, 3H), 0.93 (t, J = 7.96 Hz, 9H), 0.57 (q, J = 7.92 Hz, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 201.00, 175.4, 68.2, 52.0, 48.8, 46.7, 20.7, 6.6, 4.2.  
IR (film): 2877, 1733, 1237, 1098 cm-1. 
HRMS (ESI) (m/z): [M-C2H5]+ calcd for C11H21O4Si: 245.1209, found: 245.1205.  
[α]D20 5.00 (c = 0.8, CH2Cl2) 
 
(2S,6S)-7-(tert-Butyl-dimethyl-silanyloxy)-2,6-dimethyl-2-triethylsilanyloxymethyl-hept-
4-enoic acid methyl ester (209) 
TESO OMe
O
OTBS  
Cross metathesis: 
To olefine 203 (96 mg, 0.48 mmol) and olefine 208 (195 mg, 0.720 mmol) in degassed DCM 
(2 mL) under argon at 40 °C was added Grubbs-Hoveyda catalyst (25 mg, 7 mol%, 0.035 
mmol) in degassed DCM (0.5 mL) via syringe pump over 16 h. After the addition was 
completed, the mixture was stirred for an additional 5 h, cooled to r.t. and the solvent was 
removed under reduced pressure. Column chromatography (hexane:EtOAc = 40:1) yielded 
195 mg (98%) of olefin 209 as a 1:1 (E:Z) mixture.  
Rf = 0.85 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.41-5.32 (m, 2H), 3.64 (s, 3H), 3.65 (d, J = 9.36 Hz, 1H), 
3.55 (d, J = 9.36 Hz, 1H), 3.47 (dd, J = 9.72, 5.92 Hz, 1H), 3.35 (d, J = 7.32 Hz, 1H), 2.31 
(dd, J = 13.01, 5.68 Hz, 1H), 2.28 (m, 1H), 2.15 (dd, J = 13.13, 6.31 Hz, 1H), 1.12 (s, 3H), 
0.96 (d, J = 6.57 Hz, 3H), 0.94 (t, J = 7.96 Hz, 9H), 0.89 (s, 9H), 0.56 (q, J = 7.99 Hz, 6H), 
0.03 (s, 6H).  
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13C-NMR (100 MHz, CDCl3): δ = 176.3, 136.7, 133.8, 124.7, 68.2, 67.8, 51.4, 48.7, 39.5, 
38.2, 25.9, 19.1, 16.8, 6.7, 4.3, -5.3.  
IR (film): 2955, 1735, 1654, 1560, 1458, 1251, 1091, 1006 cm-1. 
HRMS (ESI) (m/z): [M-CH3]+ calcd for C22H45O4Si2: 429.2856, found: 429.2864.  
 
Julia-Lythgoe-Kocienski olefination:  
To sulfone 206 (1.70 g, 4.35 mmol) in THF (45 mL) was added LiHMDS (4.8 mL, 1M in THF, 
4.80 mmol) dropwise at -78 °C and stirred for 1 h. Aldehyde 210 (1.40 g, 5.27 mmol) was 
added in THF (15 mL). Stirring was continued for 1 h, and the reaction was gradually 
warmed to -20 °C over 4 h. Saturated NH4Cl solution was added, the layers were separated 
and the aqueous layer was extracted with DCM. The combined organic layer was dried over 
MgSO4 and concentrated under reduced pressure. Column chromatography (hexane:EtOAc 
= 15:1) yielded 1.85 g (96%) of olefin 209 as a 1:1 (E:Z) mixture. 
Rf = 0.85 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.41-5.32 (m, 2H), 3.64 (s, 3H), 3.65 (d, J = 9.36 Hz, 1H), 
3.55 (d, J = 9.36 Hz, 1H), 3.47 (dd, J = 9.72, 5.92 Hz, 1H), 3.35 (d, J = 7.32 Hz, 1H), 2.31 
(dd, J = 13.01, 5.68 Hz, 1H), 2.28 (m, 1H), 2.15 (dd, J = 13.13, 6.31 Hz, 1H), 1.12 (s, 3H), 
0.96 (d, J = 6.57 Hz, 3H), 0.94 (t, J = 7.96 Hz, 9H), 0.89 (s, 9H), 0.56 (q, J = 7.99 Hz, 6H), 
0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.3, 136.7, 133.8, 124.7, 68.2, 67.8, 51.4, 48.7, 39.5, 
38.2, 25.9, 19.1, 16.8, 6.7, 4.3, -5.3. 
1H-NMR (400 MHz, CDCl3): δ = 5.31-5.24 (m, 2H), 3.70 (d, J = 9.35 Hz, 1H), 3.64 (s, 3H), 
3.56 (d, J = 9.35 Hz, 1H), 3.44 (dd, J = 9.85, 5.81 Hz, 1H), 3.33 (d, J = 7.07 Hz, 1H), 2.62 (m, 
1H), 2.44 (dd, J = 14.27 Hz, 6.69 Hz, 1H), 2.19 (dd, J = 14.46, 5.48 Hz, 1H), 1.16 (s, 3H), 
0.94 (t, J = 7.96 Hz, 9H), 0.93 (d, J = 6.50 Hz, 3H), 0.89 (s, 9H), 0.57 (q, J = 7.58 Hz, 6H), 
0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.2, 135.4, 133.6, 124.5, 68.1, 67.8, 51.5, 48.6, 34.7, 
33.0, 25.9, 19.1, 17.3, 6.7, 4.3, -5.3.  
IR (film): 2955, 1735, 1654, 1560, 1458, 1251, 1091, 1006 cm-1. 
HRMS (ESI) (m/z): [M-C2H5]+ calcd for C21H43O4Si2: 415.2700, found: 415.2693. 
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(2S,6S)-7-(tert-Butyl-dimethyl-silanyloxy)-2-hydroxymethyl-2,6-dimethyl-hept-4-enoic 
acid methyl ester (497) 
 
To a stirred solution of silyl ether 209 (1.34 g, 3.02 mmol) in methanol (25 mL) at 0 °C was 
added PPTS (380 mg, 1.51 mmol). After 2.5 h brine was added and the aqueous layer was 
extracted with DCM, the combined organic layer was dried over MgSO4 and the solvent was 
removed under reduced pressure. Column chromatography (hexane:EtOAc = 3:1) yielded 
920 mg (92%) of alcohol 497 as colorless oil.  
Rf = 0.40 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.41-5.38 (m, 2H), 3.70 (s, 3H), 3.68 (dd, J = 11.24, 6.68 Hz, 
1H), 3.51 (dd, J = 11.36, 6.84 Hz, 1H), 3.45 (dd, J = 9.72, 6.16 Hz, 1H), 3.37 (dd, J = 9.72, 
6.68 Hz, 1H), 2.29-2.21 (m, 3H), 1.16 (s, 3H), 0.95 (d, J = 6.57 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 
6H).  
13C-NMR (100 MHz, CDCl3): δ = 177.3, 137.4, 124.2, 68.1, 67.8, 51.8, 48.0, 39.5, 38.9, 32.7, 
25.9, 19.6, 16.7, -5.3.  
IR (film): 3468, 2955, 2857, 1731, 1463, 1255, 1089 cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C16H31O4Si: 315.1992, found: 315.1999. 
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(2S,6S)-7-(tert-Butyl-dimethyl-silanyloxy)-2-hydroxymethyl-2,6-dimethyl-heptanoic acid 
methyl ester (211) 
HO OMe
O
OTBS  
Olefin 497 (930 mg, 2.8 mmol) and PtO2 (43 mg, 0.2 mmol) in ethyl acetate (10 mL) were 
stirred under hydrogen atmosphere (1 bar) for 2 h. The catalyst was filtered off over celite 
and the solvent was removed under reduced pressure to yield 930 mg (99%) of product 211, 
which was used without further purification. 
Rf = 0.40 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.72 (dd, J = 11.24, 6.96 Hz, 1H), 3.71 (s, 3H), 3.42 (dd, J = 
11.42, 6.44 Hz, 1H), 3.41 (dd, J = 9.72, 5.92 Hz, 1H), 3.35 (dd, J = 9.72, 6.16 Hz, 1H), 2.25 
(t, J = 6.69 Hz, 1H), 1.62-1.43 (m, 3H), 1.39-1.15 (m, 3H), 1.18 (s, 3H), 1.08-1.00 (m, 1H), 
0.89 (s, 9H), 0.85 (d, J = 6.82 Hz, 3H), 0,03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 177.7, 68.3, 68.2, 51.8, 47.8, 36.2, 35.5, 33.6, 25.9, 21.6, 
19.6, 16.6, -5.3.  
IR (film): 2953, 1730, 1471, 1251, 1093 cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C16H33O4Si: 317.2148, found: 317.2139.  
[α]D20 -2.48 (c = 1.25, CH2Cl2) 
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(2S,6S)-7-(tert-Butyl-dimethyl-silanyloxy)-2-formyl-2,6-dimethyl-heptanoic acid methyl 
ester (212) 
O
OMe
O
OTBS  
Dess-Martin periodinane (2.69 g, 6.3 mmol) was added portion wise to a solution of alcohol 
211 (700 mg, 2.1 mmol) in DCM (20 mL) at 0 °C under argon. After 4 h a saturated solution 
of NaHCO3 was added, the layers were separated and the aqueous layer was extracted with 
DCM. The combined DCM phase was dried over MgSO4 and the solvent was evaporated. 
Comlumn chromatography (hexane:EtOAc = 3:1) yielded 635 mg (91%) of aldehyde 212 as 
colorless oil. 
Rf = 0.78 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.71 (s, 1H), 3.75 (s, 3H), 3.41-3.34 (m, 2H), 1.88 (ddd, J = 
11.61, 13.64, 5.31 Hz, 1H), 1.67 (ddd, J = 13.64, 11.75, 4.93 Hz, 1H), 1.63-1.53 (m, 1H), 
1.44-1.32 (m, 1H), 1.30 (s, 3H), 1.32-1.17 (m, 2H), 1.11-1.01 (m, 1H), 0.88 (s, 9H), 0.84 (d,  
J = 6.84 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 199.7, 172.8, 68.1, 57.8, 52.4, 35.4, 34.7, 33.4, 25.9, 21.7, 
18.3, 16.7, 16.5, -5.4.  
IR (film): 2954, 2856, 1725, 1463, 1356, 1094 cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C16H31O4Si: 315.1992, found: 315.1997.  
[α]D20 -2.55 (c = 0.9, CH2Cl2) 
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2-Methyl-thiazole-4-carboxylic acid ethyl ester (213) 
 
To a stirred solution of thioacetamide (1.7 g, 22.5 mmol) in ethanol (14 mL) was added ethyl 
bromopyruvate (90%, 2.7 mL, 19.4 mmol) over 10 min. A bright yellow solution formed, 
which was stirred for 16 h. 2 M HCl solution (25 mL) was added and the mixture was stirred 
for 40 min and extracted with Et2O. The aqueous layer was cautiously neutralized with solid 
NaHCO3 and extracted with DCM. The combined extracts were dried over MgSO4 and 
concentrated under reduced pressure to give a yellow solid. Purification by column 
chromatography (hexane:EtOAc = 2:1) yielded 3.1 g (93%) of thiazole ester 213 as white 
solid.  
Rf = 0.25 (hexane:EtOAc = 2:1) 
1H-NMR (400 MHz, CDCl3): δ = 8.04 (s, 1H), 4.42 (q, J = 7.1 Hz, 2H), 2.77 (s, 3H), 1.40 (t,  
J = 7.1 Hz, 3H) 
mp = 58 °C 
 
2-Methyl-thiazole-4-carbaldehyde (214) 
 
To a solution of ester 129 (3 g, 17.5 mmol) in DCM (150 mL) at -78 °C was added DIBALH 
(17.5 mL, 1.5 M in toluene, 26.3 mmol) over 45 min. After 2 h an additional portion of 
DIBALH (5.8 mL, 1.5 M in toluene, 8.7 mmol) was added over 20 min and stirring was 
continued for 3 h. The reaction was quenched by addition of methanol (1 mL) at -78 °C and 
the mixture was stirred with saturated sodium potassium tartrate solution over night. The 
aqueous layer was extracted with DCM and the combined organic solution was washed with 
brine, dried over MgSO4 and the solvent was evaporated to yield 2.2 g (97%) of aldehyde 
130 as a yellow powder.  
Rf = 0.20 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 10.0 (s, 1H), 8.05 (s, 1H), 2.81 (s, 3H) 
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mp = 56 °C 
 
(2-Oxo-propyl)-phosphonic acid dimethyl ester (498) 
 
To a stirred suspension of KI (3.58 g, 21.60 mmol) in acetone (6 mL) and acetonitrile (5 mL) 
was added chloroacetone (1.72 mL, 21.60 mmol). The mixture was stirred for 10 min and 
trimethyl phosphite (2.45 mL, 21.60 mmol) was added. The reaction was stirred at r.t. for 5 h 
and at 50 °C for 4 h, followed by filtration and concentration. Purification by bulb-to-bulb-
distillation yielded 1.12 g (32%) of phosphonate 498 as colorless liquid.  
1H-NMR (250 MHz, CDCl3): δ = 3.79 (d, JHH = 11.18 Hz, 6H), 3.10 (d, JPH = 22.84 Hz, 2H), 
2.33 (s, 3H) 
bp = 97 °C / 5 mbar 
 
(1-Methyl-2-oxo-propyl)-phosphonic acid dimethyl ester (215) 
 
Phosphonate 498 (300 mg, 1.8 mmol) in THF (5 mL) was slowly added to a stirred 
suspension of NaH (64 mg, 1.8 mmol) in THF (5 mL) at 0 °C and the mixture was stirred at 
r.t. for 1.5 h. MeI (0.1 mL, 2.2 mmol) was added and stirring was continued over night at r.t.. 
The reaction was quenched with saturated NH4Cl solution and extracted with DCM. The 
combined extract was dried over MgSO4 and the solvent was evaporated to give 280 mg 
(87%) of alkylated phosponate 215 as colorless liquid. 
1H-NMR (250 MHz, CDCl3): δ = 3.78 (d, JHH = 10.14 Hz, 6H), 3.23 (dq, JHH = 6.93 Hz, JPH = 
24.90 Hz, 1H), 2.34 (s, 3H), 1.37 (dd, JHH = 7.19 Hz, JPH = 17.92 Hz, 3H). 
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(E)-2-Methyl-3-(2-methyl-thiazol-4-yl)-propenal (216) 
 
A mixture of phosphonate 215 (250 mg, 1.4 mmol) and Ba(OH)2·8H2O (440 mg, 1.4 mg) in 
THF (5 mL) was stirred for 1 h. The reaction was cooled to 0 °C and a solution of aldehyde 
214 (149 mg, 1.2 mmol) in wet THF (1 mL) was added. After 1 h the cooling bath was 
removed and stirring was continued over night. The reaction was quenched with saturated 
NH4Cl solution, the layers were separated and the aqueous phase was extracted with DCM. 
The combined organic phase was dried over MgSO4 and the solvent was evaporated. 
Purification by column chromatography (hexane:EtOAc = 10:1) yielded 140 mg (64%) of 
enone 216 as white needles.  
Rf = 0.50 (Hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.53 (d, J = 1.26 Hz, 1H), 7.34 (s, 1H), 2.75 (s, 3H), 2.45 (s, 
3H), 2.21 (d, J = 1.26 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 200.2, 161.5, 151.8, 137.7, 131.9, 121.2, 25.8, 19.2, 13.2.  
IR (film): 3087, 2924, 1654, 1627, 1365, 1241, 1180 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C9H11OSN: 181.0561, found: 181.0554.  
mp = 69°C 
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(E)-(2S,3R)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-hydroxy-2,6-
dimethyl-7-(2-methyl-thiazol-4-yl)-5-oxo-hept-6-enoic acid methyl ester (220) 
OH
OMe
O
OTBS
O
S
N
 
LiHMDS (0.66 mL, 1M in THF, 0.66 mmol) was added to methyl ketone 216 (120 mg, 0.66 
mmol) in THF (8 mL) at -78 °C. After 1 h a solution of aldehyde 212 (219 mg, 0.66 mmol) 
premixed with MgBr2·Et2O (342 mg, 1.32 mmol) in THF (6 mL) at 0 °C for 1 h, was slowly 
added via canula. After 3.5 h a saturated NH4Cl solution was added and the aqueous phase 
was extracted with DCM. The combined organic layer was dried over MgSO4 and the solvent 
was removed under reduced pressure. Column chromatography (hexane:EtOAc = 3:1) 
yielded 312 mg (92%) of aldol adduct 220 as colorless oil.  
Rf = 0.52 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.51 (s, 1H), 7.38 (s, 1H), 4.34-4.30 (m, 1H), 3.69 (s, 3H), 
3.42 (dd, J = 9.86, 5.82 Hz, 1H), 3.35 (dd, J = 9.93, 6.64 Hz, 1H), 3.33 (d, J = 3.52 Hz, 1H), 
2.92-2.89 (m, 2H), 2.75 (s, 3H), 2.23 (d, J = 1.00 Hz, 3H), 1.84-1.77 (m, 1H), 1.60-1.50 (m, 
2H), 1.42-1.32 (m, 2H), 1.23-1.17 (m, 1H), 1.20 (s, 3H), 1.08-1.02 (m, 1H), 0.89 (s, 9H), 0.85 
(d, J = 6.60 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 202.6, 176.3, 165.5, 151.6, 137.2, 131.2, 121.9, 71.6, 68.3, 
51.7, 50.4, 39.8, 36.9, 35.5, 33.5, 25.9, 21.9, 19.3, 18.4, 16.6, 16.5, 13.2, -5.4.  
IR (film): 3436, 2953, 1722, 1652, 1628, 1250, 1087 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C26H45O5NSSi: 511.2788, found: 511.2776.  
[α]D20 26.15 (c = 1.3, CH2Cl2) 
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2-Methyl-4-((E)-2-methyl-3-trimethylsilanyloxy-buta-1,3-dienyl)-thiazole (219) 
 
LiHMDS (1.22 mL, 1M in THF, 1.22 mmol) was added to methyl ketone 216 (150 mg, 0.82 
mmol) in THF (3 mL) at -78 °C. After 1 h TMSCl (0.13 mL, 1.07 mmol), freshly distilled from 
CaH2, was added and stirring was continued for 30 min. The mixture was warmed to r.t. and 
the solvent was removed under reduced pressure. The residue was dissolved in hexane and 
filtered over celite. After evaporation of the solvent, crude enol ether 219 was used directly in 
the following reaction. 
1H-NMR (400 MHz, C6D6): δ = 7.35 (s, 1H), 6.54 (s, 1H), 4.73 (s, 1H), 4.52 (s, 1H), 2.44 (s, 
3H), 2.26 (s, 3H), 0.22 (s, 9H).  
13C-NMR (100 MHz, CDCl3): δ = 158.2, 154.4, 120.5, 117.7, 93.6, 18.9, 15.1, 0.08.  
 
(E)-(2S,3S)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-hydroxy-2,6-
dimethyl-7-(2-methyl-thiazol-4-yl)-5-oxo-hept-6-enoic acid methyl ester (180) 
OH
OMe
O
OTBS
O
S
N
 
To aldehyde 212 (160 mg, 0.48 mmol) in DCM (5 mL) at -78 °C was added TiCl4 (0.11 mL, 
0.96 mmol). After 15 min silyl enol ether 219 (185 mg, 0.73 mmol) in DCM (2 mL) was added 
and stirring was continued for 2 h. A saturated NaHCO3 solution was cautiously added and 
layers were separated. The aqueous layer was extracted with DCM, the combined DCM 
solution was dried over MgSO4 and the solvent was evaporated. Column chromatography 
(hexane:EtOAc = 3:1) yielded 34 mg (13%) of aldol adduct 180 as colorless oil. 
Rf = 0.14 (hexane:EtOAc = 3:1) 
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1H-NMR (400 MHz, CDCl3): δ = 7.53 (s, 1H), 7.38 (s, 1H), 4.38 (ddd, J = 9.79, 4.36, 2.21 Hz, 
1H), 3.72 (s, 3H), 3.41 (dd, J = 9.85, 5.81 Hz, 1H), 3.36 (dd, J = 9.72, 6.19 Hz, 1H), 3.27 (d,  
J = 4.29 Hz, 1H (OH)), 2.95 (dd, J = 17.05, 2.40 Hz, 1H), 2.86 (dd, J = 17.05, 9.73 Hz, 1H), 
2.76 (s, 3H), 2.23 (d, J = 1.01 Hz, 3H), 1.70-1.62 (m, 1H), 1.60-1.52 (m, 1H), 1.42-1.29 (m, 
4H), 1.20 (s, 3H), 1.10-1.00 (m, 1H), 0.88 (s, 9H), 0.85 (d, J = 6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 201.0, 176.6, 165.7, 150.1, 137.5, 132.0, 121.9, 72.56, 68.3, 
51.9, 50.8, 38.8, 36.6, 35.5, 33.5, 26.0, 21.9, 19.3, 16.6, 16.4, 15.7, 13.2, -5.4.  
IR (film): 2952, 1732, 1666, 1250, 1089 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C26H45O5NSSi: 511.2788, found: 511.2786.  
[α]D20 -28.88 (c = 0.8, CH2Cl2) 
 
(2S,6S)-7-(tert-Butyl-dimethyl-silanyloxy)-2-(1-hydroxy-ethyl)-2,6-dimethyl-heptanoic 
acid methyl ester (499) 
OH
OMe
O
OTBS  
To aldehyde 212 (110 mg, 0.33 mmol) in THF (4 mL) at -78 °C was slowly added MeMgBr 
(0.35 mL, 1M in Et2O, 0.35 mmol). After 1.5 h the reaction was quenched by the addition of a 
saturated NH4Cl solution, the layers were separated and the aqueous was extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 3:1) yielded 81 mg (71%) of alcohol 99 as 1:1 
mixture of diastereoisomers and 26 mg (24%) of recovered aldehyde 499. 
Rf = 0.66 (hexane:EtOAc = 3:1) 
1H-NMR (250 MHz, CDCl3): δ = 3.89 (q, J = 6.39 Hz, 1H), 3.69 (s, 3H), 3.38 (ddd, J = 16.43, 
10.05, 6.33 Hz, 2H), 2.13 (s, 3H), 1.75 (m, 1H), 1.62-1.52 (m, 2H), 1.44-1.32 (m, 2H), 1.14 
(s, 3H), 1.12 (s, 3H), 1.16-1.00 (m, 2H), 0.89 (s, 9H), 0.85 (d, J = 6.72 Hz, 3H), 0.03 (s, 6H). 
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(2S,6S)-2-Acetyl-7-(tert-butyl-dimethyl-silanyloxy)-2,6-dimethyl-heptanoic acid methyl 
ester (222) 
O
OMe
O
OTBS  
Dess-Martin periodinane (294 mg, 0.69 mmol) was added potionwise to alcohol 499 (80 mg, 
0.23 mmol) in DCM (3 mL) at 0°C. After 4 h saturated NaHCO3 solution was added, the 
layers were separated and the aqueous layer was extracted with DCM. The combined DCM 
phase was dried over MgSO4 and the solvent was evaporated. Column chromatography 
(hexane:EtOAc = 3:1) yielded 70 mg (88%) of methyl ketone 222. 
Rf = 0.73 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.72 (s, 3H), 3.38 (ddd, J = 15.85, 9.78, 6.12 Hz, 2H), 2.13 
(s, 3H), 1.89 (ddd, J = 13.65, 12.25, 4.67 Hz, 1H), 1.70 (ddd, J = 13.84, 11.92, 4.62 Hz, 1H), 
1.57 (m, 1H), 1.40 (m, 1H), 1.33 (s, 3H), 1.28-1.03 (m, 3H), 0.88 (s, 9H), 0.84 (d, J = 6.60 Hz, 
3H), 0.02 (s, 6H) 
 
(E)-(2S,3R,5R)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3,5-dihydroxy-
2,6-dimethyl-7-(2-methyl-thiazol-4-yl)-hept-6-enoic acid methyl ester (232) 
OH
OMe
O
OTBS
OH
S
N
 
To a solution of tetramethylammonium triacetoxyboron hydride (1.06 g, 3.88 mmol) in 
acetonitrile (7 mL) and acetic acid (5 mL) at -30 °C was slowly added a solution of 220 (260 
mg, 0.48 mmol) in acetonitrile (5 mL). After stirring for 9 h a saturated solution of NaHCO3 
and solid NaHCO3 were added very carefully till gas evolution ceased. The aqueous layer 
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was extracted with DCM, the combined organic layer was dried over MgSO4 and the solvent 
was removed under reduced pressure. Column chromatography (hexane:EtOAc = 1:1) 
yielded 242 mg (97%) of dihydroxy ester 232 as colorless oil. 
Rf = 0.41 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.93 (s, 1H), 6.67 (s, 1H), 4.45 (dd, J = 6.44, 2.90 Hz, 1H), 
4.00 (dd, J = 10.22, 1.13 Hz, 1H), 3.67 (s, 3H), 3.40 (dd, J = 9.73, 5.93 Hz, 1H), 3.34 (dd, J = 
9.60, 6.32 Hz, 1H), 2.70 (s, 3H), 1.99 (d, J = 0.76 Hz, 3H), 1.81-1.63 (m, 3H), 1.60-1.52 (m, 
1H), 1.46-1.37 (m, 1H), 1.36-1.23 (m, 2H), 1.15 (s, 3H), 1.16-0.98 (m, 2H), 0.88 (s, 9H), 0.83 
(d, J = 6.57 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100M Hz, CDCl3): δ = 177.1, 164.6, 153.0, 141.9, 118.0, 115.4, 74.4, 73.0, 68.3, 
51.8, 50.6, 36.0, 35.8, 35.5, 33.6, 25.9, 21.9, 19.2, 18.4, 17.3, 16.6, 15.4, -5.4.  
IR (film): 3400, 2952, 2989, 1731, 1256, 1091 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C26H47O5NSSi: 513.2944, found: 513.2953.  
[α]D20 14.60 (c = 0.5, CH2Cl2) 
 
(E)-(2S,3R,5R)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3,5-dihydroxy-
2,6-dimethyl-7-(2-methyl-thiazol-4-yl)-hept-6-enoic acid methyl ester (231) 
OH
OMe
O
OTBS
OH
S
N
 
To a solution of 220 (950 mg, 1.90 mmol) in THF (20 mL) at -10 °C was added 
catecholborane (0.99 mL, 9.50 mmol) and stirred for 5 h. A saturated solution of potassium 
sodium tartrate was added and stirred for 1 h. The layers were separated and the aqueous 
layer was extracted with DCM. The combined organic layer was dried over MgSO4 and the 
solvent was removed under reduced pressure. Column chromatography (hexane:EtOAc = 
1:1) yielded 835 mg (88%) of dihydroxy ester 231 as colorless oil 
Rf = 0.15 (hexane:EtOAc = 3:1) 
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1H-NMR (400 MHz, CDCl3): δ = 6.97 (s, 1H), 6.60 (s, 1H), 4.40 (dd, J = 9.22, 2.90 Hz, 1H), 
4.02 (dd, J = 9.97, 1.64 Hz, 1H), 3.68 (s, 3H), 3.41 (dd, J = 9.85, 5.81 Hz, 1H), 3.34 (dd, J = 
9.72, 6.44 Hz, 1H), 2.75 (s, 3H), 2.01 (d, J = 1.01  Hz, 3H), 1.80-1.66 (m, 2H), 1.63-1.52 (m, 
2H), 1.50-1.43 (m, 1H), 1.39-1.20 (m, 3H), 1.15 (s, 3H), 1.07-0.97 (m, 1H), 0.88 (s, 9H), 0.84 
(d, J = 6.57 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.9, 165.3, 151.8, 142.8, 118.1, 115.7, 78.3, 76.3, 68.4, 
51.8, 50.9, 36.9, 36.1, 35.5, 33.6, 25.9, 22.0, 18.8, 18.4, 16.9, 16.6, 14.4, -5.4.  
IR (film): 2952, 1731, 1090, 837 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C26H47O5NSSi: 513.2945, found: 513.2936.  
[α]D20 -0.40 (c = 0.5, CH2Cl2) 
 
(E)-(2S,3R,5R)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3,5-dihydroxy-
2,6-dimethyl-7-(2-methyl-thiazol-4-yl)-hept-6-enoic acid methyl ester (217) 
 
To a solution of tetramethylammonium triacetoxyboron hydride (123 mg, 0.420 mmol) in 
acetonitrile:acetic acid (1:1, 2 mL) at -30 °C was slowly added a solution of 180 (30 mg, 
0.058 mmol) in acetonitrile (0.5 mL). After stirring for 7 h a saturated solution of NaHCO3 and 
solid NaHCO3 were added very carefully till gas evolution ceased. The aqueous layer was 
extracted with DCM, combined organic layers were dried over MgSO4 and the solvent was 
removed under reduced pressure. Column chromatography (hexane:EtOAc = 1:1) yielded 26 
mg (87%) of dihydroxy ester 217 as colorless oil. 
Rf = 0.19 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.93 (s, 1H), 6.66 (s, 1H), 4.48 (m, 1H), 4.03 (dd, J = 9.09, 
6.57 Hz, 1H), 3.69 (s, 3H), 3.40 (dd, J = 9.73, 5.94 Hz, 1H), 3.34 (dd, J = 9.85, 6.32 Hz, 1H), 
2.93 (d, J = 6.82 Hz, 1H (OH)), 2.71 (s, 3H), 2.66 (d, J = 4.80 Hz, 1H (OH)), 2.03 (d, J = 1.01 
Hz, 3H), 1.76 (ddd, J = 14.21, 7.64, 1.70 Hz, 1H), 1.68-1.51 (m, 2H), 1.60 (s, 3H), 1.48-1.42 
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(m, 1H), 1.36-1.28 (m, 2H), 1.14 (s, 3H), 1.06-0.98 (m, 2H), 0,88 (s, 9H), 0.83 (d, J = 6.57 
Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 177.7, 164.5, 153.0, 142.0, 118.2, 115.5, 74.1, 72.4, 68.2, 
51.9, 50.8, 36.9, 35.9, 35.5, 33.5, 25.9, 21.7, 19.2, 18.3, 17.3, 16.6, 15.3, -5.4.  
IR (film): 2928, 2855, 1735, 1463, 1256, 1090 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C26H47O5NSSi: 513.2944, found: 513.2951.  
[α]D20 -20.50 (c = 0.02, CH2Cl2) 
 
(3S,4R,6R)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-hydroxy-3-
methyl-6-[(E)-1-methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-tetrahydro-pyran-2-one (218) 
OO
OH
S
N
TBSO
 
LiOH (1.5 mL, 1M in water, 1.5 mmol) was added to ester 232 (240 mg, 0.47 mmol) in THF 
(5 mL) at 0 °C and vigorously stirred for 4 h. Brine was added and the aqueous layer was 
acidified with 1N HCl and extracted with DCM. The combined organic layers were dried over 
MgSO4 and the solvent was evaporated to yield the crude dihydroxy acid.  
Rf = 0.09 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.95 (s, 1H), 6.57 (s, 1H), 4.43 (t, J = 6.32 Hz, 1H), 4.03 (dd,  
J = 6.44, 5.16 Hz, 1H), 3.42 (dd, J = 9.72, 5.92 Hz, 1H), 3.35 (dd, J = 9.98, 6.18 Hz, 1H), 
2.71 (s, 3H), 2.,10 (s, 3H), 1.80-1.74 (m, 3H), 1.59 (m, 1H), 1.46-1.33 (m, 2H), 1.25 (m, 1H), 
1.21 (s, 3H), 1.05 (m, 1H), 0.88 (s, 9H), 0.85 (d, J = 6.84 Hz, 3H), 0.03 (s, 6H).  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C25H43O4NSSi: 481.2682, found: 481.2664. 
The residue was taken up in DCM (5 mL) and EDC·HCl (136 mg, 0.7 mmol) and DMAP (116 
mg, 0.94 mmol) were added. After 3 h brine was added and the aqueous layer was extracted 
with DCM. The combined DCM phases were dried over MgSO4 and the solvent was 
evaporated. Column chromatography (hexane:EtOAc = 2:1) yielded 192 mg (85%) of lactone 
218 as colorless oil.  
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Rf = 0.49 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.00 (s, 1H), 6,56 (s, 1H), 4.74 (dd, J = 9.60, 5.80 Hz, 1H), 
4.20 (dd, J = 8.48, 6.93 Hz, 1H), 3.42 (dd, J = 9.86, 6.06 Hz, 1H), 3.38 (dd, J = 9.66, 6.26 Hz, 
1H), 2.71 (s, 3H), 2.16-2.09 (m, 2H), 2.10 (d, J = 1.00 Hz, 3H), 1.85 (ddd, J = 13.72, 11.06, 
4.98 Hz, 1H), 1.63 (ddd, J = 13.79, 11.00, 5.51 Hz, 1H), 1.59-1.54 (m, 1H), 1.45-1.26 (m, 
3H), 1.29 (s, 3H), 1.26-1.17 (m, 1H), 0.89 (s, 9H), 0.86 (d, J = 6.80 Hz, 3H), 0.04 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.0, 165.0, 152.1, 136.4, 120.8, 116.9, 81.0, 68.4, 67.8, 
48.7, 36.3, 35.7, 33.6, 33.3, 25.9, 22.3, 19.2, 16.7, 14.1, -5.4.  
IR (film): 2953, 2928, 2856, 1712, 1250, 1087 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H43O4NSSi: 481.2682, found: 481.2671.  
[α]D20 -6.60 (c = 2, CH2Cl2) 
 
(3S,6S)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-methyl-6-[(E)-1-
methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-dihydro-pyran-2,4-dione (500) 
OO
O
S
N
TBSO
 
Dess-Martin periodinane (229 mg, 0.54 mmol) was added portionwise to a suspension of 
alcohol 218 (90 mg, 0.18 mmol) and NaHCO3 (45 mg, 0.54 mmol) in DCM (3 mL) at 0 °C. 
After 4 h water was added, the layers were separated and the aqueous layer was extracted 
with DCM. The combined DCM phase was dried over MgSO4 and the solvent was 
evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded 85 mg (94%) of ketone 
500 as colorless oil 
Rf = 0.66 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.04 (s, 1H), 6.61 (s, 1H), 4.97 (dd, J = 11.88, 2.28 Hz, 1H), 
3.37 (dd, J = 9.84, 6.04 Hz, 1H), 3.33 (dd, J = 9.72, 6.16 Hz, 1H), 2.83 (dd, J = 16.31, 2.66 
Hz, 1H), 2.75-2.68 (m, 1H), 2.71 (s, 3H), 2.17 (d, J = 1.00 Hz, 3H), 2.01-1.81 (m, 2H), 1.57-
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1.49 (m, 1H), 1.46 (s, 1H), 1.40-1.17 (m, 3H), 1.07-1.00 (m, 1H), 0.88 (s, 9H), 0.81 (d, J = 
6.84Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 206.6, 173.6, 165.1, 151.7, 134.2, 122.0, 117.7, 78.2, 68.2, 
56.4, 44.2, 38.4, 35.3, 33.3, 25.9, 23.6, 22.9, 19.3, 18.3, 16.5, 13.9, -5.4.  
IR (film): 2928, 1751, 1718, 1257, 1140, 1093 cm-1.  
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C21H32O4NSSi: 422.1821, found: 422.1833.  
[α]D20 -23.40 (c = 1.0, CH2Cl2) 
 
(3S,4S,6R)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-hydroxy-3-
methyl-6-[(E)-1-methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-tetrahydro-pyran-2-one (237) 
 
Sodium boron hydride (1.5 mg, 0.041 mmol) was added to keto lactone 500 (20 mg, 0.041 
mmol) in methanol (1 mL) at -78 °C. After 4 h brine was added, the mixture was warmed to 
r.t. and extracted with DCM. The combined DCM layer was dried over MgSO4 and the 
solvent was evaporated. Column chromatography (hexane:EtOAc = 1:1) yielded 18 mg 
(90%) of lactone 237 as colorless oil.  
Rf = 0.68 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.99 (s, 1H), 6.58 (s, 1H), 5.23 (dd, J = 11.62, 3.79 Hz, 1H), 
4.02 (dd, J = 4.03, 2.01 Hz, 1H), 3.47-3.36 (m, 2H), 2.72 (s, 3H), 2.24 (ddd, J = 14.00, 11.41, 
2.20 Hz, 1H), 2.10 (d, J = 0.76 Hz, 3H), 2.02 (ddd, J = 14.00, 4.61, 3.79 Hz, 1H), 1.68-1.51 
(m, 3H), 1.41-1.24 (m, 3H), 1.34 (s, 3H), 1.08-1.01 (m, 1H), 0.89 (s, 9H), 0.87 (d, J = 6.42 
Hz, 3H), 0.05 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.6, 165.0, 152.5, 136.8, 120.1, 116.7, 80.6, 70.5, 68.3, 
47.2, 38.8, 35.6, 33.7, 31.4, 25.8, 21.6, 20.2, 19.1, 18.7, 16.9, 14.2, -5.3.  
IR (film): 3400, 2928, 1712, 1462, 1251, 1182, 1088 cm-1.  
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HRMS (ESI) (m/z): [M+Na]+ calcd for C25H43O4NSSiNa: 504.2580, found: 504.2589.  
[α]D20 0.44 (c = 1.1, CH2Cl2) 
 
(3S,4R,6S)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-hydroxy-3-
methyl-6-[(E)-1-methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-tetrahydro-pyran-2-one (233) 
OO
OH
S
N
TBSO
 
LiOH (2.4 mL, 1M in water, 2.4 mmol) was added to ester 231 (400 mg, 0.78 mmol) in THF 
(10 mL) at 0 °C and the mixture was stirred vigorously for 4 h. Brine was added and the 
aqueous layer was acidified with 1N HCl and extracted with DCM. The combined organic 
layer was dried over MgSO4 and the solvent was evaporated. The residue was dissolved in 
DCM (8 mL) and EDC·HCl (227 mg, 1.17 mmol) and DMAP (190 mg, 1.56 mmol) were 
added. After 4 h brine was added and the aqueous layer was extracted with DCM. The 
combined DCM phase was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 2:1) yielded 350 mg (94%) of lactone 233 as colorless oil.  
Rf = 0.56 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.99 (s, 1H), 6.56 (s, 1H), 5.21 (dd, J = 10.98, 3.92 Hz, 1H), 
4.01 (dd, J = 4.55, 2.02 Hz, 1H), 3.40 (dd, J = 9.97, 6.19 Hz, 1H), 3.36 (dd, J = 9.85, 6.31 Hz, 
1H), 2.73 (s, 3H), 2.27 (ddd, J = 14.11, 11.14, 2.05 Hz, 1H) 2.11 (d, J = 0.75 Hz, 3H), 2.04 
(dt, J = 14.27, 4.48 Hz, 1H), 1.68-1.50 (m, 3H), 1.43-1.25 (m, 3H), 1.34 (s, 3H), 1.09-0.99 (m, 
1H), 0.88 (s, 9H), 0.84 (d, J = 6.57 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.1, 165.0, 152.1, 137.3, 119.9, 116.7, 80.6, 70.4, 68.2, 
47.1, 38.7, 35.5, 33.5, 31.4, 25.9, 21.4, 19.2, 19.1, 18.3, 16.6, 14.4, -5.4.  
IR (film): 2952, 1710, 1250, 1086 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H43O4NSSi: 481.2682, found: 481.2669.  
[α]D20 -0.54 (c = 1.4, CH2Cl2) 
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(3S,6R)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-methyl-6-[(E)-1-
methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-dihydro-pyran-2,4-dione (501) 
OO
O
S
N
TBSO
 
Dess-Martin periodinane (178 mg, 0.42 mmol) was added potionwise to a suspension of 
alcohol 233 (70 mg, 0.14 mmol) and NaHCO3 (35 mg, 0.42 mmol) in DCM (2 mL) at 0 °C. 
After 4 h water was added, layers were separated and the aqueous layer was extracted with 
DCM. The combined DCM phases were dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 3:1) yielded 66 mg (94%) of ketone 501 as 
colorless oil. 
Rf = 0.87 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.03 (s, 1H), 6.60 (s, 1H), 5.01 (dd, J = 11.11, 3.03 Hz, 1H), 
3.41-3.34 (m, 2H), 2.87 (dd, J = 16.17, 11.12 Hz, 1H), 2.77 (dd, J = 16.42, 3.28 Hz, 1H), 2.72 
(s, 3H), 2,17 (d, J = 1.26 Hz, 3H), 1.99 (ddd, J = 13.20, 11.94, 4.48 Hz, 1H), 1.73 (ddd,  
J = 12.94, 12.94, 3.72 Hz, 1H), 1.60-1.52 (m, 2H), 1.42 (s, 1H), 1.43-1.17 (m, 3H), 1.10-1.02 
(m, 1H), 0.89 (s, 9H), 0.84 (d, J = 6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 205.9, 173.7, 165.1, 151.8, 134.4, 121.9, 117.8, 78.0, 68.1, 
57.0, 42.2, 37.6, 35.4, 33.1, 26.0, 22.7, 22.1, 19.3, 18.3, 16.6, 14.0, -5.4.  
IR (film): 2953, 2928, 1749, 1716, 1256, 1090 cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C24H38O4NSSi: 464.2281, found: 464.2279.  
[α]D20 6.89 (c = 1.2, CH2Cl2) 
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(3S,4S,6S)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-hydroxy-3-
methyl-6-[(E)-1-methyl-2-(2-methyl-thiazol-4-yl)-vinyl]-tetrahydro-pyran-2-one (181) 
OO
OH
S
N
TBSO
 
Sodium borohydride (13 mg, 0.3 mmol) was added to keto lactone 501 (150 mg, 0.3 mmol) in 
methanol (4 mL) at -78 °C. After 5 h brine was added, the mixture was warmed to r.t. and 
extracted with DCM. The combined DCM layer was dried over MgSO4 and the solvent was 
evaporated. Column chromatography (hexane:EtOAc = 1:1) yielded 140 mg (93%) of lactone 
181 as colorless oil.  
Rf = 0.48 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.00 (s, 1H), 6.55 (s, 1H), 4.75 (dd, J = 11.37, 4.04 Hz, 1H), 
4.02 (dd, J = 11.11, 4.29 Hz, 1H), 3.42 (dd, J = 9.72, 5.94 Hz, 1H), 3.36 (dd, J = 9.72, 6.44 
Hz, 1H), 2.71 (s, 3H), 2.27-2.18 (m, 1H) 2.10 (d, J = 1.01 Hz, 3H), 2.13-2.06 (m, 1H), 1.75-
1.55 (m, 3H), 1.48-1.26 (m, 3H), 1.37 (s, 3H), 1.11-1.01 (m, 1H), 0.88 (s, 9H), 0.86 (d, J = 
6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 175.3, 165.0, 152.0, 136.5, 120.6, 116.9, 81.2, 72.5, 68.3, 
47.7, 35.6, 33.7, 33.0, 32.7, 25.9, 21.8, 20.9, 19.2, 18.3, 16.6, 14.0, -5,4.  
IR (film): 3420, 2954, 1727, 1250, 1127, 1078 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H43O4NSSi : 481.2682, found: 481.2676.  
[α]D20 -11.45 (c = 2.0, CH2Cl2) 
 
General procedure for the fragmentation reactions: 
To a 0.1M solution of β-hydroxy lactone (1 eq.) in Et2O:Et3N (10:1) at 0 °C under argon was 
added MsCl (1.5 eq.). After 1.5 h brine was added and the aqueous layer was extracted with 
Et2O. The combined ethereal layer was dried over MgSO4 and the solvent was removed 
under reduced pressure. The residue was taken up in THF (0.1M) and LiOH (3 eq., 1M in 
water) was added at 0 °C. After TLC showed completion, normally 1 to 2 h, a saturated 
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NH4Cl solution was added, layers were separated and the aqueous layer was extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was evaporated.  
 
(1E,5Z)-(3S,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-1-(2-methyl-
thiazol-4-yl)-undeca-1,5-dien-3-ol (235) 
OTBSOH
S
N
 
To a solution of β-hydroxy lactone 181 (25 mg, 0.05 mmol) in Et2O:Et3N (10:1, 1 mL) at 0 °C 
under argon was added MsCl (6 μL, 0.07 mmol). After 1.5 h brine was added and the 
aqueous layer was extracted with Et2O. The combined ethereal layer was dried over MgSO4 
and the solvent was removed under reduced pressure. The residue was taken up in THF  
(1 mL) and LiOH (0.15 mL, 1M in water, 0.15 mmol) was added at 0 °C. After 1 h a saturated 
NH4Cl solution was added, the layers were separated and the aqueous phase was extracted 
with DCM. The combined organic layer was dried over MgSO4 and the solvent was 
evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded 17.5 mg (81%) of di-
olefin 235 as colorless oil. 
Rf = 0.72 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.56 (s, 1H), 5.16 (t, J = 7.08 Hz, 1H), 4.14 (t,  
J = 6.30 Hz, 1H), 3.43 (dd, J = 9.46, 5.42 Hz, 1H), 3.35 (dd, J = 9.84, 6.56 Hz, 1H), 2.71 (s, 
3H), 2.35 (t, J = 6.56 Hz, 2H), 2.05 (d, J = 1.28 Hz, 3H), 2.03 (t, J = 6.94 Hz, 2H), 1.71 (d, J = 
1.24 Hz, 3H), 1.62-1.54 (m, 1H), 1.44-1.31 (m, 3H), 1.10-1.01 (m, 1H), 0.89 (s, 9H), 0.86 (d, 
J = 6.84 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 164.5, 152.9, 141.7, 139.5, 120.1, 118.8, 115.4, 77.2, 68.3, 
65.8, 35.7, 34.1, 33.1, 32.3, 26.0, 25.5, 19.2, 18.4, 16.7, 15.2, 14.5, -5.3.  
IR (film): 3390, 2955, 2928, 1256, 1093 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H43O2NSSi: 437.2784, found: 437.2779.  
[α]D20 -8.20 (c = 0.5, CH2Cl2) 
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(1E,5E)-(3R,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-1-(2-methyl-
thiazol-4-yl)-undeca-1,5-dien-3-ol (240) 
 
Rf = 0.39 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.56 (s, 1H), 5.17 (t, J = 7.34 Hz, 1H), 4.16 (t,  
J = 6.18 Hz, 1H), 3.42 (dd, J = 9.72, 5.96 Hz, 1H), 3.34 (dd, J = 9.82, 6.62 Hz, 1H), 2.71 (s, 
3H), 2.36 (t, J = 6.82 Hz, 2H), 2.06 (s, 3H), 1.99 (t, J = 6.80 Hz, 2H), 1.64 (s, 3H), 1.61-1.53 
(m, 1H), 1.46-1.23 (m, 3H), 1.06-0.96 (m, 1H), 0.89 (s, 9H), 0.85 (d, J = 6.56 Hz, 3H), 0.03 
(s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 164.7, 153.0, 141.7, 139.3, 119.5, 118.9, 115.4, 77.2, 68.4, 
40.2, 35.7, 34.4, 32.8, 29.7, 26.0, 25.4, 19.2, 16.7, 16.3, 14.4, -5.3.  
IR (film): 2928, 2357, 1255, 1091 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H43O2NSSi: 437.2784, found: 437.2776.  
[α]D20 5.10 (c = 1.0, CH2Cl2) 
 
(1E,5E)-(3S,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-1-(2-methyl-
thiazol-4-yl)-undeca-1,5-dien-3-ol (243) 
 
Rf = 0.36 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.56 (s, 1H), 5.17 (t, J = 7.20 Hz, 1H), 4.16 (t,  
J = 6.34 Hz, 1H), 3.42 (dd, J = 9.72, 5.92 Hz, 1H), 3.34 (dd, J = 9.60, 6.06 Hz, 1H), 2.71 (s, 
3H), 2.36 (t, J = 6.82 Hz, 2H), 2.06 (d, J = 1.26 Hz, 3H), 2.00 (t, J = 7.32 Hz, 2H), 1.78 (d, J = 
3.28 Hz, 1H), 1.64 (s, 3H), 1.60-1.53 (m, 1H), 1.46-1.30 (m, 3H), 1.06-1.00 (m, 1H), 0.89 (s, 
9H), 0.85 (d, J = 6.82 Hz, 3H), 0.03 (s, 6H).  
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13C-NMR (100 MHz, CDCl3): δ = 164.6, 153.0, 141.7, 139.4, 119.5, 118.9, 115.4, 77.2, 68.4, 
40.2, 35.7, 34.4, 32.9, 26.0, 25.4, 19.2, 18.3, 16.7, 16.2, 14.5, -5.3.  
IR (film): 2954, 2928, 1471, 1255, 1092 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H43O2NSSi: 437.2784, found: 437.2785.  
[α]D20 -9.06 (c = 0.85, CH2Cl2) 
 
(3S,4S)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-[(E)-(S)-2-hydroxy-3-
methyl-4-(2-methyl-thiazol-4-yl)-but-3-enyl]-3-methyl-oxetan-2-one (244) 
S
N
OH O
OTBS
O
 
Rf = 0.24 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.96 (s, 1H), 6.06 (s, 1H), 4.66 (dd, J = 9.35, 3.28 Hz, 1H), 
4.36 (dt, J = 8.96, 3.09 Hz, 1H), 3.43-3.36 (m, 2H), 2.71 (s, 3H), 2.07 (d, J = 3.28 Hz, 1H), 
2.06 (d, J =1.01 Hz, 3H), 2.00-1.86 (m, 2H), 1.74-1.67 (m, 2H), 1.62-1.56 (m, 2H), 1.49-1.34 
(m, 3H), 1.26 (s, 3H), 1.14-1.05 (m, 1H), 0.89 (s, 9H), 0.86 (d, J = 6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 175.0, 164.8, 152.5, 141.5, 119.0, 116.1, 78.4, 73.6, 68.2, 
57.4, 36.4, 36.1, 35.6, 33.3, 25.9, 21.7, 19.2, 18.3, 16.6, 14.8, 14.4, -5.4.  
IR (film): 2954, 2528, 1820, 1094 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H43O4NSSi: 481.2682, found: 481.2672.  
[α]D20 -25.90 (c = 1.35, CH2Cl2) 
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(1E,5E)-(3S,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-1-(2-methyl-
thiazol-4-yl)-undeca-1,5-dien-3-ol (243) 
 
β-lactone 244 (10 mg, 0.02 mmol) in DMF (1 mL) was heated at reflux for 2 h. Water was 
added and the aqueous layer was extracted with hexane:Et2O (1:1). The combined organic 
layer was dried over MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography (hexane:EtOAc = 5:1) yielded 5 mg (57%) of olefin 
243, whose data were identical with those of 243 obtained by fragmentation. 
Rf = 0.35 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.56 (s, 1H), 5.17 (t, J = 7.20 Hz, 1H), 4.16 (t,  
J = 6.34 Hz, 1H), 3.42 (dd, J = 9.72, 5.92 Hz, 1H), 3.34 (dd, J = 9.60, 6.06 Hz, 1H), 2.71 (s, 
3H), 2.36 (t, J = 6.82 Hz, 2H), 2.06 (d, J = 1.26 Hz, 3H), 2.00 (t, J = 7.32 Hz, 2H), 1.78 (d,  
J = 3.28 Hz, 1H), 1.64 (s, 3H), 1.60-1.53 (m, 1H), 1.46-1.30 (m, 3H), 1.06-1.00 (m, 1H), 0.89 
(s, 9H), 0.85 (d, J = 6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 164.6, 153.0, 141.7, 139.4, 119.5, 118.9, 115.4, 77.2, 68.4, 
40.2, 35.7, 34.4, 32.9, 26.0, 25.4, 19.2, 18.3, 16.7, 16.2, 14.5, -5.3.  
IR (film): 2929, 1471, 1255, 1092 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H43O2NSSi: 437.2784, found: 437.2776.  
[α]D20 -10.60 (c = 0.15, CH2Cl2) 
 
(1E,5Z)-(3R,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-1-(2-methyl-
thiazol-4-yl)-undeca-1,5-dien-3-ol (248) 
 
Rf = 0.36 (hexane:EtOAc = 3:1) 
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1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.56 (s, 1H), 5.17 (t, J = 7.20 Hz, 1H), 4.14 (dt,  
J = 6.60, 2.68 Hz, 1H), 3.43 (dd, J = 9.85, 5.81 Hz, 1H), 3.36 (dd, J = 9.85, 6.57 Hz, 1H), 
2.71 (s, 3H), 2.35 (t, J = 6.95 Hz, 2H), 2.05 (d, J = 1.26 Hz, 3H), 2.09-1.97 (m, 2H), 1.71 (d,  
J = 1.01 Hz, 1H), 1.61-1.53 (m, 1H), 1.46-1.26 (m, 3H), 1.09-1.00 (m, 1H), 0.89 (s, 9H), 0.86 
(d, J = 6.57 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 172.5, 164.6, 153.0, 141.7, 139.5, 120.15, 118.9, 115.4, 
77.3, 68.3, 40.2, 35.7, 34.1, 33.1, 32.3, 26.0, 25.4, 23.6, 22.7, 19.2, 18.3, 16.7, 14.5, -5.3.  
IR (film): 2955, 2929, 1472, 1256, 1093 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H43O2NSSi: 437.2784, found: 437.2783.  
[α]D20 1.73 (c = 0.75, CH2Cl2) 
 
(3S,4R)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-[(E)-(R)-2-hydroxy-
3-methyl-4-(2-methyl-thiazol-4-yl)-but-3-enyl]-3-methyl-oxetan-2-one (248) 
S
N
OH O
OTBS
O
 
Rf = 0.21 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.96 (s, 1H), 6.00 (s, 1H), 4.57 (dd, J = 8.46, 4.42 Hz, 1H), 
4.37 (dd, J = 8.33, 4.56 Hz, 1H), 3.41 (dd, J = 9.90, 5.86 Hz, 1H), 3.37 (dd, J = 9.72, 6.20 Hz, 
1H), 2.71 (s, 3H), 2.07 (s, 3H), 2.00-1.94 (m, 2H), 1.76-1.54 (m, 3H), 1.49-1.25 (m, 3H), 1.43 
(s, 3H), 1.12-1.04 (m, 1H), 0.88 (s, 9H), 0.86 (d, J = 6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 174.8, 164.9, 152.5, 141.4, 119.0, 116.1, 80.7, 73.7, 56.8, 
35.9, 35.5, 33.6, 25.9, 21.5, 19.6, 19.1, 18.3, 16.6, 14.4, -5.4.  
IR (film): 2953, 1820, 1175, 1093 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H43O4NSSi: 481.2682, found: 481.2688.  
[α]D20 14.40 (c = 0.5, CH2Cl2) 
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(E)-(2S,3R,5s)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-5-hydroxy-2,6-
dimethyl-3-(methylsulfonyloxy)-7-(2-methyl-thiazol-4-yl)-hept-6-enoic acid methyl ester 
(236) 
OMs
OMe
O
OTBS
OH
S
N
 
To β-hydroxy lactone 234 (18 mg, 0.035 mmol) in Et2O:NEt3 (10:1, 1 mL) at 0 °C under argon 
was added MsCl (0.05 mL, 1M in Et2O, 0.053 mmol). After 1.5 h brine was added and the 
aqueous layer was extracted with Et2O. The combined ethereal layer was dried over MgSO4 
and the solvent was removed under reduced pressure. The residue was taken up in 
methanol (1 mL) and KOH (0.07 mL, 1M in water, 0.070 mmol) was added at 0 °C. After 1.5 
h a saturated NH4Cl solution was added, layers were separated and the aqueous layer was 
extracted with DCM. The combined organic layer was dried over MgSO4 and the solvent was 
evaporated. Purification by column chromatography (hexane:EtOAc = 1:1) furnished 15 mg 
(72%) of methyl ester 236. 
Rf = 0.38 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.97 (s, 1H), 6.61 (s, 1H), 5.13 (dd, J = 7.32, 3.28 Hz, 1H), 
4.38 (dd, J = 7.32, 5.32 Hz, 1H), 3.70 (s, 3H), 3.37 (ddd, J = 14.49, 9.77, 5.97 Hz, 1H), 3.06 
(s, 3H), 2.71 (s, 3H), 2.06 (s, 3H), 2.01 (m, 1H), 1.97-1.92 (m, 1H), 1.72-1.61 (m, 1H), 1.58-
1.49 (m, 1H), 1.41-1.32 (m, 2H), 1.30-1.21 (m, 1H), 1.23 (s, 3H), 1.07-0.97 (m, 2H), 0.88 (s, 
9H), 0.83 (d, J = 6.60 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 174.7, 164.8, 152.5, 140.5, 120.1, 116.3, 85.1, 75.8, 68.0, 
52.1, 51.6, 39.0, 36.8, 36.0, 35.4, 33.4, 25.9, 21.8, 19.2, 18.3, 16.5, 15.9, 13.8, -5.4.  
HRMS (ESI) (m/z): [M]+ calcd for C27H49O7NS2Si: 591.2720, found: 591.2732.  
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4-[(1E,5Z)-(3S,10S)-3,11-Bis-(tert-butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-undeca-
1,5-dienyl]-2-methyl-thiazole (33) 
 
 
To a stirred solution of alcohol 235 (15 mg, 0.034 mmol) in DCM (1 mL) was added  
2,6-lutidine (9 µL, 0.051 mmol) and TBSOTf (10 µL, 0.041 mmol). After 1 h the reaction was 
quenched with saturated NH4Cl solution and extracted with DCM. The combined organic 
solution was dried over MgSO4 and the solvent was evaporated. Purification by column 
chromatography (hexane:EtOAc = 20:1) yielded 16 mg (85%) of protected 33 as colorless oil.  
Rf = 0.45 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.91 (s, 1H), 6.45 (s, 1H), 5.13 (t, J = 7.07 Hz, 1H), 4.08 (t,  
J = 6.57 Hz, 1H), 3.44 (dd, J = 9.85, 5.81 Hz, 1H), 3.34 (dd, J = 9.72, 6.69 Hz, 1H), 2.71 (s, 
3H), 2.30-2.20 (m, 2H), 2.04-1.94 (m, 2H), 2.00 (d, J = 1.16 Hz, 3H), 1.66 (d, J = 1.01 Hz, 
3H), 1.61-1.53 (m, 1H), 1.43-1.28 (m, 3H), 1.08-1.00 (m, 1H), 0.89 (s, 18H), 0.86 (d, J = 6.56 
Hz, 3H), 0.05 (s, 3H), 0.03 (s, 6H), 0.00 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 164.3, 153.3, 142.6, 136.9, 121.4, 118.7, 114.9, 79.1, 68.4, 
35.8, 35.3, 33.2, 32.3, 25.9, 25.8, 25.4, 23.5, 19.2, 18.4, 18.2, 16.7, 13.9, -4.6, -4.9, -5.3.  
IR (film): 2955, 2929, 1471, 1256, 1091 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C30H57O2Si2NS: 551.3849, found: 551.3635.  
[α]D20 3.50 (c = 1.1, CH2Cl2) 
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Benzoic acid (Z)-(1S,8S)-9-(tert-butyl-dimethyl-silanyloxy)-4,8-dimethyl-1-[(E)-1-methyl-
2-(2-methyl-thiazol-4-yl)-vinyl]-non-3-enyl ester (249) 
OTBSO
S
N
O
Ph
 
To a solution of β-hydroxy lactone 234 (30 mg, 0.06 mmol) in Et2O:NEt3 (10:1, 1.5 mL) at  
0 °C was added MsCl (17 μL, 0.09 mmol). After 1 h brine was added and the aqueous layer 
was extracted with Et2O. The combined ethereal layer was dried over MgSO4 and the solvent 
was removed under reduced pressure. The residue was taken up in THF (1 mL) and PhLi 
(0.18 ml, 1M in dibutyl ether, 0.18 mmol) was added at -78 °C. After 3 h a saturated NH4Cl 
solution was added, layers were separated and the aqueous was extracted with DCM. The 
combined organic layer was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 3:1) yielded 14 mg (43%) of product 249 and 5 mg (19%) 
of free alcohol 235. 
Rf = 0.88 (hexane:EtOAc = 3:1) 
1H-NMR (600 MHz, CDCl3): δ = 8.07 (m, 2H), 7.55 (m, 1H), 7.44 (m, 2H), 6.95 (s, 1H), 6.60 
(s, 1H), 5.47 (t, J = 6.78 Hz, 1H), 5.15 (t, J = 6.60 Hz, 1H), 3.43 (dd, J = 9.63, 5.85 Hz, 1H), 
3.34 (dd, J = 9.60, 6.60 Hz, 1H), 2.70 (s, 3H), 2.64-2.59 (m, 1H), 2.54-2.50 (m, 1H), 2.15 (d, 
J = 1.51 Hz, 3H), 2.07-1.98 (m, 2H), 1.66 (d, J = 1.08 Hz, 3H), 1.56 (m, 1H), 1.42-1.24 (m, 
3H), 1.07-1.02 (m, 1H), 0.88 (s, 9H), 0.85 (d, J = 6.78 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (150 MHz, CDCl3): δ = 165.7, 164.5, 152.6, 138.6, 137.6, 132.8, 130.6, 129.7, 
128.3, 120.6, 119.3, 116.2, 79.6, 68.3, 35.8, 33.1, 32.3, 31.8, 25.9, 25.4, 23.5, 22.6, 19.2, 
16.7, 14.9, -5.3.  
IR (film): 2955, 2360, 2343, 1718, 1654, 1458, 1271 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C31H47O3SiNS: 541.3046, found: 541.3055.  
[α]D20 5.20 (c = 0.25, CH2Cl2) 
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Acetic acid (Z)-(1S,8S)-9-(tert-butyl-dimethyl-silanyloxy)-4,8-dimethyl-1-[(E)-1-methyl-2-
(2-methyl-thiazol-4-yl)-vinyl]-non-3-enyl ester (250) 
OTBSO
S
N
O  
To a solution of β-hydroxy lactone 234 (18 mg, 0.036 mmol)) in Et2O:NEt3 (10:1, 1 mL) at  
0 °C under argon was added MsCl (4 μL, 0.052 mmol). After 1 h brine was added and the 
aqueous layer was extracted with Et2O. The combined ethereal layer was dried over MgSO4 
and the solvent was removed under reduced pressure. The residue was taken up in THF  
(1 mL) and MeLi (36 μL, 1.6 M in Et2O, 0.054 mmol) was added at -78 °C. After 5 h a 
saturated NH4Cl solution was added, layers were separated and the aqueous extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 3:1) yielded 4 mg (23%) of product 250 and 8 mg 
(51%) of free alcohol 235. 
Rf = 0.70 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.51 (s, 1H), 5.23 (t, J = 6.78 Hz, 1H), 5.07 (t,  
J = 6.76 Hz, 1H), 3.44 (dd, J = 9.78, 6.02 Hz, 1H), 3.35 (dd, J = 9.65, 6.64 Hz, 1H), 2.70 (s, 
3H), 2.49-2.34 (m, 2H), 2.08 (d, J = 1.20 Hz, 3H), 2.06 (s, 3H), 2.00 (t, J = 7.02 Hz, 2H), 1.67 
(d, J = 1.24 Hz, 3H), 1.57 (m, 1H), 1.42-1.32 (m, 3H), 1.05 (m, 1H), 0.89 (s, 9H), 0.86 (d, J = 
6.52 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 170.2, 164.5, 152.7, 138.5, 137.6, 120.5, 119.3, 116.1, 78.9, 
68.3, 35.7, 33.1, 32.3, 31.7, 29.7, 25.9, 25.4, 23.5, 21.2, 19.2, 18.3, 16.7, 14.9, -5.3. 
IR (film): 2929, 1508, 1458, 1238. 
HRMS (ESI) (m/z): [M]+ calcd for C26H45O3SiNS: 479.2889, found: 479.2899.  
[α]D20 -12.00 (c = 0.1, CH2Cl2) 
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(E)-(2S,3R,5S)- 5-tert-butyldimethylsilanyloxy-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-
4-methyl-pentyl]-3-hydroxy-2,6-dimethyl-7-(2-methyl-thiazol-4-yl)-hept-6-enoic acid 
methyl ester (502) 
OH
OMe
O
OTBS
TBSO
S
N
 
To a stirred solution of diol 232 (30 mg, 0.058 mmol) and imidazole (8 mg, 0.120 mmol) in 
DMF (1 mL) at r.t. was added TBSCl (8 mg, 0.063 mmol) and stirring was continued for 48 h. 
The reaction mixture was quenched with water and extracted with Et2O. The combined 
organic solution was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 5:1) furnished 15 mg (41%) of monoprotected product 
502.  
Rf = 0.60 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.46 (s, 1H), 4.41 (dd, J = 8.84, 4.52 Hz, 1H), 
3.92 (d, J = 10.12 Hz, 1H), 3.65 (s, 3H), 3.41 (dd, J = 9.72, 5.68 Hz, 1H), 3.33 (dd, J = 9.72, 
6.44 Hz, 1H), 2.70 (s, 3H), 1.99 (d, J = 0.76 Hz, 3H), 1.77-1.68 (m, 2H), 1.58 (m, 1H), 1.53-
1.44 (m, 2H), 1.38-1.21 (m, 2H), 1.12 (s, 3H), 1.10-0.97 (m, 2H), 0.91 (s, 9H), 0.88 (s, 9H), 
0.83 (d, J = 6.56 Hz, 3H), 0.14 (s, 3H), 0.10 (s, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.6, 164.5, 152.7, 141.4, 119.7, 115,.6, 79.9, 74.7, 68.3, 
51.5, 51.1, 38.9, 36.8, 35.5, 33.5, 25.9, 25.8, 21.9, 19.2, 18.3, 18.1, 16.6, 15.9, 13.7, -4.4, -
5.1, -5.4.  
 
Experimental Section 
 163
(E)-(2S,3R,5S)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-hydroxy-2,6-
dimethyl-7-(2-methyl-thiazol-4-yl)-5-triisopropylsilanyloxy-hept-6-enoic acid methyl 
ester (257) 
OH
OMe
O
OTBS
TIPSO
S
N
 
To a stirred solution of dihydroxy ester 231 (110 mg, 0.22 mmol) in DCM (4 mL) was added 
2,6-lutidine (58 µL, 0.48 mmol) and TIPSOTf (68 µL, 0.24 mmol). After 1.5 h the reaction was 
quenched with saturated NH4Cl solution and extracted with DCM. The combined organic 
solution was dried over MgSO4 and the solvent was evaporated. Purification by column 
chromatography (hexane:EtOAc = 10:1) yielded 125 mg (85%) of 257 as colorless oil.  
Rf = 0.70 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.95 (s, 1H), 6.52 (s, 1H), 4.55 (t, J = 6.82 Hz, 1H), 3.79 (dd,  
J = 9.73, 3.92 Hz, 1H), 3.65 (s, 3H), 3.39 (dd, J = 9.60, 5.81 Hz, 1H), 3.32 (dd, J = 9.73, 6.44 
Hz, 1H), 2.75 (d, J = 3.74 Hz,1H), 2.71 (s, 3H), 1.99 (d, J = 1.01 Hz, 3H), 1.78-1.66 (m, 2H), 
1.61-1.50 (m, 2H), 1.48-1.40 (m, 1H), 1.36-1.21 (m, 3H), 1.12 (s, 3H), 1.06 (s, 21H), 1.07-
0.97 (m, 1H), 0.88 (s, 9H), 0.82 (d, J = 6.57 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.8, 168.4, 152.9, 141.3, 120.1, 115.4, 78.3, 73.6, 68.4, 
51.7, 50.9, 40.5, 39.0, 36.5, 35.5, 33.5, 25.9, 22.0, 19.2, 18.1, 16.5, 13.6, 12.5, -0.4, -5.4.  
IR (film): 2948, 2865, 1734, 1465, 1256, 1088 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H43O4NSSi: 481.2682, found: 481.2688.  
[α]D20 -0.22 (c = 0.9, CH2Cl2) 
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(E)-(2S,3R,5S)-2-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-
methanesulfonyloxy-2,6-dimethyl-7-(2-methyl-thiazol-4-yl)-5-triisopropylsilanyloxy-
hept-6-enoic acid methyl ester (251) 
OMs
OMe
O
OTBS
TIPSO
S
N
 
To alcohol 257 (95 mg, 0.14 mmol) in Et2O:NEt3 (10:1, 3 mL) at r.t. was added mesyl chloride 
(38 μL, 0.42 mmol) and the mixture was stirred for 2 h. Brine was added, the layers were 
separated and the aqueous layer was extracted with Et2O. The ethereal layer was dried over 
MgSO4 and the solvent was evaporated. Column chromatography (hexane:EtOAc = 5:1) 
yielded 100 mg (96%) of 251 as colorless oil. 
Rf = 0.41 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.97 (s, 1H), 6.63 (s, 1H), 4.84 (t, J = 8.84 Hz, 1H), 4.59 (dd, 
J = 10.74, 3.66 Hz, 1H), 3.61 (s, 3H), 3.38 (dd, J = 9.73, 5.94 Hz, 1H), 3.31 (dd, J = 9.85, 
6.31 Hz, 1H), 3.05 (s, 3H), 2.71 (s, 3H), 2.03-1.94 (m, 1H), 1.98 (d, J = 1.01 Hz, 3H), 1.84-
1.74 (m, 2H), 1.56-1.48 (m, 2H), 1.46-1.23 (m, 3H), 1.17 (s, 3H), 1.05 (s, 21H), 1.07-0.97 (m, 
1H), 0.87 (s, 9H), 0.81 (d, J = 6.57 Hz, 3H), 0.01 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 175.4, 164.2, 153.8, 144.9, 138.8, 121.9, 116.2, 83.3, 79.9, 
75.2, 68.4, 63.1, 52.1, 51.5, 36.7, 35.6, 33.4, 32.8, 25.9, 19.4, 18.1, 16.7, 15.9, 12.2, -5.4.  
IR (film): 2951, 2865, 1736, 1340, 1174 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C36H69O7NS2Si2Na: 770.3952, found: 770.3968.  
[α]D20 14.27 (c = 0.55, CH2Cl2) 
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(5S,6R)-5-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-5-methyl-6-[(E)-(S)-3-
methyl-4-(2-methyl-thiazol-4-yl)-2-triisopropylsilanyloxy-but-3-enyl]-2,2-dioxo-2λ6-
[1,2]oxathian-4-one (252) 
O
O
OTBS
TIPSO
S
N
O2
S
 
Ester 251 (15 mg, 0.02 mmol) in toluene (1 mL) was treated with KOTMS (5 mg, 0.04 mmol) 
and heated under reflux for 1 h. After cooling to r.t. a saturated solution of NH4Cl was added 
and layers were separated. The aqueous layer was repeatedly extracted with DCM, 
combined organic layer was dried over MgSO4 and the solvent was removed under reduced 
pressure. Column chromatography (hexane:EtOAc = 10:1) yielded 10 mg (70%) of cyclic 
product 252 and traces of olefin 253. 
Rf = 0.50 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.95 (s, 1H), 6.44 (s, 1H), 4.52 (dd, J = 9.86, 3.78 Hz, 1H), 
4.24 (d, J = 9.84 Hz, 1H), 4.08 (d, J = 13.92 Hz, 1H), 3.96 (d, J = 13.65 Hz, 1H), 3.37 (dd, J = 
5.94, 2.40 Hz, 2H), 2.70 (s, 3H), 2.14-1.91 (m, 3H), 2.06 (s, 3H), 1.64-1.48 (m, 2H), 1.34-
1.23 (m, 2H), 1.07 (s, 3H), 1.06 (s, 21H), 0.89 (s, 9H), 0.83 (d, J = 6.56 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 197.2, 164.5, 152.7, 137.8, 121.7, 116.8, 83.2, 75.7, 67.9, 
59.7, 52.0, 35,5, 34.6, 33.6, 31.5, 25.9, 22.6, 19.4, 18.1, 18.0, 16.6, 16.3, 12.2, -5.4.  
IR (film): 2945, 2360, 1726, 1383, 1085 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C35H65O6NS2Si2Na: 738.3690, found: 738.3695.  
[α]D20 52.86 (c = 0.35, CH2Cl2) 
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Methanesulfonic acid (1R,2R,6S)-7-(tert-butyl-dimethyl-silanyloxy)-2-hydroxymethyl-
2,6-dimethyl-1-[(E)-(S)-3-methyl-4-(2-methyl-thiazol-4-yl)-2-triisopropylsilanyloxy-but-3-
enyl]-heptyl ester (503) 
OMs
OH
OTBS
TIPSO
S
N
 
To a solution of ester 251 (90 mg, 0.12 mmol) in toluene (2 mL) at -78 °C was slowly added 
DIBALH (0.1 mL, 1.5M in toluene, 0.14 mmol). After 3 h the reaction mixture was quenched 
by the addition of methanol and potassium sodium tartrate solution was added and stirring 
was continued for 2 h. The layers were separated and the aqueous layer was extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 10:1) yielded 75 mg (87%) of alcohol 503 as 
colorless oil. 
Rf = 0.23 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.94 (s, 1H), 6.64 (s, 1H), 4.70 (d, J = 7.56 Hz, 1H), 4.66 (dd, 
J = 10.34, 3.78 Hz, 1H), 3.57 (d, J = 11.88 Hz, 1H), 3.42 (dd, J = 9.84, 6.04 Hz, 1H), 3.34 
(dd, J = 9.72, 6.44 Hz, 1H), 3.33 (d, J = 12.64 Hz, 1H), 3.07 (s, 3H), 2.70 (s, 3H), 2.07 (m, 
1H), 2.02 (s, 3H), 1.91 (ddd, J = 15.40, 8.72, 3.92 Hz, 1H), 1.56 (m, 1H), 1.40-1.19 (m, 5H), 
1.07 (s, 3H), 1,05 (s, 21H), 0.99 (m, 1H), 0.89 (s, 9H), 0.84 (d, J = 6.80 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 164.4, 152.9, 139.3, 121.9, 116.1, 83.9, 75.4, 68.3, 66.5, 
42.4, 38.6, 37.4, 35.6, 34.3, 32.8, 25.9, 20.7, 19.4, 19.2, 18.1, 18.0, 16.6, 12.2, -5.4.  
IR (film): 3368, 2944, 2893, 2865, 1464, 1334, 1171, 1083, 1062 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C35H69O6NS2Si2: 719.4105, found: 719.4112.  
[α]D20 20.17 (c = 1.2, CH2Cl2) 
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Methanesulfonic acid (1R,2S,6S)-7-(tert-butyl-dimethyl-silanyloxy)-2-formyl-2,6-
dimethyl-1-[(E)-(S)-3-methyl-4-(2-methyl-thiazol-4-yl)-2-triisopropylsilanyloxy-but-3-
enyl]-heptyl ester (254) 
OMs O
OTBS
TIPSO
S
N
 
Dess-Martin periodinane (87 mg, 0.21 mmol) was added portion wise to a suspension of 
alcohol 503 (50 mg, 0.07 mmol) and NaHCO3 (52 mg, 0.63 mmol) in DCM (3 mL) at 0 °C. 
After 2 h water was added, layers were separated and the aqueous layer was extracted with 
DCM. The combined DCM phase was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 3:1) yielded 47 mg (94%) of aldehyde 254 as 
colorless oil. 
Rf = 0.59 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.46 (s, 1H), 6.98 (s, 1H), 6.65 (s, 1H), 4.78 (dd, J = 5.82, 
4.54 Hz, 1H), 4.62 (dd, J = 7.84, 6.32 Hz, 1H), 3.37 (dd, J = 9.98, 6.18 Hz, 1H), 3.32 (dd, J = 
9.72, 6.20 Hz, 1H), 3.03 (s, 3H), 2.70 (s, 3H), 2.02 (s,3H), 1.95 (dd, J = 6.82, 5.58 Hz, 2H), 
1.71 (dq, J = 12.96, 4.60 Hz, 1H), 1.52 (m, 1H), 1.46-1.32 (m, 4H), 1.27-1.14 (m, 2H), 1.08 
(s, 3H), 1.04 (s, 21H), 0.88 (s, 9H), 0.80 (d, J = 6.80 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 203.2, 164.3, 153.0, 138.6, 122.4, 116.5, 81.6, 75.2, 68.2, 
53.5, 38.9, 37.9, 35.5, 33.8, 32.4, 25.9, 21.2, 19.3, 18.1, 17.9, 16.6, 16.0, 12.5, 12.2, -5.4.  
IR (film): 2945, 2865, 1731, 1463, 1339, 1174, 1085, 1064 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C35H67O6NS2Si2: 717.3948, found: 717.3943.  
[α]D20 23.58 (c = 0.95, CH2Cl2) 
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4-[(1E,5E)-(3S,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-3-
triisopropylsilanyloxy-undeca-1,5-dienyl]-2-methyl-thiazole (253) 
 
To aldehyde 254 (25 mg, 0.035 mmol) in THF (1 mL) was added LiOH (0.1 mL, 1M in water, 
0.1 mmol) at 0 °C. After 6 h a saturated NH4Cl solution was added, layers were separated 
and the aqueous was extracted with DCM. The combined organic layer was dried over 
MgSO4 and the solvent was evaporated. Column chromatography (hexane:EtOAc = 10:1) 
yielded 17 mg (82%) of olefin 253 as colorless oil. 
Rf = 0.60 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 6.90 (s, 1H), 6,43 (s, 1H), 5.09 (t, J = 7.17 Hz, 1H), 4.24 (t,  
J = 6.60 Hz, 1H), 3.40 (dd, J = 9.81, 6.03 Hz, 1H), 3.30 (dd, J = 9.84, 6.78 Hz, 1H), 2.70 (s, 
3H), 2.38-2.34 (m, 1H), 2.33-2.28 (m, 1H), 2.00 (d, J = 1.14 Hz, 3H), 1.94-1.88 (m, 2H), 1.57 
(s, 3H), 1.52 (m, 1H), 1.39-1.35 (m, 1H), 1.32-1.25 (m, 3H), 1.06 (s, 11H), 1.04 (s, 10H), 
1.00-0.95 (m, 1H), 0.88 (s, 9H), 0.81 (d, J = 6.78 Hz, 3H), 0.02 (s, 6H).  
13C-NMR (150 MHz, CDCl3): δ = 164.1, 153.2, 142.2, 136.8, 120.2, 119.1, 114.7, 78.8, 68.4, 
40.2, 35.7, 35.6, 32.9, 29.7, 25.9, 25.4, 19.2, 18.3, 18.1, 18.0, 16.7, 16.2, 12.4, -5.3.  
IR (film): 2928, 2864, 1463, 1255, 1091, 1064 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C33H63O2NSSi2: 593.4118, found: 593.4125.  
[α]D20 8.12 (c = 0.85, CH2Cl2) 
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(3S,4R)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-3-methyl-4-[(E)-(S)-3-
methyl-4-(2-methyl-thiazol-4-yl)-2-triisopropylsilanyloxy-but-3-enyl]-oxetan-2-one (259) 
OTBS
TIPSO
S
N
O O
 
β-Hydroxy ester 257 (25 mg, 0.036 mmol) and 1-hydroxy-3-(isothiocyanato) 
tetrabutyldistannane (258) (4 mg, 0.007 mmol) in toluene (1 mL) were refluxed for 48 h. The 
solvent was removed under reduced pressure and column chromatography (hexane:EtOAc = 
10 : 1) gave 15 mg (65%) of β-lactone 259 and additionally 2 mg (9%) of olefin 260. 
Rf = 0.36 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 6.96 (s, 1H), 6.50 (s, 1H), 4.46 (dd, J = 8.85, 3.99 Hz, 1H), 
4.18 (dd, J = 10.20, 2.64 Hz, 1H), 3.42 (dd, J = 9.81, 6.03 Hz, 1H), 3.38 (dd, J = 9.81, 6.03 
Hz, 1H), 2.71 (s, 3H), 2.10-1.99 (m, 2H), 2.05 (d, J = 1.50 Hz, 3H), 1.74 (m, 1H), 1.60-1.49 
(m, 2H), 1.48-1.40 (m, 4H), 1.34 (s, 3H), 1.10 (m, 1H), 1.06 (s, 11H), 1.05 (s, 10H), 0.89 (s, 
9H), 0.86 (d, J = 6.78 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (150 MHz, CDCl3): δ = 174.9, 164.6, 152.8, 139.7, 120.4, 115.9, 80.1, 75.2, 68.1, 
56.8, 36.9, 35.5, 33.6, 30.9, 21.6, 19.6, 18.0, 16.6, 13.4, 12.2, -5.4.  
IR (film): 2946, 1827, 1698, 1651, 1574, 1463, 1091 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C34H63O4NSSi2:637.4016, found: 637.4011.  
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4-[(1E,5Z)-(3S,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-3-
triisopropylsilanyloxy-undeca-1,5-dienyl]-2-methyl-thiazole (260)w 
 
β-lactone 259 (15 mg, 0.023 mmol) was heated in DMF (1 mL) at 160 °C for 1.5 h. Brine was 
added and the aqueous phase was extracted with hexane:Et2O (1:1). The combined organic 
layer was dried over MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography (hexane:EtOAc = 10:1) yielded 10 mg (73%) of olefin 
260. 
Rf = 0.60 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 6.92 (s, 1H), 6.44 (s, 1H), 5.08 (t, J = 7.77 Hz, 1H), 4.21 (t,  
J = 6.42 Hz, 1H), 3.43 (dd, J = 9.84, 5.64 Hz, 1H), 3.33 (dd, J = 9,63, 6.63 Hz, 1H), 2.70 (s, 
3H), 2.38-2.32 (m, 1H), 2.31-2.26 (m, 1H), 1.99 (d, J = 1.50 Hz, 3H), 1.97 (m, 2H), 1.71-1.66 
(m, 1H) 1.64 (s, 3H), 1.54 (m, 1H), 1.42-1.35 (m, 2H), 1.32-1.22 (m, 1H), 1.06 (s, 11H), 1.04 
(s, 10H), 0.89 (s, 9H), 0.84 (d, J = 6.78 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (150 MHz, CDCl3): δ = 164.1, 153.5, 142.2, 134.1, 120.6, 118.9, 114.8, 68.4, 35.8, 
28.1, 25.9, 23.5, 19.2, 18.3, 18.1, 18.0, 16.7, 13.6, 12.4, -5.3.  
IR (film): 2925, 1456, 1249, 1098 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C33H63O6NSSi2: 593.4118, found: 593.4125.  
[α]D20 6.28 (c = 0.175, CH2Cl2) 
 
Experimental Section 
 171
10.2.2. Epothilone B: Lactate Route 
p-Methoxybenzyl-trichloroacatimidate (504) 
 
To a suspension of NaH (35 mg, 1.5 mmol) in Et2O (7 mL) was added a solution of  
p-methoxybenzylalcohol (2 g, 14.5 mmol) in Et2O (5 mL) and the mixture was stirred for 30 
min at r.t.. The reaction mixture was cooled down to -5 °C, trichloroacetonitrile (1.5 mL, 14.5 
mmol) was added and the reaction was allowed to warm to r.t. over 2 h. Et2O was removed 
under reduced pressure (cold water bath), the residue treated with hexane:methanol (98:2, 
15 mL), filtered over Celite and the solvent was evaporated to yield 3.7 g (90%) of the 
Bundle’s reagent. 
1H-NMR (250 MHz, CDCl3): δ = 8.38 (s, 1H), 7.42 (d, J = 9.0 Hz, 2H), 6.94 (d, J = 9.0 Hz, 
2H), 5.31 (s, 2H), 3.82 (s, 3H). 
 
(2S)-2-(4-Methoxy-benzyloxy)-propionic acid ethyl ester (505) 
 
To a stirred solution of p-methoxybenzyl-trichloroacatimidate (504) (3.70 g, 13 mmol) in 
cyclohexane (14 mL) was added (S)-(-)-ethyllactate (265) (0.97 mL, 8.50 mmol) in DCM (10 
mL). The mixture was cooled to 0 °C and a catalytic amount of trifluoromethanesulfonic acid 
was added. After 45 min the ice bath was removed and stirring was continued for 3 h at r.t.. 
The reaction mixture was diluted with pentane, the precipitate filtered off over celite and 
washed with saturated NaHCO3 solution. The combined aqueous solution was extracted with 
hexane:Et2O (1:1) and the combined organic solution was dried over MgSO4. The solvent 
was evaporated and the residue was purified by column chromatography (hexane:EtOAc = 
5:1) to yield 1.50 g (75%) of protected lactate 505.  
Rf = 0.47 (hexane:EtOAc = 3:1) 
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1H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.84 Hz, 2H), 4.62 (d,  
J = 11.37 Hz, 1H), 4.39 (d, J = 11.37 Hz, 1H), 3.80 (s, 3H), 4.21 (dq, J = 7.12, 2.33 Hz, 1H), 
4.02 (q, J = 6.90 Hz, 1H), 1.41 (d, J = 6.82 Hz, 3H), 1.30 (t, J = 7.20 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 173.3, 159.4, 129.7, 129.6, 113.8, 73.7, 71.6, 60.8, 55.3, 
18.7, 14.3.  
IR (film): 2981, 1732, 1614, 1514, 1030 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C13H18O4 : 238.1205, found: 238.1197.  
[α]D20 -64.46 (c = 1.3, CH2Cl2) 
 
(2S)-2-(4-Methoxy-benzyloxy)-propan-1-ol (266) 
 
A stirred solution of ester 505 (500 mg, 2.1 mmol) in THF (30 mL) was cooled to 0 °C and 
LiAlH4 powder (66 mg, 1.7 mmol) was added in small portions. The mixture was stirred over 
night. The reaction was quenched with methanol and diluted with saturated NH4Cl solution. 
The organic layer was separated, the aqueous layer was acidified with 1 N HCl solution to 
pH 4 and extracted with Et2O. The combined organic layer was dried over MgSO4, the 
solvent was evaporated and the residue was purified by column chromatography 
(hexane:EtOAc = 1:1) to yield 390 mg (96%) of alcohol 266 as pale yellow oil.  
Rf = 0.30 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.27 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 4.59 (d,  
J = 11.12 Hz, 1H), 4.42 (d, J = 11.12 Hz, 1H), 3.80 (s, 3H), 3.66 (m, 1H), 3.60 (ddd, J = 
11.37, 3.28, 0.1o Hz, 1H), 3.48 (ddd, J = 11.37, 6.95, 4.42 Hz, 1H), 2.02 (dd, J = 7.58, 4.55 
Hz, 1H), 1.16 (d, J = 6.31 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ =159.3, 130.5, 129.3, 113.9, 75.2, 70.5, 66.4, 55.3, 15.9.  
IR (film): 3431, 2930, 1612, 1513, 1247, 1034 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C11H16O3: 196.1099, found: 196.1088.  
[α]D20 46.22 (c = 1.2, CH2Cl2) 
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(2S)-2-(4-Methoxy-benzyloxy)-propionaldehyde (223) 
 
To a solution of oxalylchloride (0.3 mL, 3.6 mmol) in DCM (20 mL) at -78 °C was dropwise 
added DMSO (0.5 mL, 7.1 mmol) and the mixture was stirred for 30 min. Alcohol 266 (350 
mg, 1.8 mmol) in DCM (10 mL) was added and stirring was continued for 1 h before 
triethylamine (1.5 mL, 10.7 mmol) was added. The reaction mixture was shifted to an ice 
bath. After 45 min the reaction mixture was quenched with saturated NH4Cl solution, the 
organic layer was separated and the aqueous solution was extracted with DCM. The 
combined organic solution was dried over MgSO4 and the solvent was evaporated. The 
residue was taken up in hexane:EtOAc (3:1) and filtered over a short plug of silica gel to yield 
350 mg (quant.) of aldehyde 223 which was used without further purification.  
Rf = 0.81 (hexane:EtOAc = 1:1) 
1H-NMR (250 MHz, CDCl3): δ = 9.63 (d, J = 1.8 Hz, 1H), 7.28 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 
8.7 Hz, 2H), 4.56 (s, 2H), 3.86 (dq, J = 6.9, 1.4 Hz, 1H), 3.80 (s, 3H), 1.31 (d, J = 6.8 Hz, 
3H). 
 
2-Methyl-3-oxo-butyric acid tert-butyl ester (506) 
 
To a stirred suspension of NaH (794 mg, 19.8 mmol) in THF (70 mL) at 0 °C was added  
3-oxo-butyric acid tert-butyl ester (267) (3.1 mL, 18.9 mmol) and the mixture was stirred for 1 
h. MeI (2.35 mL, 37.8 mmol) was added slowly and the solution was stirred at r.t. over night. 
The reaction was quenched with a saturated NH4Cl solution, the organic layer was separated 
and the aqueous layer was extracted with Et2O. The combined organic layer was dried over 
MgSO4 and the solvent was evaporated. Purification by column chromatography 
(hexane:EtOAc = 10:1) of the crude product yielded 3.13 g (96%) of 506 as colorless liquid.  
Rf = 0.60 (hexane:EtOAc = 5:1) 
1H-NMR (250 MHz, CDCl3): δ = 3.40 (q, J = 7.12 Hz, 1H), 2.23 (s, 3H), 1.46 (s, 9H), 1.29 (d,  
J = 7.20 Hz, 3H). 
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2-Methyl-3-oxo-butyric acid methyl ester (507) 
 
To a stirred suspension of NaH (717 mg, 19.4 mmol) in THF (40 mL) at 0 °C was added  
3-oxo-butyric acid methyl ester (269) (2 mL, 18.5 mmol) and the mixture was stirred for 1 h. 
MeI (3.6 mL, 55.5 mmol) was added slowly and the solution was stirred at r.t. over night. The 
reaction was quenched with a saturated NH4Cl solution, the organic layer was separated and 
the aqueous layer was extracted with Et2O. The combined organic layer was dried over 
MgSO4 and the solvent was evaporated. Purification by column chromatography 
(hexane:EtOAc = 3:1) of the crude product yielded 1.95 g (81%) of 507 as colorless liquid.  
Rf = 0.58 (hexane:EtOAc = 3:1) 
1H-NMR (250 MHz, CDCl3): δ = 3.62 (s, 3H), 3.42 (q, J = 1.61 Hz, 1H), 2.12 (s, 3H), 1.24 (d, 
J = 1.61 Hz, 3H).  
 
2-Methyl-3-oxo-butyric acid 4-methoxy-benzyl ester (508) 
 
A solution of methyl ester 507 (5 g, 10.6 mmol) and 4-methoxybenzyl alcohol (10.6 g, 76.8 
mmol) in toluene (50 mL) was refluxed with a Dean-Stark trap for 48 h. After cooling to r.t. 
the solvent was removed under reduced pressure and column chromatography 
(hexane:EtOAc = 5:1) yielded 7.3 g (80%) of PMB ester 508. 
Rf = 0.57 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.60 Hz, 2H), 6.88 (d, J = 8.60 Hz, 2H), 5.11 (s, 
2H), 3.81 (s, 3H), 3.51 (q, J = 7.16 Hz, 1H), 2.17 (s, 3H), 1.34 (d, J = 7.08 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 203.4, 170.4, 159.7, 130.2, 127.5, 114.0, 66.9, 55.3, 53.7, 
28.4, 12.7.  
IR (film): 2943, 1716, 1248 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C13H16O4: 236.1049, found: 236.1052. 
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2,2,5,6-tetramethyl-4H-1,3-dioxin-4-one (268) 
O O
O
 
To aceto acetate 506 (2.4 g, 13.9 mmol) in acetone (8 mL) at -10 °C was added Ac2O (5.3 
mL, 55.7 mmol) and a catalytic amount of conc. H2SO4. The mixture was allowed to warm to 
r.t. over night. Ice water was added and the resulting mixture was stirred for 1 h. The 
aqueous layer was extracted with DCM. The combined organic layer was washed with brine 
and dried over MgSO4 and the solvent was evaporated. Purification by column 
chromatography (hexane:EtOAc = 10:1) yielded 1.3 g (60%) of 268.  
Rf = 0.62 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 1.97 (d, J = 0.76 Hz, 3H), 1.81 (d, J = 1.00 Hz, 3H), 1.64 (s, 
6H).  
13C-NMR (100 MHz, CDCl3): δ = 162.7, 162.6, 104.7, 100.3, 25.1, 17.4, 10.3. 
IR (film): 1728, 1654, 1399, 1348, 1270, 1238, 1207, 1155 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C8H12O3: 156.0786, 156.0793. 
 
Trimethyl-(2,2,5-trimethyl-6-methylene-6H-[1,3]dioxin-4-yloxy)-silane (261) 
 
A stirred solution of LDA (24.6 mmol), prepared by adding nBuLi (9.8 mL, 2.5M in hexane, 
24.6 mmol) dropwise to diisopropylamine (3.4 mL, 24.6 mmol) in THF (15 mL) at 0 °C and 
stirring for 15 min, was cooled to -78 °C and dioxenone 268 (3.2 g, 20.5 mmol) in THF (7 mL) 
was added dropwise. After 1 h TMSCl (2.9 mL, 22.6 mmol), freshly distilled from CaH2, was 
added. The mixture was stirred for 3 h at -78 °C; then warmed to r.t. and the solvent was 
removed under reduced pressure. The residue was purified by bulb-to-bulb distillation to 
yield 3.1 g (65%) of silylether 261 as colorless oil. 
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1H-NMR (400 MHz, C6D6): δ = 4.52 (d, J = 1.00 Hz, 1H), 4.16 (d, J = 1.04 Hz, 1H), 1.81 (s, 
3H), 1.39 (s, 6H), 0.14 (s, 9H). 
 
6-[(2S,3S)-2-Hydroxy-3-(4-methoxy-benzyloxy)-butyl]-2,2,5-trimethyl-[1,3]dioxin-4-one 
(270) 
 
Aldehyde 223 (800 mg, 4 mmol) in DCM (12 mL) at -10 °C was incubated with MgBr2·Et2O 
(2.1 g, 8 mmol) for 30 min. Silyl enol ether 261 (1.42 g, 6 mmol) in DCM (5 mL) was added 
and stirring continued for 1 h. A saturated NH4Cl solution was added, layers were separated 
and the aqueous layer was extracted with DCM. The combined DCM layer was dried over 
MgSO4 and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 1:1) to yield 1.34 g (96%) of aldol adduct 270 as pale yellow oil.  
Rf = 0.55 (Hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 8.59 Hz, 2H), 6.89 (d, J = 8.84 Hz, 2H), 4.62 (d, 
 J = 11.11 Hz, 1H), 4.36 (d, J = 11.11 Hz, 1H), 3.81 (s, 3H), 3.75-3.70 (m, 1H), 3.43 (dt, J = 
11.62, 6.18 Hz, 1H), 2.53 (dd, J = 14.16, 6.18 Hz, 1H), 2.44 (m, 1H), 2.35 (dd, J = 14.27, 
9.09 Hz, 1H), 1.84 (s, 3H), 1.64 (s, 3H), 1.63 (s, 3H), 1.24 (d, J = 6.32 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 162.9, 159.4, 129.9, 113.9, 104.9, 102.3, 76.8, 72.5, 70.7, 
55.3, 34.9, 25.8, 24.4, 15.5, 10.3.  
IR (film): 3468, 2936, 1721, 1647, 1514, 1248 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C19H26O6: 350.1729, found: 350.1737.  
[α]D20 15.83 (c = 1.2, CH2Cl2) 
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6-{[(2S,4S,5S)-2-(4-methoxyphenyl)-5-methyl-[1,3]-dioxolan-4-yl]methyl}-2,2,5-
trimethyl-4H-1,3-dioxin-4-one (271a) 
6-{[(2R,4S,5S)-2-(4-methoxyphenyl)-5-methyl-[1,3]-dioxolan-4-yl]methyl}-2,2,5-
trimethyl-4H-1,3-dioxin-4-one (271b) 
 
A suspension of monoprotected diol 270 (55 mg, 0.16 mmol) and MS 3 Å (100 mg) in Et2O (6 
mL) under argon at r.t. was stirred for 1 h before a suspension of DDQ (181 mg, 0.8 mmol) in 
Et2O (6 mL) also stirred for 1 h was added. After 2 h the reaction was quenched by the 
addition of a saturated Na2S2O3 solution and the MS was filtered off over celite. The layers 
were separated and the aqueous layer was extracted with Et2O. The combined organic 
solvent was dried over MgSO4 and the solvent was removed under reduced pressure. 
Column chromatography (hexane:EtOAc = 3:1) yielded 10 mg (18%) of acetale 271 and 40 
mg (73%) of the educt. 
271a: 1H-NMR (400 MHz, CDCl3): δ = 7.37 (d, J = 8.56 Hz, 2H), 6.89 (d, J = 7.84 Hz, 2H), 
5.91 (s, 1H), 4.03 (q, J = 6.32 Hz, 1H), 3.95 (m, 1H), 3.81 (s, 3H), 2.74 (dd, J = 14.12, 4.04 
Hz, 1H), 2.51 (dd, J = 14.40, 4.80 Hz, 1H), 1.84 (s, 3H), 1.66 (s, 3H), 1.65 (s, 3H), 1.36 (d,  
J = 6.04 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 161.5, 160.4, 127.7, 113.8, 102.6, 80.3, 78.6, 55.3, 34.6, 
25.7, 24.6, 17.8, 10.4. 
271b: 1H-NMR (400 MHz, CDCl3): δ = 7.37 (d, J = 8.56 Hz, 2H), 6.89 (d, J = 7.84 Hz, 2H), 
5.88 (s, 1H), 4.00 (q, J = 5.72 Hz, 1H), 3.95 (m, 1H), 3.81 (s, 3H), 2.76 (dd, J = 14.16, 3.80 
Hz, 1H), 2.45 (dd, J = 14.28, 4.44 Hz, 1H), 1.88 (s, 3H), 1.67 (s, 3H), 1.66 (s, 3H), 1.41 (d,  
J = 5.80 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 161.6, 160.4, 127.8, 113.7, 102.9, 80.3, 79.3, 55.3, 34.2, 
25.8, 24.5, 17.7, 10.3. 
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(S)-6-[(S)-1-(4-Methoxy-benzyloxy)-ethyl]-3-methyl-dihydro-pyran-2,4-dione (262) 
 
To a solution of lactone 270 (650 mg, 1.85 mmol) in methanol (12 mL) was added K2CO3 
(385 mg, 2.78 mmol) and the mixture was stirred over night. The solvent was evaporated and 
ice and 2N HCl were added to the residue. The acidic layer was extracted with Et2O 
repeatedly and the combined ethereal phase was dried over MgSO4. After removal of the 
solvent under reduced pressure 550 mg (quant.) of lactone 262 as yellow solid was isolated, 
in 3:1 mixture of diastereoisomers in α-position, and used without further purification.  
Rf = 0.15 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.56 Hz, 2H), 6.88 (d, J = 8.56 Hz, 2H), 4.64 (dt, 
J = 8.84, 4.04 Hz, 1H), 4.58 (d, J = 11.36 Hz, 1H), 4.42 (d, J = 11.36 Hz, 1H), 3.80 (s, 3H), 
3.70 (ddd, J = 12.68, 6.38, 3.84 Hz, 1H), 3.41 (q, J = 6.64 Hz, 1H), 2.72 (dd, J = 18.05, 4.16 
Hz, 1H), 2.60 (dd, J = 18.04, 8.96 Hz, 1H), 1.31 (d, J = 6.80 Hz, 3H), 1.29 (d, J = 6.32 Hz, 
3H).  
13C-NMR (100 MHz, CDCl3): δ = 200.8, 169.7, 159.0, 129.8, 129.4, 113.9, 76.5, 73.8, 71.1, 
55.3, 51.5, 39.4, 14.9, 8.3.  
IR (film): 2926, 1726, 1654, 1613, 1513, 1400, 1248, 1115 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O5: 292.1311, found: 292.1307.  
[α]D20 -29.50 (c = 0.8, CHCl3) 
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Carbonic acid allyl ester (S)-2-[(S)-1-(4-methoxy-benzyloxy)-ethyl]-5-methyl-6-oxo-3,6-
dihydro-2H-pyran-4-yl ester (275) 
O
O
O
OPMB
O
O
 
To a stirred solution of β-keto lactone 262 (230 mg, 0.74 mmol) in THF (6 mL) at -78 °C was 
slowly added a solution of potassium tert-butoxide (91 mg, 0.81 mmol) in THF (2 mL) and 
stirring was continued for 2.5 h. Allyl chloroformate (0.18 mL, 1.48 mmol) was added and 
after an additional 2.5 h the reaction was quenched by the addition of saturated NH4Cl 
solution. The layers were separated and the aqueous layer was extracted with DCM. The 
combined organic layer was dried over MgSO4 and the solvent was evaporated. The residue 
was purified by column chromatography (hexane:EtOAc = 3:1) to afford 172 mg (95%) of 275 
as colorless oil.  
Rf = 0.29 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 8.56 Hz, 2H), 6.88 (d, J = 8.84 Hz, 2H), 5.96 
(ddt, J = 17.15, 11.13, 5.57 Hz, 1H), 5.44-5.33 (m, 2H), 4.71 (dt, J = 6.04, 1.26 Hz, 2H), 4.59 
(d, J = 11.36 Hz, 1H), 4.48 (d, J = 11.60 Hz, 1H), 4.49 (m, 1H), 3.80 (s, 3H), 3.76 (ddd, J = 
12.74, 4.68, 0.02 Hz, 1H), 2.91 (m, 1H), 2.43 (ddd, J = 17.56, 3.91, 1.15 Hz, 1H), 1.83 (s, 
3H), 1.26 (d, J = 6.56 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 166.2, 159.3, 157.5, 150.9, 130.5, 130.1, 129.4, 120.1, 
115.8, 113.8, 77.5, 73.6, 71.1, 69.7, 55.3, 27.3, 14.7, 9.8.  
IR (film): 2930, 1764, 1744, 1722, 1612, 1514, 1228, 1125, 1053 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C20H24O7Na: 399.1420, found: 399,1416. 
[α]D20 -58.73 (c = 0.95, CH2Cl2) 
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Tsuji-Trost in biphasic system: 
To Pd(PPh3)4 (7.5 mg, 0.006 mmol) under argon atmosphere was added benzyl-triethyl-
ammonium chloride (3 mg, 0.012 mmol) in degassed water (1 mL) and cooled to 0 °C. Allyl 
acetate (14 µL, 0.13 mmol) was added and the mixture was stirred for 15 min. A degassed 
suspension of 262 (50 mg, 0.170 mmol) in ethyl acetate (1 mL) was added and stirring was 
continued for 15 min, then K2CO3 (25 mg, 0.180 mmol) in degassed water (0.5 mL) was 
added. After stirring for 2 h, the reaction mixture was quenched with saturated NH4Cl solution 
and phases were separated. The aqueous phase was extracted with DCM, the combined 
organic layer was dried over MgSO4 and the solvent was evaporated. The residue was 
purified by column chromatography (hexane:EtOAc = 3:1) to afford 43 mg (97%) of 273 in a 
d.r. of 3:1 (ax:eq). 
 
Tsuji-Trost with Trost-DACH ligand: 
Pd2(dba)3 (5 mg, 0.005 mmol) and (S,S)-Trost-DACH ligand (272) (7 mg, 0.010 mmol) were 
stirred in degassed toluene (1.5 mL) at r.t. to form a dark red solution, which turned orange 
and a precipitate formed upon the addition of allyl acetate (40 μL, 0.400 mmol). Then DBU 
(36 μL, 0.240 mmol) was added giving a clear yellow solution, which was cooled to -78 °C. A 
degassed solution of 262 (58 mg, 0.2 mmol) in toluene (0.5 mL) was added The reaction was 
quenched after 6 h with saturated NH4Cl solution, layers were separated and the aqueous 
solution was extracted with DCM. The combined organic layer was dried over MgSO4 and 
the solvent was evaporated. The residue was purified by column chromatography 
(hexane:EtOAc = 3:1) to yield 61 mg (92%) of 273 in a d.r. of 7:2 (ax:eq) as colorless oil. 
 
Intramolecular Tsuji-Trost with allyl carbonate 275: 
Pd2(dba)3 (7 mg, 0.0066 mmol) and (S,S)-Trost-DACH ligand (272) (9 mg, 0.0130 mmol) 
were stirred in degassed toluene (1 mL) for 20 min during which time the dark red solution 
turned orange. This solution was added via double needle to 275 (50 mg, 0.1300 mmol) in 
degassed toluene (1 mL) whereupon the solution turned yellow. After 1 h the solution was 
orange again and the solvent was evaporated. The residue was purified by column 
chromatography (hexane:EtOAc = 3:1) to yield 33 mg (76%) of 273 in a d.r. of 4:1 (ax:eq) as 
colorless oil. 
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(3S,6S)-3-Allyl-6-[(S)-1-(4-methoxy-benzyloxy)-ethyl]-3-methyl-dihydro-pyran-2,4-dione 
(273a) 
 
Rf = 0.21 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 5.74-
5.64 (m, 1H), 5.10-5.03 (m, 2H), 4.45 (d, J = 11.62 Hz, 1H), 4.47-4.43 (m, 1H), 4.42 (d, J = 
11.36 Hz, 1H), 3.80 (s, 3H), 3.65 (ddd, J = 12.63, 3.79, 3.79 Hz, 1H), 2.72 (dd, J = 16.16, 
3.54 Hz, 1H), 2.69 (dd, J = 13.33, 6.82 Hz, 1H), 2.53 (dd, J = 13.64, 8.33 Hz, 1H), 2.51 (dd,  
J = 16.16, 10.10 Hz, 1H), 1.40 (s, 3H), 1.29 (d, J = 6.31 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 205.8, 173.2, 159.4, 132.6, 129.7, 129.5, 119.5, 113.9, 75.9, 
73.8, 70.9, 56.5, 55.3, 40.9, 40.5, 23.7, 14.6.  
IR (film): 1749, 1713, 1513, 1246, 1031 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C19H24O5: 332.1624, found: 332.1619.  
[α]D20 -19.41 (c = 0.85, CH2Cl2) 
 
(3R,6S)-3-Allyl-6-[(S)-1-(4-methoxy-benzyloxy)-ethyl]-3-methyl-dihydro-pyran-2,4-dione 
(273b) 
O
O
O
OPMB  
Rf = 0.21 (Hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.18 (d, J = 8.59 Hz, 2H), 6.86 (d, J = 8.59 Hz, 2H), 5.69-
5.59 (m, 1H), 5.12-5.06 (m, 2H), 4.49 (d, J = 11.62 Hz, 1H), 4.47-4.45 (m, 1H), 4.32 (d, J = 
11.62 Hz, 1H), 3.80 (s, 3H), 3.49 (ddd, J = 12.69, 6.38, 2.08 Hz, 1H), 2.79 (dd, J = 16.04, 
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6.19 Hz, 1H), 2.56-2.43 (m, 2H), 2.52 (dd, J = 15.91, 4.54 Hz, 1H), 1.29 (d, J = 6.02 Hz, 3H), 
1.27 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 204.3, 174.1, 159.5, 131.9, 130.2, 128.8, 119.9, 113.8, 76.8, 
74.4, 70.6, 57.6, 55.3, 44.5, 40.5, 20.4, 15.2.  
IR (film): 1745, 1713, 1514, 1247, 1030 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C19H24O5: 332.1624, found: 332.1619.  
[α]D20 60.20 (c = 0.45, CH2Cl2) 
 
(-)-(4S)-(E)-5-(tert-Butyl-dimethyl-silyloxy)-4-methyl-pent-2-enoic acid ethyl ester (184) 
 
To a stirred suspension of anhydrous LiCl (251 mg, 5.93 mmol) in acetonitrile (40 mL) at r.t. 
was added triethylphosponoacetate (0.99 mL, 4.94 mmol) and DBU (0.88 mL, 5.93 mmol). 
The mixture was stirred for 10 min to form a clear solution, then aldehyde 494 (1 g, 4.94 
mmol) in acetonitrile (15 mL) was added and stirring was continued over night. The reaction 
mixture was quenched with saturated NaHCO3 solution, the organic layer was separated and 
the aqueous layer was extracted with Et2O. The combined organic solution was dried over 
MgSO4 and the solvent was evaporated. Purification by column chromatography 
(hexane:EtOAc = 10:1) yielded 1.18 g (84%) of 184 as colorless oil.  
Rf = 0.50 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.92 (dd, J = 15.80, 7.20 Hz, 1H), 5.83 (dd, J = 15.78, 1.38 
Hz, 1H), 4.19 (q, J = 7.08 Hz, 2H), 3.55 (dd, J = 9.86, 6.58 Hz, 1H), 3.51 (dd, J = 9.96, 6.44 
Hz, 1H), 2.50 (m, 1H), 1.28 (t, J = 7.06 Hz, 3H), 1.05 (d, J = 6.84 Hz, 3H), 0.89 (s, 9H), 0.04 
(s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 173.5, 151.4, 120.9, 66.9, 60.1, 39.1, 25.9, 15.5, 14.3, -5.4.  
IR (film): 2956, 2929, 1723, 1258, 1183, 1097 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C14H28O3Si: 272.1808, found: 272.1801.  
[α]D20 -11.80 (c = 1.5, CHCl3), [α]D20 -18.72 (c = 1.25, CH2Cl2) 
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(-)-(4S)-(E)-5-(tert-Butyl-dimethyl-silyloxy)-4-methyl-pent-2-en-1-ol (509) 
 
To a stirred solution of DIBALH (5.7 mL, 1.5 M in toluene, 8.5 mmol) in THF (15 mL) at  
-78 °C was dropwise added ester 186 (1.2 g, 4.0 mmol). After 5 h the reaction mixture was 
quenched with saturated sodium potassium tartrate solution and stirred for 2 h. The layers 
were separated, the aqueous phase was extracted with hexane:Et2O (1:1) and the combined 
organic solution was dried over MgSO4. After evaporation of the solvent, the crude product 
was purified by column chromatography (hexane:EtOAc = 10:1) to yield 875 mg (95%) of 
alcohol 509 as colorless oil.  
Rf = 0.23 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.70-5.60 (m, 2H), 4.10 (t, J = 5.32 Hz, 2H), 3.50 (dd, J = 
9.72, 6.20 Hz, 1H), 3.41 (dd, J = 9.70, 6.94 Hz, 1H), 2.34 (m, 1H), 1.26 (t, J = 5.80 Hz, 1H 
(OH)), 1.00 (d, J = 6.56 Hz, 3H), 0.89 (s, 9H), 0.04 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 135.6, 128.7, 67.9, 63.9, 38.9, 25.9, 18.3, 16.4, -5.3.  
IR (film): 3328, 2956, 2929, 2857, 1256, 1104, 1089 cm-1.  
HRMS (ESI) (m/z): [M - tBu]+ calcd for C8H17O2Si: 173.0998, found: 173.1002.  
[α]D20 -7.44 (c = 1.3, CHCl3), [α]D20 -9.91 (c = 1.15, CH2Cl2)   
 
Carbonic acid (-)-(4S)-(E)-5-(tert-butyl-dimethyl-silyloxy)-4-methyl-pent-2-enyl ester 
2,2,2-trichloro-ethyl ester (185) 
 
In a stirred solution of alcohol 509 (760 mg, 3.13 mmol) in pyridine (22 mL) was dissolved a 
catalytic amount of DMAP and 2,2,2-trichloroethyl chloroformate (0.47 mL, 3.45 mmol) was 
added. The mixture was stirred at r.t. for 1 h, quenched with brine and the layers were 
separated. The aqueous phase was extracted with Et2O, the combined organic solution was 
dried over MgSO4 and the solvent was evaporated. Purification by column chromatography 
(hexane:EtOAc = 10:1, 1% NEt3) yielded 1.4 g (quant.) of carbonate 185 as colorless oil.  
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Rf = 0.71 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.82 (dd, J = 15.64, 7.08 Hz, 1H), 5.64 (ddt, J =14.88, 6.82, 
1.30 Hz, 1H), 4.76 (s, 2H), 4.67 (d, J = 6.56 Hz, 2H), 3.49 (dd, J = 9.84, 6.32 Hz, 1H), 3.43 
(dd, J = 9.70, 6.70 Hz, 1H), 2.40-2.34 (m, 1H), 1.00 (d, J = 6.84 Hz, 3H), 0.89 (s, 9H), 0.03 
(s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 154.97, 140.61, 122.43, 69.96, 67.67, 39.16, 26.06, 26.02, 
18.48, 16.21, -5.21.  
HRMS (ESI) (m/z): [M - tBu]+ calcd for C11H18O4SiCl3: 349.0012, found: 349.0008.  
[α]D20 -6.15 (c = 2.1, CHCl3) 
 
Chloro-acetic acid (E)-(4S)-5-(tert-butyl-dimethyl-silanyloxy)-4-methyl-pent-2-enyl ester 
(510) 
 
To stirred solution of alcohol 509 (100 mg, 0.43 mmol) in pyridine (4 mL) was added 
chloroacetic anhydride (88 mg, 0.52 mmol). The mixture was stirred at r.t. for 1 h, quenched 
with brine and the layers were separated. The aqueous phase was extracted with Et2O, the 
combined organic solution was dried over MgSO4 and the solvent was evaporated. 
Purification by column chromatography (hexane:EtOAc = 10:1) yielded 130 mg (99%) of 
chloroactate 510.  
Rf = 0.65 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.75 (d, J = 15.41, 7.08 Hz, 1H), 5.60 (dtd, J = 15.47, 6.48, 
1.09 Hz, 1H), 4,64 (d, J = 6.32 Hz, 2H), 4.06 (s, 2H), 3.48 (dd, J = 9.88, 6.56 Hz, 1H), 3.44 
(dd, J = 9.72, 6.44 Hz, 1H), 2.36 (m, 1H), 1.00 (d, J = 6.80 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 167.1, 140.0, 122.6, 118.1, 67.5, 66.9, 40.9, 39.0, 25.9, 
18.3, 16.1, -5.4.  
IR (film): 2956, 2857, 1762, 1257, 1168, 1107 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C14H27O3SiClNa: 329,1316, found: 329,1323.  
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[α]D20 -9.80 (c = 1.5, CH2Cl2)  
 
Carbonic acid (E)-(S)-5-(tert-butyl-dimethyl-silanyloxy)-4-methyl-pent-2-enyl ester ethyl 
ester (511) 
 
To stirred solution of alcohol 509 (150 mg, 0.64 mmol) in pyridine (5 mL) was added ethyl 
chloroformate (73 μL, 0.76 mmol). The mixture was stirred at r.t. for 20 min, quenched with 
brine and the layers were separated. The aqueous phase was extracted with Et2O, the 
combined organic solution was washed with water, dried over MgSO4 and the solvent was 
evaporated. Purification by column chromatography (hexane:EtOAc = 10:1) yielded 170 mg 
(88%) of ethyl carbonate 511.  
Rf = 0.64 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.76 (d, J = 15.52, 6.96 Hz, 1H), 5.61 (dtd, J = 15.58, 6.41, 
1.08 Hz, 1H), 4.57 (d, J = 6.32 Hz, 2H), 4.19 (q, J = 7.16 Hz, 2H), 3.49 (dd, J = 9.86, 6.30 Hz, 
1H), 3.41 (dd, J = 9.86, 6.82 Hz, 1H), 2.35 (m, 1H), 1.30 (t, J = 7.20 Hz, 3H), 1.00 (d, J = 
6.60 Hz, 3H), 0.88 (s, 9H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 155.0, 139.3, 123.0, 68.5, 67.6, 63.9, 39.0, 25.9, 18.3, 16.1, 
14.3, -5.4.  
IR (film): 2956, 2930, 2857, 1747, 1258, 1105 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C15H30O4SiNa: 325.1811, found: 325.1817.  
[α]D20 -9.20 (c = 1.25, CH2Cl2)  
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(3S,6S)-3-[(E)-(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pent-2-enyl]-6-[(S)-1-(4-
methoxy-benzyloxy)-ethyl]-3-methyl-dihydro-pyran-2,4-dione (277) 
 
To Pd(PPh3)4 (87 mg, 0.075 mmol) and benzyl-triethyl-ammonium chloride (34 mg, 0.150 
mmol) in degassed water (4 mL) at 0 °C was added ethyl carbonate 511 (453 mg, 1.500 
mmol) in ethyl acetate (3 mL) and the mixture was stirred for 15 min. A degassed suspension 
of 23 (650 mg, 1.800 mmol) in ethyl acetate (3 mL) was added and stirring was continued for 
15 min before K2CO3 (270 mg, 1.950 mmol) in degassed water (2 mL) was added. After 
stirring for 3 h, the reaction mixture was quenched with saturated NH4Cl solution and phases 
were separated. The aqueous phase was extracted with DCM and the combined organic 
layer was dried over MgSO4 and the solvent was evaporated. The residue was purified by 
column chromatography (hexane:EtOAc = 3:1) to afford 730 mg (97%) of 277 as 3:1 mixture 
as pale yellow oil. 
Major: 277a 
Rf = 0.24 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.60 Hz, 2H), 5.44 (dd, 
J = 15.42, 7.06 Hz, 1H), 5.32 (dt, J = 14.76, 7.38 Hz, 1H), 4.58 (d, J = 11.60 Hz, 1H), 4.43 (d, 
J = 11.60 Hz, 1H), 4.42 (m, 1H), 3.80 (s, 3H), 3.69 (dd, J = 6.30, 3.78 Hz, 1H), 3.66 (dd, J = 
6.32, 3.80 Hz, 1H), 3.43 (dd, J = 9.70, 5.94 Hz, 1H), 3.31 (dd, J = 9.73, 7.20 Hz, 1H), 2.68 
(dd, J = 15.93, 3.28 Hz, 1H), 2.64 (dd, J = 13.24, 6.68 Hz, 1H), 2.49 (dd, J = 15.90, 10.86 Hz, 
1H), 2.45 (dd, J = 13.14, 8.06 Hz, 1H), 2.22 (m,1H), 1.37 (s, 3H), 1.26 (d, J = 6.32 Hz, 3H), 
0.92 (d, J = 6.56 Hz, 3H), 0.87 (s, 9H), 0.01 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 206.2, 173.4, 159.4, 138.5, 129.6, 129.5, 123.3, 113.9, 75.6, 
73.8, 71.0, 67.9, 56.7, 55.3, 40.7, 40.6, 39.3, 25.9, 23.0, 18.3, 16.6, 14.5, -5.3, -5.4.  
IR (film): 2955, 2930, 1717, 1635, 1615, 1250 cm-1.  
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C24H35O6Si: 447.2203, found: 447.2212.  
[α]D20 -35.33 (c = 0.3, CH2Cl2) 
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Minor: 277b 
 
Rf = 0.24 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.18 (d, J = 8.59 Hz, 2H), 6.86 (d, J = 8.59 Hz, 2H), 5.43 (dd, 
J = 15.54, 6.95 Hz, 1H), 5.28 (dt, J = 15.28, 7.52Hz, 1H), 4.48 (d, J = 11.34 Hz, 1H), 4.44 (m, 
1H), 4.31 (d, J = 11.62 Hz, 1H), 3.80 (s, 3H), 3.48 (m, 1H), 3.44 (dd, J = 9.85, 6.06 Hz, 1H), 
3.35 (dd, J = 9.72, 6.95 Hz, 1H), 2.78 (dd, J = 16.01, 6.19 Hz, 1H), 2.50 (dd, J = 16.16, 4.54 
Hz, 1H), 2.49 (m,1H), 2.39 (dd, J = 13.51, 8.21 Hz, 1H), 2.26 (m, 1H), 1.28 (d, J = 6.31 Hz, 
3H), 1.26 (s, 3H), 0.94 (d, J = 6.82 Hz, 3H), 0.87 (s, 9H), 0,01 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 204.5, 174.3, 159.5, 138.7, 130.2, 128.8, 123.0, 113.8, 76.8, 
74.4, 70.5, 67.8, 57.9, 55.2, 43.6, 40.6, 39.2, 25.9, 20.3, 18.3, 16.6, 15.2, -5.3, -5.4.  
IR (film): 2955, 2930, 1716, 1613, 1514, 1250, 1082 .cm-1.  
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C24H35O6Si: 447.2203, found: 447.2210.  
[α]D20 38.31 (c = 0.95, CH2Cl2) 
 
(3S,4S,6S)-3-[(E)-(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pent-2-enyl]-4-
hydroxy-6-[(S)-1-(4-methoxy-benzyloxy)-ethyl]-3-methyl-tetrahydro-pyran-2-one (278) 
O
OH
O
OPMB
TBSO
 
To ß-keto lactone 277 (220 mg, 0.44 mmol) in methanol (9 mL) at 0 °C was added NaBH4 
(17 mg, 0.44 mmol) and the solution was stirred for 1.5 h. The reaction mixture was 
quenched with saturated NH4Cl solution, the organic layer was separated and the aqueous 
layer was extracted with DCM. The combined organic solution was dried over MgSO4 and 
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the solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 3:1) 
yielded 218 mg (98%) of reduction product 278. 
Rf = 0.30 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.26 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.84 Hz, 2H), 5.47 (m, 
2H), 4.63 (d, J = 11.40 Hz, 1H), 4.43 (d, J = 11.36 Hz, 1H), 4.42 (m, 1H), 3.82 (m, 1H), 3.80 
(s, 3H), 3.56 (ddd, J = 12.63, 6.31, 3.28 Hz, 1H), 3.46 (dd, J = 9.60, 6.31 Hz, 1H), 3.39 (dd,  
J = 9.85, 6.82 Hz, 1H), 2.55 (dd, J = 13.64, 5.81 Hz, 1H), 2.40 (dd, J = 13.89, 6.06 Hz, 1H), 
2.29 (m, 1H), 2.16 (ddd, J = 14.21, 7.14, 4.35 Hz, 1H), 1.98 (dt, J = 14.14, 7.07 Hz, 1H), 1.20 
(d, J = 6.56 Hz, 3H), 1.20 (s, 3H), 0.96 (d, J = 6.82 Hz, 3H), 0.88 (s, 9H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ =175.2, 159.4, 137.4, 129.7, 129.4, 129.2, 124.7, 113.9, 78.3, 
75.0, 70.8, 70.4, 68.0, 55.2, 47.1, 39.4, 37.4, 28.9, 25.9, 21.0, 18.3, 16.6, 14.6, -5.3, -5.4.  
IR (film): 3435, 2956, 2856, 1732, 1514, 1463, 1250, 1089, 1036 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C28H46O6: 506.3069, found: 506.3055.  
[α]D20 23.41 (c = 0.85, CH2Cl2) 
 
(2R,3R)-3-(4-methoxybenzyloxy)-1-(2,2,5-trimethyl-4-oxo-4H-[1,3]-dioxin-6-yl)butan-2-yl 
acetate (512) 
 
To alcohol 270 (100 mg, 0.28 mmol) in pyridine (1.5 mL) in at r.t. was added acetic anhydride 
(0.13 mL, 1.40 mmol) and a catalytic amount of DMAP. After 1 h the reaction was quenched 
by the addition of a saturated NaHCO3 solution and the aqueous layer was extracted with 
Et2O. The combined ethereal phase was dried over MgSO4 and the solvent was removed 
under reduced pressure. Purification by column chromatography (hexane:EtOAc = 2:1) 
yielded 95 mg (86%) of acetate 512. 
Rf = 0.53 (Hexane:EtOAc = 1:1) 
1H-NMR (250 MHz, CDCl3): δ = 7.25 (d, J = 8.55 Hz, 2H), 6.88 (d, J = 8.67 Hz, 2H), 5.21 (dt, 
J = 9.59, 3.77 Hz, 1H), 4.58 (d, J = 11.43 Hz, 1H), 4.42 (d, J = 11.53 Hz, 1H), 3.80 (s, 3H), 
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3.63 (m, 1H), 2.76 (dt, J = 14.73, 9.48 Hz, 1H), 2.46 (dd, J = 14.78, 3.47 Hz, 1H), 2.04 (s, 
3H), 1.83 (s, 3H), 1.61 (s, 3H), 1.58 (s, 3H), 1.17 (d, J = 6.40 Hz, 3H). 
 
(2R,3R)-3-hydroxy-1-(2,2,5-trimethyl-4-oxo-4H-[1,3]-dioxin-6-yl)butan-2-yl acetate (279) 
 
To a stirred solution of diprotected diol 512 (300 mg, 0.75 mmol) in wet DCM (6 mL) was 
added DDQ (198 mg, 0.83 mmol) in small portions and the mixture was stirred vigorously for 
4 h. The reaction was quenched with saturated NaHCO3 solution, the organic layer was 
separated and the aqueous solution was extracted with DCM. The combined organic solution 
was dried over MgSO4, the solvent was evaporated and the residue was purified by column 
chromatography (hexane:EtOAc = 1:1) to yield 203 mg (quant.) of monoprotected diol 279.  
Rf = 0.28 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.06 (m, 1H), 3.86 (ddd, J = 12.49, 6.33, 4.05 Hz, 1H), 2.79 
(dd, J = 14.40, 8.60 Hz, 1H), 2.55 (dd, J = 14.52, 4.68 Hz, 1H), 2.08 (d, J = 1.28 Hz, 3H), 
1.85 (s, 3H), 1.64 (s, 3H), 1.61 (s, 3H), 1.22 (dd, J = 6.56, 1.28 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 170.2, 105.0, 73.8, 68.5, 32.4, 25.6, 24.6, 21.1, 19.4, 10.3. 
 
(R)-3-oxo-1-(2,2,5-trimethyl-4-oxo-4H-[1,3]-dioxin-6-yl)butan-2-yl acetate (280) 
 
To a stirred solution of alcohol 279 (110 mg, 0.41 mmol) in DCM (6 mL) was added Dess-
Martin periodinane (514 mg, 1.24 mmol) in small portions and the suspension was stirred for 
2 h. The reaction was quenched with saturated NaHCO3 solution, the organic layer was 
separated and the aqueous layer was extracted with DCM. The combined organic solution 
was dried over MgSO4, the solvent was evaporated and the residue was purified by column 
chromatography (hexane:EtOAc = 1:1) to yield 110 mg (quant.) of ketone 280.  
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Rf = 0.13 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.28 (t, J = 6.32 Hz, 1H), 2.82 (d, J = 6.32 Hz, 1H), 2.22 (s, 
3H), 2.14 (s, 3H), 1.85 (s, 3H), 1.64 (s, 3H), 1.60 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 203.4, 169.8, 105.3, 40.9, 31.6, 26.1, 25.2, 24.7, 20.5, 10.2.  
HRMS (ESI) (m/z): [M]+ calcd for C13H18O6: 270.1103, found: 270.1094. 
 
(3S,4S,6S)-3-[(S)-5-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-pentyl]-4-hydroxy-6-[(S)-1-
(4-methoxy-benzyloxy)-ethyl]-3-methyl-tetrahydro-pyran-2-one (284) 
 
To β-hydroxyl lactone 278 (350 mg, 0.65 mmol) in ethyl acetate (6 mL) was added PtO2 (12 
mg, 0.07 mmol) and the resulting suspension was stirred under an atmosphere of hydrogen. 
After 1.5 h the reaction mixture was filtered through Celite and the filtrate was evaporated to 
yield 350 mg (quant.) of 284 as colorless oil. 
Rf = 0.30 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.26 (d, J = 8.84 Hz, 2H), 6.87 (d, J = 8.84 Hz, 2H), 4.63 (d, 
J = 11.64 Hz, 1H), 4.42 (d, J = 11.60 Hz, 1H), 4.39 (m, 1H), 3.86 (ddd, J = 6.95, 6.69, 4.29 
Hz, 1H), 3.80 (s, 3H), 3.56 (ddd, J = 12.67, 6.39, 3.21 Hz, 1H), 3.42 (dd, J = 9.84, 5.80 Hz, 
1H), 3.34 (dd, J = 9.84, 6.56 Hz, 1H), 2.83 (d, J = 6.32 Hz, 1H), 2.14 (ddd, J = 14.07, 6.75, 
4.23 Hz, 1H), 2.01 (dt, J = 14.22, 7.65 Hz, 1H), 1.75-1.67 (m, 2H), 1.59 (m, 1H), 1.33-1.28 
(m, 2H), 1.31 (d, J = 6.28 Hz, 3H), 1.25 (s, 3H), 1.05 (m, 1H), 0.84 (d, J = 6.80 Hz, 3H), 0.88 
(s, 9H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ =175.3, 159.4, 129.7, 129.5, 113.9, 78.1, 74.9, 70.8, 70.7, 
68.4, 55.3, 47.0, 35.6, 33.7, 33.1, 28.6, 25.9, 21.1, 18.3, 16.7, 14.6, -5,4.  
IR (film): 2953, 1732, 1514, 1463, 1250, 1092 cm-1. 
HRMS (ESI) (m/z): [M]+ calcd for C28H48O6Si: 508.3220, found: 508.3224.  
[α]D20 24.75 (c = 0.4, CH2Cl2) 
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(Z)-(2S,3S,10S)-11-(tert-Butyl-dimethyl-silanyloxy)-2-(4-methoxy-benzyloxy)-6,10-
dimethyl-undec-5-en-3-ol (264) 
 
Alcohol 284 (60 mg, 0.12 mmol) was dissolved in Et2O (3 mL), triethylamine (0.30 mL) was 
added at 0 °C and the mixture was stirred for 15 min. Methanesulfonyl chloride (10 µL, 0.13 
mmol) was added and stirring was continued. After 1.5 h the reaction mixture was quenched 
with brine, the organic layer was separated and the aqueous layer was extracted with Et2O. 
The combined organic layers were dried over MgSO4 and the solvent was evaporated. This 
yielded 80 mg of the crude mesylate which was used without further purification. 
To a stirred solution of the mesylate (70 mg, 0.10 mmol) in methanol (3 mL) at 0 °C was 
added 1 M KOH (0.2 mL, 0.20 mmol) and the solution was stirred for 2 h. The reaction was 
quenched with saturated NH4Cl solution, the organic layer was separated and the aqueous 
layer was extracted with DCM. The combined organic layer was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 15:1) 
yielded 42 mg (91%) of 264 as colorless oil.  
Rf = 0.20 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.26 (d, J = 8.84 Hz, 2H), 6.88 (d, J = 8.84 Hz, 2H), 5.21 (t,  
J = 7.07 Hz, 1H), 4.59 (d, J = 11.11 Hz, 1H), 4.38 (d, J = 11.11 Hz, 1H), 3.80 (s, 3H), 3.46-
3.40 (m, 3H), 3.35 (dd, J = 9.85, 6.57 Hz, 1H), 2.47 (d, J = 3.54 Hz, 1H), 2.28-2.21 (m, 1H), 
2.19-2.11 (m, 1H), 2.00 (t, J = 7.96 Hz, 2H), 1.70 (d, J = 1.01 Hz, 3H), 1.61-1.53 (m, 1H), 
1.45-1.31 (m, 3H), 1.18 (d, J = 5.81 Hz, 3H), 1.08-1.01 (m, 1H), 0.90 (s, 9H), 0.86 (d, J = 
6.82 Hz, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 159.3, 137.9, 130.5, 129.3, 120.5, 113.9, 77.3, 75.1, 70.7, 
68.3, 55.3, 35.7, 33.1, 32.2, 25.9, 25.3, 23.5, 18.3, 16.7, 15.7, -5.3.  
IR (film): 2929, 1726, 1514, 1249, 1180, 1093 cm-1. 
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C23H39O4Si: 407.2617, found: 407.2610.  
[α]D20 20.00 (c = 1.9, CH2Cl2)   
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1-[(Z)-(1S,2S,9S)-2,10-Bis-(tert-butyl-dimethyl-silanyloxy)-1,5,9-trimethyl-dec-4-
enyloxymethyl]-4-methoxy-benzene (513) 
 
To a stirred solution of alcohol 264 (150 mg, 0.32 mmol) in DCM (4 mL) was added  
2,6-lutidine (58 µL, 0.48 mmol) and TBSOTf (92 µL, 0.38 mmol). After 1 h the reaction was 
quenched with saturated NH4Cl solution. The layers were separated and the aqueous layer 
was extracted with DCM. The combined organic solution was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 20:1) 
yielded 185 mg (quant.) of protected triole 513 as colorless oil.  
Rf = 0.62 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 8.50 Hz, 2H), 6.86 (d, J = 8.59 Hz, 2H), 5.15 (t,  
J = 7.33 Hz, 1H), 4.51 (d, J = 11.62 Hz, 1H), 4.44 (d, J = 11.62 Hz, 1H), 3.80 (s, 3H), 3.69-
3.65 (m, 1H), 3.47-3.44 (m, 1H), 3.44 (dd, J = 11.87, 6.06 Hz, 1H), 3.34 (dd, J = 9.72, 6.69 
Hz, 1H), 2.31-2.23 (m, 1H), 2.12-1.93 (m, 3H), 1.67 (s, 3H), 1.61-1.54 (m, 1H), 1.42-1.28 (m, 
3H), 1.12 (d, J = 6.32 Hz, 3H), 1.08-1.00 (m, 1H), 0.89 (s, 9H), 0.86 (s, 9H), 0.86 (d, J = 6.82 
Hz, 3H), 0.03 (s, 6H), 0.00 (s, 3H), -0.02 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.1, 136.5, 131.3, 129.1, 122.3, 113.8, 77.0, 74.4, 70.6, 
68.4, 55.3, 35.8, 33.2, 32.3, 29.9, 25.9, 25.8, 25.5, 23.5, 18.1, 16.7, 14.1, -4.5, -4.6 -5.3.  
IR (film): 2856, 1513, 1472, 1249, 1249, 1093 cm-1. 
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C29H53O4Si2: 521.3482, found: 521.3489.  
[α]D20 -2.66 (c = 1.2, CH2Cl2) 
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(Z)-(2S,3S,10S)-3,11-Bis-(tert-butyl-dimethyl-silanyloxy)-6,10-dimethyl-undec-5-en-2-ol 
(283) 
 
To a stirred solution of triol 513 (85 mg, 0.14 mmol) in DCM (2 mL) and water (0.5 mL) was 
added DDQ (37 mg, 0.16 mmol) in small portions and the mixture was stirred vigorously for 
20 min. The reaction was quenched with saturated NaHCO3 solution, the organic layer was 
separated and the aqueous solution was extracted with DCM. The combined organic solution 
was dried over MgSO4, the solvent was evaporated and the residue was purified by column 
chromatography (hexane:EtOAc = 20:1) to yield 63 mg (98%) of 283.  
Rf = 0.45 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.13 (t, J = 7.20 Hz, 1H), 3.66-3.58 (m, 1H), 3.42 (m, 1H), 
3.43 (dd, J = 9.73, 5.94 Hz, 1H), 3.36 (dd, J = 9.85, 6.57 Hz, 1H), 2.34-2.27 (m, 1H), 2.17 (d, 
J = 6.56 Hz, 1H), 2.17-2.11 (m, 1H), 2.05-1.95 (m, 2H), 1.68 (d, J = 1.01 Hz, 3H), 1.62-1.54 
(m, 1H), 1.45-1.27 (m, 3H), 1.12 (d, J = 6.30 Hz, 3H), 1.08-1.01 (m, 1H), 0.91 (s, 9H), 0.89 
(s, 9H), 0.87 (d, J = 6.82 Hz, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 137.7, 120.3, 76.7, 68.7, 68.3, 35.7, 33.2, 32.4, 32.2, 25.9, 
25.8, 25.4, 23.5, 19.9, 18.1, 16.7, -4.1, -4.7, -5.3.  
IR (film): 2929, 2857, 1472, 1256, 1094 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H54O3Si2: 458.3612, found: 458.3618.  
[α]D20 11.81 (c = 1.05, CH2Cl2) 
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(Z)-(3S,10S)-3,11-Bis-(tert-butyl-dimethyl-silanyloxy)-6,10-dimethyl-undec-5-en-2-one 
(284) 
 
To a stirred solution of alcohol 283 (40 mg, 0.087 mmol) in DCM (2 mL) was added Dess-
Martin periodinane (74 mg, 0.170 mmol) and the suspension was stirred for 1.5 h. The 
reaction was quenched with saturated NaHCO3 solution, the organic layer was separated 
and the aqueous layer was extracted with DCM. The combined organic solution was dried 
over MgSO4, the solvent was evaporated and the residue was purified by column 
chromatography (hexane:EtOAc = 20:1) to yield 39 mg (quant.) of ketone 284.  
Rf = 0.57 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.11 (t, J = 7.32 Hz, 1H), 3.97 (dd, J = 6.82, 5.58 Hz, 1H), 
3.43 (dd, J = 9.85, 5.81 Hz, 1H), 3.35 (dd, J = 9.72, 6.44 Hz, 1H), 2.38-2.22 (m, 2H), 2.15 (s, 
3H), 2.04-1.91 (m, 2H), 1.68 (d, J = 1.01 Hz, 3H), 1.61-1.53 (m, 1H), 1.39-1.27 (m, 3H), 1.08-
1.00 (m, 1H), 0.91 (s, 9H), 0.89 (s, 9H), 0.86 (d, J = 6.57 Hz, 3H), 0.05 (s, 3H), 0.04 (s, 3H), 
0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 212.0, 138.6, 119.0, 79.2, 68.3, 35.7, 33.4, 33.1, 32.2, 25.9, 
25.7, 25.4, 25.3, 23.5, 16.7, 14.1, -4.9, -5.0, -5.3.  
HRMS (ESI) (m/z): [M]+ calcd for C25H52O3Si2: 456.3455, found: 456.3461.  
 
4-[(1E,5Z)-(3S,10S)-3,11-Bis-(tert-butyl-dimethyl-silanyloxy)-2,6,10-trimethyl-undeca-
1,5-dienyl]-2-methyl-thiazole (33) 
 
To a stirred solution of (2-methyl-thiazol-4-yl)methyltributylphosphonium chloride (115 mg, 
0.330 mmol) in THF (1 mL) at 0 °C was added nBuLi (130 µL, 2.5 M in hexane, 0.330 mmol) 
to form a bright red solution, which was stirred for 1 h. The mixture was cooled to -78 °C and 
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ketone 284 (15 mg, 0.033 mmol) in THF (0.5 mL) was slowly added. The cooling bath was 
removed and the mixture was stirred at 60 °C for 1.5 h. After cooling down to r.t., the reaction 
was quenched with saturated NH4Cl solution, the organic layer was separated and the 
aqueous layer was extracted with Et2O. The combined organic solution was dried over 
MgSO4 and the solvent was evaporated. The crude product was purified by column 
chromatography (hexane:EtOAc = 20:1) to yield 17 mg (93%) of northern fragment 33.  
Rf = 0.36 (hexane:EtOAc = 15:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.91 (s, 1H), 6.45 (s, 1H), 5.13 (t, J = 6.82 Hz, 1H), 4.08 (t, J 
= 6.44 Hz, 1H), 3.44 (dd, J = 9.85, 5.81 Hz, 1H), 3.34 (dd, J = 9.85, 6.57 Hz, 1H), 2.71 (s, 
3H), 2.29-2.20 (m, 2H), 2.05-1.94 (m, 2H), 2.00 (d, J = 1.26 Hz, 3H), 1.66 (d, J = 1.26 Hz, 
3H), 1.61-1.53 (m, 1H), 1.45-1.28 (m, 3H), 1.08-1.00 (m, 1H), 0.89 (s, 18H), 0.86 (d, J = 6.56 
Hz, 3H), 0.05 (s, 3H), 0.03 (s, 6H), 0.00 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 164.3, 153.3, 142.6, 136.9, 121.4, 118.7, 114.9, 79.1, 68.4, 
35.8, 35.3, 33.2, 32.3, 25.9, 25.8, 25.4, 23.5, 19.2, 16.7, 13.9, -4.6, -4.9, -5.3.  
IR (film): 2929, 1472, 1257, 1090 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C30H57O2Si2NS: 551.3849, found: 551.3635.  
[α]D20 0.66 (c = 0.3, CH2Cl2) 
 
 
10.2.3. Discodermolide 
(S)-MTPA ester (299) 
 
Major: 
1H-NMR (400 MHz, CDCl3): δ = 7.50 (m, 2H), 7.39 (m, 3H), 4.84 (s, 1H), 4.62 (s, 1H), 4.47 
(d, J = 10.60 Hz, 1H), 4.26 (d, J = 10.84 Hz, 1H), 3.64 (s, 3H), 3.52 (s, 3H), 2.32 (q, J = 14.56 
Hz, 2H), 1.64 (s, 3H), 1.21 (s, 3H). 
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Minor: 
1H-NMR (400 MHz, CDCl3): δ = 7.50 (m, 2H), 7.39 (m, 3H), 4.84 (s, 1H), 4.62 (s, 1H), 4.52 
(d, J = 10.84 Hz, 1H), 4.22 (d, J = 10.60 Hz, 1H), 3.60 (s, 3H), 3.52 (s, 3H), 2.33 (q, J = 14.48 
Hz, 2H), 1.64 (s, 3H), 1.21 (s, 3H). 
 
(R)-MTPA ester (300) 
 
Major: 
1H-NMR (400 MHz, CDCl3): δ = 7.50 (m, 2H), 7.40 (m, 3H), 4.85 (s, 1H), 4.64 (s, 1H), 4.51 
(d, J = 10.84 Hz, 1H), 4.22 (d, J = 10.84 Hz, 1H), 3.60 (s, 3H), 3.52 (s, 3H), 2.37 (d, J = 13.12 
Hz, 1H), 2.30 (d, J = 13.64 Hz, 1H), 1.64 (s, 3H), 1.21 (s, 3H). 
Minor: 
1H-NMR (400 MHz, CDCl3): δ = 7.50 (m, 2H), 7.40 (m, 3H), 4.85 (s, 1H), 4.64 (s, 1H), 4.47 
(d, J = 10.84 Hz, 1H), 4.26 (d, J = 10.84 Hz, 1H), 3.64 (s, 3H), 3.52 (s, 3H), 2.36 (d, J = 13.16 
Hz, 1H), 2.29 (d, J = 13.64 Hz, 1H), 1.64 (s, 3H), 1.21 (s, 3H). 
 
 (2S,3R,4S,6S)-3-Hydroxy-7-(4-methoxy-benzyloxy)-2,4,6-trimethyl-2-(2-methyl-allyl)-5-
oxo-heptanoic acid methyl ester (303) 
 
To a solution of chlorodicyclohexylborane (0.94 mL, 1M in hexane, 0.94 mmol) in Et2O (1 
mL) at 0 °C was added triethylamine (0.14 mL, 1.00 mmol). After 15 min a solution of ethyl 
ketone 288 (148 mg, 0.63 mmol) in Et2O (1 mL) was slowly added. Stirring was continued for 
1 h and then cooled to -78 °C where a solution of aldehyde ent-292 (160 mg, 0.94 mmol) in 
Et2O (1 mL) was added. The reaction was kept at -78 °C for 3.5 h, then it was warmed to 0 
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°C for 15 min and pH 7 buffer solution (5 mL), methanol (1 mL) and H2O2 (1 mL, 30% 
aqueous) were added. After stirring for 1 h at room temperature the mixture was extracted 
with DCM, the combined organic layer was dried over MgSO4 and the solvent was 
evaporated. The crude aldol product was purified by column chromatography (hexane:EtOAc 
= 5:1) to yield 250 mg (98%) of 303.  
Rf = 0.48 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.20 (d, J = 8.60 Hz, 2H), 6.86 (d, J = 8.60 Hz, 2H), 4.81 (s, 
1H), 4.65 (s, 1H), 4.42 (d, J = 11.12 Hz, 1H), 4.38 (d, J = 11.60 Hz, 1H), 3.90 (dd, J = 8.08, 
4.52 Hz, 1H), 3.80 (s, 3H), 3.65 (s, 3H), 3.61 (t, J = 8.60 Hz, 1H), 3,40 (dd, J = 9.10, 4.54 Hz, 
1H), 3.01 (m, 1H), 2.75 (ddd, J = 14.40, 7.20, 4.40 Hz, 1H), 2.50 (d, J = 13.40 Hz, 1H), 2.40 
(d, J = 13.40 Hz, 1H), 1.63 (s, 3H), 1.16 (d, J = 7.32 Hz, 3H), 1.07 (d, J = 7.08 Hz, 3H), 1.03 
(s, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 219.0, 141.9, 129.8, 129.2, 114.9, 113.8, 79.4, 73.0, 71.6, 
70.3, 55.2, 51.5, 51.1, 46.4, 45.5, 23.6, 15.6, 15.0, 13.8. 
 
(2S,3R,4R,5S,6S)-3,5-Dihydroxy-7-(4-methoxy-benzyloxy)-2,4,6-trimethyl-2-(2-methyl-
allyl)-heptanoic acid methyl ester (304) 
 
To a solution of tetramethylammonium triacetoxyboron hydride (1.09 g, 4.96 mmol) in 
acetonitrile:acetic acid (1:1, 14 mL) at -30 °C was slowly added a solution of hydroxyketone 
303 (250 mg, 0.62 mmol) in acetonitrile (3 mL). After stirring for 9 h a saturated solution of 
NaHCO3 and solid NaHCO3 was added very carefully till gas evolution ceased. The aqueous 
layer was extracted with DCM. The combined organic layer was dried over MgSO4 and the 
solvent was removed under reduced pressure. Column chromatography (hexane:EtOAc = 
5:1) yielded 95 mg (38%) of dihydroxy ester 304 and 22 mg (9%) of the wrong 
diastereoisomer and 110 mg (44%) of educt 303. 
Rf = 0.31 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.22 (d, J = 8.56 Hz, 2H), 6.88 (d, J = 8.84 Hz, 2H), 4.80 (s, 
1H), 4.68 s, 1H), 4.45 (s, 2H), 4.41 (s, 1H (OH)), 4.17 (d, J = 6.32 Hz, 1H (OH)), 3.96 (d, J = 
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9.36 Hz, 1H), 3.80 (s, 3H), 3.69 (dd, J = 6.30, 3.54 Hz, 1H), 3.64 (s, 3H), 3.55 (dd, J = 9.08, 
4.04 Hz, 1H), 3.43 (t, J = 9.34 Hz, 1H), 2.58 (d, J = 13.60 Hz, 1H), 2.48 (d, J = 13.64 Hz, 1H), 
2.01-1.94 (m, 1H), 1.72-1.67 (m, 1H), 1.63 (s, 3H), 1.22 (s, 3H), 1.00 (d, J = 7.08 Hz, 3H), 
0.69 (d, J = 7.08 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 176.9, 159.4, 142.3, 129.4, 114.5, 113.9, 81.2, 77.9, 76.8, 
73.2, 55.3, 51.5, 51.3, 46.3, 35.9, 35.6, 23.4, 15.1, 12.7, 12.3. 
 
(3S,4R,5S,6S)-4-hydroxy-6-((S)-1-(4-methoxybenzyloxy)propan-2-yl)-3,5-dimethyl-3-(2-
methylallyl)tetrahydro-2H-pyran-2-one (305) 
 
LiOH (1.8 mL, 1M in water, 1.76 mmol) was added to ester 304 (237 mg, 0.58 mmol) in THF 
(5 mL) at 0 °C and vigorously stirred for 4 h. Brine was added and the aqueous layer was 
acidified with 1N HCl and extracted with DCM. The combined organic layers were dried over 
MgSO4 and the solvent was evaporated.  
The residue was taken up in DCM (6 mL) and EDC·HCl (171 mg, 0.88 mmol) and DMAP 
(138 mg, 1.16 mmol) were added and stirred over night. Brine was added and the aqueous 
layer was extracted with DCM. The combined DCM phasewas dried over MgSO4 and the 
solvent was evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded 172 mg 
(79%) of lactone 305 as colorless oil.  
Rf = 0.50 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.56 Hz, 2H), 4.91 (s, 
1H), 4.80 (s, 1H), 4.44 (s, 2H), 4.17 (bs, 1H), 4.11 (dd, J = 10.36, 2.00 Hz, 1H), 3.80 (s, 3H), 
3.64 (dd, J = 8.98, 5.18 Hz, 1H), 3.57 (dd, J = 8.84, 2.80 Hz, 1H), 2.61 (d, J = 13.40 Hz, 1H), 
2.35 (d, J = 13.36 Hz, 1H), 2.23 (m, 1H), 2.01 (m, 1H), 1.71 (s, 3H), 1.35 (s, 3H), 1.00 (d, J = 
7.32 Hz, 3H), 0.98 (d, J = 7.56 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 176.9, 142.5, 130.7, 129.1, 116.1, 113.7, 79.2, 72.9, 71.1, 
70.6, 55.3, 48.2, 46.8, 35.2, 35.1, 23.4, 23.0, 13.2, 5.7. 
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(E)-(2S,3R,4S)- 1-(4-methoxybenzyloxy)-2,4,6,8-tetramethylnona-5,8-dien-3-ol (307) 
 
To lactone 305 (80 mg, 0.21 mmol) in Et2O:trietyhlamine (10:1, 2 mL) at 0 °C was added 
methanesulfonyl chloride (0.025 mL, 0.32 mmol). After 2 h brine was added, the layers were 
separated and the aqueous layer extracted with Et2O. The combined organic phase was 
dried over MgSO4 and the solvent was evaporated. The residue was dissolved in THF (2 mL) 
and LiOH (0.63 mL, 1M in water, 0.63 mmol) was added. After 2 h the reaction was 
quenched with saturated NH4Cl solution and the aqueous layer was extracted with DCM. The 
combined organic layer was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 3:1) yielded 25 mg (36%) of fragmentation product 307. 
Rf = 0.83 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.26 (d, J = 8.56 Hz, 2H), 6.87 (d, J = 8.60 Hz, 2H), 5.10 (d, 
J = 9.60 Hz, 1H), 4.77 (s, 1H), 4.71 (s, 1H), 4.44 (s, 2H), 3.80 (s, 3H), 3.52 (dd, J = 8.84, 
6.32 Hz, 1H), 3.45 (dd, J = 10.02, 8.14 Hz, 1H), 3.42 (dd, J = 8.96, 5.96 Hz, 1H), 3.00 (s, 1H 
(OH)), 2.71 (s, 2H), 2.54 (m, 1H), 1.99 (m, 1H), 1.65 (s, 3H), 1.59 (s, 3H), 0.95 (d, J = 7.08 
Hz, 3H), 0.90 (d, J = 6.84 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 159.1, 143.7, 135.0, 130.6, 129.9, 129.2, 113.7, 111.8, 76.1, 
74.2, 72.9, 55.3, 48.9, 36.3, 35.0, 21.7, 17.1, 15.9, 9.9. 
 
((2S,3S)-3-methyl-3-(4-methylpent-3-enyl)oxiran-2-yl)methanol (514) 
OH
O
 
To a suspension of MS 4 Å (900 mg) in DCM (25 mL), freshly distilled from P2O5, at 0 °C was 
added L-(+)-DET (0.41 mL, 2.4 mmol) followed by freshly distilled Ti(OiPr)4 (0.48 mL, 1.6 
mmol) and the mixture was cooled to -20 °C. tert-Butylhydroperoxide (8.80 mL, 5.5M in 
octane, 48.5 mmol) was added slowly and stirring was continued for 40 min. Geraniol (5.70 
mL, 32.5 mmol) was slowly added and the mixture was kept at -20 °C for 1 h before it was 
warmed to 0 °C over 45 min. Water (10 mL) was added and after 1 h 30% aqueous NaOH 
saturated with NaCl (3 mL) was added and the mixture was stirred for further 45 min. The 
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MS was filtered off over celite and the aqueous layer was extracted with DCM. The combined 
organic layer was dried over MgSO4 and concentrated under reduced pressure. Purification 
by bulb-to-bulb distillation yielded at 100 °C 5.90 g (quant.) of epoxide 514.  
1H-NMR (400 MHz, CDCl3): δ = 5.08 (tt, J = 7.08, 1.26 Hz, 1H), 3.81 (ddd, J = 11.87, 7.07, 
4.54 Hz, 1H), 3.67 (ddd, J = 11.83, 6.98, 4.51 Hz, 1H), 2.97 (dd, J = 6.82, 4.29 Hz, 1H), 2.08 
(q, J = 7.66 Hz, 2H), 1.72-1.64 (m, 1H), 1.68 (s, 3H), 1.60 (s, 3H), 1.47 (ddd, J = 13.70, 8.65, 
7.76 Hz, 1H), 1.29 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 132.1, 123.3, 62.9, 61.5, 38.5, 25.7, 23.7, 17.6, 16.7. 
 
tert-butyldimethyl[((2S,3S)-3-methyl-3-(4-methylpent-3-enyl)oxiran-2-yl)methoxy]silane 
(342) 
 
To a stirred solution of epoxide 514 (5.4 g, 32.0 mmol) and imidazole (4.35 g, 64.0 mmol) in 
DMF (40 mL) was added TBSCl (4.6 g, 35.2 mmol) at 0 °C and stirring was continued at r.t. 
for 3 h. The reaction mixture was quenched with water and extracted with hexane:Et2O (1:1). 
The combined organic solution was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 50:1) furnished 9.1 g (quant.) of TBS ether 342 as 
colorless oil.  
Rf = 0.78 (hexane:EtOAc = 10:1) 
1H-NMR (250 MHz, CDCl3): δ = 5.09 (bt, J = 7.01 Hz, 1H), 3.73 (d, J = 5.25 Hz, 2H), 2.90 (t, 
J = 5.49 Hz, 1H), 2.13-2.03 (m, 2H), 1.68 (s, 3H), 1.64 (m, 1H), 1.60 (s, 3H), 1.52-1.41 (m, 
1H), 1.26 (s, 3H), 0.91 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H). 
 
(S)-2-[(tert-butyldimethylsilyloxy)methyl]-2,6-dimethylhept-5-enal (339) 
 
To 4-bromo-2,6-ditert-butylphenol (3.18 g, 11.2 mmol) in degassed DCM (130 mL), distilled 
from P2O5, at r.t. was added AlMe3 (2.80 mL, 2M in hexane, 5.6 mmol) under gas evolution 
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and the mixture was stirred for 1 h. TBS epoxide 342 (8.00 g. 28.1 mmol) in degassed DCM 
(40 mL) was added at -78 °C over 45 min via cannula and stirring was continued for 30 min. 
Then the mixture was brought to 0 °C over 30 min and KF (651 mg, 11.2 mmol) and water 
(152 μL, 8.4 mmol) were added and stirring was continued for 30 min. After warming to r.t. 
the mixture was filtered over celite and the solvent was removed under reduced pressure. 
Column chromatography (hexane:EtOAc = 50:1) furnished 8.00 g (quant.) of aldehyde 339. 
Rf = 0.88 (hexane:EtOAc = 20:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.55 (s, 1H), 5.01 (tt, J = 7.14, 1.44 Hz, 1H), 3.68 (d, J = 9.84 
Hz, 1H), 3.56 (d, J = 10.08 Hz, 1H), 1.97-1.83 (m, 2H), 1.67 (s, 3H), 1.60 (m, 1H), 1.58 (s, 
3H), 1.46 (m, 1H), 1.04 (s, 3H), 0.87 (s, 9H), 0.03 (s, 6H).  
HRMS (ESI) (m/z): [M]+ calcd for C16H32O2Si: 284.2172, found: 284.2153. 
 
(2S,4S,5R,6S)-6-(tert-Butyl-dimethyl-silanyloxymethyl)-5-hydroxy-1-(4-methoxy-
benzyloxy)-2,4,6,10-tetramethyl-undec-9-en-3-one (345) 
 
To a solution of chlorodicyclohexylborane (55 mL, 1M in hexane, 54.6 mmol) in Et2O (200 
mL) at 0 °C under argon atmosphere was added triethylamine (8 mL, 58.2 mmol). After 15 
min a solution of ethyl ketone 288 (8.60 g, 36.4 mmol) in Et2O (50 mL) was added dropwise. 
Stirring was continued for 1 h and then the mixture was cooled to -78 °C and a solution of 
aldehyde 339 (11.38 g, 40.0 mmol) in Et2O (70 mL) was added over 25 min. After the 
addition was completed the reaction was kept at -78 °C for 3 h, then it was warmed to 0 °C 
over 15 min and pH 7 buffer solution (500 mL), methanol (100 mL) and H2O2 (50 mL, 30% 
aqueous) were added. After stirring for 1.5 h at room temperature the mixture was extracted 
with DCM, the combined organic layer was dried over MgSO4 and the solvent was 
evaporated. The crude aldol product was purified by column chromatography (hexane:EtOAc 
= 50:1 to 10:1) to yield 14.30 g (75%) of 345 as a pale yellow oil. At smaller scales (5 mmol) 
the yield was quantitative.  
Rf = 0.35 (hexane:EtOAc = 10:1) 
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1H-NMR (400 MHz, CDCl3): δ = 7.21 (d, J = 8.59 Hz, 2H), 6.86 (d, J = 8.59 Hz, 2H), 5.07 (bt, 
J = 7.07 Hz, 1H), 4.43 (d, J = 11.37 Hz, 1H), 4.39 (d, J = 11.62 Hz, 1H), 3.98 (d, J = 8.08 Hz, 
1H (OH)), 3.80 (s, 3H), 3.62-3.55 (m, 3H), 3.44-3.37 (m, 2H), 3.09-3.00 (m, 2H), 1.97-1.88 
(m, 2H), 1.67 (s, 3H), 1.59 (s, 3H), 1.45-1.37 (m, 1H), 1.26-1.18 (m, 1H), 1.21 (d, J = 7.07 
Hz, 3H), 1.07 (d, J = 7.32 Hz, 3H), 0.89 (s, 9H), 0.77 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 219.0, 159.2, 131.3, 130.1, 129.2, 124.9, 113.8, 79.9, 73.0, 
72.0, 67.9, 55.3, 47.5, 45.5, 42.5, 35.0, 25.9, 22.1, 18.2, 16.7, 13.6, -5.6.  
IR (film): 3474, 2931, 1696, 1613, 1514, 1463, 1249, 1092 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C30H52O5SiNa: 543.3482, found: 543.3476.  
[α]D20 16.23 (c = 1.4, CH2Cl2). 
 
(2S,3S,4R,5R,6S)-6-(tert-Butyl-dimethyl-silanyloxymethyl)-1-(4-methoxy-benzyloxy)-
2,4,6,10-tetramethyl-undec-9-ene-3,5-diol (346) 
 
To a solution of tetramethylammonium triacetoxyboron hydride (17.07 g, 102.90 mmol) in 
acetonitrile:acetic acid (1:1, 120 mL) at -30 °C was slowly added a solution of 345 (6.70 g, 
12.86 mmol) in acetonitrile (30 mL). After stirring for 7 h, the reaction was kept in the freezer 
(-25 °C) for 96 h, then a saturated solution of NaHCO3 and solid NaHCO3 was added very 
carefully until the gas evolution ceased. The aqueous layer was extracted with DCM, the 
combined organic layer was dried over MgSO4 and the solvent was removed under reduced 
pressure. Column chromatography (hexane:EtOAc = 1:1) yielded 4.30 g (64%) of dihydroxy 
ester 346 and 2.01 g (30%) of educt 345. 
Rf = 0.12 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.25 (d, J = 8.69 Hz, 2H), 6.86 (d, J = 8.69 Hz, 2H), 5.07 (bt,  
J = 6.99 Hz, 1H), 4.46 (d, J = 11.33 Hz, 1H), 4.43 (d, J = 11.33 Hz, 1H), 3.86 (d, J = 9.82 Hz, 
1H), 3.80 (s, 3H), 3.65-3.60 (m, 2H), 3.57 (m, 1H), 3.49-3.40 (m, 2H), 1.98-1.87 (m, 4H), 1.68 
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(s, 3H), 1.60 (s, 3H), 1.45-1.40 (m, 1H), 1.33-1.25 (m, 1H), 1.04 (d, J = 7.17 Hz, 3H), 0.90 (s, 
3H), 0.89 (s, 9H), 0.86 (d, J = 6.79 Hz, 3H), 0.06 (s, 3H), 0.05 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 159.0, 131.3, 130.5, 129.2, 124.7, 113.7, 82.4, 74.8, 74.3, 
70.2, 55.2, 41.7, 36.3, 35.5, 25.8, 22.0, 18.0, 17.7, 13.8, 13.4, -5.7, -5.8.  
IR (film): 3447, 2930, 2856, 1513, 1406, 1249, 1094 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C30H54O5SiNa: 545.3638, found: 545.3632.  
[α]D20 -2.98 (c = 1.5, CH2Cl2). 
 
tert-butyl{(S)-2-[(2R,4R,5R,6S)-6-[(S)-1-(4-methoxybenzyloxy)propan-2-yl]-2-(4-
methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-2,6-dimethylhept-5-enyloxy}dimethylsilane 
(348) 
PMBO
O O
OTBS
PMP
 
To diol 346 (45 mg, 0.086 mmol) in DCM (2 mL) was added anisaldehyde dimethyl acetal (22 
μL, 0.130 mmol) and CSA (cat.) at r.t. and the mixture was stirred for 1.5 h. Brine was added 
and the mixture was diluted with DCM. The layers were separated and the aqueous layer 
was extracted with DCM. The combined organic layer was dried over MgSO4 and the solvent 
was removed under reduced pressure. Column chromatography (hexane:EtOAc = 10:1) 
yielded 43 mg (75%) of acetal 348 as colorless oil. 
Rf = 0.54 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 8.84 Hz, 2H), 7.20 (d, J = 8.60 Hz, 2H), 6.86 (d, 
J = 7.60 Hz, 2H), 6.85 (d, J = 8.60 Hz, 2H), 5.64 (s, 1H), 5.11 (bt, J = 7.06 Hz, 1H), 4.35 (s, 
2H), 3.80 (s, 3H), 3.73 (dd, J = 10.05, 2.90 Hz, 1H), 3.63 (dd, J = 8.96, 3.16 Hz, 1H), 3.58 (d, 
J = 9.60 Hz, 1H), 3.41-3.38 (m, 2H), 3.32 (dd, J = 8.76, 6.64 Hz, 1H), 2.15 (m, 1H), 2.01-1.88 
(m, 3H), 1.69 (s, 3H), 1.61 (s, 3H), 1.46-1.37 (m, 1H), 1.32-1.21 (m, 1H), 1.00 (d, J = 6.80 
Hz, 3H), 0.95 (d, J = 6.84 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 3H), 0.02 (s, 3H), 0.01 (s, 3H).  
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13C-NMR (100 MHz, CDCl3): δ = 159.6, 159.0, 133.7, 131.1, 129.1, 127.3, 125.2, 113.7, 
113.3, 98.1, 83.8, 72.8, 72.5, 70.7, 65.1, 55.2, 42.5, 34.4, 32.5, 31.4, 26.0, 25.7, 22.0, 17.6, 
16.1, 14.2, -5.6. 
 
(2S,3R,4S)-4-[(tert-butyldimethylsilyloxy)methyl)-2-[(2S,4S,5S)-2-(4-methoxyphenyl]-5-
methyl-[1,3]-dioxan-4-yl]-4,8-dimethylnon-7-en-3-ol (349) 
O O OH
OTBS
PMP
 
To a suspension of diol 346 (45 mg, 0.086 mmol) and MS 3Å (50 mg) in DCM (1.5 mL) under 
argon at r.t. was added DDQ (23 mg, 0.103 mmol). After 2.5 h another equivalent of DDQ 
was added and stirring was continued for 2 h. The reaction was quenched by the addition of 
a saturated Na2S2O3 solution and the MS was filtered off over celite. The layers were 
separated and the aqueous layer was extracted with DCM. The combined organic slayer was 
dried over MgSO4 and the solvent was removed under reduced pressure. Column 
chromatography (hexane:EtOAc = 10:1) yielded 18 mg (38%) of acetale 349.   
Rf = 0.28 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 8.56 Hz, 2H), 6.87 (d, J = 8.84 Hz, 2H), 5.45 (s, 
1H), 5.10 (bt, J = 6.96 Hz, 1H), 4.10 (dd, J = 11.24, 4.68 Hz, 1H), 3.99 (dd, J = 10.24, 1.64 
Hz, 1H), 3.79 (s, 3H), 3.58 (d, J = 9.84 Hz, 1H), 3.56 (m, 1H), 3.52 (t, J = 11.00 Hz, 1H), 3.36 
(d, J = 9.60 Hz, 1H), 3.20 (d, J = 6.80 Hz, 1H (OH)), 2.17-2.09 (m, 2H), 2.00-1.94 (m, 2H), 
1.69 (s, 3H), 1.61 (s, 3H), 1.43-1.27 (m, 2H), 1.15 (d, J = 7.08 Hz, 3H), 0.89 (s, 9H), 0.88 (s, 
3H), 0.77 (d, J = 6.84 Hz, 3H), 0.04 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 159.9, 131.1, 130.9, 127.3, 125.2, 113.6, 101.1, 84.4, 78.5, 
73.4, 66.9, 55.3, 42.7, 34.4, 33.4, 30.5, 25.9, 25.7, 22.3, 18.2, 17.5, 13.8, 11.9, -5.6. 
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(2S,3R,4R,5S,6S)-7-(4-Methoxy-benzyloxy)-2,4,6-trimethyl-2-(4-methyl-pent-3-enyl)-
heptane-1,3,5-triol (353) 
 
To a stirred solution of silyl ether 346 (1.1 g, 2.1 mmol) in acetonitrile (8 mL) and pyridine (4 
mL) in a plastic vessel was added HF·pyridine (2 mL, 70%) and stirring was continued for 4 
h. The reaction was quenched by the addition of saturated NaHCO3 solution and DCM was 
added. The aqueous layer was extracted with DCM, the combined organic layer was dried 
over MgSO4 and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 1:1) yielded 790 mg (92%) of triol 353 as colorless oil.  
Rf = 0.26 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.56 Hz, 2H), 6.88 (d, J = 8.56 Hz, 2H), 5.10 (tt, 
J = 6.73, 1.01 Hz, 1H), 4.68 (d, J = 3.28 Hz, 1H (OH)), 4.46 (d, J = 2.52 Hz, 2H), 3.96 (d, J = 
9.32 Hz, 1H), 3.81 (s, 3H), 3.64-3.51 (m, 4H), 3.46 (m, 1H), 2.07-1.92 (m, 4H), 1.68 (s, 3H), 
1.60 (s, 3H), 1.41-1.37 (m, 2H), 1.03 (d, J = 7.04 Hz, 3H), 0.91 (s, 3H), 0.77 (d, J = 7.08 Hz, 
3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.5, 131.4, 129.4, 124.8, 113.9, 83.7, 78.0, 76.8, 73.3, 
70.6, 55.3, 41.6, 35.9, 35.6, 33.9, 25.7, 22.0, 17.6, 17.4, 13.5, 12.9.  
IR (film): 3392, 2964, 2928, 1613, 1513, 1463, 1377, 1305, 1248, 1173, 1076, 1038 cm-1.  
[α]D20 43.50 (c = 0.6, CH2Cl2) 
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(2S,3S,4R)-1-(4-methoxybenzyloxy)-4-[(2S,4R,5S)-2-(4-methoxyphenyl)-5-methyl-5-(4-
methylpent-3-enyl)-[1,3]-dioxan-4-yl]-2-methylpentan-3-ol (347) 
PMBO
OH O O
PMP
 
To diol 353 (20 mg, 0.049 mmol) in DCM (1 mL) was added anisaldehyde dimethyl acetal (12 
μL, 0.073 mmol) and CSA (cat.) at r.t. under argon. The mixture was stirred for 1 h. Brine 
was added and the mixture was diluted with DCM. The layers were separated and the 
aqueous layer was extracted with DCM. The combined organic layer was dried over MgSO4 
and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 10:1) yielded 23 mg (84%) of acetal 347 as colorless oil. 
Rf = 0.71 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.38 (d, J = 8.84 Hz, 2H), 7.25 (d, J = 8.60 Hz, 2H), 6.88 (d, 
J = 8.60 Hz, 2H), 6.85 (d, J = 8.60 Hz, 2H), 5.41 (s, 1H), 5.06 (bt, J = 6.94 Hz, 1H), 4.44 (q,  
J = 12.04 Hz, 2H), 3.90 (d, J = 10.12 Hz, 1H), 3.83 (d, J = 11.12 Hz, 1H), 3.80 (s, 3H), 3.79 
(s, 3H), 3.71 (d, J = 11.08 Hz, 1H), 3.68-3.64 (m, 2H), 3.36 (dd, J = 8.96, 7.20 Hz, 1H), 2.99 
(d, J = 1.76 Hz, 1H (OH)), 2.05-1.96 (m, 2H), 1.94-1.84 (m, 2H), 1.69 (s, 3H), 1.61 (s, 3H), 
1.34-1.18 (m, 2H), 1.24 (s, 3H), 1.05 (d, J = 7.08 Hz, 3H), 0.92 (d, J = 6.80 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 160.0, 159.1, 132.0, 131.0, 130.9, 129.1, 127.3, 124.1, 
113.8, 113.7, 102.2, 89.3, 77.8, 73.5, 72.8, 72.7, 55.3, 55.2, 36.6, 36.5, 36,2, 33.8, 25.7, 
21.4, 17.6, 14.3, 13.2.  
IR (film): 2963, 1614, 1515, 1249, 1171, 1093, 1036 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C32H46O6: 526.3294, found: 526.3289.  
[α]D20 6.22 (c = 0.45, CH2Cl2) 
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(4R,5R,6S)-4-[(S)-1-(tert-butyldimethylsilyloxy)-2,6-dimethylhept-5-en-2-yl]-6-[(S)-1-(4-
methoxybenzyloxy)propan-2-yl]-5-methyl-1,3-dioxan-2-one (350) 
PMBO
O O
OTBS
O
 
To a stirred solution of diol 346 (30 mg, 0.057 mmol) in DCM (1 mL) at r.t. was added 
pyridine (0.1 mL) and phosgene (43 μL, 2M in toluene, 0.085 mmol) and stirring was 
continued for 1 h. A saturated NH4Cl solution was added and the layers were separated. The 
aqueous layer was extracted with DCM and the combined organic layer was dried over 
MgSO4 and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 5:1) yielded 31 mg (quant.) of carbonate 350. 
Rf = 0.35 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.60 Hz, 2H), 5.07 (m, 
1H), 4.44 (m, 2H), 4.11 (dd, J = 10.26, 2.64 Hz, 1H), 4.02 (d, J = 2.56 Hz, 1H), 3.81 (s, 3H), 
3.61-3.50 (m, 3H), 3.44 (d, J = 10.10 Hz, 1H), 2.38 (m, 1H), 2.02-1.90 (m, 3H), 1.68 (s, 3H), 
1.60 (s, 3H), 1.36-1.26 (m, 2H), 1.04 (d, J = 7.04 Hz, 3H), 0.98 (d, J = 6.84 Hz, 3H), 0.89 (s, 
3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.05 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 159.3, 151.7, 131.8, 130.6, 129.3, 124.2, 113.8, 88.8, 79.1, 
73.1, 70.7, 65.3, 55.2, 42.5, 34.6, 32.5, 28.7, 25.9, 21.9, 17.8, 16.9, 13.9, 13.0, -5.6. 
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(4R,5R,6S)-4-[(S)-1-hydroxy-2,6-dimethylhept-5-en-2-yl]-6-[(S)-1-(4-
methoxybenzyloxy)propan-2-yl]-5-methyl-1,3-dioxan-2-one (515) 
PMBO
O O
OH
O
 
Silyl ether 350 (80 mg, 0.14 mmol) in THF (3 mL) at r.t. was treated with TBAF (0.17 mL, 1M 
in THF, 0.17 mmol) and the mixture was stirred for 12 h. Brine was added and the layers 
were separated. The aqueous layer was extracted with DCM and the combined organic layer 
was dried over MgSO4 and the solvent was removed under reduced pressure. Column 
chromatography (hexane:EtOAc = 3:1) yielded 50 mg (83%) of 515. 
Rf = 0.38 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.56 Hz, 2H), 6.87 (d, J = 8.56 Hz, 2H), 5.07 (bt, 
J = 7.06 Hz, 1H), 4.44 (s, 2H), 4.16 (dd, J = 10.61, 2.77 Hz, 1H), 4.08 (d, J = 2.52 Hz, 1H), 
3.80 (s, 3H), 3.65 (dd, J = 11.12, 3.28 Hz, 1H), 3.59-3.50 (m, 3H), 2.37 (m, 1H), 2.04-1.95 
(m, 3H), 1.68 (s, 3H), 1.60 (s, 3H), 1.42-1.26 (m, 2H), 1.06 (d, J = 7.08 Hz, 3H), 0.99 (d, J = 
7.08 Hz, 3H), 0.90 (s, 3H). 
 
(R)-2-[(4R,5R,6S)-6-((S)-1-(4-methoxybenzyloxy)propan-2-yl)-5-methyl-2-oxo-[1,3]-
dioxan-4-yl]-2,6-dimethylhept-5-enal (351) 
PMBO
O O O
O
 
Dess-Martin periodinane (117 mg, 0.270 mmol) was added portion wise to a solution of 
alcohol 515 (40 mg, 0.088 mmol) in DCM (2 mL) at 0 °C under argon. After 2.5 h a saturated 
NaHCO3 solution was added, the layers were separated and the aqueous layer was 
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extracted with DCM. The combined DCM phase was dried over MgSO4 and the solvent was 
evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded 27 mg (68%) of 
aldehyde 351 as colorless oil. 
Rf = 0.45 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.22 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.60 Hz, 2H), 5.03 (bt, 
J = 6.96 Hz, 1H), 4.43 (s, 2H), 4.21 (d, J = 2.80 Hz, 1H), 4.06 (dd, J = 10.48, 2.88 Hz, 1H), 
3.80 (s, 3H), 3.53 (d, J = 4.04 Hz, 2H), 2.25 (m, 1H), 2.04-1.94 (m, 2H), 1.86 (m, 1H), 1.67 
(m, 1H), 1.67 (s, 3H), 1.60 (m, 1H), 1.58 (s, 3H), 1.15 (s, 3H), 1.10 (d, J = 7.32 Hz, 3H), 0.98 
(d, J = 6.80 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 203.0, 159.2, 150.5, 133.3, 130.5, 129.2, 122.8, 113.9, 88.0, 
78.8, 73.0, 70.4, 55.3, 53.4, 34.3, 32.6, 29.3, 25.8, 22.1, 17.7, 13.6, 12.9.  
IR (film): 2929, 1766, 1613, 1513, 1462, 1247, 1098 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H36O6Na: 455.2410, found: 455.2400.  
[α]D20 -19.67 (c = 0.3, CH2Cl2) 
 
(2S,4S,5R,6S)-5-hydroxy-6-(hydroxymethyl)-1-(4-methoxybenzyloxy)-2,4,6,10-
tetramethylundec-9-en-3-one (354) 
 
Dess-Martin periodinane (19 mg, 0.04 mmol) was added potion wise to a solution of alcohol 
353 (15 mg, 0.038 mmol) in DCM (1 mL) at 0 °C. After 1.5 h saturated NaHCO3 solution was 
added, the layers were separated and the aqueous layer was extracted with DCM. The 
combined DCM phase was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 5:1) yielded 9 mg (60%) of ketone 354 as colorless oil. 
Rf = 0.28 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.60 Hz, 2H), 6.86 (d, J = 8.60 Hz, 2H), 5.04 (bt, 
J = 6.94 Hz 1H), 4.45 (d, J = 11.64 Hz, 1H), 4.42 (d, J = 11.64 Hz, 1H), 3.80 (s, 3H), 3.74 
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(dd, J = 11.36, 5.80 Hz, 1H), 3.67-3.63 (m, 1H), 3.60-3.56 (m, 1H+1H (OH)), 3.51-3.45 (m, 
1H), 3.17 (dq, J = 6.85, 2.59 Hz, 1H), 2.26 (t, J = 6.56 Hz, 1H (OH)), 1.94-1.85 (m, 3H), 1.67 
(s, 3H), 1.61-1.47 (m, 2H), 1.58 (s, 3H), 1.22 (s, 3H),1.07 (d, J = 6.84 Hz, 3H), 0.94 (d, J = 
6.80 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 221.6, 159.2, 132.3, 130.3, 129.4, 123.6, 113.9, 73.4, 73.1, 
72.9, 67.8, 55.3, 53.8, 41.8, 36.1, 35.2, 25.6, 22.7, 17.6, 14.1, 10.2.  
IR (film): 3468, 2930, 1682, 1513, 1455, 1302, 1248, 1036 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C24H38O5Na: 429.2617, found: 429.2621.  
[α]D20 -28.00 (c = 0.45, CH2Cl2) 
 
tert-Butyl-((S)-2-{(4R,5R,6S)-6-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-2,2,5-
trimethyl-[1,3]dioxan-4-yl}-2,6-dimethyl-hept-5-enyloxy)-dimethyl-silane (356) 
PMBO
O O
OTBS
 
To a stirred solution of 346 (2.50 g, 4.75 mmol) in DCM (50 mL) at r.t. under argon was 
added 2,2-dimethoxypropane (2.25 mL, 14.25 mmol) followed by CSA (110 mg, 0.47 mmol). 
After 2 h brine was added and the aqueous layer was extracted with DCM, the combined 
DCM layer was dried over MgSO4 and the solvent was removed under reduced pressure. 
Column chromatography (hexane:EtOAc = 10:1) yielded 1.82 g (68%) of acetonide 356 as 
colorless oil and 0.78 g (31%) of starting material 346.  
Rf = 0.66 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 7.83 Hz, 2H), 6.87 (d, J = 8.59 Hz, 2H), 5.08 (bt, 
J = 6.57 Hz, 1H), 4.45-4.38 (m, 2H), 3.80 (s, 3H), 3.56 (dd, J = 8.82, 3.03 Hz, 1H), 3.48 (dd, 
J = 10.36, 2.78 Hz, 1H), 3.46 (d, J = 9.35 Hz, 1H), 3.40-3.32 (m, 3H), 1.99-1.89 (m, 3H), 
1.84-1.76 (m, 1H), 1.68 (s, 3H), 1.60 (s, 3H), 1.36-1.18 (m, 2H), 1.29 (s, 3H), 1.22 (s, 3H), 
0.92 (d, J = 6.57 Hz, 3H), 0.88 (s, 12H), 0.80 (s, 3H), 0.03 (s, 6H).  
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13C-NMR (100 MHz, CDCl3): δ = 159.0, 131.1, 129.1, 125.3, 113.7, 99.9, 76.9, 72.8, 72.5, 
70.5, 65.2, 55.3, 41.9, 33.8, 32.7, 32.0, 25.9, 23.5, 22.0, 18.2, 17.6, 16.1, 13.4, 13.3, -5.5,  
-5.6.  
IR (film): 2932, 1614, 1513, 1458, 1376, 1248, 1098 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C33H58O5Si: 562.4054, found: 562.4049.  
[α]D20 6.90 (c = 0.86, CH2Cl2). 
 
(S)-2-{(4R,5R,6S)-6-[(S)-2-(4-Methoxy-benzyloxy)-1-methyl-ethyl]-2,2,5-trimethyl-
[1,3]dioxan-4-yl}-2,6-dimethyl-hept-5-en-1-ol (357) 
PMBO
O O
OH
 
To a stirred solution of silyl ether 356 (1.20 g, 2.07 mmol) in acetonitrile (8 mL) and pyridine 
(3 mL) in a plastic vessel was added HF·pyridine (2 mL, 70%) and stirring was continued 
over night. HF·pyridine (1 mL, 70%) was added and the mixture was stirred for another 5 h, 
the reaction was quenched by addition of saturated NaHCO3 solution and DCM was added. 
The aqueous layer was extracted with DCM, the combined organic layer was dried over 
MgSO4 and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 5:1) yielded 900 mg (97%) of alcohol 357 as colorless oil.  
Rf = 0.39 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.56 Hz, 2H), 5.11 (bt, 
J = 6.94 Hz, 1H), 4.41 (s, 2H), 3.80 (s, 3H), 3.72 (dd, J = 11.36, 3.80 Hz, 1H), 3.59 (dd, J = 
10.74, 3.42 Hz, 1H), 3.53 (dd, J = 8.71, 2.90 Hz, 1H), 3.39-3.32 (m, 3H), 2.01-1.94 (m, 3H), 
1.86-1.79 (m, 1H), 1.69 (s, 3H), 1.61 (s, 3H), 1.53-1.38 (m, 2H), 1.33 (s, 3H), 1.27 (s, 3H), 
0.95 (d, J = 6.82 Hz, 3H), 0.92 (d, J = 6.57 Hz, 3H), 0.81 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 131.4, 130.9, 129.2, 124.7, 113.7, 100.6, 81.9, 72.9, 
72.1, 70.6, 68.6, 55.3, 40.8, 34.8, 33.7, 32.5, 25.7, 23.2, 21.9, 17.0, 13.4, 13.2.  
IR (film): 3509, 2967, 2933, 1513, 1377, 1247, 1085, 1038 cm-1.  
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HRMS (ESI) (m/z): [M]+ calcd for C27H44O5: 448.3189, found: 448.3192.  
[α]D20 10.72 (c = 0.97, CH2Cl2). 
 
(R)-2-{(4R,5R,6S)-6-[(S)-2-(4-Methoxy-benzyloxy)-1-methyl-ethyl]-2,2,5-trimethyl-
[1,3]dioxan-4-yl}-2,6-dimethyl-hept-5-enal (516) 
PMBO
O O O
 
To a solution of alcohol 357 (2.1 g, 4.68 mmol) in ethyl acetate (40 mL) was added IBX (2.62 
g, 9.35 mmol). The mixture was heated under reflux for 2 h, then the white precipitate was 
filtered off and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 10:1) yielded 1.78 g (86%) of aldehyde 516 as colorless oil.  
Rf = 0.76 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.54 (s, 1H), 7.24 (d, J = 8.59 Hz, 2H), 6.87 (d, J = 8.59 Hz, 
2H), 5.03 (tt, J = 7.04, 1.33 Hz, 1H), 4.40 (s, 2H), 3.80 (s, 3H), 3.54-3.49 (m, 3H), 3.36 (dd,  
J = 8.71, 6.19 Hz, 1H), 1.98-1.85 (m, 2H), 1.83-1.71 (m, 2H), 1.67 (s, 3H), 1.64-1.46 (m, 2H), 
1.57 (s, 3H), 1.31 (s, 3H), 1.22 (s, 3H), 1.06 (s, 3H), 0.94 (d, J = 6.57 Hz, 3H), 0.91 (d, J = 
6.82 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 206.1, 159.0, 132.3, 130.9, 129.2, 123.7, 113.7, 100.5, 78.3, 
72.9, 72.0, 70.1, 55.3, 53.3, 33.6, 32.8, 32.6, 25.7, 25.3, 23.2, 22.2, 17.7, 13.6, 13.2, 13.0.  
IR (film): 2969, 2935, 1726, 1515, 1456, 1378, 1247, 1096, 1037 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C27H42O5: 446.3032, found: 446.3028.  
[α]D20 4.56 (c = 1.36, CH2Cl2). 
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(R)-2-{(4R,5R,6S)-6-[(S)-2-(4-Methoxy-benzyloxy)-1-methyl-ethyl]-2,2,5-trimethyl-
[1,3]dioxan-4-yl}-2,6-dimethyl-hept-5-enoic acid (358) 
PMBO
O O O
OH
 
To a solution of aldehyde 516 (1.65 g, 3.69 mmol) in tert-butanol (25 mL) with 2-methyl-2-
butene (5 mL) was added dropwise a solution of NaClO2 (4.95 g, 55.00 mmol) and NaH2PO4 
(4.95 g) in water (15 mL). After 3 h 0.01N NaOH was added and the aqueous layer was 
extracted with Et2O, 1N HCl was added until pH 2 was reached and the aqueous layer was 
extracted with DCM. The organic layer was dried over MgSO4 and the solvent was removed 
under reduced pressure. Column chromatography (hexane:EtOAc = 1:1) yielded 1.71 g 
(quant.) of acid 358. 
Rf = 0.25 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.56 Hz, 2H), 5.06 (bt, 
J = 6.96 Hz, 1H), 4.41 (s, 2H), 3.80 (s, 3H), 3.56 (dd, J = 10.74, 3.42 Hz, 1H), 3.49 (dd, J = 
8.60, 2.80 Hz, 1H), 3.48 (d, J = 6.08 Hz, 1H), 3.37 (dd, J = 8.58, 6.06 Hz, 1H), 2.08-1.96 (m, 
3H), 1.89-1.70 (m, 1H), 1.67 (s, 3H), 1.59 (s, 3H), 1.48-1.38 (m, 2H), 1.34 (s, 3H), 1.30 (s, 
3H), 1.19 (s, 3H), 0.97 (d, J = 6.57 Hz, 3H), 0.91 (d, J = 6.82 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 178.4, 159.0, 132.4, 130.9, 129.1, 123.4, 113.7, 101.5, 79.1, 
72.9, 71.9, 70.6, 55.3, 50.8, 35.9, 33.9, 33.6, 25.6, 25.2, 23.3, 22.7, 17.6, 16.5, 13.6, 13.2, 
13.0.  
IR (film): 2981, 2935, 1701, 1513, 1226 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C27H42O6Na: 485.2879, found: 485.2896.  
[α]D20 14.26 (c = 1.36, CH2Cl2). 
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(3R,4R,5S,6S)-4-Hydroxy-6-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-3,5-dimethyl-
3-(4-methyl-pent-3-enyl)-tetrahydro-pyran-2-one (340) 
 
To a stirred solution of acid 358 (1.66 mg, 3.5 mmol) in DCM (35 mL) at r.t. under argon was 
added CSA (783 mg, 3.5 mmol) and stirring was continued for 6 h. Brine was added and the 
aqueous layer was extracted with DCM. The combined organic layer was dried over MgSO4 
and the solvent was evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded  
1.18 g (83%) of lactone 340 as colorless oil. 
Rf = 0.16 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.59 Hz, 2H), 6.86 (d, J = 8.59 Hz, 2H), 5.01 (bt, 
J = 7.20 Hz, 1H), 4.45 (d, J = 11.37 Hz, 1H), 4.36 (d, J = 11.62 Hz, 1H), 4.18 (dd, J = 7.70, 
4.42 Hz, 1H), 3.79 (s, 3H), 3.73 (d, J = 4.04 Hz, 1H), 3.62 (dd, J = 8.84, 6.06 Hz, 1H), 3.60 
(m, 1H), 3.49 (dd, J = 8.97, 4.67 Hz, 1H), 2.42-2.29 (m, 2H), 2.07-1.97 (m, 3H), 1.69-1.59 (m, 
1H), 1.66 (s, 3H), 1.58 (s, 3H), 1.31 (s, 3H), 1.08 (d, J = 7.07 Hz, 3H), 0.96 (d, J = 7.07 Hz, 
3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.1, 159.3, 131.7, 129.9, 129.6, 124.3, 113.7, 81.3, 76.0, 
72.9, 71.6, 55.2, 46.5, 34.4, 34.1, 33.8, 25.8, 25.6, 22.8, 15.9, 8.8.  
IR (film): 3435, 2968, 1706, 1513, 1248, 1102 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H36O5: 404.2563, found: 404.2559.  
[α]D20 -23.50 (c = 0.92, CH2Cl2). 
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(Z)-(2S,3R,4S)-1-(4-Methoxy-benzyloxy)-2,4,6,10-tetramethyl-undeca-5,9-dien-3-ol (341) 
 
To lactone 340 (450 mg, 1.05 mmol) in 1:1 DCM:pyridine (10 mL) at r.t. was added 
methanesulfonyl chloride (0.25 mL, 3.15 mmol) and DMAP (136 mg, 1.05 mmol). After 3 h 
brine was added, the layers were separated and the aqueous layer was extracted with DCM. 
The combined organic phases were dried over MgSO4 and the solvent was evaporated. The 
residue was dissolved in THF (10 mL) and LiOH (3.15 mL, 1M in water, 3.15 mmol) was 
added. After 2 h the reaction was quenched with saturated NH4Cl solution and the aqueous 
layer was extracted with DCM. The combined organic layer was dried over MgSO4 and the 
solvent was evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded 333 mg 
(88%) of olefin 341. 
Rf = 0.60 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.59 Hz, 2H), 6.87 (d, J = 8.59 Hz, 2H), 5.10 (m, 
2H), 4.46-4.39 (m, 2H), 3.80 (s, 3H), 3.59 (dd, J = 9.09, 4.04 Hz, 1H), 3.41 (dd, J = 9.09, 6.32 
Hz, 1H), 3.30-3.23 (m, 1H + 1H (OH)), 2.53-2.44 (m, 1H), 2.08-1.94 (m, 4H), 1.93-1.86 (m, 
2H), 1.68 (s, 6H), 1.61 (s, 3H), 0.96 (d, J = 6.82 Hz, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 159.3, 134.0, 129.9, 129.3, 129.1, 124.3, 113.8, 80.4, 74.5, 
73.2, 55.3, 35.7, 35.6, 32.2, 26.6, 25.7, 23.4, 22.6, 15.4, 14.8.  
IR (film): 3503, 2930, 1513, 1248, 1083, 1037 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C23H36O3: 360.2664, found: 360.2671.  
[α]D20 18.42 (c = 1.14, CH2Cl2). 
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tert-Butyl-{(Z)-(1R,2S)-1-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-ethyl]-2,4,8-trimethyl-
nona-3,7-dienyloxy}-dimethyl-silane (517) 
 
To a stirred solution of alcohol 341 (240 mg, 0.65 mmol) in DCM (6 mL) was added  
2,6-lutidine (120 µL, 0.98 mmol) and TBSOTf (160 µL, 0.72 mmol). After 1 h the reaction was 
quenched with saturated NH4Cl solution and the layers were separated. The aqueous layer 
was extracted with DCM. The combined organic solution was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 10:1) 
yielded 320 mg (quant.) of protected diol 517 as colorless oil.  
Rf = 0.55 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.59 Hz, 2H), 6.86 (d, J = 8.59 Hz, 2H), 5.10 (t,  
J = 6.06 Hz, 1H), 4.98 (d, J = 9.85 Hz, 1H), 4.39 (s, 2H), 3.80 (s, 3H), 3.51 (dd, J = 9.09, 4.80 
Hz, 1H), 3.39 (t, J = 5.30 Hz, 1H), 3.20 (t, J = 8.72 Hz, 1H), 2.59-2.50 (m, 1H), 2.12-1.91 (m, 
5H), 1.68 (s, 3H), 1.65 (s, 3H), 1.60 (s, 3H), 0.96 (d, J = 6.82 Hz, 3H), 0.89 (d, J = 6.06 Hz, 
3H), 0.89 (s, 9H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 133.3, 131.5, 130.2, 129.1, 124.1, 113.7, 78.6, 72.7, 
72.6, 55.3, 38.5, 35.5, 32.2, 26.6, 26.1, 25.7, 23.3, 18.4, 17.6, 16.9, 14.8, -3.8, -3.9.  
IR (film): 2957, 2929, 1462, 1249, 1083, 1040 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C29H50O3Si: 474.3529, found: 474.3532.  
[α]D20 6.64 (c = 1.28, CH2Cl2). 
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tert-Butyl-{(Z)-(1R,2S)-6-dimethyloxIRanyl-1-[(S)-2-(4-methoxy-benzyloxy)-1-methyl-
ethyl]-2,4-dimethyl-hex-3-enyloxy}-dimethyl-silane (360) 
 
To a stirred solution of 517 (320 mg, 0.65 mmol) in DCM (7 mL) at -20 °C NaOAc (60 mg, 
0.68 mmol) and mCPBA (168 mg, 80% of weight, 0.68 mmol) was added. The mixture was 
warmed to 0 °C over 2 h and saturated NaHCO3 solution was added. The organic layer was 
separated and the aqueous layer was extracted with DCM. The combined organic layer was 
dried over MgSO4 and the solvent was evaporated. Column chromatography (hexane:EtOAc 
= 10:1) yielded 293 mg (92%) of epoxide 360 as 1:1 mixture of diastereoisomers.  
Rf = 0.25 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.34 Hz, 2H), 6.87 (d, J = 8.59 Hz, 2H), 5.03 (d, 
J = 9.85 Hz, 1H), 4.39 (s, 2H), 3.80 (s, 3H), 3.51 (dd, J = 8.84, 4.80 Hz, 1H), 3.40 (t, J = 5.43 
Hz, 1H), 3.21 (t, J = 8.59 Hz, 1H), 2.68 or 2.67 (t, J = 6.19 Hz, 1H), 2.60-2.54 (m, 1H), 2.30-
2.16 (m, 2H), 2.10-1.93 (m, 3H), 1.66 (s, 3H), 1.64-1.53 (m, 3H), 1.30 (s, 3H), 1.26 (s, 3H), 
0.96 (d, J = 6.82 Hz, 3H), 0.90 (d, J = 6.90 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 3H), 0.02 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 132.5, 130.9, 130.8/130.7, 129.1/129.0, 113.7, 78.6, 
72.6, 72.5/72.4, 64.1/64.0, 58.3/58.2, 55.3, 38.4, 36.5/36.4, 35.6/35.5, 28.8, 27.6/27.5, 26.2, 
24.9/24.8, 23.3, 18.7/18.6, 18.4, 17.0/16.9, 14.9/14.8, -3.8, -3.9.  
IR (film): 2952, 1612, 1513, 1458, 1376, 1248, 1037 cm-1.  
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C25H41O4Si: 433.2774, found: 433.2768. 
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(Z)-(6S,7R,8S)-7-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-benzyloxy)-4,6,8-
trimethyl-non-4-enal (365) 
 
To a stirred solution of epoxide 360 (190 mg, 0.38 mmol) in Et2O (3 mL) at 0 °C was added 
dropwise a solution of HIO4·2H2O (97 mg, 0.42 mmol) in THF (2 mL). The mixture was stirred 
for 2.5 h and then a saturated NaHCO3 solution was added. The organic layer was separated 
and the aqueous layer was extracted with DCM. The combined organic layer was dried over 
MgSO4 and the solvent was evaporated. Column chromatography (hexane:EtOAc = 10:1) 
yielded 155 mg (90%) of aldehyde 365 as colorless oil.  
Rf = 0.24 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.70 (t, J = 1.64 Hz, 1H), 7.24 (d, J = 8.59 Hz, 2H), 6.87 (d,  
J = 8.84 Hz, 2H), 5.03 (d, J = 9.85 Hz, 1H), 4.39 (s, 2H), 3.80 (s, 3H), 3.50 (dd, J = 9.09, 5.05 
Hz, 1H), 3.39 (dd, J = 6.06, 4.29 Hz, 1H), 3.20 (dd, J = 9.15, 7.78 Hz, 1H), 2.60-2.53 (m, 1H), 
2.47-2.33 (m, 2H), 2.26-2.17 (m, 1H), 2.01-1.93 (m, 1H), 1.63 (s, 3H), 0.96 (d, J = 7.07 Hz, 
3H), 0.90 (d, J = 5.30 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 202.1, 159.0, 132.5, 131.4, 131.4, 130.7, 129.1, 113.7, 78.7, 
72.7, 72.4, 55.3, 42.2, 38.3, 35.8, 28.8, 27.5, 26.2, 24.4, 23.1, 18.4, 17.3, 15.1, -3.8, -3.9.  
IR (film): 2958, 2930, 2856, 1725, 1513, 1249, 1089, 1037 cm-1.  
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C22H35O4Si: 391.2305, found: 391.2308.  
[α]D20 2.20 (c = 1.00, CH2Cl2). 
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(Z)-(6S,7R,8S)-7-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-benzyloxy)-4,6,8-
trimethyl-non-4-enoic acid (361) 
 
To a solution of aldehyde 365 (155 mg, 0.34 mmol) in tert-butanol (3 mL) with 2-methyl-2-
butene (0.5 mL) was added dropwise a solution of NaClO2 (465 mg, 5.2 mmol) and NaH2PO4 
(465 mg) in water (2 mL). After 3 h 0.01N NaOH was added and the aqueous layer was 
extracted with Et2O. 1N HCl was added until pH 2 was reached and the aqueous layer was 
extracted with DCM. The organic layer was dried over MgSO4 and the solvent was removed 
under reduced pressure to give 160 mg of crude acid 361 which was directly used for the 
following reaction.  
1H-NMR (400 MHz, C6D6): δ = 7.27 (d, J = 8.56 Hz, 2H), 6.82 (d, J = 8.59 Hz, 2H), 5.11 (d,  
J = 10.10 Hz, 1H), 4.40 (d, J = 2.00 Hz, 2H), 3.60 (dd, J = 9.09, 5.30 Hz, 1H), 3.53 (dd, J = 
6.30, 4.30 Hz, 1H), 3.33 (s, 3H), 3.32 (m, 1H), 2.81-2.72 (m, 1H), 2.37-2.20 (m, 4H), 2.18-
2.11 (m, 1H), 1.53 (d, J = 1.26 Hz, 3H), 1.08 (d, J = 7.07 Hz, 3H), 1.04 (d, J = 6.57 Hz, 3H), 
1.01 (s, 9H), 0.10 (s, 6H).  
13C-NMR (100 MHz, C6D6): δ = 179.1, 159.7, 132.1, 131.8, 131.2, 129.6, 114.1, 79.1, 73.0, 
72.6, 54.8, 39.0, 36.0, 32.7, 27.6, 26.4, 22.9, 18.7, 17.5, 15.4, -3.6, -3.7. 
 
(Z)-(6S,7R,8S)-7-(tert-butyldimethylsilyloxy)-9-(4-methoxybenzyloxy)-4,6,8-
trimethylnon-4- enoic acid methyl ester (362) 
 
Crude acid 361 (10 mg, 0.022 mmol) in methanol (1 mL) was treated with diazomethane (0.5 
mL, ~0.1M in Et2O) until the solution stayed yellow. Acetic acid was added to quench excess 
diazomethane and the solution was colorless again. The solvent was removed under 
reduced pressure and purification by column chromatography (hexane:EtOAc = 10:1) yielded 
11 mg (quant.) of methyl ester 362. 
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Rf = 0.40 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CHCl3): δ = 7.24 (d, J = 8.59 Hz, 2H), 6.87 (d, J = 8.59 Hz, 2H), 5.02 (d,  
J = 9.85 Hz, 1H), 4.39 (s, 2H), 3.80 (s, 3H), 3.66 (s, 3H), 3.50 (dd, J = 9.09, 4.80 Hz, 1H), 
3.39 (dd, J = 5.94, 4.67 Hz, 1H), 3.20 (t, J = 8.59 Hz, 1H), 2.61-2.52 (m, 1H), 2.43-2.33 (m, 
3H), 2.29-2.20 (m, 1H), 2.02-1.93 (m, 1H), 1.64 (d, J = 1.26 Hz, 3H), 0.96 (d, J = 6.82 Hz, 
3H), 0.89 (d, J = 6.06 Hz, 3H), 0.89 (s, 9H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CHCl3): δ = 173.7, 159.0, 131.5, 131.4, 131.0, 129.2, 113.7, 78.6, 72.6, 
72.5, 55.3, 51.5, 38.4, 35.7, 32.7, 27.4, 26.1, 22.9, 18.4, 17.2, 14.9, -3.8, -3.9.  
IR (film): 2957, 1741, 1513, 1249, 1087, 1038 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C27H46O5Si: 478.3115, found: 478.3107.  
[α]D20 2.20 (c = 0.5, CH2Cl2) 
 
(Z)-(6S,7R,8S)-7-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-benzyloxy)-4,6,8-
trimethyl-non-4-enoic acid 2,6-dimethyl-phenyl ester (363) 
 
To acid 361 (5 mg, 0.010 mmol) in DCM (1 mL) at r.t. was added 2,6-dimethylphenol (2 mg, 
0.015 mmol) followed by DMAP (1.5 mg, 0.011 mmol) and DIC (2 μL, 0.011 mmol) and the 
mixture was stirred for 18 h. Brine was added and the organic layer was separated. The 
aqueous layer was extracted with DCM, the combined organic phase was dried over MgSO4 
and the solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 
20:1) yielded 6 mg (99%) of aromatic ester 363.  
Rf = 0.39 (hexane:EtOAc = 20:1) 
1H-NMR (400 MHz, CHCl3): δ = 7.23 (d, J = 8.56 Hz, 2H), 7.05 (s, 3H), 6.85 (d, J = 8.56 Hz, 
2H), 5.09 (d, J = 9.60 Hz, 1H), 4.41 (d, J = 11.36 Hz, 1H), 4.37 (d, J = 11.60 Hz, 1H), 3.78 (s, 
3H), 3.51 (dd, J = 9.10, 5.06 Hz, 1H), 3.42 (t, J = 5.16 Hz, 1H), 3.21 (dd, J = 8.93, 8.20 Hz, 
1H), 2.68-2.55 (m, 4H), 2.44-2.36 (m, 1H), 2.12 (s, 6H), 2.02-1.95 (m, 1H), 1.64 (d, J = 1.26 
Hz, 3H), 0.97 (d, J = 6.84 Hz, 3H), 0.92 (d, J = 6.56 Hz, 3H), 0.89 (s, 9H), 0.04 (s, 3H), 0.03 
(s, 3H).  
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13C-NMR (100 MHz, CHCl3): δ = 171.0, 159.0, 148.2, 131.8, 131.3, 131.0, 129.1, 128.6, 
125.8, 113.7, 78.6, 72.6, 72.5, 55.3, 38.4, 35.7, 32.6, 27.5, 26.2, 23.0, 18.4, 16.9, 16.3, 14.9, 
-3.8, -3.9.  
IR (film): 2928, 1757, 1249 cm-1.  
HRMS (ESI) (m/z): [M-C4H9]+ calcd for C30H43O5Si: 511.2880, found: 511.2875.  
[α]D20 10.40 (c = 0.25, CH2Cl2) 
 
(Z)-(6S,7R,8S)-N-[7-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-benzyloxy)-4,6,8-
trimethyl-non-4-enoyl]-(1’R)-bornan-2’,10’-sultam (368) 
 
To a stirred solution of crude acid 361 (60 mg, 0.13 mmol), DMAP (16 mg, 0.13 mmol) and 
(1R)-camphore-2,10-sultam (367) (29 mg, 0.13 mmol) in DCM (2 mL) under argon at r.t. was 
slowly added DIC (23 μL. 0.14 mmol). Stirring was continued for 2 h, brine was added and 
the layers were separated. The aqueous layer was extracted with DCM and the combined 
organic phase was dried over MgSO4 and the solvent was evaporated. Purification by 
column chromatography (hexane:EtOAc = 3:1) yielded 83 mg (96%) of N-acyl sultam 368. 
Rf = 0.28 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CHCl3): δ = 7.25 (d, J = 8.84 Hz, 2H), 6.86 (d, J = 8.60 Hz, 2H), 5.03 (d, 
J = 9.32 Hz, 1H), 4.39 (s, 2H), 3.85 (dd, J = 7.58, 5.54 Hz, 1H), 3.80 (s, 3H), 3.51 (dd, J = 
9.34, 5.06 Hz, 1H), 3.48 (d, J = 13.92 Hz, 1H), 3.41 (d, J = 13.36 Hz, 1H), 3.39 (t, J = 5.30 
Hz, 1H), 3.19 (t, J = 8.72 Hz, 1H), 2.82-2.69 (m, 2H), 2.64-2.55 (m, 1H), 2.53-2.46 (m, 1H), 
2.32-2.20 (m, 1H), 2.15-2.02 (m, 2H), 1.99-1.84 (m, 4H), 1.65 (d, J = 1.28 Hz, 3H), 1.43-1.25 
(m, 3H), 1.15 (s, 3H), 0.97 (s, 3H), 0.96 (d, J = 7.07 Hz, 3H), 0.89 (d, J = 6.82 Hz, 3H), 0.88 
(s, 9H), 0.01 (s, 6H).  
13C-NMR (100 MHz, CHCl3): δ = 171.5, 159.0, 131.3, 131.1, 129.1, 113.7, 78.5, 72.6, 72.5, 
65.2, 55.3, 52.9, 48.4, 47.7, 44.7, 38.6, 38.5, 35.4, 34.0, 32.9, 26.9, 26.5, 26.2, 23.0, 20.9, 
19.9, 18.4, 16.8, 14.7, -3.8, -3.9.  
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IR (film): 2958, 2855, 1698, 1513, 1461, 1332, 1248, 1212, 1171, 1133, 1085 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C36H59O6SNSiNa: 684.3730, found: 684.3736.  
[α]D20 34.95 (c = 1.58, CH2Cl2) 
 
(Z)-(2S,6S,7R,8S)-N-[7-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-benzyloxy)-2,4,6,8-
tetramethyl-non-4-enoyl]-(1’R)-bornan-2’,10’-sultam (369) 
 
To N-acyl sultam 368 (35 mg, 0.050 mmol) in THF (1 mL) at -78 °C was slowly added 
NaHMDS (55 μL, 1M in THF, 0.055 mmol) and the solution was stirred for 1 h. MeI (9 μL, 
0.100 mmol) was added and stirring was continued for 1.5 h. The reaction was quenched by 
the addition of a saturated NH4Cl solution and the layers were separated. The aqueous layer 
was extracted with DCM and the combined organic phase was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 5:1) 
yielded 30 mg (89%) of α-methylated N-acyl sultam 369. 
Rf = 0.29 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CHCl3): δ = 7.25 (d, J = 8.59 Hz, 2H), 6.86 (d, J = 8.56 Hz, 2H), 5.09 (d, 
J = 9.88 Hz, 1H), 4.39 (d, J = 1.76 Hz, 2H), 3.87 (t, J = 6.32 Hz, 1H), 3.80 (s, 3H), 3.49 (dd,  
J = 14.78, 9.72 Hz, 1H), 3.49 (d, J = 13.64 Hz, 1H), 3.42 (d, J = 13.64 Hz, 1H), 3.40 (t, J = 
5.18 Hz, 1H), 3.19 (t, J = 8.72 Hz, 1H), 2.65-2.56 (m, 1H), 2.40 (dd, J = 13.52, 9.47 Hz, 1H), 
2.23 (dd, J = 13.16, 4.79 Hz, 1H), 2.08-1.93 (m, 3H), 1.91-1.79 (m, 3H), 1.64 (s, 3H), 1.44-
1.23 (m, 3H), 1.16 (s, 3H), 1.12 (d, J = 6.82 Hz, 3H), 0.97 (s, 3H), 0.96 (d, J = 6.82 Hz, 3H), 
0.90 (d, J = 7.07 Hz, 3H), 0.88 (s, 9H), 0.02 (s, 3H), 0.01 (s, 3H).  
13C-NMR (100 MHz, CHCl3): δ = 176.0, 159.0, 132.8, 131.1, 130.2, 129.1, 113.7, 78.5, 72.7, 
72.5, 65.2, 55.3, 53.2, 48.3, 47.7, 44.6, 38.6, 38.4, 37.9, 35.5, 34.2, 32.9, 29.5, 26.4, 26.2, 
23.0, 20.9, 19.9, 18.4, 17.8, 16.9, 14.7, -3.8, -3.9.  
IR (film): 2959, 1696, 1513, 1332, 1248, 1132, 1036 cm-1.  
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HRMS (ESI) (m/z): [M+Na]+ calcd for C37H61O6SNSiNa: 698.3887, found: 698.3902.  
[α]D20 55.30 (c = 1.00, CH2Cl2) 
 
(Z)-(2S,6S,7R,8S)-7-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-benzyloxy)-2,4,6,8-
tetramethyl-non-4-enal (370) 
 
To N-acyl sultam 369 (65 mg, 0.092 mmol) in DCM (2 mL) at -100 °C was slowly added 
DIBALH (62 μL, 1.5 M in toluene, 0.092 mmol) and the mixture was stirred for 1 h. A second 
equivalent of DIBALH (62 μL, 1.5 M in toluene, 0.092 mmol) was added and stirring was 
continued for 1 h, at which time the temperature reached -65 °C. The reaction was quenched 
by the addition of a small amount of methanol and potassium sodium tartrate was added and 
the mixture was stirred vigorously at r.t. for 2 h. The layers were separated and the aqueous 
layer was extracted with DCM. The combined organic phase was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 10:1) 
yielded 40 mg (94%) of aldehyde 370. 
Rf = 0.50 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.61 (d, J = 1.52 Hz, 1H), 7.24 (d, J = 8.84 Hz, 2H), 6.87 (d, 
J = 8.60 Hz, 2H), 5.12 (d, J = 10.64 Hz, 1H), 4.39 (s, 2H), 3.80 (s, 3H), 3.48 (dd, J = 9.08, 
5.04 Hz, 1H), 3.38 (dd, J = 5.82, 4.78 Hz, 1H), 3.19 (dd, J = 8.82, 8.10 Hz, 1H), 2.57-2.43 (m, 
2H), 2.22 (dd, J = 13.90, 5.82 Hz, 1H), 2.16 (dd, J = 13.78, 9.46 Hz, 1H), 2.26-2.17 (m, 1H), 
2.00-1.88 (m, 1H), 1.63 (d, J = 1.24 Hz, 3H), 1.00 (d, J = 6.84 Hz, 3H), 0.94 (d, J = 6.80 Hz, 
3H), 0.90 (d, J = 6.84 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 204.5, 158.6, 134.0, 133.0, 130.9, 129.3, 113.8, 78.5, 72.7, 
72.4, 57.6, 55.2, 44.5, 38.4, 35.7, 32.6, 26.8, 23.3, 17.1, 14.9, 13.0, -4.1, -4.2.  
IR (film): 2958, 2930, 2856, 1727, 1513, 1472, 1462, 1249, 1091, 1037 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C27H46O4Si: 462.3165, found: 462.3171.  
[α]D20 3.92 (c = 1.30, CH2Cl2) 
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(1-bromoallyl)trimethylsilane (385) 
  
To allyl bromide (8.5 mL, 100 mmol) and freshly distilled chlorotrimethylsilane (9.5 mL, 75 
mmol) in THF (25 mL) at -78 °C was added LDA, prepared by the addition of nBuLi (20 mL, 
2.5 M in hexane, 50 mmol) to diisopropylamine (7 mL, 50 mmol) in THF (25 mL) and hexane 
(15 mL) at 0 °C and stirring for 15 min, via cannula over 20 min. After another 20 min water 
(50 mL) and 1M HCl (110 mL) was added. The aqueous solution was extracted with pentane 
and the combined organic solution was dried over MgSO4. After filtration the solvent was 
distilled off through a Vigreux column. Vacuum distillation at 55 °C (12 mmHg) of the 
remaining liquid yielded 5.5 g (52%) of the desired product as colorless liquid.  
1H-NMR (250 MHz, CDCl3): δ = 5.92 (td, J = 16.60, 9.86 Hz, 1H), 5.20-5.02 (m, 2H), 3.80 (d, 
J = 9.70 Hz, 1H), 0.14 (s, 9H).  
 
(Z)-(S)-1-methoxy-4-((2-methylhexa-3,5-dienyloxy)methyl)benzene (386) 
 PMBO  
To chromium(III) chloride (793 mg, 5.00 mmol) in THF (10 mL) at r.t. was added lithium 
aluminium hydride (95 mg, 2.50 mmol) whereupon the violet solution turned black and 
stirring was continued for 30 min. The mixture was cooled to 0 °C and a solution of aldehyde 
279 (350 mg, 1.67 mmol) and (1-bromoallyl)trimethylsilane (385) (800 mg, 4.23 mmol) in 
THF (2 mL) was added. After 2 h the reaction was brought to r.t. and was allowed to age 
over night. 6N KOH (20 mL) and methanol (10 mL) were added at 0 °C and stirred for 1 h at 
0 °C and 2 h at r.t.. The mixture was acidified with 3N HCl and the aqueous solution was 
extracted with DCM. The combined organic phase was dried over MgSO4 and the solvent 
was evaporated. Purification by column chromatography (hexane:EtOAc = 20:1) yielded 350 
mg (90%) of diene 386. 
Rf = 0.60 (hexane:EtOAc = 10:1) 
1H-NMR (250 MHz, CDCl3): δ = 7.25 (d, J = 8.45 Hz, 2H), 6.87 (d, J = 8.57 Hz, 2H), 6.64 (td, 
J = 16.73, 10.59 Hz, 1H), 6.02 (t, J = 10.97 Hz, 1H), 5.27 (m, 1H), 5.13 (m, 2H), 4.45 (s, 2H), 
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3.81 (s, 3H), 3.30 (ddd, J = 14.83, 9.07, 6.70 Hz, 2H), 2.97 (m, 1H), 1.02 (d, J = 6.62 Hz, 
3H). 
 
(Z)-(S)-2-methylhexa-3,5-dien-1-ol (518) 
 HO  
To a stirred solution of diene 386 (200 mg, 0.86 mmol) in wet DCM (6 mL) was added DDQ 
(215 mg, 0.95 mmol) in small portions and the mixture was stirred vigorously for 1 h. The 
reaction was quenched with saturated NaHCO3 solution, the organic layer was separated 
and the aqueous solution was extracted with DCM. The combined organic solution was dried 
over MgSO4, the solvent was evaporated and the residue was purified by column 
chromatography (hexane:DCM = 1:1) to yield 90 mg (93%) of volatile 518. 
Rf = 0.30 (hexane:EtOAc = 10:1) 
1H-NMR (250 MHz, CDCl3): δ = 6.64 (td, J = 17.26, 10.39 Hz, 1H), 6.14 (t, J = 10.97 Hz, 1H), 
5.27-5.13 (m, 3H), 3.54 (ddd, J = 7.99, 10.45, 5.70 Hz, 1H), 3.38 (ddd, J = 10.62, 7.93, 4.04 
Hz, 1H), 2.89 (m, 1H), 1.39 (dd, J = 7.94, 4.16 Hz, 1H (OH)), 0.99 (d, J = 6.62 Hz, 3H). 
 
(Z)-(S)-4-Methyl-octa-5,7-dien-3-ol (519) 
 OH  
To a stirred suspension of alcohol 518 (90 mg, 0.8 mmol) and NaHCO3 (403 mg, 4.8 mmol) 
in DCM (8 mL) at r.t. was added Dess-Martin periodinane (679 mg, 1.6 mmol) and the 
suspension was stirred for 4 h. The reaction was quenched with water, the organic layer was 
separated and the aqueous layer was extracted with DCM. The combined organic solution 
was dried over MgSO4 and the solvent was evaporated to yield crude aldehyde 387.  
To aldehyde 387 (90 mg, 0.8 mmol) in Et2O (8 mL) at 0 °C was slowly added EtMgBr (0.4 
mL, 3M in Et2O, 1.2 mmol). After 3 h brine was added and acidified with 5% H2SO4. The 
layers were separated and the aqueous layer was extracted with Et2O. The combined 
organic phase was dried over MgSO4 and the solvent was carefully evaporated. Purification 
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by column chromatography (hexane:DCM = 1:1) yielded 100 mg (89%) of volatile alcohol 
519 as 1:1 mixture of diastereoisomers.  
Rf = 0.40 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.68 (m, 1H), 6.03 (t, J = 10.99 Hz, 1H), 5.38-5.28 (m, 1H), 
5.26-5.11 (m, 2H), 3.38-3.30 (m, 1H), 2.77-2.65 (m, 1H), 1.64-1.53 (m, 2H), 1.04 (d, J = 6.82 
Hz, 3H), 0.97 (t, J = 7.45 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 134.8, 132.3, 129.6, 117.8, 77.3, 38.2, 27.3, 16.4, 10.3.  
1H-NMR (400 MHz, CDCl3): δ = 6.68 (m, 1H), 6.13 (t, J = 10.99 Hz, 1H), 5.29 (m, 1H), 5.26-
5.11 (m, 2H), 3.38-3.30 (m, 1H), 2.77-2.65 (m, 1H), 1.42-1.26 (m, 2H), 1.01 (d, J = 6.82 Hz, 
3H), 0.96 (t, J = 7.45 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 134.1, 132.2, 130.8, 118.1, 77.3, 38.0, 27.1, 17.2, 9.9.  
IR (film): 3585, 3391, 2964, 1651, 1644, 1634 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C9H16O: 140.1201, found: 140.1211. 
 
(Z)-(S)-4-Methyl-octa-5,7-dien-3-one (388) 
 
Dess-Martin periodinane (1.14 g, 2.70 mmol) was added portion wise to a suspension of 
alcohol 519 (190 mg, 1.35 mmol) and NaHCO3 (684 mg, 8.1 mmol) in DCM (14 mL) at r.t. 
under argon. After 3 h water was added and the layers were separated. The aqueous layer 
was extracted with DCM and the combined DCM layer was dried over MgSO4 and the 
solvent was carefully evaporated. Column chromatography (hexane:DCM = 1:1) yielded 190 
mg (99%) of ethyl ketone 388. 
Rf = 0.45 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 6.70-6.60 (m, 1H), 6.10 (t, J = 10.86 Hz, 1H), 5.32 (t, J = 
10.48 Hz, 1H), 5.32-5.20 (m, 2H), 3.65 (dq, J = 10.10, 6.82 Hz, 1H), 2.52 (dq, J = 17.81, 7.28 
Hz, 1H), 2.41 (dq, J = 17.81, 7.28Hz, 1H), 1.16 (d, J = 6.57 Hz, 3H), 1.02 (t, J = 7.20 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 211.6, 131.4, 131.0, 130.9, 119.3, 45.9, 33.9, 16.6, 7.7.  
Experimental Section 
 227
IR (film): 2976, 2937, 1716, 1458, 1375 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C9H14O: 138.1045, found: 138.1057.  
[α]D20 350.12 (c = 0.85, CH2Cl2) 
 
(3Z,11Z)-(5S,7R,8R,9S,13S,14S,15S)-14-(tert-Butyl-dimethyl-silanyloxy)-8-hydroxy-17-
(4-methoxy-phenoxy)-5,7,9,11,13,15-hexamethyl-heptadeca-1,3,11-trien-6-one (520) 
 
To ethyl ketone 388 (12 mg, 0.09 mmol) in DCM (1 mL) at -78 °C was added Bu2BOTf (110 
μL, 1M in DCM, 0.11 mmol) and triethylamine (18 μL, 0.12 mmol). After 10 min at -78 °C the 
mixture was brought to 0 °C for 30 min and was recooled to -78 °C. Aldehyde 370 (30 mg, 
0.06 mmol) in DCM (1 mL) was added and stirring was continued for 3 h at -78 °C, then the 
mixture was kept at 0 °C for 1 h and quenched by the addition of pH 7 buffer, methanol and 
H2O2. After 1.5 h at r.t. the layers were separated and the aqueous layer was extracted with 
DCM. The combined organic phase was dried over MgSO4 and the solvent was evaporated. 
Purification by column chromatography (hexane:EtOAc = 10:1) yielded 25 mg (69%) of aldol 
adduct 256 and 6 mg (20%) of aldehyde 520. 
Rf = 0.47 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.25 (d, J = 8.86 Hz, 2H), 6.87 (d, J = 8.59 Hz, 2H), 6.73-
6.61 (m, 1H), 6.14 (t, J = 10.86 Hz, 1H), 5.35-5.22 (m, 3H), 5.04 (d, J = 10.10 Hz, 1H), 4.39 
(s, 2H), 3.80 (s, 3H), 3.79 (m, 1H), 3.57-3.43 (m, 2H), 3.41-3.35 (m, 1H), 3.20 (dd, J = 9.09, 
8.33 Hz, 1H), 2.98 (t, J = 6.95 Hz, 1H), 2.60-2.50 (m, 1H), 2.47-2.41 (m, 1H), 2.20-1.93 (m, 
3H), 1.76-1.66 (m, 1H), 1.58 (s, 3H), 1.17 (d, J = 6.82 Hz, 3H), 1.16 (d, J = 6.57 Hz, 3H), 
1.09 (d, J = 7.07 Hz, 3H), 1.07 (d, J = 7.07 Hz, 3H), 0.95 (d, J = 7.07 Hz, 3H), 0.90 (d, J = 
6.84 Hz, 3H), 0.89 (s, 9H), 0.03 (s, 3H), 0.02 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 216.6, 159.0, 131.9, 131.6, 131.3, 131.0, 130.1, 129.0, 
119.7, 113.8, 79.1, 78.5, 76.5, 72.7, 72.5, 55.3, 50.1, 47.2, 46.5, 38.6, 35.5, 33.9, 32.6, 26.1, 
23.2, 22.7, 17.0, 16.3, 15.0, 14.6, 14.2, -3.8, -4.0.  
IR (film): 3503, 2940, 2930, 2856, 1711, 1513, 1458, 1249, 1092, 1037, 1004 cm-1.  
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HRMS (ESI) (m/z): [M]+ calcd for C36H60O5Si: 600.4210, found: 600.4219.  
[α]D20 154.00 (c = 0.85, CH2Cl2) 
 
(R)- and (S)-MTPA esters of 520 were prepared according to the general procedure (page 
123) and comparison of the shift differences between the two side chains from the C17 
center of the two diastereoisomers confirmed the absolute configuration to be (17R). 
carbon (S)-Mosher ester (R)-Mosher ester R vs. S 
13 6,106 6,114 R>S 
14’ 1,5415 1,5656 R>S 
15a 2,1490 2,2134 R>S 
15b 1,7340 1,8184 R>S 
16 2,008 2,020 R>S 
16’ 0,7797 0,8059 R>S 
17 5,4256 5,4488 R>S 
18 3,1347 3,1653 R>S 
18’ 1,0170 1,0013 R<S 
20 3,4850 3,5350 R>S 
20’ 0,9549 0,9294 R<S 
21 5,2430 5,2480 R~S 
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(S)-MTPA ester of 520: 
 
1H-NMR (400 MHz, CDCl3): δ = 7.47 (m, 2H), 7.40 (m, 3H), 7.24 (d, J = 8.69 Hz, 2H), 6.86 
(d, J = 8.69 Hz, 2H), 6.55 (dt, J = 17.18, 10.29 Hz, 1H), 6.11 (t, J = 10.57 Hz, 1H), 5.42 (dd,  
J = 9.44, 3.02 Hz, 1H), 5.31-5.19 (m, 3H), 5.04 (d, J = 10.20 Hz, 1H), 4.39 (d, J = 11.70 Hz, 
1H), 4.36 (d, J = 11.70 Hz, 1H), 3.80 (s, 3H), 3.48 (m, 1H), 3.45 (m, 1H), 3.44 (s, 3H), 3.36 
(dd, J = 6.23, 4.72 Hz, 1H), 3.20 (dd, J = 9.06, 8.31 Hz, 1H), 3.13 (dd, J = 9.44, 7.18 Hz, 1H), 
2.43 (m, 1H), 2.01 (m, 1H), 1.94 (m, 1H), 1.73 (m, 1H), 1.55 (s, 3H), 1.02 (d, J = 7.17 Hz, 
3H), 0.95 (d, J = 6.79 Hz, 3H), 0.92 (d, J = 7.17 Hz, 3H), 0.89 (s, 9H), 0.84 (d, J = 6.42 Hz, 
3H), 0.77 (d, J = 6.80 Hz, 3H), 0.03 (s, 3H), 0.02 (s, 3H). 
 
(R)-MTPA ester of 520: 
OTBS
PMBO
O O
(R)
O
Ph
F3C
MeO  
1H-NMR (400 MHz, CDCl3): δ = 7.52 (m, 2H), 7.39 (m, 3H), 7.23 (d, J = 8.69 Hz, 2H), 6.86 
(d, J = 8.69 Hz, 2H), 6.64 (dt, J = 16.81, 10.10 Hz, 1H), 6.11 (t, J = 10.58 Hz, 1H), 5.45 (dd,  
J = 9.44, 2.64 Hz, 1H), 5.32-5.21 (m, 3H), 5.05 (d, J = 10.57 Hz, 1H), 4.39 (d, J = 11.71 Hz, 
1H), 4.35 (d, J = 11.71 Hz, 1H), 3.80 (s, 3H), 3.53 (m, 1H), 3.44 (s, 3H), 3.43 (dd, J =9.25, 
5.09 Hz, 1H), 3.38 (dd, J = 6.42, 4.53 Hz, 1H), 3.20 (dd, J = 9.19, 8.24 Hz, 1H), 3.17 (dd, J = 
9.63, 6.98 Hz, 1H), 2.46 (m, 1H), 2.21 (t, J = 12.46 Hz, 1H), 2.02 (m, 1H), 1.96 (m, 1H), 1.81 
(d, J = 11.70 Hz, 1H), 1.55 (s, 3H), 1.00 (d, J = 7.17 Hz, 3H), 0.93 (d, J = 6.42 Hz, 3H), 0.92 
(d, J = 6.70 Hz, 3H), 0.89 (s, 9H), 0.86 (d, J = 6.42 Hz, 3H), 0.80 (d, J = 6.80 Hz, 3H), 0.03 
(s, 6H). 
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(3Z,11Z)-(5S,6S,7R,8R,9S,13S,14S,15S)-14-(tert-Butyl-dimethyl-silanyloxy)-17-(4-
methoxy-phenoxy)-5,7,9,11,13,15-hexamethyl-heptadeca-1,3,11-triene-6,8-diol (521) 
 
To a solution of 520 (10 mg, 0.016 mmol) in THF (0.5 mL) at -10 °C under argon was added 
catecholborane (9 μL, 0.083 mmol) and the mixture was stirred for 2 h. A saturated solution 
of potassium sodium tartrate was added and stirring was continued for 1 h. The layers were 
separated and the aqueous layer was extracted with DCM. The combined organic layer was 
dried over MgSO4 and the solvent was removed under reduced pressure. Column 
chromatography (Hexane:EtOAc = 5:1) yielded 6.5 mg (65%) of diol 521 as colorless oil. 
Rf = 0.35 (hexane:EtOAc = 5:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.25 (d, J = 8.65 Hz, 2H), 6.87 (d, J = 8.64 Hz, 2H), 6.63-
6.57 (m, 1H), 6.02 (t, J = 11.31 Hz, 1H), 5.51 (t, J = 9.99 Hz, 1H) 5.24-5.12 (m, 2H), 5.04 (d, 
J = 10.20 Hz, 1H), 4.39 (m, 2H), 3.80 (s, 3H), 3.56-3.47 (m, 2H), 3.37 (dd, J = 6.03, 4.53 Hz, 
1H), 3.20 (dd, J = 9.06, 8.28 Hz, 1H), 2.96-2.91 (m, 1H), 2.61-2.53 (m, 1H), 2.25-2.21 (m, 
1H), 2.00-1.89 (m, 3H), 1.82-1.77 (m, 1H), 1.62 (d, J = 1.14 Hz, 3H), 1.01 (d, J = 6.84 Hz, 
3H), 0.95 (d, J = 6.78 Hz, 3H), 0.88 (s, 18H), 0.03 (s, 3H), 0.02 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 159.7, 135.9, 132.0, 131.8, 131.7, 129.1, 128.8, 117.9, 
113.7, 80.7, 78.7, 72.7, 72.6, 55.3, 38.1, 35.6, 34.9, 33.0, 31.8, 29.7, 26.2, 25.4, 23.3, 21.0, 
17.0, 16.7, 15.0, 14.2, 13.8, 11.3, -3.8, -3.9.  
IR (film): 3398, 2960, 1613, 1513, 1458, 1249, 1038 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C36H62O5SiNa: 625.4264, found: 625.4260.  
[α]D20 33.20 (c = 0.25, CH2Cl2) 
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tert-Butyl-{(Z)-(1S,2S,6S)-1-[(S)-3-(4-methoxy-phenoxy)-1-methyl-propyl]-6-
[(2R,4R,5R,6S)-2-(4-methoxy-phenyl)-5-methyl-6-((Z)-(S)-1-methyl-penta-2,4-dienyl)-
[1,3]dioxan-4-yl]-2,4-dimethyl-hept-3-enyloxy}-dimethyl-silane (397) 
 
To diol 521 (5 mg, 0.0083 mmol) in DCM (0.5 mL) was added anisaldehyde dimethyl acetal 
(3 μL, 0.0170 mmol) and CSA (0.5 mg, 0.0020 mmol) at r.t. under argon. The mixture was 
stirred for 1 h. Brine was added and the mixture was diluted with DCM. The layers were 
separated and the aqueous layer was extracted with DCM. The combined organic layer was 
dried over MgSO4 and the solvent was removed under reduced pressure. Column 
chromatography (Hexane:EtOAc = 20:1) yielded 6 mg (99%) of acetal 397 as colorless oil. 
Rf = 0.70 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.40 (d, J = 8.28 Hz, 2H), 7.19 (d, J = 8.64 Hz, 2H), 6.85 (d, 
J = 8.70 Hz, 2H), 6.83 (d, J = 8.70 Hz, 2H), 6.63 (m, 1H), 5.98 (t, J = 10.77 Hz, 1H), 5.71 (t, J 
= 10.20 Hz, 1H), 5.45 (s, 1H), 5.24-5.12 (m, 2H), 5.07 (d, J = 10.14 Hz, 1H), 4.36 (d, J = 
11.71 Hz, 1H), 4.30 (d, J = 11.71 Hz, 1H), 3.79 (s, 3H), 3.78 (s, 3H), 3.49 (dd, J = 9.06, 4.14 
Hz, 1H), 3.38 (m, 1H), 3.35 (t, J = 5.28 Hz, 1H), 3.16 (t, J = 8.88 Hz, 1H), 3.01 (m, 1H), 2.58 
(m, 1H), 2.48 (dd, J = 13.41, 12.27 Hz, 1H), 2.04-1.84 (m, 3H), 1.64 (d, J = 0.78 Hz, 
3H),1.33-1.22 (m, 2H), 0.95 (d, J = 6.78 Hz, 3H), 0.94 (d, J = 7.20 Hz, 3H), 0.89 (d, J = 6.78 
Hz, 3H), 0.88 (d, J = 6.42 Hz, 3H), 0.87 (s, 9H), 0.85 (d, J = 6.78 Hz, 3H), 0.00 (s, 3H), -0.01 
(s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 159.4, 158.9, 132.3, 131.9, 131.8, 129.1, 127.3, 113.6, 
113.2, 100.2, 86.5, 80.4, 78.7, 72.6, 72.4, 65.1, 55.3, 55.1, 38.1, 36.6, 35.3, 31.8, 31.5, 31.4, 
26.2, 25.9, 23.2, 22.7, 18.4, 18.3, 16.8, 16.3, 14.1, 11.3, 9.7, -3.8, -3.9, -5.3, -5.4.  
IR (film): 2930, 1615, 1515, 1249, 1083, 1037 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C44H68O6SiNa: 743.4683, found: 743.4650.  
[α]D20 43.43 (c = 0.175, CH2Cl2) 
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(Z)-(2S,4R,5R,6S,10S,11S,12S)-1,11-Bis-(tert-butyl-dimethyl-silanyloxy)-5-hydroxy-14-
(4-methoxy-phenoxy)-2,4,6,8,10,12-hexamethyl-tetradec-8-en-3-one (398) 
 
To ethyl ketone 382 (14 mg, 0.060 mmol) in DCM (1 mL) at -78 °C was added Bu2BOTf (72 
μL, 1M in DCM, 0.072 mmol) and triethylamine (11 μL, 0.080 mmol). After 15 min at -78 °C 
the mixture was brought to 0 °C for 30 min and was recooled to -78 °C. Aldehyde 370 (20 
mg, 0.040 mmol) in DCM (0.5 mL) was added and stirring was continued for 3 h at -78 °C, 
then the mixture was kept at 0 °C for 1 h and quenched by the addition of pH 7 buffer, 
methanol and H2O2. After 1 h at r.t. the layers were separated and the aqueous layer was 
extracted with DCM. The combined organic phase was dried over MgSO4 and the solvent 
was evaporated. Purification by column chromatography (hexane:EtOAc = 10:1) yielded 15 
mg (54%) of aldol adduct 398 and 6 mg (43%) of aldehyde 370. 
Rf = 0.47 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.25 (d, J = 8.65 Hz, 2H), 6.87 (d, J = 8.60 Hz, 2H), 5.05 (d, 
J = 10.08 Hz, 1H), 4.39 (m, 2H), 3.81 (dd, J = 9.60, 8.34 Hz, 1H), 3.80 (s, 3H), 3.54 (dd, J = 
9.70, 4.94 Hz, 1H), 3.51-3.48 (m, 2H), 3.39 (dd, J = 5.78, 4.86 Hz, 1H), 3.19 (t, J = 8.72 Hz, 
1H), 2.97-2.87 (m, 2H), 2.74 (d, J = 6.80 Hz, 1H (OH)), 2.61-2.52 (m, 1H), 2.15 (dd, J = 
12.95, 11.76 Hz, 1H), 2.01-1.93 (m, 2H), 1.82-1.77 (m, 1H), 1.60 (s, 3H), 1.14 (d, J = 7,32 
Hz, 3H), 0.99 (d, J = 7.04 Hz, 3H), 0.95 (d, J = 6.84 Hz, 3H), 0.89 (d, J = 7.20 Hz, 3H), 0.88 
(s, 9H), 0.87 (s, 9H), 0.83 (d, J = 6.80 Hz, 3H), 0.05 (s, 3H), 0.03 (s, 3H), 0,02 (s, 3H), 0.01 
(s, 3H).  
13C-NMR (100 MHz, CDCl3): δ =  218.6, 159.0, 131.8, 131.7, 131.1, 129.1, 113.7, 78.6, 78.1, 
72.7, 72.5, 65.2, 55.3, 48.3, 48.2, 38.5, 35.4, 33.5, 32.6, 26.2, 25.9, 23.2, 18.4, 16.9, 16.4, 
14.7, 13.6, 13.3, -3.8, -3.9, -5.5, -5.6.  
IR (film): 2958, 2930, 2857, 1514, 1463, 1361, 1250, 1097 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C39H72O6Si2Na: 715.4765, found: 715.4761.  
[α]D20 15.48 (c = 0.58, CH2Cl2) 
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(2R,4S,5R,6R)-4-[(Z)-(1S,5S,6S,7S)-6-(tert-Butyl-dimethyl-silanyloxy)-9-(4-methoxy-
phenoxy)-1,3,5,7-tetramethyl-non-3-enyl]-6-[(S)-2-(tert-butyl-dimethyl-silanyloxy)-1-
methyl-ethyl]-2-(4-methoxy-phenyl)-5-methyl-[1,3]dioxane (401) 
 
To diol 399 (9 mg, 0.013 mmol) in DCM (0.5 mL) was added anisaldehyde dimethyl acetal (5 
μL, 0.026 mmol) and CSA (1 mg, 0.003 mmol) at r.t. and the mixture was stirred for 1 h. 
Brine was added and the mixture was diluted with DCM. The layers were separated and the 
aqueous layer was extracted with DCM. The combined organic layer was dried over MgSO4 
and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc = 20:1) yielded 15 mg (99%) of acetal 401 as colorless oil. 
Rf = 0.63 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.38 (d, J = 9.06 Hz, 2H), 7.19 (d, J = 8.70 Hz, 2H), 6.85 (d, 
J = 8.70 Hz, 2H), 6.83 (d, J = 8.70 Hz, 2H), 5.45 (s, 1H), 5.07 (d, J = 9.84 Hz, 1H), 4.36 (d,  
J = 11.70 Hz, 1H), 4.30 (d, J = 11.76 Hz, 1H), 3.79 (s, 6H), 3.67 (t, J = 9.06 Hz, 1H), 3.64 
(dd, J = 9.81, 1.89 Hz, 1H), 3.49 (dd, J = 9.03, 4.53 Hz, 1H), 3.47 (dd, J = 9.63, 5.49 Hz, 1H), 
3.40 (dd, J = 9.42, 1.92 Hz, 1H), 3.35 (t, J = 5.28 Hz, 1H), 3.15 (t, J = 8.67 Hz, 1H), 2.61-2.57 
(m, 1H), 2.37 (dd, J = 13.38, 11.88 Hz, 1H), 2.05-1.98 (m, 2H), 1.96 (m, 3H), 1.63 (d, J = 
1.14 Hz, 3H),1.31-1.25 (m, 2H), 0.95 (d, J = 6.84 Hz, 3H), 0.93 (d, J = 7.20 Hz, 3H), 0.90 (s, 
9H), 0.88 (d, J = 6.06 Hz, 3H), 0.86 (d, J = 7.20 Hz, 3H), 0.87 (s, 9H), 0.79 (d, J = 6.42 Hz, 
3H), 0.05 (s, 3H), 0.04 (s, 3H), 0.00 (s, 3H), -0.01 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 159.4, 158.9, 132.3, 131.9, 131.8, 129.1, 127.3, 113.6, 
113.2, 100.2, 86.5, 80.4, 78.7, 72.6, 72.4, 65.1, 55.3, 55.1, 38.1, 36.6, 35.3, 31.8, 31.5, 31.4, 
26.2, 25.9, 23.2, 22.7, 18.4, 18.3, 16.8, 16.3, 14.1, 11.3, 9.7, -3.8, -3.9, -5.3, -5.4.  
IR (film): 2728, 1722, 1435, 1293, 1233, 1150 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C47H80O7Si2Na: 835.5340, found: 835.5351.  
[α]D20 7.67 (c = 0.3, CH2Cl2) 
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(S)-4-Benzyl-3-[(Z)-(2S,3R,4S,8S,9R,10S)-9-(tert-butyl-dimethyl-silanyloxy)-3-hydroxy-
11-(4-methoxy-benzyloxy)-2,4,6,8,10-pentamethyl-undec-6-enoyl]-oxazolidin-2-one 
(402) 
 
To a stirred solution of acyloxazolidinone ent-373 (17 mg, 0.071 mmol) in DCM (0.7 mL) at  
-78 °C under argon was slowly added dibutylboron triflate (74 μL, 1M in DCM, 0.074 mmol) 
followed by triethylamine (12 μL, 0.081 mmol) and stirring was continued for 10 min. The 
reaction mixture was warmed to 0 °C for 1 h and then recooled to -78 °C. Aldehyde 370 (29 
mg, 0.062 mmol) in DCM (0.5 mL) was added dropwise. After 1 h the reaction mixture was 
warmed to 0 °C and stirred for 1.5 h. pH 7 buffer solution (2 mL), methanol (1 mL) and H2O2 
(0.1 mL, 30% aqueous) were added and the mixture was stirred for 1 h at r.t.. Layers were 
separated and the aqueous layer was extracted with DCM, the combined organic layer was 
dried over MgSO4 and the solvent was evaporated. The crude aldol product was purified by 
column chromatography (hexane:EtOAc = 5:1 to 3:1) to yield 28 mg (65%) of aldol adduct 
402 and 10 mg (34%) of aldehyde 370.  
Rf = 0.33 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.36-7.28 (m, 4H), 7.24-7.19 (m, 3H), 6.86 (d, J = 8.53 Hz, 
2H), 5.05 (d, J = 10.04 Hz, 1H), 4.67 (ddt, J = 9.45, 6.88, 3.43 Hz, 1H), 4.44 (d, J = 11.54 Hz, 
1H), 4,38 (d, J = 11.79 Hz, 1H), 4.18 (m, 2H), 3,94 (m, 1H), 3.80 (s, 3H), 3.65 (dd, J = 10.04, 
5.02 Hz, 1H), 3.58 (dd, J = 9.29, 4.77 Hz, 1H), 3.35 (dd, J = 6.65, 3.64 Hz, 1H), 3.24 (dd, J = 
13.30, 3.26 Hz, 1H), 3.20-3.16 (m, 2H), 2.77 (dd, J = 13.30, 9.53 Hz, 1H), 2.64 (dt, J = 9.91, 
6.71 Hz, 1H), 2.10 (dd, J = 13.30, 6.77 Hz, 1H), 1.98-1.86 (m, 2H), 1.77 (m, 1H), 1.63 (d, J = 
1.00 Hz, 3H), 1.20 (d, J = 6.77 Hz, 3H), 0.94 (d, J = 7.02 Hz, 3H), 0.89 (d, J = 6.22 Hz, 3H), 
0.88 (s, 9H), 0.88 (d, J = 6.27 Hz, 3H), 0.04 (s, 3H), 0.02 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 177.0, 159.1, 152.8, 135.1, 132.0, 131.8, 130.7, 129.4, 
128.9, 127.4, 113.7, 79.1, 74.0, 72.7, 72.5, 65.9, 55.3, 55.1, 40.5, 38.2, 37.7, 35.9, 35.8, 
33.4, 29.2, 26.2, 23.1, 18.4, 17.3, 15.6, 14.4, 12.7, -3.7, -3.8.  
IR (film): 2928, 1781, 1701, 1512, 1458, 1388, 1248, 1080 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C40H61NO7Si: 695.4217, found: 695.4225.  
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[α]D20 32.22 (c = 0.45, CH2Cl2) 
 
(S)-4-Benzyl-3-[(Z)-(2S,3R,4S,8S,9R,10S)-3,9-bis-(tert-butyl-dimethyl-silanyloxy)-11-(4-
methoxy-benzyloxy)-2,4,6,8,10-pentamethyl-undec-6-enoyl]-oxazolidin-2-one (523) 
 
To a stirred solution of alcohol 402 (14 mg, 0.019 mmol) in DCM (1 mL) was added  
2,6-lutidine (4 µL, 0.029 mmol) and TBSOTf (5 µL, 0.023 mmol). After 1 h the reaction was 
quenched with saturated NH4Cl solution, the layers were separated and the aqueous layer 
was extracted with DCM. The combined organic solution was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 5:1) 
yielded 16 mg (quant.) of 523 as colorless oil.  
Rf = 0.73 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.35-7.27 (m, 3H), 7.24-7.19 (m, 4H), 6.86 (d, J = 8.53 Hz, 
2H), 5.02 (d, J = 10.04 Hz, 1H), 4.65-4.59 (m, 1H), 4.41 (d, J = 11.54 Hz, 1H), 4.36 (d, J = 
11.79 Hz, 1H), 4.16 (d, J = 5.02 Hz, 2H), 3.98 (m, 2H), 3.80 (s, 3H), 3.49 (dd, J = 9.16 Hz, 
4.89 Hz, 1H), 3.37 (dd, J = 6.02, 4.77 Hz, 1H), 3.26 (dd, J = 13.30, 3.26 Hz, 1H), 3.21 (t, J = 
8.90 Hz, 1H), 2.75 (dd, J = 13.30, 9.54 Hz, 1H), 2.51 (m, 1H), 2.21 (t, J = 12.42 Hz, 1H), 1.96 
(m, 1H), 1.86 (m, 1H), 1.75 (m, 1H), 1.57 (s, 3H), 1.24 (d, J = 6.28 Hz, 3H), 0.95 (d, J = 7.02 
Hz, 3H), 0.93 (s, 9H), 0.88 (d, J = 6.52 Hz, 3H), 0.88 (s, 9H), 0.74 (d, J = 6.77 Hz, 3H), 0.09 
(s, 3H), 0.06 (s, 3H), 0.01 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 176.0, 159.0, 152.8, 135.3, 131.2, 129.5, 129.1, 128.9, 
127.4, 113.7, 78.5, 76.9, 72.7, 72.5, 65.9, 55.6, 55.3, 41.6, 38.7, 37.7, 36.5, 35.5, 26.1, 25.7, 
23.1, 18.4, 17.0, 14.5, 14.4, 14.0, -3.5, -3.8, -4.0.  
IR (film):2930, 1784, 1698, 1514, 1463, 1385, 1249, 1040 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C46H75NO7Si2Na: 832.4980, found: 832.4987.  
[α]D20 48.00 (c = 0.6, CH2Cl2) 
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(Z)-(2R,3R,4S,8S,9R,10S)-3,9-Bis-(tert-butyl-dimethyl-silanyloxy)-11-(4-methoxy-
benzyloxy)-2,4,6,8,10-pentamethyl-undec-6-en-1-ol (403) 
 
To aldol adduct 523 (18 mg, 0.022 mmol) in Et2O (0.5 mL) with methanol (10 μL) at  
0 °C was slowly added LiBH4 (12 μL, 2M in THF, 0.024 mmol). After 1.5 h the reaction was 
quenched by the addition of brine and the layers were separated. The aqueous layer was 
extracted with DCM and the combined organic layer was dried over MgSO4. After 
evaporation of the solvent, purification by column chromatography (hexane:EtOAc = 5:1) 
yielded 12 mg (86%) of 403. 
Rf = 0.59 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.78 Hz, 2H), 6.86 (d, J = 8.78 Hz, 2H), 5.02 (d, 
J = 10.04 Hz, 1H), 4.40 (d, J = 11.54 Hz, 1H), 4.36 (d, J = 11.54 Hz, 1H), 3.80 (s, 3H), 3.60 
(m, 2H), 3.49-3.43 (m, 2H), 3.38 (dd, J = 6.15, 4.64 Hz, 1H), 3.21 (t, J = 8.78 Hz, 1H), 2.51 
(m, 1H), 2.16 (t, J = 12.04 Hz, 1H), 1.99-1.88 (m, 2H), 1.83 (m, 1H), 1.77 (m, 1H), 1.59 (s, 
3H), 0.94 (d, J = 7.02 Hz, 3H), 0.91 (d, J = 6.50 Hz, 3H), 0.92 (s, 9H), 0.89 (s, 9H), 0.88 (d,  
J = 8.09 Hz, 3H), 0.79 (d, J = 6.77 Hz, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.03 (s, 3H), 0.02 (s, 
3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 131.9, 131.5, 131.1, 129.1, 113.7, 78.5, 77.8, 72.6, 
72.5, 66.4, 55.3, 39.4, 38.5, 36.6, 35.6, 34.5, 26.1, 26.0, 23.1, 18.4, 18.3, 17.0, 15.0, 14.8, 
12.3, -3.8, -3.9, -4.1.  
IR (film): 2929, 2856, 1613, 1513, 1462, 1250, 1039 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C36H68O5Si2Na: 636.4605, found: 636.4598.  
[α]D20 1.81 (c = 0.55, CH2Cl2) 
 
Stock solution (E)-Crotylboronate (408) 
To KOtBu (561 mg, 5.0 mmol) in THF (5 mL) at -78 °C was added trans-butene (0.51 mL, 5.5 
mmol). nBuLi (2 mL, 2.5M in hexane, 5.0 mmol) was added via syringe pump over 1 h. The 
orange mixture was warmed to -50 °C and the mixture was stirred for 15 min. After recooling 
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to -78 °C, triisopropylborate (1.15 mL, 5.0 mmol) was added via syringe pump over 1 h. After 
addition was completed the mixture was stirred another 10 min and then rapidly poured on a 
1N HCl solution (10 mL) saturated with NaCl. DIPT (1.06 mL, 5.0 mmol) in Et2O  
(2 mL) was added and vigorously shaken. The layers were separated and the aqueous 
phase was repeatedly extracted with Et2O. The combined ethereal layer was dried over 
MgSO4 for 2 h and filtered into a Schlenk flask. The solvent was removed and the crude 
product was taken up in toluene (10 mL) to give a 0.3 M stock solution. 
 
(3R,4R,5S,6S,7S)-6-(tert-Butyl-dimethyl-silanyloxy)-8-(4-methoxy-benzyloxy)-3,5,7-
trimethyl-oct-1-en-4-ol (409) 
TBSO
PMBO
OH  
To (E)-(S,S)-crotyl boronate (408) (2.6 mL, 0.3M in toluene, 0.78 mmol) at -78 °C was added 
aldehyde 76 (100 mg, 0.26 mmol) in toluene (1 mL) very slowly. The mixture was allowed to 
warm to 0 °C over night and then 1N NaOH was added and the mixture was stirred for  
45 min at 0 °C. The layers were separated and the aqueous layer was extracted with DCM. 
The combined organic layers were dried over MgSO4 and the solvent was removed under 
reduced pressure. Purification by column chromatography (hexane:EtOAc = 5:1) yielded 110 
mg (97%) of olefin 409 as single diastereoisomer.  
Rf = 0.49 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.60 Hz, 2H), 6.87 (d, J = 8.56 Hz, 2H), 5.79-
5.60 (m, 1H), 5.10-5.06 (m, 2H), 4.43 (d, J = 11.60 Hz, 1H), 4.39 (d, J = 11.64 Hz, 1H), 3.80 
(s, 3H), 3.75 (t, J = 4.42 Hz,1H), 3.51 (dd, J = 9.22, 6.18 Hz, H), 3.38 (dt, J = 7.06, 3.53 Hz, 
1H), 3.25 (t, J = 9.08, 6.84 Hz, 1H), 2.27 (m, 1H), 2.13 (m, 1H), 1.96 (d, J = 3.28 Hz, 1H 
(OH)), 1.81 (m, 1H), 0.96 (d, J = 7.08 Hz, 3H), 0.92 (d, J = 7.56 Hz, 3H), 0.89 (s, 9H), 0.89 
(d, J = 9.12 Hz, 3H), 0.07 (s, 3H), 0.06 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.1, 141.5, 130.7, 129.2, 115.7, 113.7, 77.0, 75.7, 72.7, 
72.5, 55.3, 42.0, 38.0, 37.5, 26.1, 18.4, 16.8, 15.4, 9.2, -3.8, -3.9.  
IR (film): 3479, 2957, 2930, 1514, 1463, 1249, 1039 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C25H44O4Si: 436.3009, found: 436.3015.  
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[α]D20 -2.43 (c = 1.15, CH2Cl2) 
 
(2S,3S,4S,5S,6S)-5-(tert-Butyl-dimethyl-silanyloxy)-8-(4-methoxy-phenoxy)-4,6-
dimethyl-2-oxiranyl-octan-3-ol (410) 
TBSO
PMBO
OH O  
To olefin 409 (18 mg, 0.041 mmol) in DCM (1.5 mL) was added VO(acac)2 (0.6 mg, 5 mol%, 
0.002 mmol) at 0 °C followed by tBuOOH (16 μL, 5.5M in decane, 0.082 mmol). The reaction 
mixture was allowed to warm to r.t. over night. A saturated Na2S2O3 solution was added and 
the layers were separated. The aqueous phase was extracted with DCM and the combined 
organic layer was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 5 :1) yielded 15 mg (81%) of epoxide 410 as colorless oil.  
Rf = 0.45 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.84 Hz, 2H), 6.86 (d, J = 8.84 Hz, 2H), 4.43 (d, 
J = 11.60 Hz, 1H), 4.39 (d, J = 11.36 Hz, 1H), 3.79 (s, 3H), 3.76 (dd, J = 5.42, 3.42 Hz,1H), 
3.66 (dt, J = 7.92, 2.60 Hz, H), 3.26 (dd, J = 9.08, 6.65 Hz, 1H), 2.93 (ddd, J = 7.19, 4.17, 
2.89 Hz, 1H), 2.70 (m, 1H), 2.45 (dd, J = 4.80, 2.76 Hz, 1H), 2.20 (m, 1H), 1.84 (m, 1H), 1.43 
(m, 1H), 0.98 (d, J = 7.04 Hz, 3H), 0.89 (s, 9H), 0.88 (d, J = 7.08 Hz, 3H), 0.80 (d, J = 7.08 
Hz, 3H), 0.06 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 159.1, 130.7, 129.3, 113.7, 77.3, 76.2, 72.7, 72.2, 55.4, 
55.2, 44.8, 39.5, 38.4, 37.2, 26.1, 18.4, 15.7, 12.6, 9.0, -3.7, -3.9. 
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(2R,3R,4S,5S,6S)-5-(tert-Butyl-dimethyl-silanyloxy)-8-(4-methoxy-phenoxy)-2,4,6-
trimethyl-octane-1,3-diol (524) 
 
To epoxide 410 (15 mg, 0.033 mmol) in Et2O:THF (1:1, 1 mL) at 0 °C was added HIO4·2H2O 
(12 mg, 0.055 mmol) and the mixture was stirred over night at 0 °C. A saturated NaHCO3 
solution was added and diluted with DCM, the layers were separated and the aqueous layer 
was extracted with DCM. The combined organic layer was dried over MgSO4 and the solvent 
was evaporated. The residue was taken up in methanol (1 mL) and NaBH4 was added. After 
30 min brine was added, the layers were separatd and the aqueous layer was extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was evaporated. 
Column chromatography (hexane:EtOAc = 3:1) yielded 12 mg (82%) of alcohol 524. 
Rf = 0.39 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 8.56 Hz, 2H), 6.88 (d, J = 8.56 Hz, 2H), 4.43 (d, 
J = 11.36 Hz, 1H), 4.39 (d, J = 11.36 Hz, 1H), 3.80 (s, 3H), 3.77 (t, J = 4.04 Hz, 1H), 3.66 
(dd, J = 9.46, 1.66 Hz, 1H), 3.55 (m, 2H), 3.52 (t, J = 8.84 Hz, 1H), 3.28 (dd, J = 9.10, 5.06 
Hz, 1H), 2.24 (m, 1H), 1.84-1.75 (m, 2H), 0.92 (d, J = 8.08 Hz, 3H), 0.91 (s, 9H), 0.90 (d, J = 
7.32 Hz, 3H), 0.71 (d, J = 7.08 Hz, 3H), 0.08 (s, 6H).  
13C-NMR (100 MHz, CDCl3): δ = 159.4, 129.9, 129.4, 113.8, 79.1, 78.1, 73.0, 72.6, 69.2, 
55.3, 38.7, 37.4, 36.5, 26.0, 18.2, 15.9, 13.9, 8.5, -3.9, -4.4.  
IR (film): 2929, 1514, 1250, 1037 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C24H44O5Si: 440.2958, found: 440.2968.  
[α]D20 -2.00 (c = 0.2, CH2Cl2) 
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tert-Butyl-((1S,2S)-4-(4-methoxy-phenoxy)-1-{(S)-1-[(2R,4R,5R)-2-(4-methoxy-phenyl)-5-
methyl-[1,3]dioxan-4-yl]-ethyl}-2-methyl-butoxy)-dimethyl-silane (411) 
 
To diol 524 (8 mg, 0.018 mmol) in DCM (0.5 mL) was added anisaldehyde dimethyl acetal (7 
μL, 0.036 mmol) and CSA (cat.) at r.t. under argon. The mixture was stirred for 1 h. Brine 
was added and the mixture was diluted with DCM. The layers were separated and the 
aqueous layer was extracted with DCM. The combined organic layer was dried over MgSO4 
and the solvent was removed under reduced pressure. Column chromatography 
(Hexane:EtOAc = 10:1) yielded 10 mg (99%) of acetal 411 as colorless oil 
Rf = 0.42 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.37 (d, J = 8.84 Hz, 2H), 7.19 (d, J = 8.60 Hz, 2H), 6.85 (d, 
J = 8.84 Hz, 2H), 6.84 (d, J = 8.60 Hz, 2H), 5.37 (s, 1H), 4.36 (d, J = 11.36 Hz, 1H), 4.32 (d, 
J = 11.36 Hz, 1H), 4.06 (dd, J = 11.36, 4.80 Hz, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 3.68 (dd, J = 
7.08, 2.28 Hz,1H), 3.56 (dd, J = 9.22, 5.42 Hz, H), 3.55 (J = 9.92, 1.60 Hz, 1H), 3.44 (t, J = 
11.10 Hz, 1H), 3.25 (dd, J = 9.10, 7.82 Hz, 1H), 2.16 (m, 1H), 2.03 (m, 1H), 1.95 (dt, J = 
7.08, 1.76 Hz, 1H), 1.00 (d, J = 6.80 Hz, 3H), 0,99 (d, J = 7.08 Hz, 3H), 0.87 (s, 9H), 0.65 (d, 
J = 6.56 Hz, 3H), 0.02 (s, 3H), 0.00 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.7, 159.0, 131.5, 130.9, 129.2, 127.3, 113.7, 113.4, 
100.9, 83.0, 77.1, 73.3, 72.6, 71.9, 55.26, 55.24, 37.9, 36.8, 30.8, 26.2, 18.4, 16.3, 12.0, 
10.9, -3.9.  
IR (film): 2929, 1614, 1514, 1462, 1248, 1036 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C32H50O6Si: 558.3377, found: 558.3371.  
[α]D20 -32.75 (c = 0.4, CHCl3) 
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(Z)-(3S,4S,5R,6R,7S,11S,12R,13S)-6,12-Bis-(tert-butyl-dimethyl-silanyloxy)-14-(4-
methoxy-benzyloxy)-3,5,7,9,11,13-hexamethyl-tetradeca-1,9-dien-4-ol (413) 
 
To alcohol 403 (10 mg, 0.015 mmol) in DMSO (0.5 mL) at r.t. under argon was added IBX (9 
mg, 0.031 mmol) and the mixture was stirred for 2 h. Water and Et2O were added and the 
phases were separated. The aqueous layer was extracted with Et2O and the combined 
ethereal layer was dried over MgSO4. After evaporation of the solvent crude aldehyde 412 
was used without further purification.  
To (E)-(R,R)-crotyl boronate (ent-408) (0.5 mL, 0.3M in toluene, 0.150 mmol) at -78°C was 
added aldehyde 412 (9 mg, 0.015 mmol) in toluene (0.5 mL) very slowly. The mixture was 
kept at -78 °C over night and then 1N NaOH was added and the mixture was stirred for 45 
min at 0 °C. The layers were separated and the aqueous layer was extracted with DCM. The 
combined organic layer was dried over MgSO4 and the solvent was removed under reduced 
pressure. Purification by column chromatography (hexane:EtOAc = 10:1) yielded 9 mg (87%) 
of olefin 413 as single diastereoisomer.  
Rf = 0.49 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.56 Hz, 2H), 6.86 (d, J = 8.84 Hz, 2H), 5.79-
5.69 (m, 1H), 5.15-5.09 (m, 2H), 5.02 (d, J = 10.12 Hz, 1H), 4.40 (d, J = 11.64 Hz, 1H), 4.36 
(d, J = 11.60 Hz, 1H), 3.80 (s, 3H), 3.64 (dd, J = 5.56 Hz, J = 3.28 Hz, 1H), 3.48 (dd, J = 
9.10, 4.54 Hz, 1H), 3.39 (dd, J = 5.74, 5.10 Hz, 1H), 3.31 (dt, J = 7.32, 3.66 Hz, 1H), 3.21 (t, 
J = 8.84 Hz, 1H), 2.52 (m, 1H), 2.29 (dd, J = 14.60, 7.52 Hz, 1H), 2.22 (t, J = 12.12 Hz, 1H), 
1.99-1.87 (m, 2H), 1.83-1.77 (m, 2H), 1.60 (s, 3H), 0.99 (d, J = 6.80 Hz, 3H), 0.95 (d, J = 
7.32 Hz, 3H), 0.93 (d, J = 7.04 Hz, 3H), 0.92 (s, 9H), 0.89 (s, 9H), 0.89 (d, J = 8.08 Hz, 3H), 
0.75 (d, J = 6.84 Hz, 3H), 0.09 (s, 6H), 0.03 (s, 3H), 0.02 (s, 3H).  
13C-NMR (100MHz, CDCl3): δ = 159.1, 141.3, 132.1, 131.4, 131.0, 129.1, 116.4, 113.7, 78.8, 
78.5, 75.8, 72.6, 72.5, 55.3, 42.4, 38.6, 37.9, 36.2, 35.6, 35.1, 26.2, 26.1, 23.2, 18.5, 18.4, 
16.9, 16.7, 14.6, 13.5, 9.4, -3.3, -3.7, -3.9.  
IR (film): 2958, 2930, 2856, 1514, 1463, 1250, 1079, 1040 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C40H74O5Si2: 690.5075 , found: 690.5081.  
Experimental Section  
 242 
[α]D20 12.00 (c = 0.4, CH2Cl2) 
 
(Z)-(2R,3S,4R,5R,6S,10S,11R,12S)-5,11-Bis-(tert-butyl-dimethyl-silanyloxy)-13-(4-
methoxy-benzyloxy)-4,6,8,10,12-pentamethyl-2-oxIRanyl-tridec-8-en-3-ol (414) 
OTBS
PMBO
OTBSOH O
 
To olefin 413 (9 mg, 0.013 mmol) in DCM (0.5 mL) was added VO(acac)2 (0.2 mg, 5 mol%) 
at 0 °C followed by tBuOOH (5 μL, 5.5M in decane, 0.026 mmol). The reaction mixture was 
kept over night at 0 °C. A saturated Na2S2O3 solution was added and the layers were 
separated. The aqueous phase was extracted with DCM and the combined organic layer was 
dried over MgSO4 and the solvent was evaporated. Column chromatography (hexane:EtOAc 
= 5:1) yielded 8 mg (87%) of epoxide 414 as colorless oil.  
Rf = 0.47 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.24 (d, J = 8.60 Hz, 2H), 6.86 (d, J = 8.56 Hz, 2H), 5.03 (d, 
J = 10.36 Hz, 1H), 4.40 (d, J = 11.60 Hz, 1H), 4.36 (d, J = 11.60 Hz, 1H), 3.80 (s, 3H), 3.68 
(dd, J = 6.06, 3.02 Hz, 1H), 3.64 (dt, J = 8.20, 2.84 Hz, 1H), 3.49 (dd, J = 9.12, 4.80 Hz, 1H), 
3.40 (t, J = 5.56 Hz, 1H), 3.21 (t, J = 8.70 Hz, 1H), 2.92 (ddd, J = 7.83, 4.05, 2.81 Hz, 1H), 
2.75 (t, J = 4.42 Hz, 1H), 2.53 (m, 1H), 2.48 (dd, J = 4.80, 2.76 Hz, 1H), 2.40 (d, J = 3.04 Hz, 
1H (OH)), 2.27 (t, J = 12.24 Hz, 1H), 2.00-1.93 (m, 2H), 1.84-1.78 (m, 2H), 1.62 (s, 3H), 0.97 
(d, J = 6.84 Hz, 3H), 0.95 (d, J = 6.80 Hz, 3H), 0.92 (s, 9H), 0.89 (s, 12H), 0.86 (d, J = 6.32 
Hz, 3H), 0.75 (d, J = 6.84 Hz, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 132.1, 131.3, 131.1, 129.1, 113.7, 78.7, 78.5, 77.1, 
72.6, 72.5, 55.8, 55.3, 45.1, 4.0, 38.6, 38.2, 36.2, 35.6, 34.9, 26.2, 26.1, 23.2, 18.5, 18.4, 
16.9, 14.6, 14.1, 13.3, 12.9, 9.2, -3.3, -3.7, -3.9.  
IR (film): 2929, 1513, 1462, 1250, 1039 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C40H74O6Si2: 706.5024, found: 706.5029. 
 
Experimental Section 
 243
(Z)-(2S,3S,4R,5R,6S,10S,11R,12S)-5,11-Bis-(tert-butyl-dimethyl-silanyloxy)-13-(4-
methoxy-benzyloxy)-2,4,6,8,10,12-hexamethyl-tridec-8-ene-1,3-diol (525) 
 
To epoxide 414 (7 mg, 0.0099 mmol) in Et2O:THF (1:1, 1 mL) at 0 °C was added HIO4·2H2O 
(3 mg, 0.0140 mmol) and the mixture was stirred 16 h at 0 °C. A saturated NaHCO3 solution 
was added and DCM, the layers were separated and the aqueous layer was extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was evaporated. 
The residue was taken up in methanol (1 mL) and NaBH4 was added at 0 °C. After 30 min 
brine was added and DCM, the layers were separated and the aqueous layer was extracted 
with DCM. The combined organic layer was dried over MgSO4 and the solvent was 
evaporated. Column chromatography (hexane:EtOAc = 3:1) yielded 2 mg (29%, 51% 
b.r.s.m.) of alcohol 525 and 3 mg of epoxide 414.  
Rf = 0.41 (hexane:EtOAc = 10:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.24 (d, J = 8.64 Hz, 2H), 6.86 (d, J = 8.64 Hz, 2H), 5.04 (d, 
J = 10.20 Hz, 1H), 4.39 (d, J = 11.70 Hz, 1H), 4.37 (d, J = 11.70 Hz, 1H), 3.80 (s, 3H), 3.68 
(t, J = 3.96 Hz, 1H), 3.66 (m, 2H), 3.54 (dd, J = 9.39, 0.09 Hz, 1H), 3.49 (dd, J = 9.06, 4.50 
Hz, 1H), 3.38 (dd, J = 6.03, 4.89 Hz, 1H), 3.21 (t, J = 8.67 Hz, 1H), 2.53 (m, 1H), 2.20 (t, J = 
12.27 Hz, 1H), 1.97 (m, 1H), 1.91 (m, 1H), 1.88-1.83 (m, 2H), 1.60 (s, 3H), 0.95 (d, J = 6.78 
Hz, 6H), 0.91 (d, J = 9.48 Hz, 3H), 0.92 (s, 9H), 0.88 (s, 9H), 0.79 (d, J = 6.78 Hz, 3H), 0.76 
(d, J = 6.78 Hz, 3H), 0.12 (s, 3H), 0.11 (s, 3H), 0.03 (s, 3H), 0.02 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 159.8, 131.8, 129.1, 116.1, 113.7, 81.4, 80.4, 78.5, 72.6, 
68.8, 55.3, 38.5, 37.6, 37.2, 36.9, 35.7, 35.0, 26.2, 26.1, 23.2, 16.8, 14.8, 14.5, 13.7, 9.8, 8.2, 
-3.3, -3.8, -4.6.  
IR (film): 3325, 2928, 2855, 1513, 1466, 1364, 1248, 1098, 1039 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C39H74O6Si2: 694.5024 , found: 694.5018.  
[α]D20 4.00 (c = 0.1, CH2Cl2) 
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(2S,4S,5S)-4-[(Z)-(1R,2R,3S,7S,8R,9S)-2,8-Bis-(tert-butyl-dimethyl-silanyloxy)-10-(4-
methoxy-benzyloxy)-1,3,5,7,9-pentamethyl-dec-5-enyl]-2-(4-methoxy-phenyl)-5-methyl-
[1,3]dioxane (415) 
 
To diol 525 (1 mg, 0.0014 mmol) in DCM (0.5 mL) was added anisaldehyde dimethyl acetal 
(1 μL, 0.0056 mmol) and CSA (cat.) at r.t. and the mixture was stirred for 1.5 h. Brine was 
added and the mixture was diluted with DCM. The layers were separated and the aqueous 
layer was extracted with DCM. The combined organic layer was dried over MgSO4 and the 
solvent was removed under reduced pressure. Column chromatography (Hexane:EtOAc = 
15:1) yielded 1 mg (86%) of acetal 415 as colorless oil. Data were in every aspect identical 
with the literature data. 
Rf = 0.51 (hexane:EtOAc = 15:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.37 (d, J = 8.70 Hz, 2H), 7.23 (d, J = 8.70 Hz, 2H), 6.87 (d, 
J = 8.64 Hz, 2H), 6.85 (d, J = 8.70 Hz, 2H), 5.38 (s, 1H), 5.01 (d, J = 10.20 Hz, 1H), 4.39 (d, 
J = 11.70 Hz, 1H), 4.35 (d, J = 11.70 Hz, 1H), 4.10 (dd, J = 10.95, 4.53 Hz, 1H), 3.79 (s, 3H), 
3.78 (s, 3H), 3.61 (dd, J = 7.02, 1.68 Hz, 1H), 3.51 (dd, J = 9.81, 1.89 Hz, 1H), 3.48 (t, J = 
11.13 Hz, 1H), 3.47 (dd, J = 9.06, 4.92 Hz, 1H), 3.38 (dd, J = 5.85, 4.71 Hz, 1H), 3.19 (t, J = 
8.88 Hz, 1H), 2.51 (m, 1H), 2.32 (t, J = 12.09 Hz, 1H), 2.05 (m, 1H), 1.99-1.94 (m, 2H), 1.88 
(m, 1H), 1.67 (d, J = 11.70 Hz, 1H), 1.55 (s, 3H), 1.01 (d, J = 7.20 Hz, 3H), 0.94 (d, J = 6.78 
Hz, 3H), 0.91 (s, 9H), 0.89 (d, J = 6.96 Hz, 3H), 0.88 (s, 9H), 0.74 (d, J = 6.78 Hz, 3H), 0.73 
(d, J = 6.42 Hz, 3H), 0.03 (s, 3H), 0.018 (s, 3H), 0.014 (s, 3H), 0.012 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 159.7, 159.0, 131.9, 131.5, 129.0, 127.3, 113.7, 113.4, 
101.0, 83.3, 78.42, 78.40, 73.3, 72.6, 72.5, 55.3, 55.2, 38.7, 38.2, 37.6, 35.6, 33.6, 30.8, 
26.2, 26.1, 23.1, 18.43, 18.39, 17.0, 14.6, 12.5, 12.1, 10.9, -3.6, -3.7, -3.8, -3.9.  
IR (film): 2929, 1514, 1470, 1242, 830 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C47H80O7Si2: 812.5443, found: 812.5449.  
[α]D20 24.00 (c = 0.05, CHCl3) 
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10.2.4. Peloruside A 
Dimethyl 2-(tert-butoxymethyl)malonate (429) 
 
tBuOMOM: To a suspension of NaH (8.8 g, 0.22 mol) in THF (150 mL) at r.t. was added 
tBuOH (18.8 mL, 0.20 mol) and the mixture was heated under reflux for 2 h. MOMCl (15.2 
mL, 0.20 mol) was added at 0 °C and after 10 min, stirring was continued at r.t. for 3 h. The 
solids were filtered off over celite and purification by distillation gave 6.5 g of the MOM ether 
(b.p. 95 °C). 
Alkylation: To tBuOMOM (1 g, 8.30 mmol) in DCM (5 mL) at 0 °C was added BCl3 (2.8 mL, 
2.77 mmol) and after 15 min the reaction was stirred at r.t. for 2 h to give crude tBuOCH2Cl. 
To a suspension of NaH (260 mg, 6.50 mmol) in THF (20 mL) at r.t. was added dimethyl 
malonate (186) (0.68 mL, 6.00 mmol) and after 1 h the crude chloride was added. The 
mixture was stirred over night. The reaction was quenched with saturated NH4Cl solution, the 
layers were separated and the aqueous solution was extracted with DCM. The combined 
organic layer was dried over MgSO4 and the solvent was evaporated. The crude product was 
purified by column chromatography (hexane:EtOAc = 5:1) to yield 850 mg (65%) of 429 as 
colorless oil.  
Rf = 0.45 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.81 (d, J = 7.60 Hz, 2H), 3.74 (s, 6H), 3.63 (dd, J = 7.84, 
7.32 Hz, 1H), 1.17 (s, 9H). 
 
Dimethyl 2-(tert-butoxymethyl)-2-methylmalonate (427) 
 
To malonate 429 (4.3 g, 19.72 mmol) in THF (100 mL) was added NaH (868 mg, 60% 
dispersion in mineral oil, 21.70 mmol) and the mixture was stirred for 1 h. MeI (1.8 mL, 29.58 
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mmol) was added and stirring was continued for 1 h. The reaction was quenched with 
saturated NH4Cl solution, layers were separated and the aqueous solution was extracted 
with DCM. The combined organic layer was dried over MgSO4 and the solvent was 
evaporated. The crude product was purified by column chromatography (hexane:EtOAc = 
10:1) to yield 4.2 g (92%) of 429 as colorless oil.  
Rf = 0.46 (hexane:EtOAc = 5:1) 
1H-NMR (250 MHz, CDCl3): δ = 3.71 (s, 6H), 3.69 (s, 2H), 1.48 (s, 3H), 1.13 (s, 9H). 
 
(R)-2-tert-butoxymethyl-2-methyl-malonic acid (428) 
OMe
O
HO
OtBu
O
 
To malonate 427 (4 g, 17 mmol) suspended in 0.05M KH2PO4 buffer (180 mL) at pH 7 was 
added PLE and a pH-stat-controlled burette containing 0.5M NaOH added 34 mL over 24 h. 
After addition was completed, 1N NaOH was added to the mixture to pH 10 and by-products 
were removed by extraction with Et2O. Upon acidification with 3N HCl to pH 1 mono acid 292 
was extracted with DCM, the combined organic layers were dried over MgSO4 and the 
solvent was evaporated to give 3.5 g of crude mono acid 428. 
Rf = 0.05 (hexane:EtOAc = 3:1) 
1H-NMR (250 MHz, CDCl3): δ = 3.82 (d, J = 8.58 Hz, 1H), 3.77 (s, 3H), 3.61 (d, J = 8.45 Hz, 
1H), 1.45 (s, 3H), 1.21 (s, 9H). 
 
(R)-4-benzyl-3-butyryl-oxazolidin-2-one (37) 
 
To (R)-4-(phenylmethyl)-2-oxazolidinone (372) (3 g, 17.0 mmol) in THF (55 mL) at -78 °C 
was slowly added nBuLi (11.7 mL, 1.6M in hexane, 18.7 mmol) followed by butyryl chloride 
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(1.9 mL, 18.7 mmol). After 30 min the mixture was warmed to r.t. and quenched by the 
addition of saturated NH4Cl solution. The organic solvent was removed under reduced 
pressure and the remaining aqueous solution was extracted with DCM. The combined 
organic layer was washed with 1N NaOH and brine, dried over MgSO4 and the solvent was 
evaporated. Purification by column chromatography (hexane:EtOAc = 3:1) gave 3.9 g (93%) 
of acylated oxazolidinone 37. 
Rf = 0.38 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.35-7.27 (m, 3H), 7.21 (m, 2H), 4.67 (ddt, J = 9.66, 7.12, 
3.34 Hz, 1H), 4.22-4.13 (m, 2H), 3.30 (dd, J = 13.26, 3.42 Hz, 1H), 2.96 (ddd, J = 16.93, 
7.96, 6.96 Hz, 1H), 2.88 (ddd, J = 16.87, 7.63, 7.25 Hz, 1H), 2.77 (dd, J = 13.40, 9.60 Hz, 
1H), 1.73 (dsext, J = 7.40, 1.60 Hz, 2H), 1.01 (t, J = 7.44 Hz, 3H). 
 
(S)-2-tert-Butoxymethyl-3-hydroxy-2-methyl-propionic acid methyl ester (526) 
OMe
O
HO
OtBu  
To a solution of mono acid 428 (1.20 g, 5.50 mmol) in THF (15 mL) at 0 °C was added 
triethylamine (0.84 mL, 6.05 mmol) followed by methyl chloroformate (0.47 mL, 6.05 mmol). 
After 10 min at 0 °C, the reaction mixture was warmed to r.t. and stirred for 45 min. The white 
precipitate was filtered off, washed with Et2O and concentrated. To the residue was added 
MeOH (15 mL) and the mixture was cooled to 0 °C, then NaBH4 (416 mg, 11.00 mmol) was 
added portionwise. After 1 h the reaction was quenched with a saturated solution of NH4Cl, 
layers were separated and the aqueous layer was extracted with DCM. The combined 
organic extract was dried over MgSO4 and the organic solvent was emoved under reduced 
pressure. Column chromatography (hexane:EtOAc = 3:1) gave 934 mg (83%) of alcohol 526. 
Rf = 0.23 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.80 (dd, J = 10.98, 5.43 Hz, 1H), 3.74-3.69 (m, 2H), 3.71 (s, 
3H), 3.36 (d, J = 8.59 Hz, 1H), 2.92 (dd, J = 7.58, 5.56 Hz, 1H (OH)), 1.16 (s, 9H), 1.15 (s, 
3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.8, 73.4, 67.7, 66.4, 51.9, 48.6, 27.5, 18.0, 14.0.  
IR (film): 3467, 2975, 1732, 1364, 1234, 1197, 1084, 1049 cm-1.  
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HRMS (ESI) (m/z): [M-CH3]+ calcd for C9H17O4: 189.1127, found: 189.1129.  
[α]D20 2.00 (c = 1.3, CH2Cl2) 
 
(R)-2-tert-Butoxymethyl-2-methyl-3-oxo-propionic acid methyl ester (430) 
OMe
OO
OtBu  
To a stirred solution of alcohol 526 (3.50 g, 17.13 mmol) in DMSO (50 mL) was added IBX 
(9.40 g, 34.26 mmol) and stirring was continued for 2.5 h. Water and Et2O were added and 
the organic layer was separated. The aqueous layer was extracted with Et2O and the 
combined ethereal phase was dried over MgSO4 and the solvent was evaporated. Column 
chromatography (hexane:EtOAc = 5:1) yielded 2.80 g (80%) of aldehyde 430 as colorless oil.  
Rf = 0.57 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.79 (s, 1H), 3.80 (d, J = 8.59 Hz, 1H), 3.75 (s, 3H), 3.52 (d, 
J = 8.34 Hz, 1H), 1.30 (s, 3H), 1.14 (s, 9H).  
13C-NMR (100 MHz, CDCl3): δ = 199.8, 171.8, 73.4, 65.0, 58.1, 52.3, 27.2, 15.0.  
IR (film): 1724, 1455, 1237, 1195, 1087cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C9H15O4: 187.0970, found: 187.0973.  
[α]D20 0.86 (c = 1.4, CH2Cl2)  
 
(2R,3R,4R)-4-((R)-4-Benzyl-2-oxo-oxazolidine-3-carbonyl)-2-tert-butoxymethyl-3-
hydroxy-2-methyl-hexanoic acid methyl ester (431) 
 
To a stirred solution of oxazolidinone 37 (612 mg, 2.47 mmol) in DCM (3 mL) at -78 °C was 
slowly added dibutylboron triflate (3.2 mL, 1M in DCM, 3.20 mmol) followed by triethylamine 
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(0.48 mL, 3.45 mmol) and stirring was continued for 30 min. The reaction mixture was 
warmed to 0 °C for 1 h and then recooled to -78 °C. Aldehyde 430 (500 mg, 2.47 mmol) in 
DCM (1 mL) was added dropwise. After 30 min the reaction mixture was warmed to 0 °C and 
stirred for 3 h. pH 7 buffer solution (10 mL), methanol (3 mL) and H2O2 (3 mL, 30% aqueous) 
were added and the mixture was stirred for 2 h at r.t..The layers were separated and the 
aqueous layer was extracted with DCM.The combined organic layer was dried over MgSO4 
and the solvent was evaporated. The crude aldol product was purified by column 
chromatography (hexane:EtOAc = 10:1 to 3:1) to yield 950 mg (85%) of 431 as pale yellow 
oil.  
Rf = 0.36 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.35-7.21 (m, 5H), 4.60-4.54 (m, 1H), 4.23-4.07 (m, 4H), 
3.87 (d, J = 9.03 Hz, 1H), 3.77 (d, J = 10.29 Hz, 1H), 3.64 (s, 3H), 3.43 (d, J = 9.03 Hz, 1H), 
3.33 (dd, J = 13.17, 3.14 Hz, 1H), 2.68 (dd, J = 13.30, 10.29 Hz, 1H), 1.97-1.83 (m, 2H), 1.39 
(s, 3H), 1.19 (s, 9H), 0.98 (t, J = 7.52 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.7, 174.9, 153.3, 135.6, 129.3, 128.9, 127.3, 76.3, 74.0, 
65.9, 65.7, 63.8, 55.9, 52.0, 49.5, 46.4, 38.1, 27.2, 23,4, 19.3, 10.7.  
IR (film): 2974, 1781, 1718, 1387, 1208, 1072 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C24H35O7Na: 472.2311, found: 472.2323.  
[α]D20 -38.47 (c = 1.24, CH2Cl2) 
 
(2R,3R,4S)-2-tert-Butoxymethyl-3-hydroxy-4-hydroxymethyl-2-methyl-hexanoic acid 
methyl ester (432) 
OMe
OOH
OtBu
HO
 
To aldol adduct 431 (440 mg, 0.98 mmol) in Et2O (10 mL) and methanol (20 μL) at  
0 °C was slowly added LiBH4 (21 mg, 0.98 mmol). After 30 min the reaction was quenched 
by the addition of saturated NH4Cl solution and the layers were separated. The aqueous 
layer was extracted with DCM and the combined organic layer was dried over MgSO4. After 
evaporation of the solvent, the crude diol was purified by column chromatography 
(hexane:EtOAc = 3:1) to yield 215 mg (80%) of 432 as colorless oil. 
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Rf = 0.22 (hexane:EtOAc = 2:1) 
1H-NMR (400 MHz, CDCl3): δ = 3.99 (dd, J = 8.33, 2.02 Hz, 1H), 3.90 (d, J = 8.59 Hz, 1H 
(OH)), 3.76-3.66 (m, 2H), 3.70 (s, 3H), 3.64 (d, J = 8.84 Hz, 1H), 3.54 (d, J = 8.59 Hz, 1H), 
1.53-1.39 (m, 2H), 1.36-1.27 (m, 1H), 1.23 (s, 3H), 1.14 (s, 9H), 0.94 (t, J = 7.20 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.9, 77.6, 73.5, 66.6, 64.6, 60.3, 52.0, 49.9, 43.3, 27.2, 
18.1, 16.7, 12.1.  
IR (film): 3435, 3974, 1728, 1364, 1234, 1197, 1141, 1079, 1046 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C14H28O5Na: 299.1834, found: 299.1832.  
[α]D20 19.90 (c = 0.97, CH2Cl2) 
 
(3R,4R,5S)-3-tert-Butoxymethyl-5-ethyl-4-hydroxy-3-methyl-tetrahydro-pyran-2-one 
(433) 
 
To a stirred solution of ester 432 (180 mg, 0.65 mmol) in methanol (8 mL) was added K2CO3 
(180 mg, 1.30 mmol) and stirring was continued for 3 h. The mixture was diluted with water, 
acidified with 1N HCl and extracted with DCM. After drying the combined organic layer over 
MgSO4, the solvent was removed to yield 159 mg (quant.) of lactone 433 as white crystals, 
which was directly used in the following reaction. For analytical purposes a small sample was 
purified by column chromatography (hexane:EtOAc = 3:1). 
Rf = 0.44 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 4.37 (dd, J = 11.49, 4.67 Hz, 1H), 3.88 (t, J = 10.99 Hz, 1H), 
3.83 (d, J = 8.84 Hz, 1H), 3.67 (d, J = 7.83 Hz, 1H (OH)), 3.56 (d, J = 8.59 Hz, 1H), 3.49 (dd, 
J = 9.22, 8.21 Hz, 1H), 2.07-1.97 (m, 2H), 1.87-1.77 (m, 1H), 1.36 (s, 3H), 1.29-1.20 (m, 1H), 
1.19 (s, 9H), 0.97 (t, J = 7.45 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.2, 77.2, 74.5, 69.1, 66.9, 48.2, 41.6, 27.2, 22.0, 21.6, 
11.2. 
IR (film): 3503, 2973, 1701, 1364, 1237, 1198, 1147, 1089 cm-1.  
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HRMS (ESI) (m/z): [M]+ calcd for C13H24O4: 229.1440, found: 229.1442.  
[α]D20 11.56 (c = 1.15, CH2Cl2) 
 
Methanesulfonic acid (3R,4R,5S)-3-tert-butoxymethyl-5-ethyl-3-methyl-2-oxo-
tetrahydro-pyran-4-yl ester (435) 
 
To lactone 433 (160 mg, 0.64 mmol) in DCM (6 mL) and pyridine (0.6 mL) at r.t. was added 
mesyl chloride (99 μL, 1.28 mmol) and DMAP (cat.). After 1 h brine was added, the layers 
were separated and the aqueous layer was extracted with DCM. The combined organic 
phase was dried over MgSO4 and the solvent was evaporated. Column chromatography 
(hexane:EtOAc = 3:1) yielded 205 mg (99%) of mesylate 435. 
Rf = 0.45 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 4.66 (d, J = 9.85 Hz, 1H), 4.45 (dd, J = 11.62, 5.30 Hz, 1H), 
3.88 (t, J = 11.24 Hz, 1H), 3.63 (d, J = 8.34 Hz, 1H), 3.54 (d, J = 8.34 Hz, 1H), 3.11 (s, 3H), 
2.88-2.78 (m, 1H), 1.83-1.72 (m, 1H), 1.37 (s, 3H), 1.28-1.18 (m, 1H), 1.16 (s, 9H), 0.96 (t,  
J = 7.58 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.0, 85.2, 73.6, 68.6, 66.4, 48.7, 38.8, 38.4, 27.2, 21.9, 
21.5, 10.8.  
IR (film): 2974, 1732, 1339, 1177, 1093 cm-1.  
HRMS (ESI) (m/z): [M-CH3]+ calcd for C13H23O6S: 307.1215, found: 307.1211.  
[α]D20 44.58 (c = 1.2, CH2Cl2) 
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(Z)-(R)-5-tert-Butoxy-2-ethyl-4-methyl-pent-3-en-1-ol (437) 
 
Mesylate 435 (200 mg, 0.6 mmol) was dissolved in dioxane (8 mL) and LiOH (1.8 mL, 1M in 
water, 1.8 mmol) was added. After 1.5 h the reaction was quenched with saturated NH4Cl 
solution and the aqueous layer was extracted with DCM. The combined organic layer was 
dried over MgSO4 and the solvent was evaporated. Column chromatography (hexane:EtOAc 
= 5:1) yielded 110 mg (83%) of olefin 437 
Rf = 0.40 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.07 (d, J = 10.10 Hz, 1H), 3.98 (d, J = 9.34 Hz, 1H), 3.63 (d, 
J = 8.34 Hz, 1H), 3.57 (ddd, J = 10.23, 6.69, 3.92 Hz, 1H), 3.21 (t, J = 9.85 Hz, 1H), 2.87 (dd, 
J = 7.19, 2.64 Hz, 1H (OH)), 2.47-2.38 (m, 1H), 1.82 (s, 3H),1.42-1.33 (m, 1H), 1.27-1.12 (m, 
2H), 1.23 (s, 9H), 0.87 (t, J = 7.32 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 136.1, 131.8, 73.6, 65.9, 60.8, 43.0, 27.4, 24.9, 23.2, 11.8.  
IR (film): 3629, 2970, 1653, 2559, 1056 cm-1.  
HRMS (ESI) (m/z): [M-H]+ calcd for C12H23O2: 199.1698, found: 199.1703.  
[α]D20 32.66 (c = 0.65, CH2Cl2) 
 
((Z)-(R)-5-tert-Butoxy-2-ethyl-4-methyl-pent-3-enyloxy)-triisopropylsilane (527) 
 
To a stirred solution of alcohol 437 (12 mg, 0.06 mmol) in DCM (1 mL) was added  
2,6-lutidine (11 µL, 0.09 mmol) and TIPSOTf (18 µL, 0.07 mmol). After 1 h the reaction was 
quenched by the addition of a saturated NH4Cl solution, layers were separated and the 
aqueous layer was extracted with DCM. The combined organic solution was dried over 
MgSO4 and the solvent was evaporated. Purification by column chromatography 
(hexane:EtOAc = 10:1) yielded 18 mg (85%) of 527 as colorless oil.  
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Rf = 0.63 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.03 (d, J = 9.60 Hz, 1H), 3.91 (d, J = 10.36 Hz, 1H), 3.84 (d, 
J = 10.36 Hz, 1H), 3.55 (dd, J = 9.60, 5.80 Hz, 1H), 3.48 (dd, J = 9.48, 7.20 Hz, 1H), 2.48 (m, 
1H), 1.76 (s, 3H),1.70-1.60 (m, 1H), 1.25-1.15 (m, 2H), 1.21 (s, 9H), 1.05 (s, 21H), 0.85 (t,  
J = 7.44 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 134.9, 129.6, 72.8, 66.9, 61.1, 42.5, 27.6, 24.7, 21.9, 18.1, 
12.0, 11.7.  
IR (film): 2943, 2866, 1463, 1362, 1197, 1103, 1059, 1014 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C21H44O2Si: 356.3111, found: 356.3105.  
[α]D20 -25.56 (c = 0.45, CH2Cl2) 
 
((Z)-(R)-5-tert-Butoxy-2-ethyl-4-methyl-pent-3-enyloxymethyl)-benzene (528) 
 
To a stirred solution of alcohol 435 (15 mg, 0.070 mmol) in benzylbromide (0.3 mL) was 
added tetrabutylammonium iodide (2 mg, 0.007 mmol), after 10 min silver(I)oxide (32 mg, 
0.140 mmol) was added. After 24 h the mixture was filtered over celite, washed with Et2O 
and the solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 
40:1) yielded 21 mg (quant.) of benzyl ether 528 as colorless oil.  
Rf = 0.59 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.33 (m, 4H), 7.28 (m, 1H), 5.05 (d, J = 9.60 Hz, 1H), 4.49 (s, 
2H), 3.88 (s, 2H), 3.36 (dd, J = 9,22, 5.93 Hz, 1H), 3.31 (dd, J = 9.22, 7.20 Hz, 1H), 2.59 (m, 
1H), 1.78 (s, 3H), 1.68-1.60 (m, 1H), 1.26-1.17 (m, 1H), 1.21 (s, 9H), 0.86 (t, J = 7.45 Hz, 
3H).  
13C-NMR (100 MHz, CDCl3): δ = 138.8, 135.2, 129.2, 128.3, 127.5, 127.4, 74.1, 72.9, 61.0, 
39.8, 27.6, 25.2, 21.9, 11.6.  
IR (film): 2970, 1454, 1362, 1197, 1058, 1021 cm-1.  
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HRMS (ESI) (m/z): [M]+ calcd for C19H30O2: 290.2246, found: 290.2251.  
[α]D20 -37.07 (c = 0.75, CH2Cl2) 
 
(Z)-(R)-4-Benzyloxymethyl-2-methyl-hex-2-en-1-ol (437) 
 
To a solution of 528 (21 mg, 0.07 mmol) in DCM (1 mL) at r.t. was added TFA (50 μL) and 
the mixture was stirred for 16 h. The reaction mixture was diluted with water and the layers 
were separated. The aqueous layer was extracted with DCM, the combined organic phase 
was dried over MgSO4 and the solvent was removed under reduced pressure. Purification by 
column chromatography (hexane:EtOAc = 40:1) yielded 15 mg (92%) of alcohol 437 as 
colorless oil. 
Rf = 0.43 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.36-7.27 (m, 5H), 5.29 (d, J = 10.10 Hz, 1H), 4.94 (d, J = 
11.87 Hz, 1H), 4.80 (d, J = 12.38 Hz, 1H), 4.48 (s, 2H), 3.38 (dd, J = 9.22, 5.93 Hz, 1H), 3.28 
(dd, J = 9.22, 6.94 Hz, 1H), 2.57 (m, 1H), 1.81 (d, J = 1.51 Hz, 3H), 1.61-1.55 (m, 1H), 1,23-
1.16 (m, 1H), 0.84 (t, J = 7.45 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 158.3, 138.5, 134.9, 129.3, 128.3, 127.5, 127.4, 73.5, 73.0, 
67.0, 40.4, 24.8, 21.2, 11.5.  
IR (film): 2963, 2895, 1785, 1454, 1364, 1222, 1167 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C15H22O2: 234.1620, found: 234.1917.  
[α]D20 -38.80 (c = 0.25, CH2Cl2) 
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10.2.5. Nuclephile Additions 
(S)-2-Formyl-2-methyl-pent-4-enoic acid methyl ester (439) 
O
OMe
O
 
To a solution of alcohol 197 (2.30 g, 14.45 mmol) in ethyl acetate (45 mL) was added IBX 
(7.96 g, 28.90 mmol). The mixture was heated under reflux for 2 h, the white precipitate was 
filtered off and the solvent was removed under reduced pressure. Column chromatography 
(hexane:EtOAc =10:1) yielded 1.90 mg (84%) of aldehyde 439 as colorless oil.  
Rf = 0.75 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 9.69 (s, 1H), 5.73-5.62 (m, 1H), 5.14-5.09 (m, 2H), 3.75 (s, 
3H), 2.62 (dd, J = 13.90, 7.34 Hz, 1H), 2.49 (dd, J = 13.88, 7.32 Hz, 1H), 1.30 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 199.0, 172.1, 131.7, 119.5, 119.4, 52.4, 38.5, 16.8.  
IR (film): 1722, 1456, 1435, 1235, 1150, 1121 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C8H12O3: 156.0786, found: 156.0778.  
[α]D20 -4.09 (c = 1.6, CH2Cl2) 
 
Allylation procedures: 
Roush allylation:  
Triisopropyl borate (0.92 mL, 4.00 mmol) and allylmagnesium bromide (4.4 mL, 0.9 M in 
Et2O, 4.00 mmol) were added simultaneously and very slowly to Et2O (1 mL) at -78 °C. The 
mixture was stirred for 30 min at -78 °C, than for 3 h at r.t. and recooled to 0 °C. 1N HCl (4 
mL) saturated with NaCl was slowly added and the mixture was stirred for 15 min at r.t.. The 
organic layer was separated and the aqueous layer was extracted with Et2O:DCM (5:1) and 
the combined organic phase was divided in two parts. Each part was treated with either L-(+)- 
or D-(-)-DIPT (0.42 mL, 2.00 mmol), MgSO4 was added and the mixture was stirred for 2.5 h. 
Filtration under argon and removal of the solvent under reduced pressure gave a colorless 
liquid which was taken up in toluene (4 mL) and 4 Å MS (70 mg) was added. The suspension 
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was cooled to -78 °C and aldehyde 439 (70 mg, 0.45 mmol) was added in toluene (1 mL). 
The reaction was stirred at -78 °C over night and then quenched by the addition of NaBH4 in 
ethanol and 1N NaOH. After stirring for 1 h at r.t. the layers were separated and the aqueous 
layer was extracted with Et2O. The combined organic layer was dried over MgSO4 and the 
solvent was removed under reduced pressure. Purification by column chromatography 
(hexane:EtOAc = 15:1 to 5:1) gave with L-(+)-DIPT ester 62 mg (69%) of 440:441 in a 8:1 
ratio and with D-(-)-DIPT ester 53 mg (60%) of 440:441 in a 20:1 ratio always favouring the 
Felkin-Anh adduct 440. 
 
Brown allylation: 
To methoxydiisopinocampheylborane (632 mg, 2.00 mmol) in Et2O (1 mL) at 0 °C was slowly 
added allymagnesium bromide (2.44 mL, 0.9 M in Et2O, 2.20 mmol). The mixture was stirred 
at r.t. for 3 h and then the solvent was removed under reduced pressure, whereas the 
residue was always kept under argon. Pentane (2 mL) was added and the supernatant 
solution used for the following allylation. To aldehyde 439 (50 mg, 0.32 mmol) in Et2O (6 mL) 
at -100 °C was very slowly added the allyldiisopinocampheylborane solution and the mixture 
was allowed to warm to -85 °C over 2.5 h. The reaction was quenched by the addition of 
methanol and the solvent was removed under reduced pressure. The residue was taken up 
in water:THF (1:1, 5 mL), NaBO3·4H2O was added and the mixture was stirred over night. 
The layers were separated and the aqueous layer was extracted with Et2O. The combined 
organic layer was dried over MgSO4 and the solvent was removed under reduced pressure. 
Purification by column chromatography (hexane:EtOAc = 15:1 to 5:1) gave with (+)-iPc 63 
mg (quant.) of 440:441 as 20:1 mixture and with (-)-iPc 43 mg (51%) of 440:441 as 1:1 
mixture always favouring the Felkin-Anh adduct 440. 
 
Allylation with allyltrimethylsilane: 
TiCl4 (70 μL, 0.64 mmol) or BF3·Et2O (64 μL, 0.64 mmol) was added to a solution of aldehyde 
439 (50 mg, 0.32 mmol) in DCM (3 mL) at -78 °C. After 15 min allyltrimethylsilane (76 μL, 
0.48 mmol) was added and the resulting solution was stirred for 2 h. The reaction was 
quenched by the addition of a saturated NaHCO3 solution. The layers were separated and 
the aqueous layer was extracted with DCM. The combined organic layer was dried over 
MgSO4 and the solvent was removed under reduced pressure. Purification by column 
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chromatography (hexane:EtOAc = 5:1) gave with BF3·Et2O 53 mg (85%) of 440 and with 
TiCl4 52 mg (84%) of 441. 
 
Allylation with allyltributylstannane: 
TiCl4 (70 μL, 0.64 mmol) was added to a solution of aldehyde 439 (50 mg, 0.32 mmol) in 
DCM (3 mL) at -78 °C. After 15 min allyltributylstannane (76 μL, 0.48 mmol) was added and 
the resulting solution was stirred for 2 h. The reaction was quenched by the addition of 1 N 
HCl. The layers were separated and the aqueous layer was extracted with DCM. The 
combined organic layer was dried over MgSO4 and the solvent was removed under reduced 
pressure. Purification by column chromatography (hexane:EtOAc = 5:1) gave 55 mg (87%) of 
a 7:1 mixture of 441:440. 
 
MgBr2·Et2O (248 mg, 0.96 mmol) was added to a solution of aldehyde 439 (50 mg, 0.32 
mmol) in DCM (3 mL) at r.t.. After 25 min allyltributylstannane (76 μL, 0.48 mmol) was added 
and the resulting solution was stirred for 2 h. The reaction was quenched by the addition of 
1N HCl. The layers were separated and the aqueous layer was extracted with DCM. The 
combined organic layer was dried over MgSO4 and the solvent was removed under reduced 
pressure. Purification by column chromatography (hexane:EtOAc = 5:1) gave 64 mg (quant.) 
of a 2:1 mixture of 441:440. 
 
(2S,3R)-2-Allyl-3-hydroxy-2-methyl-hex-5-enoic acid methyl ester (440) 
OH
OMe
O
 
Rf = 0.71 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.90-5.70 (m, 2H), 5.15-5.05 (m, 4H), 3.79 (ddd, J = 10.04, 
4.86, 2.59 Hz, 1H), 3.69 (s, 3H), 2.59 (dd, J = 13.68, 7.07 Hz, 1H), 2.31 (dd, J = 13.76, 7.70 
Hz, 1H), 2.26-2.19 (m, 1H), 2.14 (d, J = 5.05 Hz, 1H), 2.13-2.06 (m, 1H), 1.16 (s, 3H).  
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13C-NMR (100 MHz, CDCl3): δ = 176.2, 135.4, 134.0, 118.1, 117.9, 74.6, 51.7, 50.8, 40.6, 
37.2, 16.8.  
IR (film): 3502, 1722, 1435, 1219, 1150 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H18O3: 198.1256, found: 198.1253.   
[α]D20 -6.50 (c = 1.4, CH2Cl2) 
 
(2S,3S)-2-Allyl-3-hydroxy-2-methyl-hex-5-enoic acid methyl ester (441) 
OH
OMe
O
 
Rf = 0.71 (hexane:EtOAc = 10:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.93-5.82 (m, 1H), 5.75-5.65 (m, 1H), 5.15-5.06 (m, 4H), 
3.73 (ddd, J = 10.16, 6.63, 2.46 Hz, 1H), 3.70 (s, 3H), 2.49 (d, J = 6.57 Hz, 1H (OH)), 2.47 
(dd, J = 14.02, 7.45 Hz, 1H), 2.36-2.30 (m, 1H), 2.29 (dd, J = 13.77, 7.45 Hz, 1H), 2.08-1.99 
(m, 1H), 1.16 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.7, 135.4, 133.2, 118.5, 117.6, 74.9, 51.8, 50.8, 40.9, 
36.4, 17.1.  
IR (film): 3502, 1726, 1641, 1435, 1220, 1148 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H18O3: 198.1256, found: 198.1249.  
[α]D20 -10.00 (c = 1.05, CH2Cl2) 
 
General procedure for the conversion of 440 and 441 into the β-lactone: 
LiOH (3 eq.) was added to the β-hydroxy ester (1 eq.) in THF (0.1M) at r.t. and the solution 
was vigorously stirred for 16 h. Brine was added and the aqueous layer acidified with 1N HCl 
and extracted with DCM. The combined organic layer was dried over MgSO4 and the solvent 
was evaporated. The residue was dissolved in DCM (0.1M) and EDC·HCl (1.5 eq.) and 
DMAP (2 eq.) were added. After 4 h brine was added and the aqueous layer was extracted 
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with DCM. The combined DCM phase was dried over MgSO4 and the solvent was 
evaporated. The crude β-lactone was purified by column chromatography (hexane:EtOAc = 
5:1).  
 
(3S,4R)-3,4-diallyl-3-methyloxetan-2-one (442) 
 
Rf = 0.62 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.87-5.76 (m, 2H), 5.21-5.13 (m, 4H), 4.31 (dd, J = 8.59, 
5.56 Hz, 1H), 2.63-2.49 (m, 3H), 2.35 (dd, J = 14.27, 7.96 Hz, 1H), 1.40 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.0, 132.0, 131.9, 119.5, 118.6, 82.2, 56.4, 34.8, 34.6, 
19.9.  
IR (film): 2980, 1823, 1701, 1643, 1457, 1384, 1125 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C10H14O2: 166.0992, found: 166.0982.  
[α]D20 17.11 (c = 0.9, CH2Cl2) 
 
(3S,4S)-3,4-diallyl-3-methyloxetan-2-one (443) 
 
Rf = 0.61 (hexane:EtOAc = 5:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.81-5.70 (m, 2H), 5.21-5.15 (m, 4H), 4.38 (dd, J = 7.96, 
6.19 Hz, 1H), 2.61-2.37 (m, 4H), 1.29 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.1, 131.7, 131.6, 119.9, 118.6, 79.2, 57.0, 40.1, 34.8, 
14.5.  
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IR (film): 2982, 1824, 1645, 1454, 1125 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C10H14O2: 166.0992, found: 166.0988.  
[α]D20 -11.89 (c = 0.45, CH2Cl2) 
 
Paterson aldol addition: 
Syn-selective: To (R)-ketone ent-380 or (S)-ketone 380 (66 mg, 0.32 mmol) in DCM (1 mL) 
at -78 °C was added Bu2BOTf (0.38 mL, 1M in DCM, 0.38 mmol) and triethylamine (60 μL, 
0.42 mmol). After 10 min at -78 °C the mixture was warmed to 0 °C for 30 min and 
afterwards recooled to -78°C. Aldehyde 439 (50 mg, 0.32 mmol) in DCM (1 mL) was added 
slowly and stirring was continued for 1 h at -78 °C. The mixture was kept at 0 °C for 2 h and 
quenched by the addition of pH 7 buffer solution (5mL), methanol (1mL) and H2O2 (0.5 mL, 
30% aqueous). After 1 h at r.t. the layers were separated and the aqueous layer was 
extracted with DCM. The combined organic phase was dried over MgSO4 and the solvent 
was evaporated. Purification by column chromatography (hexane:EtOAc = 10:1 to 3:1) 
yielded the aldol adduct. 
Anti-selective: To a solution of chlorodicyclohexylborane (0.38 mL, 1M in hexane, 0.38 
mmol) in Et2O (1 mL) at 0 °C was added triethylamine (60 μL, 0.42 mmol), followed by  
(R)-ketone ent-380 or (S)- ketone 380 (66 mg, 0.32 mmol) in Et2O (0.5 mL) and the mixture 
was stirred for 20 min. Then the reaction was warmed to r.t. and after 20 min recooled to -78 
°C. A solution of aldehyde 439 (50 mg, 0.32 mmol) in Et2O (1 mL) was added slowly. After 
the addition was completed, the reaction was kept at -78 °C for 2 h, then it was warmed to  
0 °C for 15 min and pH 7 buffer solution (5 mL), methanol (1 mL) and H2O2 (0.5 mL, 30% 
aqueous) were added. After stirring for 1 h at r.t. the mixture was extracted with DCM, the 
combined organic layer was dried over MgSO4 and the solvent was evaporated. The crude 
aldol product was purified by column chromatography (hexane:EtOAc = 10:1 to 5:1). 
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(2S,3R,4S,6S)-methyl 2-allyl-7-(benzyloxy)-3-hydroxy-2,4,6-trimethyl-5-oxoheptanoate 
(444) 
 
1H-NMR (400 MHz, CDCl3): δ = 7.35-7.26 (m, 5H), 5.74-5.63 (m, 1H), 5.06-5.01 (m, 2H), 
4.50 (d, J = 11.60 Hz, 1H), 4.45 (d, J = 11.88 Hz, 1H), 4.00 (dd, J = 7.68, 5.44 Hz, 1H), 4.79 
(d, J = 7.56 Hz, 1H (OH)), 3.65-3.60 (m, 1H), 3.64 (s, 3H), 3.43 (dd, J = 9.08, 4.80 Hz, 1H), 
3.08-2.99 (m, 1H), 2.80 (ddd, J = 14.35, 7.25, 5.49 Hz, 1H), 2.44 (dd, J = 13.64, 7.08 Hz, 
1H), 2.33 (dd, J = 13.64, 7.80 Hz, 1H), 1.12 (t, J = 7.32 Hz, 3H), 1.08 (d, J = 5.04 Hz, 3H), 
1.06 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 218.4, 175.8, 137.8, 133.7, 128.4, 127.6, 118.3, 78.1, 73.4, 
71.9, 51.6, 51.1, 47.2, 46.2, 42.6, 15.4, 14.9, 13.8.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C21H30O5Na: 385.1991, found: 385.1987. 
 
(2S,3R,4R,6S)-methyl 2-allyl-7-(benzyloxy)-3-hydroxy-2,4,6-trimethyl-5-oxoheptanoate 
(445) 
 
1H-NMR (400 MHz, CDCl3): δ = 7.37-7.25 (m, 5H), 5.74-5.63 (m, 1H), 5.07-5.00 (m, 2H), 
4.47 (s, 2H), 4.21 (dd, J = 4.54, 2.02 Hz, 1H), 3.64 (m, 1H); 3.62 (s, 3H), 3,43 (dd, J = 8.71, 
5.43 Hz, 1H), 3.11 (m, 1H), 2.86 (ddd, J = 14.15, 7.07, 2.02 Hz, 1H), 2.79 (d, J = 4.54 Hz, 1H 
(OH)), 2.51 (dd, J = 13.64, 6.82 Hz, 1H), 2.27 (dd, J = 13.64, 8.08 Hz, 1H), 1.19 (s, 3H), 1.11 
(d, J = 7.07 Hz, 3H), 1.05 (d, J = 7.07 Hz, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 216.7, 175.8, 137.9, 133.9, 128.5, 127.6, 118.5, 73.5, 72.9, 
72.4, 65.5, 51.8, 50.9, 47.8, 44.7, 42.0, 17.4, 13.9, 10.0.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C21H30O5Na: 385.1991, found: 385.1995. 
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(2S,3S,4R,6R)-methyl 2-allyl-7-(benzyloxy)-3-hydroxy-2,4,6-trimethyl-5-oxoheptanoate 
(446) 
 
1H-NMR (400 MHz, CDCl3): δ = 7.34-7.27 (m, 5H), 5.72-5.62 (m, 1H), 5.05-5.01 (m, 2H), 
4.47 (s, 2H), 3.99 (m, 1H), 3.62 (s, 3H), 3.61 (m, 1H), 3.43 (dd, J = 8.96, 4.92 Hz, 1H), 3.03 
(m, 1H), 2.92 (ddd, J = 14.36, 5.67, 0.17 Hz, 1H), 2.44 (dd, J = 13.51, 7.20 Hz, 1H), 2.32 (dd, 
J = 13.64, 7.83 Hz, 1H), 1.11 (d, J = 7.32 Hz, 3H), 1.07 (d, J = 7.07 Hz, 3H), 1.06 (s, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 218.9, 175.9, 133.8, 128.5, 127.7, 118.3, 78.6, 73.4, 72.4, 
51.5, 51.0, 47.3, 46.5, 42.4, 15.4, 13.9, 13.5.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C21H30O5Na: 385.1991, found: 385.1997. 
 
(2S,3R,4R)-2-Allyl-4-((R)-4-benzyl-2-oxo-oxazolidine-3-carbonyl)-3-hydroxy-2-methyl-
hexanoic acid methyl ester (449) 
NO
Bn
O O
Et
OH
CO2Me
 
To a stirred solution of oxazolidinone 37 (79 mg, 0.32 mmol) in DCM (0.5 mL) at -78 °C was 
slowly added dibutylboron triflate (0.38 mL, 1M in DCM, 0.38 mmol) followed by triethylamine 
(60 μL, 0.42 mmol) and stirring was continued for 30 min. The reaction mixture was warmed 
to 0 °C for 1 h and then recooled to -78 °C. Aldehyde 439 (50 mg, 0.32 mmol) in DCM (0.5 
mL) was added dropwise. After 30 min the reaction mixture was warmed to 0 °C and stirred 
for 2.5 h. pH 7 buffer solution (2 mL), methanol (0.5 mL) and H2O2 (0.5 mL, 30% aqueous) 
were added and the mixture was stirred for 2 h at r.t..The layers were separated and the 
aqueous layer was extracted with DCM.The combined organic layer was dried over MgSO4 
and the solvent was evaporated. The crude aldol product was purified by column 
chromatography (hexane:EtOAc = 10:1 to 3:1) to yield 130 mg (quant.) of 449 as a 10:1 
mixture of diastereoisomers.  
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1H-NMR (400 MHz, CDCl3): δ = 7.36-7.31 (m, 2H), 7.29-7.20 (m, 3H), 5.76-5.66 (m, 1H), 
5.12-5.06 (m, 2H), 4.63 (m, 1H), 4.27 (d, J = 9.34 Hz, 1H (OH)), 4.19-4.11 (m, 2H), 4.01 (m, 
2H), 3.69 (s, 3H), 3.47 (dd, J = 13.39, 3.28 Hz, 1H), 2.68 (dd, J = 13.26, 10.74 Hz, 1H), 2.56 
(dd, J = 13.77, 6.69 Hz, 1H), 2.35 (dd, J = 13.52, 8.21 Hz, 1H), 1.83-1.71 (m, 2H), 1.16 (s, 
3H), 0.97 (t, J = 7.32 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 177.8, 175.6, 153.1, 135.5, 133.5, 129.4, 129.0, 127.3, 
118.5, 77.6, 66.0, 55.6, 51.9, 51.7, 43.4, 41.9, 37.6, 25.3, 16.5, 11.7. 
 
General procedure for aldol with Li-enolates: 
To methyl ketone 450 or 452 (1.1 eq) in THF (0.2M) at -78 °C was added LiHMDS (1.2 eq., 
1M in hexane) and the mixture was stirred for 1 h. Aldehyde 439 (1 eq.) was added in THF 
(1M) and stirring was continued for 1.5 h. The reaction was quenched by the addition of 
saturated NH4Cl solution and warmed to r.t.. The layers were separated and the aqueous 
layer was extracted with DCM. The combined organic layer was dried over MgSO4 and the 
solvent was removed under reduced pressure. The crude product was purified by column 
chromatography.  
 
(S)-2-((R)-1-Hydroxy-3-oxo-3-phenyl-propyl)-2-methyl-pent-4-enoic acid methyl ester 
(451) 
 
Rf = 0.55 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.95 (m, 2H), 7.59 (m, 1H), 7.50-7.45 (m, 2H), 5.81-5.71 (m, 
1H), 5.12-5.07 (m, 2H), 4.48 (ddd, J = 6.76, 4.99, 3.72 Hz, 1H), 3.68 (s, 3H), 3.32 (d, J = 3.53 
Hz, 1H (OH)), 3.10 (m, 2H), 2.61 (dd, J = 13.89, 7.07 Hz, 1H), 2.40 (dd, J = 13.62, 7.58 Hz, 
1H), 1.25 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 200.0, 176.0, 136.9, 133.5, 133.3, 128.7, 128.1, 118.6, 71.9, 
51.9, 50.6, 40.3, 40.2, 17.3.  
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IR (film): 3525, 2981, 1725, 1684, 1448, 1324, 1215 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C16H20O4Na: 299.1259, found: 299.1271.  
[α]D20 18.67 (c = 0.8, CH2Cl2) 
 
(S)-2-[(R)-1-hydroxy-3-(4-methoxyphenyl)-3-oxopropyl]-2-methyl-pent-4-enoic acid 
methyl ester (453) 
 
Rf = 0.40 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.93 (d, J = 9.09 Hz, 2H), 6.94 (d, J = 8.84 Hz, 2H), 5.81-
5.70 (m, 1H), 5.12-5.06 (m, 2H), 4.41 (dt, J = 9.09, 3.16 Hz, 1H), 3.87 (s, 3H), 3.69 (s, 3H), 
3.43 (d, J = 3.54 Hz, 1H (OH)), 3.03 (m, 2H), 2.60 (dd, J = 13.77, 6.95 Hz, 1H), 2.39 (dd, J = 
13.64, 7.83 Hz, 1H), 1.34 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 199.1, 175.8, 163.9, 133.8, 130.5, 129.8, 118.3, 113.8, 71.1, 
55.5, 51.8, 50.7, 41.0, 40.3, 16.4.  
IR (film): 1729, 1671, 1601, 1263, 1225, 1170 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C17H20O4: 288.1362, found: 288.1355.  
[α]D20 20.63 (c = 0.95, CH2Cl2) 
 
General procedure for the preparation of TMS enol ether: 
LDA was prepared by the addition of nBuLi (1.5 eq., 2.5M in hexane) to diisopropylamine 
(1.5 eq.) in THF (0.6M) at 0 °C and the solution was stirred for 15 min. Methyl ketone 450 or 
452 (1 eq.) was added at -78 °C and stirring was continued for 1 h. Then TMSCl (1.3 eq.), 
freshly distilled from CaH2, was added and after 30 min the cooling bath was removed and 
the mixture was allowed to warm to r.t.. The solvent was removed under reduced pressure 
and hexane was added. The white precipitate was filtered off and the solvent removed under 
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reduced pressure. The crude silyl enol ether was used in the following aldol reaction without 
further purification.  
 
trimethyl(1-phenylvinyloxy)silane (454) 
 
1H-NMR (400 MHz, C6D6): δ = 7.68 (d, J = 7.28 Hz, 2H), 7.15-7.07 (m, 3H), 4.92 (d, J = 1.76 
Hz, 1H), 4.46 (d, J = 1.52 Hz, 1H), 0.18 (s, 9H). 
 
1-(4-methoxyphenyl)vinyloxy)trimethylsilane (456) 
 
1H-NMR (400 MHz, C6D6): δ = 7.64 (d, J = 9.01 Hz, 2H), 6.76 (d, J = 9.05 Hz, 2H), 4.87 (d,  
J = 1.76 Hz, 1H), 4.44 (d, J = 1.76 Hz, 1H), 3.27 (s, 3H), 0.21 (s, 9H). 
 
General procedure for Mukaiyama aldol with TMS enol ethers: 
To aldehyde 439 (1 eq.) in DCM (0.1M) at -78 °C was added TiCl4 (2 eq.) and the mixture 
was stirred for 15 min. TMS enol ether 454 or 456 (1.5 eq) in DCM (1M) was added and 
stirring was continued for 1 h. The reaction was quenched by the addition of saturated 
NaHCO3 solution and warmed to r.t.. The layers were separated and the aqueous layer was 
extracted with DCM. The combined organic layer was dried over MgSO4 and the solvent was 
removed under reduced pressure. The crude product was purified by column 
chromatography.  
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(S)-2-((S)-1-Hydroxy-3-oxo-3-phenyl-propyl)-2-methyl-pent-4-enoic acid methyl ester 
(455) 
 
Rf = 0.53 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.96 (m, 2H), 7.59 (m, 1H), 7.47 (t, J = 7.70 Hz, 2H), 5.81-
5.70 (m, 1H), 5.13-5.08 (m, 2H), 4.44 (dd, J = 8.08, 4.04 Hz, 1H), 3.74 (s, 3H), 3.11 (m, 2H), 
2.52 (dd, J = 13.64, 7.32 Hz, 1H), 2.30 (dd, J = 13.64, 7.58 Hz, 1H), 1.24 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 200.6, 175.7, 136.7, 133.7, 133.5, 128.7, 128.2, 118.3, 70.9, 
51.8, 50.6, 41.0, 40.8, 16.4.  
IR (film): 3503, 29481, 1734, 1684, 1597, 1449, 1221 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.13531.  
[α]D20 -20.89 (c = 1.12, CH2Cl2) 
 
(S)-2-[(S)-1-hydroxy-3-(4-methoxyphenyl)-3-oxopropyl]-2- methyl-pent-4-enoic acid 
methyl ester (457) 
 
Rf = 0.41 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.94 (d, J = 9.09 Hz, 2H), 6.94 (d, J = 8.84 Hz, 2H), 5.81-
5.70 (m, 1H), 5.13-5.08 (m, 2H), 4.41 (ddd, J = 9.34, 4.55, 2.53 Hz, 1H), 3.88 (s, 3H), 3.73 (s, 
3H), 3.35 (d, J = 4.80 Hz, 1H (OH)), 3.10 (dd, J = 16.92, 2.78 Hz, 1H), 3.02 (dd, J = 16.92, 
9.35 Hz, 1H), 2.51 (dd, J = 13.39, 7.07 Hz, 1H), 2.28 (dd, J = 13.64, 7.58 Hz, 1H), 1.23 (s, 
3H).  
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13C-NMR (100 MHz, CDCl3): δ = 198.5, 176.0, 163.9, 133.4, 130.5, 130.0, 118.5, 113.8, 72.1, 
55.5, 51.9, 50.6, 40.3, 39.6, 17.3.  
IR (film): 1734, 1671, 1601, 1512, 1261, 1225, 1172 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C17H22O5: 306.1467, found: 306.1457.  
[α]D20 -21.92 (c = 1.12, CH2Cl2) 
 
General procedure for the syn-reduction with catecholborane: 
To β-hydroxy ketone (1 eq.) in THF (0.1M) at -15 °C was slowly added catecholeborane  
(5 eq.) and the mixture was stirred for 3 h. The reaction was quenched by the addition of 
methanol warmed to r.t. and the mixture was stirred with a saturated potassium sodium 
tartrate solution for 2 h. The layers were separated and the aqueous layer was extracted with 
DCM. The combined organic layer was dried over MgSO4 and the solvent was removed 
under reduced pressure. The crude product was purified by column chromatography.  
 
(S)-2-((1R,3S)-1,3-dihydroxy-3-phenylpropyl)-2-methylpent-4-enoic acid methyl ester 
(458) 
 
Rf = 0.18 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.35 (m, 4H), 7.31-7.26 (m, 1H), 5.81-5.71 (m, 1H), 5.08-
5.02 (m, 2H), 4.94 (ddd, J = 9.74, 2.89, 1.37 Hz, 1H), 4.09 (ddd, J = 10.23, 3.54, 1.89 Hz, 
1H), 3.67 (s, 3H), 3.61 (d, J = 3.79 Hz, 1H (OH)), 3.37 (d, J = 1.77 Hz, 1H (OH)), 2.54 (dd,  
J = 13.89, 7.07 Hz, 1H), 2.28 (dd, J = 13.89, 7.83 Hz, 1H), 1.85 (dt, J = 14.40, 9.98 Hz, 1H), 
1.73 (ddd, J = 14.40, 2.91, 1.89 Hz,1H), 1.15 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.4, 144.2, 133.9, 128.5, 127.7, 125.7, 118.2, 76.2, 75.3, 
51.9, 50.8, 40.8, 39.9, 17.4.  
IR (film): 3435, 2951, 1719, 1455, 1222, 1061 cm-1.  
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HRMS (ESI) (m/z): [M+Na]+ calcd for C16H22O4Na: 301.1416, found: 301.1421.  
[α]D20 -6.96 (c = 1.15, CH2Cl2) 
 
(S)-2-((1R,3S)-1,3-dihydroxy-3-(4-methoxyphenyl)propyl)-2-methylpent-4-enoic acid 
methyl ester (460) 
 
Rf = 0.13 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.84 Hz, 2H), 5.80-
5.70 (m, 1H), 5.08-5.02 (m, 2H), 4.87 (dd, J = 9.60, 3.03 Hz, 1H), 4.05 (d, J = 10.36 Hz, 1H), 
3.80 (s, 3H), 3.66 (s, 3H), 2.53 (dd, J = 13.89, 6.82 Hz, 1H), 2.27 (dd, J = 13.77, 7.96 Hz, 
1H), 1.84 (dt, J = 14.40, 10.10 Hz, 1H), 1.68 (ddd, J = 14.33, 3.09, 1.70 Hz, 1H), 1.15 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.4, 159.2, 136.4, 133.9, 127.0, 118.2, 113.9, 76.1, 74.9, 
55.3, 51.8, 50.8, 40.6, 40.0, 17.2.  
IR (film): 3435, 1722, 1612, 1514, 1247, 1034 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C17H24O5Na: 331.1521, found: 331.1526.  
[α]D20 -8.00 (c = 0.65, CH2Cl2) 
 
(S)-2-((1S,3R)-1,3-dihydroxy-3-phenylpropyl)-2-methylpent-4-enoic acid methyl ester 
(462) 
 
Rf = 0.15 (hexane:EtOAc = 3:1) 
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1H-NMR (400 MHz, CDCl3): δ = 7.39-7.33 (m, 4H), 7.28 (m, 1H), 5.70-5.60 (m, 1H), 5.09-
5.03 (m, 2H), 4.94 (dd, J = 9.34, 2.27 Hz, 1H), 4.07 (ddd, J = 10.42, 5.24, 2.21 Hz, 1H), 3.79 
(d, J = 1.26 Hz, 1H (OH)), 3.72 (s, 3H), 3.62 (d, J = 5.30 Hz, 1H (OH)), 2.36 (dd, J = 13.96, 
7.65 Hz, 1H), 2.30 (dd, J = 13.89, 7.33 Hz, 1H), 1.85-1.70 (m, 2H), 1.15 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 177.0, 144.3, 132.9, 128.5, 127.6, 125.8, 118.6, 76.0, 75.1, 
52.0, 50.8, 40.8, 39.8, 17.2.  
IR (film):1725, 1455, 1435, 1277, 1222, 1150, 1061 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C16H22O4Na: 301.1416, found: 301.1424.  
[α]D20 3.56 (c = 0.9, CH2Cl2) 
 
(S)-2-((1S,3R)-1,3-dihydroxy-3-(4-methoxyphenyl)propyl)-2-methylpent-4-enoic acid 
methyl ester (464) 
 
Rf = 0.06 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.59 Hz, 2H), 6.89 (d, J = 8.84 Hz, 2H), 5.70-
5.60 (m, 1H), 5.08-5.02 (m, 2H), 4.89 (dd, J = 8.71, 3.91 Hz, 1H), 4.02 (ddd, J = 9.73, 5.05, 
2.90 Hz, 1H), 3.80 (s, 3H), 3.71 (s, 3H), 3.62 (d, J = 1.26 Hz, 1H (OH)), 3.60 (d, J = 5.05 Hz, 
1H (OH)), 2.36 (dd, J = 13.76, 7.45 Hz, 1H), 2.28 (dd, J = 13.76, 7.20 Hz, 1H), 1.81-1.69 (m, 
2H), 1.15 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 177.0, 159.0, 136.6, 133.0, 127.0, 118.6, 113.9, 75.9, 74.6, 
55.3, 52.0, 50.8, 40.7, 39.8, 17.2.  
IR (film): 3435, 1719, 1513, 1302, 1247, 1175 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C17H24O5Na: 331.1521, found: 331.1526.  
[α]D20 3.12 (c = 0.8, CH2Cl2) 
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General procedure for anti-selective Evans-Carreira reduction: 
To a solution of tetramethylammonium triacetoxyboron hydride (8 eq.) in acetonitrile:acetic 
acid (1:1, 1M) at -30 °C was slowly added a solution of β-hydroxy ketone (1 eq.) in 
acetonitrile (0.15M). After stirring for 9 h a saturated solution of NaHCO3 and solid NaHCO3 
was added very carefully till gas evolution ceased. The aqueous layer was extracted with 
DCM, the combined organic layer was dried over MgSO4 and the solvent was removed under 
reduced pressure. Crude dihydroxy ester was purified by column chromatography. 
 
(S)-2-((1R,3R)-1,3-dihydroxy-3-phenylpropyl)-2-methylpent-4-enoic acid methyl ester 
(466) 
 
Rf = 0.14 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.35 (m, 4H), 7.29-7.25 (m, 1H), 5.77-5.67 (m, 1H), 5.07-
5.01 (m, 3H), 3.99 (d, J = 9.85 Hz, 1H), 3.63 (s, 3H), 2.49 (dd, J = 13.77, 7.20 Hz, 1H), 2.23 
(dd, J = 13.89, 7.58 Hz, 1H), 1.87 (ddd, J = 14.18, 3.48, 0.08 Hz, 1H), 1.79 (ddd, J = 14.34, 
7.78, 2.21 Hz, 1H), 1.14 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.6, 144.4, 133.8, 128.4, 127.3, 125.5, 118.2, 72.4, 71.4, 
51.8, 50.6, 40.3, 39.8, 17.6.  
IR (film): 3435, 1718, 1701, 1222, 1056 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C16H22O4Na: 301.1416, found: 301.1414.  
[α]D20 14.06 (c = 1.55, CH2Cl2) 
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(S)-2-((1R,3R)-1,3-dihydroxy-3-(4-methoxyphenyl)propyl)-2-methylpent-4-enoic acid 
methyl ester (468) 
 
Rf = 0.09 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.84 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 5.79-
5.68 (m, 1H), 5.08-4.99 (m, 2H), 4.87 (dd, J = 9.46, 5.44 Hz, 1H), 4.05 (d, J = 3.17 Hz, 1H), 
3.81 (s, 3H), 3.65 (s, 3H), 2.87 (d, J = 5.30 Hz, 1H (OH)), 2.60 (d, J = 5.05 Hz, 1H (OH)), 
2.49 (dd, J = 14.02, 6.94 Hz, 1H), 2.24 (dd, J = 13.89, 7.83 Hz, 1H), 1.84-1.78 (m, 2H), 1.15 
(s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.6, 158.9, 136.6, 133.9, 126.7, 118.2, 113.8, 72.5, 71.1, 
55.3, 51.9, 50.6, 40.3, 39.8, 17.7.  
IR (film): 3435, 2952, 1724, 1513, 1302, 1248, 1176, 1037 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C17H24O5Na: 331.1521, found: 331.1517.  
[α]D20 8.33 (c = 0.9, CH2Cl2) 
 
(S)-2-((1S,3S)-1,3-dihydroxy-3-phenylpropyl)-2-methylpent-4-enoic acid methyl ester 
(470) 
 
Rf = 0.13 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.39-7.33 (m, 4H), 7.28-7.24 (m, 1H), 5.67-5.56 (m, 1H), 
5.09 (dd, J = 8.21, 2.90 Hz, 1H), 5.06-5.00 (m, 2H), 3.98 (d, J = 10.86 Hz, 1H), 3.68 (s, 3H), 
2.40 (dd, J = 13.64, 7.33 Hz, 1H), 2.29 (dd, J = 13.89, 7.58 Hz, 1H), 1.89 (ddd, J = 14.14, 
8.08, 2.02 Hz, 1H), 1.73 (ddd, J = 14.08, 10.92, 3.09 Hz,1H), 1.13 (s, 3H).  
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13C-NMR (100 MHz, CDCl3): δ = 177.2, 144.6, 132.9, 128.4, 127.3, 125.5, 118.6, 72.0, 71.3, 
51.9, 50.7, 40.9, 39.8, 17.4.  
IR (film): 3435, 1722, 1455, 1222, 1056 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C16H22O4Na: 301.1416, found: 301.1425.  
[α]D20 -23.20 (c = 0.75, CH2Cl2) 
 
(S)-2-((1S,3S)-1,3-dihydroxy-3-(4-methoxyphenyl)propyl)-2-methylpent-4-enoic acid 
methyl ester (472) 
OH OH
OMe
O
MeO
 
Rf = 0.06 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.84 Hz, 2H), 5.69-
5.59 (m, 1H), 5.07-5.01 (m, 3H), 3.98 (dd, J = 9.47, 6.95 Hz, 1H), 3.81 (s, 3H), 3.68 (s, 3H), 
3.01 (d, J = 6.72 Hz, 1H (OH)), 2.67 (d, J = 3.78 Hz, 1H (OH)), 2.41 (dd, J = 13.64, 7.33 Hz, 
1H), 2.28 (dd, J = 13.64, 7.58 Hz, 1H), 1.87 (ddd, J = 14.15, 8.21, 1.89 Hz, 1H), 1.69 (ddd,  
J = 14.15, 11.11, 3.03 Hz, 1H), 1.13 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 177.1, 159.2, 136.8, 133.0, 126.7, 118.6, 113.9, 72.2, 70.8, 
55.3, 51.9, 50.7, 40.9, 39.9, 17.4.  
IR (film): 3435, 1718, 1513, 1302, 1248, 1176, 1036 cm-1.  
HRMS (ESI) (m/z): [M+Na]+ calcd for C17H24O5Na: 331.1521, found: 331.1526.  
[α]D20 -18.53 (c = 0.95, CH2Cl2) 
 
General procedure for saponification followed by lactonisation: 
LiOH (3 eq.) was added to the dihydroxy ester (1 eq.) in THF (0.1M) at 0 °C and vigorously 
stirred for 3 h. Brine was added and the layers were separated. The aqueous layer was 
acidified with 1N HCl and extracted with DCM. The combined organic layer was dried over 
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MgSO4 and the solvent was evaporated. The residue was dissolved in DCM (0.1M) and 
EDC·HCl (1.5 eq.) and DMAP (2 eq.) were added. After 2 h, brine was added and the 
aqueous layer was extracted with DCM, the combined DCM phase was dried over MgSO4 
and the solvent was evaporated. The crude lactone was purified by column chromatography.  
 
(3S,4R,6S)-3-allyl-4-hydroxy-3-methyl-6-phenyltetrahydro-2H-pyran-2-one (459) 
 
Rf = 0.58 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.40-7.30 (m, 5H), 5.85-5.76 (m, 1H), 5.75 (dd, J = 10.19, 
4.38 Hz, 1H), 5.16-5.09 (m, 2H), 4.01 (dd, J = 5.05, 2.52 Hz, 1H), 2.47 (d, J = 7.32 Hz, 2H), 
2.32 (ddd, J = 14.40, 10.10, 2.52 Hz, 1H), 2.22 (dd, J = 14.40, 4.80 Hz, 1H), 1.39 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.9, 140.0, 132.4, 128.6, 128.2, 125.6, 119.4, 77.4, 69.4, 
47.1, 42.9, 34.9, 19.3.  
IR (film): 3435, 2980, 1707, 1142 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H16O2: 228.1150, found: 228.1154.  
[α]D20 -2.00 (c = 0.6, CH2Cl2) 
 
(3S,4R,6S)-3-allyl-4-hydroxy-6-(4-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one 
(461) 
 
Rf = 0.46 (hexane:EtOAc = 1:1) 
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1H-NMR (400 MHz, CDCl3): δ = 7.27 (d, J = 8.34 Hz, 2H), 6.91 (d, J = 8.84 Hz, 2H), 5.85-
5.75 (m, 1H), 5.77 (dd, J = 10.36, 4.04 Hz, 2H), 5.17-5.10 (m, 2H), 4.02 (m, 1H), 3.81 (s, 3H), 
2.47 (d, J = 7.33 Hz, 2H), 2.33 (ddd, J = 14.03, 2.62, 0.10 Hz, 1H), 2.18 (ddd, J = 14.40, 
4.29, 0.01 Hz, 1H), 1.39 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.9, 159.5, 134.1, 132.4, 127.1, 119.4, 114.0, 77.2, 69.6, 
55.3, 46.9, 43.0, 34.8, 19.3.  
IR (film): 3435, 1706, 1517, 1253, 1176, 1141 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.1368.  
[α]D -1.50 (c = 1.2, CH2Cl2) 
 
(3S,4S,6R)-3-allyl-4-hydroxy-3-methyl-6-phenyltetrahydro-2H-pyran-2-one (463) 
 
Rf = 0.32 (hexane:EtOAc = 2:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.39-7.31 (m, 5H), 6.03-5.96 (m, 1H), 5.76 (dd, J = 11.89, 
3.96 Hz, 1H), 5.32-5.22 (m, 2H), 4.01 (m, 1H), 2.76 (dd, J = 14.54, 8.12 Hz, 1H), 2.60 (dd,  
J = 14.54, 6.99 Hz, 1H), 2.35 (dd, J = 3.21, 1.32 Hz, 1H (OH)), 2.25 (m, 1H), 2.18 (dt, J = 
14.54, 4.06 Hz, 1H), 1.37 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 175.9, 140.2, 134.0, 128.7, 128.3, 125.7, 119.3, 77.4, 70.6, 
45.9, 39.5, 34.9, 24.0.  
IR (film): 3435, 1701, 1233, 1182, 1091 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H16O2: 228.1150, found: 228.1145.  
[α]D20 16.92 (c = 0.65, CH2Cl2) 
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(3S,4S,6R)-3-allyl-4-hydroxy-6-(4-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one 
(465) 
 
Rf = 0.35 (hexane:EtOAc = 2:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.29 (d, J = 8.31 Hz, 2H), 6.90 (d, J = 9.06 Hz, 2H), 6.03-
5.96 (m, 1H), 5.71 (dd, J = 11.89, 3.59 Hz, 1H), 5.32-5.21 (m, 2H), 4.01 (m, 1H), 3.81 (s, 3H), 
2.75 (dd, J = 14.54, 8.12 Hz, 1H), 2.65 (dd, J = 14.35, 6.80 Hz, 1H), 2.33 (dd, J = 3.21, 1.32 
Hz, 1H (OH)), 2.26 (m, 1H), 2.14 (dt, J = 14.54, 3.87 Hz, 1H), 1.37 (s, 3H) 
13C-NMR (150 MHz, CDCl3): δ = 176.1, 158.1, 134.1, 130.8, 127.4, 119.2, 114.1, 77.2, 70.6, 
55.3, 45.8, 39.4, 34.8, 24.0.  
IR (film): 3435, 1705, 1613, 1516, 1250, 1175, 1112, 1085, 1033 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.1350.  
[α]D20 10.86 (c = 1.4, CH2Cl2) 
 
(3S,4R,6R)-3-allyl-4-hydroxy-3-methyl-6-phenyltetrahydro-2H-pyran-2-one (467) 
 
Rf = 0.35 (hexane:EtOAc = 2:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.40-7.32 (m, 5H), 5.91-5.85 (m, 2H), 5.24-5.19 (m, 2H), 
4.29 (dd, J = 11.49, 4.48 Hz, 1H), 2.75 (dd, J = 13.89, 6.06 Hz, 2H), 2.47 (dd, J = 13.77, 8.71 
Hz, 1H), 2.26 (dt, J = 13.64, 4.04 Hz, 1H), 2.17 (dt, J = 13.63, 11.62 Hz, 1H), 1.39 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 175.6, 139.2, 134.0, 128.7, 128.5, 125.7, 119.4, 77.9, 67.6, 
48.7, 40.8, 36.4, 19.6.  
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IR (film): 3435, 1707, 1235, 1146, 1084, 1051 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H16O2: 228.1150, found: 228.1151.  
[α]D20 18.42 (c = 1.2, CH2Cl2) 
 
(3S,4R,6R)-3-allyl-4-hydroxy-6-(4-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one 
(469) 
 
Rf = 0.45 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.26 (d, J = 7.83 Hz, 2H), 6.90 (d, J = 8.59 Hz, 2H), 5.91-
5.79 (m, 1H), 5.70 (dd, J = 10.48, 4.17 Hz, 1H), 5.24-5.15 (m, 2H), 4.28 (dt, J = 10.48, 5.24 
Hz, 1H), 3.81 (s, 3H), 2.75 (dd, J = 13.77, 5.94 Hz, 1H), 2.47 (dd, J = 14.40, 8.08 Hz, 1H), 
2.22 (d, J = 9.34 Hz, 2H), 1.37 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 176.7, 159.6, 134.2, 131.2, 127.3, 119.4, 114.1, 77.7, 68.0, 
55.4, 48.6, 40.8, 36.2, 19.6.  
IR (film): 3435, 1707, 1613, 1516, 1238, 1176, 1145, 1081, 1033 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.1358.  
[α]D20 10.61 (c = 1.65, CH2Cl2) 
 
(3S,4S,6S)-3-allyl-4-hydroxy-3-methyl-6-phenyltetrahydro-2H-pyran-2-one (471) 
 
Rf = 0.29 (hexane:EtOAc = 2:1) 
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1H-NMR (600 MHz, CDCl3): δ = 7.40-7.32 (m, 5H), 5.97-5.89 (m, 1H), 5.30 (dd, J = 9.82, 
5.66 Hz, 1H), 5.20-5.15 (m, 2H), 4.12 (ddd, J = 9.35, 5.76, 5.19 Hz, 1H), 2.60-2.54 (m, 2H), 
2.33 (m, 2H), 1.93 (d, J = 5.29 Hz, 1H (OH)), 1.42 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 174.9, 139.6, 134.0, 128.7, 128.5, 125.7, 118.7, 77.9, 72.7, 
38.2, 36.8, 21.7.  
IR (film): 3435, 1734, 1718, 1701, 1227, 1124, 1069 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H16O2: 228.1150, found: 228.11435.  
[α]D20 -3.28 (c = 1.25, CH2Cl2) 
 
(3S,4S,6S)-3-allyl-4-hydroxy-6-(4-methoxyphenyl)-3-methyltetrahydro-2H-pyran-2-one 
(473) 
 
Rf = 0.37 (hexane:EtOAc = 2:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.28 (d, J = 9.06 Hz, 2H), 6.90 (d, J = 8.69 Hz, 2H), 5.96-
5.89 (m, 1H), 5.25 (dd, J = 10.95, 4.53 Hz, 1H), 5.20-5.15 (m, 2H), 4.10 (dt, J = 10.20, 5.09 
Hz, 1H), 3.81 (s, 3H), 2.58-2.54 (m, 2H), 2.33 (dd, J = 13.97, 10.76 Hz, 1H), 2.28 (dd, J = 
13.97, 4.72 Hz, 1H), 1.93 (d, J = 5.29 Hz, 1H), 1.41 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 175.1, 159.7, 134.1, 131.5, 127.4, 118.6, 114.0, 77.7, 72.7, 
55.4, 48.0, 38.3, 36.6, 21.7.  
IR (film): 3435, 2935, 1718, 1613, 1517, 1250, 1125, 1072 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.1351.  
[α]D20 2.59 (c = 0.85, CH2Cl2) 
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General procedure for the fragmentation: 
To β-hydroxy lactone (1 eq.) in Et2O:triethylamine (10:1, 0.1M) at 0 °C under argon was 
added MsCl (1.5 eq.). After 1.5 h brine was added and the aqueous layer was extracted with 
Et2O. The combined ethereal layer was dried over MgSO4 and the solvent was removed 
under reduced pressure. The residue was taken up in THF (0.1M) and LiOH (3 eq., 1M in 
water) was added at 0 °C. After TLC showed complete consumption of the starting material, 
normally 1 to 2 h, a saturated NH4Cl solution was added. The layers were separated and the 
aqueous layer was extracted with DCM. The combined organic layer was dried over MgSO4 
and the solvent was evaporated. Purification by column chromatography furnished the olefin 
and the β-lactone, respectively.  
 
(R,E)-4-methyl-1-phenylhepta-3,6-dien-1-ol (474) 
 
Rf = 0.68 (hexane:EtOAc = 2:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.34 (m, 4H), 7.28 (m, 1H), 5.80-5.73 (m, 1H), 5.23 (t, J = 
6.70 Hz, 1H), 5.02 (m, 2H), 4.70 (t, J = 5.81 Hz, 1H), 2.74 (d, J = 6.80 Hz, 2H), 2.52 (dd, J = 
14.52, 7.70 Hz, 1H), 2.45 (dt, J = 14.15, 7.07 Hz, 1H), 1.97 (s, 1H (OH)), 1.56 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 144.3, 137.7, 136.6, 128.4, 127.4, 125.8, 120.6, 115.9, 74.1, 
44.2, 38.2, 16.3.  
IR (film): 3391, 2913, 1635, 1453, 1045 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C14H16: 184.1252, found: 184.1246.  
[α]D20 11.00 (c = 0.7, CH2Cl2) 
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(R,E)-1-(4-methoxyphenyl)-4-methylhepta-3,6-dien-1-ol (475) 
 
Rf = 0.59 (hexane:EtOAc = 2:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 5.81-
5.71 (m, 1H), 5.21 (t, J = 7.45 Hz, 1H), 5.04-4.99 (m, 2H), 4.65 (ddd, J = 7.80, 5.20, 2.50 Hz, 
1H), 3.81 (s, 3H), 2.73 (d, J = 6.57 Hz, 2H), 2.51 (dt, J = 15.03, 7.15 Hz, 1H), 2.41 (dt, J = 
13.26, 6.03 Hz, 1H), 1.59 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 136.6, 136.4, 127.0, 120.8, 115.8, 113.8, 73.7, 55.3, 
44.2, 38.1, 16.3.  
IR (film): 2913, 1611, 1512, 1246, 1174, 1036 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H18O: 214.1358, found: 214.1360.  
[α]D20 5.20 (c = 0.5, CH2Cl2) 
 
(S,Z)-4-methyl-1-phenylhepta-3,6-dien-1-ol (476) 
 
Rf = 0.55 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.38-7.33 (m, 4H), 7.28 (m, 1H), 5.75-5.65 (m, 1H), 5.27 (t,  
J = 6.82 Hz, 1H), 5.06-4.98 (m, 2H), 4.69 (ddd, J = 7.96, 5,05, 2.90 Hz, 1H), 2.82-2.73 (m, 
2H), 2.55-2.40 (m, 2H), 1.97 (d, J = 3.03 Hz, 1H (OH)), 1.72 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 144.2, 137.1, 135.7, 128.4, 127.4, 125.8, 121.2, 115.4, 74.1, 
38.1, 36.6, 23.6.  
IR (film): 3391, 2914, 1636, 1453, 1048 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C14H16: 184.1252, found: 184.1249.  
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[α]D20 -19.64 (c = 1.1, CH2Cl2) 
 
(S,Z)-1-(4-methoxyphenyl)-4-methylhepta-3,6-dien-1-ol (477) 
 
Rf = 0.40 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 5.76-
5.66 (m, 1H), 5.24 (t, J = 7.32 Hz, 1H), 5.06-4.98 (m, 2H), 4.64 (t, J = 5.94 Hz, 1H), 3.81 (s, 
3H), 2.82-2.72 (m, 2H), 2.55-2.47 (m, 1H), 2.44-2.37 (m, 1H), 1.91 (d, J = 2.27 Hz, 1H (OH)), 
1.71 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 136.8, 136.4, 135.7, 127.0, 121.3, 115.4, 113.8, 73.7, 
55.3, 37.9, 36.5, 23.6.  
IR (film): 2913, 1612, 1513, 1247, 1174, 1037 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H18O: 214.1358, found: 214.1351.  
[α]D -16.67 (c = 1.05, CH2Cl2) 
 
(3S,4S)-3-allyl-4-((S)-2-hydroxy-2-phenylethyl)-3-methyloxetan-2-one (478) 
 
Rf = 0.43 (hexane:EtOAc = 2:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.37 (m, 4H), 7.32 (m, 1H), 5.85-5.75 (m, 1H), 5.23-5.17 (m, 
2H), 4.91 (dt, J = 8.21, 4.10 Hz, 1H), 4.77 (dd, J = 7.20, 5.94 Hz, 1H), 2,51 (dd, J = 14.02, 
6.94 Hz, 1H), 2.42 (dd, J = 14.02, 7.71 Hz, 1H), 2.04 (m, 2H + 1H (OH)), 1.24 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.3, 144.0, 131.6, 128.8, 128.0, 125.5, 120.0, 77.5, 70.5, 
56.9, 40.0, 39.9, 14.8.  
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IR (film): 3432, 1818, 1457 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C15H18O3: 246.1256, found: 246.1251.  
[α]D20 -28.00 (c = 0.45, CH2Cl2) 
 
(S,E)-4-methyl-1-phenylhepta-3,6-dien-1-ol (479) 
 
Rf = 0.67 (hexane:EtOAc = 2:1) 
1H-NMR (600 MHz, CDCl3): δ = 7.34 (m, 4H), 7.28 (m, 1H), 5.80-5.73 (m, 1H), 5.23 (tdd, J = 
7.36, 0.38, 1.38 Hz, 1H), 5.02 (m, 2H), 4.70 (ddd, J = 8.12, 5.09, 3.02 Hz, 1H), 2.74 (d, J = 
6.80 Hz, 2H), 2.52 (dt, J = 15.11, 7.55 Hz, 1H), 2.45 (dt, J = 13.22, 6.61 Hz, 1H), 1.97 (d, J = 
3.02 Hz, 1H (OH)), 1.56 (s, 3H).  
13C-NMR (150 MHz, CDCl3): δ = 144.3, 137.7, 136.6, 128.4, 127.4, 125.8, 120.6, 115.9, 74.1, 
44.2, 38.2, 16.3.  
IR (film): 3400, 1634, 1454 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C14H16: 184.1252, found: 184.1254.  
[α]D20 -7.33 (c = 0.15, CH2Cl2) 
 
(3S,4S)-3-allyl-4-((S)-2-hydroxy-2-(4-methoxyphenyl)ethyl)-3-methyloxetan-2-one (480) 
O OOH
MeO
 
Rf = 0.65 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.59 Hz, 2H), 6.90 (d, J = 8.59 Hz, 2H), 5.85-
5.75 (m, 1H), 5.22-5.17 (m, 2H), 4.86 (td, J = 9.09, 3.41 Hz, 1H), 4.74 (dd, J = 9.09, 4.04 Hz, 
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1H), 3.81 (s, 3H), 2.51 (dd, J = 14.02, 6.95 Hz, 1H), 2.42 (dd, J = 14.04, 7.70 Hz, 1H), 2.04-
1.98 (m, 2H), 1.59 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.4, 159.5, 136.0, 131.7, 126.7, 119.9, 114.2, 77.6, 70.1, 
56.9, 55.3, 40.0, 14.9.  
IR (film): 3436, 2929, 1814, 1611, 1512, 1246, 1173 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.1371.  
[α]D20 -28.55 (c = 0.55, CH2Cl2) 
 
(S,E)-1-(4-methoxyphenyl)-4-methylhepta-3,6-dien-1-ol (481) 
 
Rf = 0.73 (hexane:EtOAc = 1:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.28 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 5.81-
5.71 (m, 1H), 5.21 (ddd, J = 7,31, 2.18, 1.35 Hz, 1H), 5.04-4.99 (m, 2H), 4.65 (ddd, J = 7.80, 
5.20, 2.50 Hz, 1H), 3.81 (s, 3H), 2.73 (d, J = 6.57 Hz, 2H), 2.51 (dt, J = 14.90, 7.45 Hz, 1H), 
2.41 (dt, J = 13.51, 6.12 Hz, 1H), 1.59 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 136.6, 136.4, 127.0, 120.8, 115.8, 113.8, 73.7, 55.3, 
44.2, 38.1, 16.3.  
IR (film): 2918, 1611, 1512, 1246, 1036 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H18O: 214.1358, found: 214.1355.  
[α]D20 -7.00 (c = 0.3, CH2Cl2) 
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(3S,4R)-3-allyl-4-((R)-2-hydroxy-2-phenylethyl)-3-methyloxetan-2-one (482) 
O OOH
 
Rf = 0.31 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.41-7.36 (m, 4H), 7.32 (m, 1H), 5.83-5.73 (m, 1H), 5.17-
5.09 (m, 2H), 4.94 (td, J = 9.85, 3.03 Hz, 1H), 4.69 (dd, J = 9.98, 3.12 Hz, 1H), 2.50 (tdd, J = 
14.36, 6.61, 1.37 Hz, 1H), 2.32 (dd, J = 14.27, 7.71 Hz, 1H), 2.15 (ddd, J = 14.59, 9.91, 3.35 
Hz, 1H), 2.10-2.03 (m, 1H + 1H (OH)), 1.42 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.3, 144.0, 131.9, 128.8, 128.1, 125.5, 119.4, 80.3, 70.5, 
56.1, 39.7, 34.9, 19.8.  
IR (film): 3435, 1815, 1454, 1111 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H16O2: 228.1150, found: 228.1145.  
[α]D20 48.00 (c = 0.25, CH2Cl2) 
 
(R,Z)-4-methyl-1-phenylhepta-3,6-dien-1-ol (483) 
OH
 
Rf = 0.60 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.38-7.33 (m, 4H), 7.28 (m, 1H), 5.75-5.65 (m, 1H), 5.27 (t,  
J = 7.70 Hz, 1H), 5.06-4.98 (m, 2H), 4.69 (dd, J = 8.08, 5.30 Hz, 1H), 2.82-2.73 (m, 2H), 
2.55-2.40 (m, 2H), 1.72 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 144.2, 137.1, 135.7, 128.4, 127.4, 125.8, 121.2, 115.4, 74.1, 
38.1, 36.6, 23.6. 
IR (film): 3390, 1634, 1449, 1045 cm-1.  
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HRMS (ESI) (m/z): [M-H2O]+ calcd for C14H16: 184.1252, found: 184.1250.  
[α]D20 20.00 (c = 0.45, CH2Cl2) 
 
(3S,4R)-3-allyl-4-((R)-2-hydroxy-2-(4-methoxyphenyl)ethyl)-3-methyloxetan-2-one (484) 
O OOH
MeO
 
Rf = 0.24 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 7.29 (d, J = 8.34 Hz, 2H), 6.91 (d, J = 8.84 Hz, 2H), 5.84-
5.73 (m, 1H), 5.17-5.10 (m, 2H), 4.87 (dd, J = 10.10, 2.02 Hz, 1H), 4.67 (dd, J = 10.10, 3.03 
Hz, 1H), 3.81 (s, 3H), 2.50 (tdd, J = 14.40, 6.40, 1.39 Hz, 1H), 2.32 (dd, J = 14.40, 7.83 Hz, 
1H), 2.14 (ddd, J = 14.53, 10.10, 3.16 Hz, 1H), 2.03 (ddd, J = 14.74, 9.89, 3.19 Hz, 1H), 1.42 
(s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 174.3, 159.4, 136.1, 131.9, 126.8, 119.4, 114.1, 80.4, 70.1, 
56.1, 55.3, 39.7, 34.9, 19.8.  
IR (film): 2917, 1811, 1610, 1510, 1244, 1172, 1031 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C16H20O4: 276.1362, found: 276.1358.  
[α]D20 35.50 (c = 0.2, CH2Cl2) 
 
(R,Z)-1-(4-methoxyphenyl)-4-methylhepta-3,6-dien-1-ol (485) 
 
Rf = 0.50 (hexane:EtOAc = 3:1) 
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1H-NMR (400 MHz, CDCl3): δ = 7.27 (d, J = 8.59 Hz, 2H), 6.88 (d, J = 8.59 Hz, 2H), 5.76-
5.66 (m, 1H), 5.24 (t, J = 7.20 Hz, 1H), 5.06-4.98 (m, 2H), 4.64 (t, J = 6.56 Hz, 1H), 3.81 (s, 
3H), 2.82-2.72 (m, 2H), 2.55-2.47 (m, 1H), 2.44-2.37 (m, 1H), 1.71 (s, 3H).  
13C-NMR (100 MHz, CDCl3): δ = 159.0, 136.8, 136.4, 135.7, 127.0, 121.3, 115.4, 113.8, 73.7, 
55.3, 37.9, 36.5, 23.6. 
IR (film): 3392, 2929, 1612, 1512, 1247, 1173, 1037 cm-1.  
HRMS (ESI) (m/z): [M-H2O]+ calcd for C15H18O: 214.1358, found: 214.1352.  
[α]D20 16.66 (c = 0.3, CH2Cl2) 
 
(2S)-2-(1-Hydroxy-propyl)-2-methyl-pent-4-enoic acid methyl ester (487) 
OH
OMe
O
 
To aldehyde 439 (425 mg, 2.70 mmol) in Et2O (30 mL) at 0 °C was slowly added EtMgBr 
(0.95 mL, 3M in Et2O, 2.83 mmol). After 1 h brine was added and the mixture was acidified 
with 5% H2SO4. The layers were separated and the aqueous layer was extracted with Et2O. 
The combined organic phase was dried over MgSO4 and the solvent was carefully 
evaporated. Purification by column chromatography (hexane:EtOAc = 10:1 to 3:1) yielded 
355 mg (71%) of alcohol 487 as 4:1 mixture of diastereoisomers. 
Rf = 0.65 (hexane:EtOAc = 3:1) 
Major: 1H-NMR (400 MHz, CDCl3): δ = 5.75-5.65 (m, 1H), 5.09-5.04 (m, 2H), 3.70 (s, 3H), 
3.51 (ddd, J = 10.48, 8.08, 2.28 Hz, 1H), 2.46 (dd, J = 13.64, 7.32 Hz, 1H), 2.40 (d, J = 7.84 
Hz, 1H (OH)), 2.29 (dd, J = 13.62, 7.58 Hz, 1H), 1.63-1.53 (m, 1H), 1.27-1.20 (m, 1H), 1.13 
(s, 3H), 1.02 (t, J = 7.34 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 177.0, 133.5, 118.4, 77.3, 51.8, 51.2, 41.1, 24.6, 17.5, 11.1. 
Minor: 1H-NMR (400 MHz, CDCl3): δ = 5.82-5.72 (m, 1H), 5.09-5.04 (m, 2H), 3.68 (s, 3H), 
3.59 (ddd, J = 10.29, 6.63, 2.21 Hz, 1H), 2.50 (dd, J = 14.90, 7.34 Hz, 1H), 2.28 (dd, J = 
13.90, 7.50 Hz, 1H), 2.08 (d, J = 6.56 Hz, 1H (OH)),1.49-1.41 (m, 1H), 1.37-1.27 (m, 1H), 
1.15 (s, 3H), 1.00 (t, J = 6.94 Hz, 3H). 
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13C-NMR (100 MHz, CDCl3): δ = 176.6, 134.2, 118.0, 77.7, 51.7, 48.4, 40.4, 25.4, 17.2, 11.2. 
HRMS (ESI) (m/z): [M]+ calcd for C10H18O3: 186.1256, found: 186.1263. 
 
(S)-2-Methyl-2-propionyl-pent-4-enoic acid methyl ester (488) 
O
OMe
O
 
To a solution of alcohol 365 (320 mg, 1.72 mmol) in DMSO (15 mL) was added IBX (962 mg, 
3.44 mmol). The mixture was stirred at r.t. for 2 h, water was added and the aqueous layer 
was extracted with Et2O. The combined ethereal phase was dried over MgSO4 and the 
solvent was evaporated. Purification by column chromatography (hexane:EtOAc = 10:1) 
gave 260 mg (81%) of keto ester 366. 
Rf = 0.67 (hexane:EtOAc = 3:1) 
1H-NMR (400 MHz, CDCl3): δ = 5.69-5.58 (m, 1H), 5.11-5.06 (m, 2H), 3.71 (s, 3H), 2.63 (dd, 
J = 14.02, 7.18 Hz, 1H), 2.51 (dd, J = 13.88, 7.56 Hz, 1H), 2.44 (dq, J = 7.28, 2.64 Hz, 2H), 
1.33 (s, 3H), 1.05 (t, J = 7.20 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ = 207.9, 173.2, 132.7, 118.9, 59.2, 52.3, 39.5, 31.7, 19.1, 8.0.  
IR (film): 2982, 1744, 1715, 1641, 1458, 1378, 1232, 1145 cm-1.  
HRMS (ESI) (m/z): [M]+ calcd for C10H16O3: 184.1099, found: 184.1108.  
[α]D20 -9.28 (c =1.25, CH2Cl2) 
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11. Appenices 
11.1. Abbrevations 
Ac     acetyl 
AIBN     2,2’-azobisisobutyronitrile 
9-BBN    9-borabicyclo[3.3.1]nonane 
Bn     benzyl 
BOM    benzyloxymethyl 
Bu     butyl 
c     concentration 
cat.     catalyst 
CM    cross metathesis 
COSY     correlated spectroscopy 
CSA     camphorsulfonic acid  
Cy     cyclohexyl 
dba    dibenzylideneacetone 
DBU     1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC     N,N′-dicyclohexylcarbodiimide 
DCM    dichloromethane  
DDQ     2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DET    diethyl tartrate 
DIAD    diisopropyl azodicarboxylate 
DIBALH    diisobutylaluminium hydride 
DIC    N,N′-diisopropylcarbodiimide 
DIPEA    N,N-diisopropylethylamine 
DIPT    diisopropyl tartrate 
DMAP     4-(dimethylamino)pyridine 
DMF     N,N-dimethylformamide 
DMP     Dess-Martin periodinane 
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DMS    dimethylsulfide 
DMSO    dimethylsulfoxide 
EDC    N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
eq.     equivalent 
et al.    latin: “et alii”, meaning “and others” 
HMPA     hexamethylsilylphosphoramide 
HMQC    heteronuclear multiple quantum coherence 
HRMS    high resolution mass spectroscopy 
HSQC    heteronuclear single quantum coherence 
HPLC     high pressure liquid chromatography 
HWE    Horner-Wadsworth-Emmons 
Hz     Hertz 
IBX     o-iodoxybenzoic acid 
J     coupling constant 
KHMDS   potassium hexamethylsilylazide 
LA     Lewis acid 
LDA     lithium diisopropylamide 
LG    leaving group 
LiHMDS   lithium hexamethylsilylazide 
mCPBA   meta-chloroperbenzoic acid 
MMPP    magnesium monoperoxyphthalate 
mp     melting point 
MTPA    α-Methoxy-α-trifluoromethylphenylacetyl 
MOM     methoxymethyl 
Ms     methansulfonyl 
MS     mass spectroscopy 
MVK    methyl vinyl ketone 
NaHMDS   sodium hexamethylsilylazide 
NBS     N-bromosuccinimide 
NCS    N-iodosuccinimide 
NEt3    triethylamine 
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NIS    N-iodosuccinimide 
NMR     nuclear magnetic resonance 
NOE     nuclear Overhauser effect 
NOESY    nuclear Overhauser effect spectroscopy 
PG     protecting group 
Ph     phenyl 
PMB    para-methoxybenzyl 
PMP    para-methoxyphenyl 
ppm     parts per million 
py    pyridine 
R(1,2…n)    any substituent 
RCM    ring closing metathesis 
Rf     ratio of fronts (TLC) 
r.t.    room temperature 
sat.    saturated 
SEM    (trimethylsilyl)ethoxymethyl 
TBAF     tetra-n-butylammonium fluoride 
TBAI     tetra-n-butylammonium iodide 
TBDPS   tert-butyldiphenylsilyl 
TBS     tert-butyldimethylsilyl 
TEA     triethylamine 
TFA    trifluoroacetic acid  
THF     tetrahydrofurane 
THP    tetrahydropyran 
Tf    trifluoromethanesulfonate 
TLC     thin layer chromatography 
TMEDA   tetramethylethylendiamin 
TMS    trimethylsilyl 
Troc    2,2,2-trichloroethyl carbonate 
pTsOH     para-toluene-4-sulfonic acid  
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11.2. Selected Spectra 
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